14-4375-cv l - vitamin c antitrustvitamincantitrust.com/indirect/portals/0/documents/8... ·...

235
14-4375-cv ( L ) 14-4378-cv ( XAP ) IN THE United States Court of Appeals FOR THE SECOND CIRCUIT IN RE: VITAMIN C ANTITRUST LITIGATION THE RANIS COMPANY , INC., Appellant-Cross-Appellee, —against— HEBEI WELCOME PHARMACEUTICAL CO. L TD., NORTH CHINA PHARMACEUTICAL GROUP CORPORATION, Appellees-Cross-Appellants. ON APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF NEW YORK JOINT APPENDIX VOLUME I OF II ( Pages A - 1 to A - 228 ) d JOHN HAN KOBRE & KIM LLP ICBC Tower 3 Garden Road Central, Hong Kong + 852 2127 3288 MICHAEL S. KIM CARRIE A. TENDLER MARCUS J. GREEN KOBRE & KIM LLP 800 Third Avenue New York, New York 10022 (212) 488-1201 Attorneys for Appellant-Cross-Appellee The Ranis Company, Inc. as Representative of the Direct Purchaser Class (Counsel continued on inside cover) Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page1 of 191

Upload: others

Post on 24-May-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

14-4375-cv(L)14-4378-cv(XAP)

IN THE

United States Court of AppealsFOR THE SECOND CIRCUIT

IN RE: VITAMIN C ANTITRUST LITIGATION

THE RANIS COMPANY, INC.,Appellant-Cross-Appellee,

—against—

HEBEI WELCOME PHARMACEUTICAL CO. LTD., NORTH CHINA PHARMACEUTICAL GROUP CORPORATION,

Appellees-Cross-Appellants.

ON APPEAL FROM THE UNITED STATES DISTRICT COURTFOR THE EASTERN DISTRICT OF NEW YORK

JOINT APPENDIXVOLUME I OF II

(Pages A-1 to A-228)

d

JOHN HANKOBRE & KIM LLPICBC Tower3 Garden RoadCentral, Hong Kong+ 852 2127 3288

MICHAEL S. KIMCARRIE A. TENDLERMARCUS J. GREENKOBRE & KIM LLP800 Third AvenueNew York, New York 10022(212) 488-1201

Attorneys for Appellant-Cross-Appellee The Ranis Company, Inc.as Representative of the Direct Purchaser Class

(Counsel continued on inside cover)

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page1 of 191

Page 2: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

JONATHAN M. JACOBSONDANIEL P. WEICKWILSON SONSINI GOODRICH

& ROSATI, P.C.1301 Avenue of the Americas,

40th FloorNew York, New York 10019(212) 497-7758

Attorneys for Defendant-Appellee North China PharmaceuticalGroup Corporation and Defendant-Appellee-Cross-Appellant HebeiWelcome Pharmaceutical Co. Ltd.

DANIEL C. HEDLUNDGUSTAFSON GLUEK PLLC120 South Sixth StreetMinneapolis, Minnesota 55402(612) 333-8844

Attorneys for Defendants-AppelleesDefendant(s) in Civil ActionAudette vs. Hebei WelcomePharmaceutical Co. Ltd. 06-CV-988, Defendant(s) in Civil Action Keane vs. HebeiWelcome Pharmaceutical Co. Ltd.06-CV-149, and Defendant(s) inCivil Action Philion vs. HebeiWelcome Pharmaceutical Co. Ltd. 06-CV-987

RICHARD S. GOLDSTEINORRICK, HERRINGTON

& SUTCLIFFE LLP51 West 52nd StreetNew York, New York 10019(212) 506-5000

Attorneys for Defendants-AppelleesAland (Jiangsu) Nutraceutical Co.,Ltd. and JSPC America, Inc.

WILLIAM A. ISAACSONBOIES, SCHILLER & FLEXNER LLP5301 Wisconsin Avenue, N.W.,

Suite 800Washington, D.C. 20015(202) 237-2727

JAMES T. SOUTHWICKSHAWN L. RAYMONDKATHERINE KUNZSUSMAN GODFREY LLP1000 Louisiana Street, Suite 5100Houston, Texas 77002(713) 651-9366

MICHAEL D. HAUSFELDBRIAN A. RATNERMELINDA COOLIDGEBRENT W. LANDAUHAUSFELD LLP1700 K Street NW, Suite 650Washington, D.C. 20006(202) 540-7200

Attorneys for Appellant-Cross-Appellee The Ranis Company, Inc.as Representative of the DirectPurchaser Class

JAMES I. SEROTAGREENBERG TRAURIG, LLP200 Park AvenueMetlife BuildingNew York, New York 10166(212) 801-2277

Attorneys for Defendant-AppelleeNortheast Pharmaceutical GroupCompany, Limited

DALE C. CHRISTENSEN, JRSEWARD & KISSEL LLP1 Battery Park PlazaNew York, New York 10004(212) 574-1200

Attorneys for Defendants-AppelleesDefendant(s) in Civil ActionAnimal Science vs. Hebei, 05-CV-453, WeishengPharmaceutical Co. Ltd., and China Pharmaceutical Group Ltd.

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page2 of 191

Page 3: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

TABLE OF CONTENTS

PAGE

District Court Docket Entries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-1

Judgment, dated March 14, 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-138

Amended Judgment and Final Decree, dated November 27, 2013 . . . . . . A-140

Second Amended Judgment and Final Decree, dated December 30, 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-143

Third Amended Judgment and Final Decree, dated February 12, 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-146

Declaration of Carrie A. Tendler, for Plaintiff, in Support of Renewed Motion for Turnover Orders, dated April 25, 2014

Exhibit A to Tendler Declaration— Original and Certified Translation of North China Pharmaceutical Group Corporation’s Website, downloaded on February 19, 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-149

Defendants’ Memorandum in Opposition to Motion for Leave to Register the Judgment, dated May 5, 2014

Exhibit A to Defendants’ Memorandum— Declaration of Liu Rongliang, dated April 17, 2014 . . . . . . . . . . . . . . A-154

Exhibit B to Defendants’ Memorandum— Declaration of Yang Jianfu, dated April 11, 2008 . . . . . . . . . . . . . . . . . A-157

Letter from Daniel P. Weick to the Honorable Brian M. Cogan, dated May 9, 2014, with Declaration of Zhang Wencheng, dated April 30, 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-168

Job # __________ Descriptions Picked up from Client Docs Client Supplied TOC Checked Against Bookmarks Proofread __________ Prefix _____ Suffix _____ N/A

Initials

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page3 of 191

Page 4: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

PAGE ii

Declaration of Daniel P. Weick, for Defendants, in Support of Motion to Dissolve Restraining Notices and Partially Stay Enforcement Proceedings and in Opposition to Plaintiffs’ Renewed Motion for Turnover Orders, dated May 9, 2014

Exhibit A to Weick Declaration— Enterprise Property Rights Registration Certificate for State-Owned Assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-173

Exhibit B to Weick Declaration— Equity Structure of the Companies Involved in Vitamin C Antitrust Litigation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-185

Exhibit E to Weick Declaration— “North China Pharmaceutical Completes Private Placement”, Reuters, dated April 10, 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-186

Exhibit F to Weick Declaration— “North China Pharmaceutical Announces No Dividend Payment for FY 2013”, Reuters, dated April 25, 2014 . . . . . . . . . . . . . . . . . . . . . A-187

Exhibit J to Weick Declaration— Catalogue for the Guidance of Foreign Investment Industries, Ministry of Commerce, People’s Republic of China, dated February 21, 2012 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-188

Exhibit K to Weick Declaration— Provisions on Guiding Foreign Investment Direction, Ministry of Commerce, People’s Republic of China, dated July 26, 2007 . . . A-205

Exhibit M to Weick Declaration— Notice of Subpoenas, dated March 25, 2014 . . . . . . . . . . . . . . . . . . . . . . A-208

Exhibit R to Weick Declaration— China— Central Authority and Practical Information . . . . . . . . . . . . . A-210

Exhibit S to Weick Declaration— Letter from Michael S. Kim to Daniel P. Weick, dated April 10, 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-213

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page4 of 191

Page 5: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

PAGE iii

Exhibit T to Weick Declaration— Letter from John Han to Hebei Welcome Pharmaceutical Co., dated April 15, 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-215

Exhibit U to Weick Declaration— Letter from John Han to North China Pharmaceutical Group Corporation, dated April 15, 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-219

Exhibit Z to Weick Declaration— Supplemental Declaration of Liu Rongliang, dated May 6, 2014 . . . A-223

Exhibit AA to Weick Declaration— Supplemental Declaration of Zhang Wencheng, dated May 4, 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-226

Exhibit CC to Weick Declaration— Law of the People’s Republic of China on the State-Owned Assets of Enterprises. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-229

Exhibit DD to Weick Declaration— Constitution of the People’s Republic of China . . . . . . . . . . . . . . . . . . . A-256

Exhibit EE to Weick Declaration— “Hebei to merge two producers”, China Coal Monthly, dated July 25, 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-277

Exhibit FF to Weick Declaration— “NCPC becomes Jizhong Energy’s Wholly-Owned Subsidiary”, China Pharmaceuticals & Health Technologies Newswire, dated August 5, 2009 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-278

Exhibit GG to Weick Declaration— “Jizhong Energy Group OKed to Add Shares in North China Pharm”, SinoCast, dated November 3, 2011 . . . . . . . A-280

Declaration of Michael S. Kim, for Plaintiff, in Opposition to Motion to Dissolve Restraining Notices and Partially Stay Enforcement Proceedings, dated May 23, 2014

Exhibit A to Kim Declaration— Company Introduction on Hebei Welcome Pharmaceutical Co., Ltd.’s Website . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-282

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page5 of 191

Page 6: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

PAGE iv

Exhibit B to Kim Declaration— Excerpt of North China Pharmaceutical Co., Ltd.’s 2013 Annual Report . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-284

Exhibit C to Kim Declaration— Excerpt of North China Pharmaceutical Co., Ltd. Explanation of Mid-Term Notes, Issued in Term 1, 2012 . . . . . . . . . . A-297

Exhibit D to Kim Declaration— Exchange Rate, as of May 21, 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-304

Exhibit E to Kim Declaration— Excerpt of North China Pharmaceutical Co., Ltd.’s 2012 Annual Report . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-307

Reply Declaration of Daniel P. Weick, for Defendants, in Further Support of Motion to Dissolve Restraining Notices and Partially Stay Enforcement Proceedings, dated May 30, 2014

Exhibit A to Weick Declaration— Excerpts of Trial Transcript, dated March 7, 2013 . . . . . . . . . . . . . . . . A-314

Exhibit B to Weick Declaration— Excerpts of Deposition Transcript of Yang Jianfu, dated November 7, 2012 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-317

Exhibit C to Weick Declaration— Excerpts of Deposition Transcript of Huang Pinqi, dated June 20, 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-324

Exhibit D to Weick Declaration— Press Release from North China Pharmaceutical Group’s Website, dated April 27, 2012 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-326

Exhibit E to Weick Declaration— Press Release from North China Pharmaceutical Group’s Website, dated December 30, 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-337

Exhibit F to Weick Declaration— Tentative Measures for the Supervision and Administration of State-Owned Assets of Enterprises, dated May 27, 2003 . . . . . . . . A-350

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page6 of 191

Page 7: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

PAGE v

Exhibit I to Weick Declaration— “China Wary of Vitamin C-Making Sector Over-Expansion”, China Pharmaceuticals & Health Technologies Newswire, dated November 27, 2009 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-364

Exhibit L to Weick Declaration— “New Capacity Causes Price Slashing for Vitamin C”, China Chemical Reporter, dated August 21, 2010 . . . . . . . . . . . . . . . . . A-366

Exhibit Q to Weick Declaration— “Vitamin C Makers Halt Production Amid Overcapacity, Paper says”, Economic Journal Insight, dated July 31, 2013 . . . . . . . A-369

Declaration of Daniel P. Weick, for Defendants, in Opposition to Plaintiffs’ Motion to Compel, dated August 12, 2014

Exhibit F to Weick Declaration— Second Supplemental Declaration of Liu Rongliang, dated August 8, 2014, with Translation . . . . . . . . . . . . . . . . . . . . . . . . . . A-370

Exhibit G to Weick Declaration— Declaration of Wang Ruicheng, dated August 8, 2014, with Translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-375

Exhibit H to Weick Declaration— Civil Procedure Law of the People’s Republic of China . . . . . . . . . . . A-379

Plaintiff’s Notice of Appeal, dated November 21, 2014 . . . . . . . . . . . . . . . A-457

Defendant Hebei Welcome Pharmaceutical Co. Ltd.’s Notice of Cross-Appeal, dated November 24, 2014 . . . . . . . . . . . . . . . A-460

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page7 of 191

Page 8: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 1/137

APPEAL

U.S. District CourtEastern District of New York (Brooklyn)

CIVIL DOCKET FOR CASE #: 1:06-md-01738-BMC-JO

In Re Vitamin C Antitrust LitigationAssigned to: Judge Brian M. CoganReferred to: Magistrate Judge James OrensteinCause: 15:1 Antitrust Litigation

Date Filed: 02/22/2006Jury Demand: PlaintiffNature of Suit: 410 Anti-TrustJurisdiction: Federal Question

In ReVitamin C Antitrust Litigation represented by Charles Edgar Tompkins

Hausfeld LLP 1146 19th Street NW 5th Floor Washington, DC 20036 202-579-1089 Email: [email protected] LEAD ATTORNEY

James Quadra Moscone, Emblidge & Quadra, LLP 220 Montgomery Street Suite 2100 SAN FRANCISCO, CA 94104 415-362-3599 Fax: 415-362-2006 LEAD ATTORNEY ATTORNEY TO BE NOTICED

Alanna Rutherford Boies, Schiller & Flexner LLP 575 Lexington Avenue 7th Floor New York, NY 10022 (212) 446-2300 Fax: (212) 446-2350 Email: [email protected] ATTORNEY TO BE NOTICED

Besrat J. Gebrewold Cohen Milstein Sellers Toll PLLC 1100 New York Avenue, Nw Suite 500 - West Tower Washington, DC 20005 202-408-4600 Fax: 202-408-4699

A-1Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page8 of 191

Page 9: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 2/137

TERMINATED: 04/05/2012 PRO HAC VICE ATTORNEY TO BE NOTICED

Carrie Ann Tendler Kobre & Kim LLP 800 Third Avenue, 6fl New York, NY 10022 (212)488-1200 Fax: (212)488-1220 Email: [email protected] ATTORNEY TO BE NOTICED

Daniel Mason Zelle, Hofmann, Voelbel & Mason LLP 44 Montgomery Street Suite 3400 San Francisco, CA 94104 415-693-0700 Fax: 415-693-0770 Email: [email protected] ATTORNEY TO BE NOTICED

Eric Buetzow Zelle Hofmann Voelbel & Mason LLP 44 Montgomery Street, Suite 3400 San Francisco, CA 94104 415-693-0700 Fax: 415-693-0770 Email: [email protected] ATTORNEY TO BE NOTICED

Eric B. Fastiff Lieff Cabraser Heimann & BernsteinLLP 275 Battery Street 30th Fl San Francisco, CA 94111 (415)956-1000 Fax: (415)956-1008 Email: [email protected] ATTORNEY TO BE NOTICED

Ian P. Otto Glancy Binkow & Goldberg LLP One Embarcadero Center Suite 760 San Francisco, CA 94111 415-972-8160 Fax: 415-972-8166

A-2Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page9 of 191

Page 10: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 3/137

Email: [email protected] ATTORNEY TO BE NOTICED

John Han Kobre & Kim LLP Icbc Tower 6th Floor 3 Garden Road Central, HK 00000 HONG KONG (212)488-1200 Fax: (212)488-1220 Email: [email protected] ATTORNEY TO BE NOTICED

Joseph W. Bell Zelle Hofmann Voelbel & Mason LLP Furth Building 44 Montgomery Street Suite 3400 San Francisco, CA 94104 415-693-0700 Fax: 415-693-0770 Email: [email protected] ATTORNEY TO BE NOTICED

Joseph R. Saveri Lieff, Cabraser, Heimann & Bernstein,LLP 275 Battery Street Suite 3000 San Francisco, CA 94111 415-956-1000 Fax: 415-956-1008 ATTORNEY TO BE NOTICED

Joseph G. Veenstra Johns, Flaherty & Collins, S.C. 205 5th Avenue South Suite 600 La Crosse, WI 54601 608-784-5678 Fax: 608-784-0557 Email: [email protected] ATTORNEY TO BE NOTICED

Michael S Kim Kobre & Kim 888 Seventh Avenue New York, NY 10019 212-586-9150

A-3Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page10 of 191

Page 11: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 4/137

Fax: 212-586-9600 Email: [email protected] ATTORNEY TO BE NOTICED

Patricia K. Oliver Liner Yankelevitz Sunshine &Regenstreif LLP 1100 Glendon Avenue 14th Floor Los Angeles, CA 90024 310-500-3500 Fax: 310-500-3501 ATTORNEY TO BE NOTICED

Rebecca Bedwell-Coll Lieff, Cabraser, Heimann & Bernstein,LLP 780 Third Avenue 48th Fl New York, NY 10017 (212)355-9500 Fax: (212)355-9592 ATTORNEY TO BE NOTICED

Suyash Agrawal Susman Godfrey LLP 560 Lexington Avenue, 15th Floor New York, NY 10022 212.471.8349 Fax: 212.336.8330 TERMINATED: 07/13/2012 ATTORNEY TO BE NOTICED

Sylvia Sokol Moscone, Emblidge & Quadra, LLP 220 Montgomery Street Suite 2100 SAN FRANCISCO, CA 94104 415-362-3599 Fax: 415-362-2006 ATTORNEY TO BE NOTICED

MovantJulius Anderson

PlaintiffPlaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453

represented by Alanna Rutherford (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED

A-4Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page11 of 191

Page 12: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 5/137

Besrat J. Gebrewold (See above for address) TERMINATED: 04/05/2012 LEAD ATTORNEY PRO HAC VICE

Shawn L. Raymond Susman Godfrey L.L.P. 1000 Louisiana Street, Suite 5100 Houston, TX 77002 713-651-9366 Fax: 713-654-6666 Email: [email protected] LEAD ATTORNEY ATTORNEY TO BE NOTICED

Tanya S. Chutkan Boies, Schiller & Flexner LLP 5301 Wisconsin Ave., N.W. Suite 800 Washington, DC 20015 202-237-2727 Email: [email protected] TERMINATED: 07/07/2014 LEAD ATTORNEY ATTORNEY TO BE NOTICED

William A. Isaacson Boies, Schiller & Flexner LLP 5301 Wisconsin Ave., N.W. Suite 800 Washington, DC 20015 202-237-2727 Email: [email protected] LEAD ATTORNEY ATTORNEY TO BE NOTICED

Benjamin D. Brown Cohen, Milstein, Sellers & Toll, P.L.L.C 1100 New York Avenue, Nw Suite 500, West Tower Washington, DC 20005 202-408-4600 Fax: 202-408-4699 Email: [email protected] PRO HAC VICE ATTORNEY TO BE NOTICED

Brent W. Landau

A-5Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page12 of 191

Page 13: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 6/137

Hausfeld LLP 1604 Locust Street 2nd floor Philadelphia, PA 19103 215-985-2315 Fax: 215-985-3270 Email: [email protected] PRO HAC VICE ATTORNEY TO BE NOTICED

Brian C. Baker Boies, Schiller & Flexner LLP 5301 Wisconsin Avenue NW Suite 800 Washington, DC 20015 202-237-2727 Fax: 202-237-6131 ATTORNEY TO BE NOTICED

Brian A. Ratner Hausfeld LLP 1700 K Street, N W Suite 650 Washington, DC 20006 202-540-7200 Fax: 202-540-7201 Email: [email protected] PRO HAC VICE ATTORNEY TO BE NOTICED

Carrie Ann Tendler (See above for address) ATTORNEY TO BE NOTICED

James T. Southwick Susman Godfrey LLP 1000 Louisiana, Suite 5100

Houston, TX 77002

713-653-7811 Fax: 713-654-6666 Email: [email protected] ATTORNEY TO BE NOTICED

Jennifer Milici Boies, Schiller & Flexner LLP 5301 Wisconsin Ave, Nw Suite 800

A-6Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page13 of 191

Page 14: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 7/137

Washington, DC 20015 202-237-2727 Fax: 202-237-6131 Email: [email protected] ATTORNEY TO BE NOTICED

John Han (See above for address) ATTORNEY TO BE NOTICED

Katherine H. Kunz Susman Godfrey, LLP 1000 Louisiana Suite 5100 Houston, TX 77002 713-653-7828 Fax: 713-654-6666 Email: [email protected] ATTORNEY TO BE NOTICED

Marcus Johnson Green Kobre & Kim LLP 800 Third Avenue Floor 6 New York, NY 10022 212-488-1200 Fax: 212-488-1220 Email: [email protected] ATTORNEY TO BE NOTICED

Melinda R. Coolidge Hausfeld LLP 325 Chestnut Street Suite 900 Philadelphia, PA 19106 202-540-7200 Fax: 202-540-7201 Email: [email protected] PRO HAC VICE ATTORNEY TO BE NOTICED

Michael S Kim (See above for address) ATTORNEY TO BE NOTICED

Suyash Agrawal (See above for address) TERMINATED: 07/13/2012 ATTORNEY TO BE NOTICED

Plaintiff

A-7Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page14 of 191

Page 15: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 8/137

Plaintiff(s) in Civil Action Cribbs vsHebei Welcome Pharmaceutical Co.Ltd. 05-CV-6059

represented by David E. Kovel Kirby McInerney LLP 825 Third Avenue 16th Floor New York, NY 10022 212-371-6600 Fax: 212-751-2540 Email: [email protected] LEAD ATTORNEY ATTORNEY TO BE NOTICED

Alanna Rutherford (See above for address) ATTORNEY TO BE NOTICED

Melinda R. Coolidge (See above for address) PRO HAC VICE ATTORNEY TO BE NOTICED

Suyash Agrawal (See above for address) TERMINATED: 07/13/2012 ATTORNEY TO BE NOTICED

PlaintiffPlaintiff(s) in Civil Action Keane vsHebei Welcome Pharmaceutical Co.Ltd. 06-CV-149

represented by David Boies Straus & Boies, LLP 4041 University Drive 5th Floor Fairfax, VA 22030 703-764-8700 Fax: 703-764-8704 LEAD ATTORNEY ATTORNEY TO BE NOTICED

David E. Kovel (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED

Timothy D. Battin Strauss & Boies, LLP 4041 University Drive Fairfax, VA 22030 (703) 764-8700 Fax: (703) 764-8704 Email: [email protected] LEAD ATTORNEY

A-8Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page15 of 191

Page 16: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 9/137

ATTORNEY TO BE NOTICED

Alanna Rutherford (See above for address) ATTORNEY TO BE NOTICED

Christopher V. Le 4041 University Drive 5th Floor Fairfax, VA 22030 703-764-8700 Fax: 703-764-8704 Email: [email protected] PRO HAC VICE ATTORNEY TO BE NOTICED

Melinda R. Coolidge (See above for address) PRO HAC VICE ATTORNEY TO BE NOTICED

Richard Saveri Saveri & Saveri Inc. 706 Sansome Street San Francisco, CA 94111 415-217-6810 Fax: 415-217-6813 Email: [email protected] ATTORNEY TO BE NOTICED

Suyash Agrawal (See above for address) TERMINATED: 07/13/2012 ATTORNEY TO BE NOTICED

William J. Heye Saveri & Saveri, Inc. 706 Sansome Street San Francisco, CA 94111 415-217-6810 Fax: 415-217-6813 Email: [email protected] ATTORNEY TO BE NOTICED

PlaintiffPlaintiff(s) in Civil Action Audette vsHebei Welcome Pharmaceutical Co.Ltd. 06-CV-988

represented by David Boies (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED

A-9Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page16 of 191

Page 17: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 10/137

Kenneth G. Walsh Kirby McInerney LLP 825 Third Avenue, 16th Floor New York, NY 10022 212-371-6600 Fax: 212-751-2540 Email: [email protected] LEAD ATTORNEY ATTORNEY TO BE NOTICED

Timothy D. Battin (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED

Alanna Rutherford (See above for address) ATTORNEY TO BE NOTICED

Daniel C. Hedlund Gustafson Gluek PLLC 650 Northstar East 608 Second Avenue South Minneapolis, MN 55402 (612)333-8844 Fax: (612)339-6622 Email: [email protected] PRO HAC VICE ATTORNEY TO BE NOTICED

Melinda R. Coolidge (See above for address) PRO HAC VICE ATTORNEY TO BE NOTICED

Richard Saveri (See above for address) ATTORNEY TO BE NOTICED

Suyash Agrawal (See above for address) TERMINATED: 07/13/2012 ATTORNEY TO BE NOTICED

William J. Heye (See above for address) ATTORNEY TO BE NOTICED

PlaintiffOne or more Plaintiffs in 06-cv-05561, represented by Robert W. Coykendall

A-10Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page17 of 191

Page 18: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 11/137

Diana Kitch v. Hebei WelcomePharmaceutical Co et al

Morris, Laing, Evans, Brock & Kennedy,Chtd, --Wichita Old Town Square 300 N Mead Suite 200 Wichita, KS 67202-2722 316-262-2671 Fax: 316-262-6226 Email: [email protected] LEAD ATTORNEY ATTORNEY TO BE NOTICED

Tina J. Moore Morris, Laing, Evans, Brock & Kennedy,Chtd, --Wichita Old Town Square 300 N Mead Suite 200 Wichita, KS 67202-2722 316-262-2671 Fax: 316-262-6226 LEAD ATTORNEY ATTORNEY TO BE NOTICED

Alanna Rutherford (See above for address) ATTORNEY TO BE NOTICED

Melinda R. Coolidge (See above for address) PRO HAC VICE ATTORNEY TO BE NOTICED

Suyash Agrawal (See above for address) TERMINATED: 07/13/2012 ATTORNEY TO BE NOTICED

PlaintiffPlaintiff(s) in Civil Action Carroll vs.China Pharmaceuticals Group, 07-CV-0226

represented by Donald Chidi Amamgbo Amamgbo & Associates 7901 Oakport Street Suite 4900 Oakland, CA 94621 Email: [email protected] LEAD ATTORNEY ATTORNEY TO BE NOTICED

Judith Blackwell Blackwell & Blackwell

A-11Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page18 of 191

Page 19: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 12/137

584 Valle Vista Avenue Oakland, CA 94610 510-689-8888 Fax: 510-835-2848 LEAD ATTORNEY ATTORNEY TO BE NOTICED

Reginald Von Terrell The Terrell Law Group 223 25th Street Richmond, CA 94804 510-237-9700 Fax: 510-237-4616 Email: [email protected] LEAD ATTORNEY ATTORNEY TO BE NOTICED

Alanna Rutherford (See above for address) ATTORNEY TO BE NOTICED

Melinda R. Coolidge (See above for address) PRO HAC VICE ATTORNEY TO BE NOTICED

Suyash Agrawal (See above for address) TERMINATED: 07/13/2012 ATTORNEY TO BE NOTICED

PlaintiffPlaintiff(s) in Civil Action Philion vsHebei Welcome Pharmaceutical Co.Ltd. 06-CV-987

represented by Jon T. King The Furth Firm LLP 225 Bush Street 15th Floor San Francisco, CA 94104 415-433-2070 Fax: 415-982-2076 TERMINATED: 05/07/2008 LEAD ATTORNEY ATTORNEY TO BE NOTICED

Michael P. Lehmann Cohen Milstein Hausfeld & Toll LLP 1 Embercadero Ctr Suite 526 A&B San Francisco, CA 94111 415-523-2048 TERMINATED: 05/07/2008

A-12Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page19 of 191

Page 20: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 13/137

LEAD ATTORNEY ATTORNEY TO BE NOTICED

R. Alexander Saveri Saveri & Saveri, Inc. 706 Sansome Street San Francisco, CA 94111 (415) 217-6810 Email: [email protected] LEAD ATTORNEY ATTORNEY TO BE NOTICED

Alanna Rutherford (See above for address) ATTORNEY TO BE NOTICED

Melinda R. Coolidge (See above for address) PRO HAC VICE ATTORNEY TO BE NOTICED

Richard Saveri (See above for address) ATTORNEY TO BE NOTICED

Suyash Agrawal (See above for address) TERMINATED: 07/13/2012 ATTORNEY TO BE NOTICED

Timothy D. Battin Strauss & Boies, LLP 4041 University Drive Fairfax, VA 22030 703-764-8700 Fax: 703-764-8704 Email: [email protected] ATTORNEY TO BE NOTICED

William J. Heye (See above for address) ATTORNEY TO BE NOTICED

PlaintiffJabo's Pharmacy, Inc. represented by Jabo's Pharmacy, Inc.

PRO SE

PlaintiffNiall Vignoles represented by Niall Vignoles

PRO SE

A-13Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page20 of 191

Page 21: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 14/137

PlaintiffHunt & Behrens, Inc. represented by Hunt & Behrens, Inc.

PRO SE

PlaintiffDion D. Lee represented by Dion D. Lee

PRO SE

PlaintiffMauricio Ajanel represented by Mauricio Ajanel

PRO SE

PlaintiffGreat Earth Chemical, LLC represented by Keith A. Pitt

Slinde Nelson Stanford 111 Sw Fifth Avenue Suite 1740 Portland, OR 97204 503-417-7777 Fax: 503-417-4250 Email: [email protected] PRO HAC VICE ATTORNEY TO BE NOTICED

Philip J. Nelson 503-417-7777 Fax: 503-417-4250 Email: [email protected] PRO HAC VICE ATTORNEY TO BE NOTICED

PlaintiffNorth American World Trade Group,Inc.

represented by Keith A. Pitt (See above for address) PRO HAC VICE ATTORNEY TO BE NOTICED

V.DefendantDefendant(s) in Civil Action AnimalScience vs Hebei, 05-CV-453

represented by Dale C. Christensen Seward & Kissel LLP One Battery Park Plaza New York, NY 10004 (212)574-1200 Fax: (212)480-8421 Email: [email protected] LEAD ATTORNEY

A-14Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page21 of 191

Page 22: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 15/137

ATTORNEY TO BE NOTICED

Daniel Mason (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED

James I. Serota Greenberg Traurig LLP 200 Park Ave. New York, NY 10166 212-801-2277 Fax: 212-224-6155 Email: [email protected] LEAD ATTORNEY ATTORNEY TO BE NOTICED

Kenneth Alan Lapatine Greenberg Traurig LLP 885 Third Avenue New York, NY 10022 212-801-2100 Fax: 212-688-2449 LEAD ATTORNEY ATTORNEY TO BE NOTICED

Richard Scott Goldstein Orrick, Herrington & Sutcliffe LLP 51 West 52nd Street New York, NY 10019 212-506-5000 Fax: 212-506-5151 Email: [email protected] LEAD ATTORNEY ATTORNEY TO BE NOTICED

Sophia Tsokos Greenberg Traurig, LLP 200 Park Avenue New York, NY 10166 212-801-2280 Fax: 212-801-6400 TERMINATED: 01/23/2012 LEAD ATTORNEY

Stephen V. Bomse Orrick Herrington & Sutcliffe LLP 666 Fifth Avenue New York, NY 10103 212-506-5325

A-15Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page22 of 191

Page 23: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 16/137

Fax: 212-506-5151 Email: [email protected] LEAD ATTORNEY ATTORNEY TO BE NOTICED

Anastasia Angelova Angelova Greenberg Traurig, LLP Metlife Building 200 Park Avenue New York, NY 10166 212-801-2132 Fax: 212-805-5580 Email: [email protected] TERMINATED: 06/08/2012 ATTORNEY TO BE NOTICED

Darrell Prescott Baker & McKenzie LLP 452 Fifth Avenue New York, NY 10018 212-626-4476 Fax: 212-310-1637 Email: [email protected] TERMINATED: 01/17/2014 ATTORNEY TO BE NOTICED

James I. Serota (See above for address) ATTORNEY TO BE NOTICED

Jiangxiao Hou Zelle Hofmann Voelbel Mason & GetteLLP 44 Montgomery Street Suite 3400 San Francisco, CA 94104 415-693-0700 Fax: 415-693-0770 Email: [email protected] ATTORNEY TO BE NOTICED

Joseph W. Bell (See above for address) ATTORNEY TO BE NOTICED

Rachel Lois Izower-Fadde Greenberg Traurig, LLP Met Life Building 200 Park Avenue New York, NY 10166

A-16Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page23 of 191

Page 24: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 17/137

212-801-6992 Fax: 212-805-9382 Email: [email protected] TERMINATED: 06/08/2012 ATTORNEY TO BE NOTICED

DefendantDefendant(s) in Civil Action Cribbs vsHebei Welcome Pharmaceutical Co.Ltd. 05-CV-6059

DefendantDefendant(s) in Civil Action Keane vsHebei Welcome Pharmaceutical Co.Ltd. 06-CV-149

represented by Daniel C. Hedlund Gustafson Gluek PLLC 120 South 6th Street Suite 2600 Minneapolis, MN 55402 (612)333-8844 Fax: (612)339-6622 Email: [email protected] ATTORNEY TO BE NOTICED

DefendantDefendant(s) in Civil Action Audette vsHebei Welcome Pharmaceutical Co.Ltd. 06-CV-988

represented by Annapoorni R. Sankaran Greenberg Taurig, LLP 20th Floor One International Place Boston, MA 02110 617-310-6000 Fax: 617-310-6001 Email: [email protected] LEAD ATTORNEY ATTORNEY TO BE NOTICED

Gary R. Greenberg Greenberg Taurig, LLP 20th Floor One International Place Boston, MA 02110 617-310-6013 Fax: 617-310-6001 Email: [email protected] TERMINATED: 06/08/2012 LEAD ATTORNEY ATTORNEY TO BE NOTICED

Daniel C. Hedlund (See above for address) ATTORNEY TO BE NOTICED

A-17Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page24 of 191

Page 25: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 18/137

DefendantHebei Welcome Pharmaceutical Co.Ltd.

represented by Charles Howard Critchlow Baker & McKenzie 452 Fifth Avenue New York, NY 10018 212-626-4496 Fax: 212-310-1614 Email:[email protected] TERMINATED: 01/17/2014 LEAD ATTORNEY ATTORNEY TO BE NOTICED

Daniel Paul Weick Wilson Sonsini Goodrich & Rosati 1301 Avenue Of The Americas, 40thFloor New York, NY 10019 212-497-7759 Fax: 212-999-5899 Email: [email protected] LEAD ATTORNEY ATTORNEY TO BE NOTICED

Jonathan Mitchell Jacobson Wilson Sonsini Goodrich & Rosati. PC 1301 Avenue of the Americas, 39thFloor New York, NY 10019 212-397-7758 Fax: 212-999-5899 Email: [email protected] LEAD ATTORNEY ATTORNEY TO BE NOTICED

Catherine Yunie Stillman Baker & McKenzie LLP 1114 Avenue of the Americas New York, NY 10036 212-626-4218 Fax: 212-310-1679 Email:[email protected]: 01/17/2014 ATTORNEY TO BE NOTICED

Daniel Mason (See above for address) ATTORNEY TO BE NOTICED

A-18Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page25 of 191

Page 26: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 19/137

Darrell Prescott (See above for address) TERMINATED: 01/17/2014 ATTORNEY TO BE NOTICED

DefendantOne or more Defendants in 06-cv-05561, Diana Kitch v. Hebei WelcomePharmaceutical Co et al

DefendantDefendant(s) in Civil Action Carrollvs. China Pharmaceuticals Group, 07-CV-0226

DefendantDefendant(s) in Civil Action Philion vsHebei Welcome Pharmaceutical Co.Ltd. 06-CV-987

represented by Daniel C. Hedlund (See above for address) ATTORNEY TO BE NOTICED

DefendantAland (Jiangsu) Nutraceutical Co., Ltd represented by Richard Scott Goldstein

(See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED

Stephen V. Bomse (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED

Steven Robert Newmark Orrick Herrington & Sutcliffe LLP 51 West 52nd Street New York, NY 10019 212-506-5000 Fax: 212-506-5151 LEAD ATTORNEY ATTORNEY TO BE NOTICED

Annabelle Chan Orrick, Herrington & Sutcliffe LLP 666 Fifth Avenue New York, NY 10103 212-506-5000 Fax: 212-506-5151 Email: [email protected] TERMINATED: 10/29/2009 ATTORNEY TO BE NOTICED

A-19Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page26 of 191

Page 27: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 20/137

Catharine Louise Zurbrugg Orrick Herrington & Sutcliffe 51 West 52nd Street New York, NY 10019 212-506-5000 Fax: 212-506-5151 Email: [email protected] ATTORNEY TO BE NOTICED

DefendantLegend Ingredients Group, Inc.

DefendantJSPC America, Inc. represented by Richard Scott Goldstein

(See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED

Stephen V. Bomse (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED

Steven Robert Newmark (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED

Annabelle Chan (See above for address) TERMINATED: 10/29/2009 ATTORNEY TO BE NOTICED

Catharine Louise Zurbrugg (See above for address) ATTORNEY TO BE NOTICED

DefendantChina Pharmaceutical Group Ltd. represented by Daniel Mason

(See above for address) ATTORNEY TO BE NOTICED

Eric Buetzow (See above for address) ATTORNEY TO BE NOTICED

DefendantWeisheng Pharmaceutical Co. Ltd. represented by Daniel Mason

(See above for address) ATTORNEY TO BE NOTICED

A-20Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page27 of 191

Page 28: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 21/137

Eric Buetzow (See above for address) ATTORNEY TO BE NOTICED

DefendantNortheast Pharmaceutical Group Co.,Ltd.

represented by James I. Serota (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED

Daniel Mason (See above for address) ATTORNEY TO BE NOTICED

Scott Allan Martin Greenberg Traurig, LLP 200 Park Avenue New York, NY 10166 212-801-2231 Fax: 212-801-6400 Email: [email protected] ATTORNEY TO BE NOTICED

DefendantShijiazhuang Pharma. WeishengPharmaceutical Co., Ltd.

DefendantNorth China Pharmaceutical GroupCorp.

represented by Daniel Paul Weick (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED

Darrell Prescott (See above for address) TERMINATED: 01/17/2014 LEAD ATTORNEY ATTORNEY TO BE NOTICED

Jonathan Mitchell Jacobson (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED

Catherine Yunie Stillman (See above for address) TERMINATED: 01/17/2014 ATTORNEY TO BE NOTICED

A-21Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page28 of 191

Page 29: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 22/137

Daniel Mason (See above for address) ATTORNEY TO BE NOTICED

ClaimantQualChem, LLC d/b/a Great EarthChemical

represented by Gary Neal Smith Houser & Allison APC 1 Gateway Center Suite 2500 Newark, NJ 07102 (862)902-4796 Fax: (862)902-4797 Email: [email protected] LEAD ATTORNEY

Douglas A Gross Hofheimer Garlir & Gross LLP 530 Fifth Avenue New York, NY 10036 212-897-7895 Fax: 212-897-4995 Email: [email protected] ATTORNEY TO BE NOTICED

Zachary Bennett Grendi Hofheimer Gartlir & Gross LLP 530 5th Avenue New York, NY 10036 212-818-9000 Fax: 212-869-4930 ATTORNEY TO BE NOTICED

AmicusMinistry of Commerce for the PeoplesRepublic of China

represented by Joel M. Mitnick Sidley Austin LLP 787 Seventh Avenue New York, NY 10019 212-839-5871 Fax: 212-839-5599 Email: [email protected] ATTORNEY TO BE NOTICED

Tracey R. Seraydarian Sidley Austin LLP 787 Seventh Avenue New York, NY 10019 212-839-7356 ATTORNEY TO BE NOTICED

A-22Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page29 of 191

Page 30: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 23/137

V.IntervenorChristopher Donnelly TERMINATED: 06/03/2014

represented by Christopher Donnelly JK5048 301 Instutition Dr. Bellefonte, PA 16823 PRO SE

IntervenorChristopher Wirth TERMINATED: 06/03/2014

represented by Christopher Wirth LA 2120 301 Instutition Dr. Bellefonte, PA 16823 PRO SE

IntervenorJimmy Thule TERMINATED: 06/03/2014

represented by Jimmy Thule 518 George Rd. Toms River, NJ 08753 PRO SE

IntervenorJonathan Rich TERMINATED: 06/03/2014

represented by Jonathan Rich KX 9662 301 Institution Dr. Bellefonte, PA 16823 PRO SE

IntervenorTerry Nichols TERMINATED: 06/03/2014

represented by Terry Nichols 5880 Highway 67 Florence, CO 81226 PRO SE

IntervenorJohn Lindh TERMINATED: 06/03/2014

represented by John Lindh 5880 Highway 67 Florence, CO 81226 PRO SE

IntervenorJames Holmes TERMINATED: 06/03/2014

represented by James Holmes 7375 S. Potomac Street Centennial, CO 80112 PRO SE

ObjectorNeil Freedman

A-23Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page30 of 191

Page 31: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 24/137

Date Filed # Docket Text

02/15/2006 1 Letter dated February 14, 2006 from the MDL Panel, enclosing a copy of thePanels Transfer Order consolidating this MDL action in EDNY, and assigning itto Judge Trager. (Attachments: # 1 MDL Transfer Order)Associated Cases: 1:06-md-01738-DGT-RML,1:05-cv-00453-DGT-RML,1:05-cv-06059-DGT-RML,1:06-cv-00149-DGT-RML(Brown, Marc) (Entered: 02/22/2006)

02/24/2006 2 ORDER endorsed on letter dated 2/21/06 from James I. Serota to Mag. Levy.Application granted. The conference is adjourned to 5/3/06 at 11:00. Ordered byJudge Robert M. Levy on 2/22/06. Associated Cases: 1:06-md-01738-DGT-RML,1:05-cv-00453-DGT-RML,1:05-cv-06059-DGT-RML,1:06-cv-00149-DGT-RML(Greene, Donna) (Entered: 02/24/2006)

03/06/2006 3 MOTION for Extension of Time to File Answer by Hebei WelcomePharmaceutical Co. Ltd.. Associated Cases: 1:06-md-01738-DGT-RML,1:05-cv-00453-DGT-RML,1:05-cv-06059-DGT-RML,1:06-cv-00149-DGT-RML(Bailey,James) (Entered: 03/06/2006)

03/08/2006 NOTICE - This matter is being reassigned from Magistrate Judge Robert M. Levyto Magistrate Judge James Orenstein for pretrial supervision.Associated Cases:1:06-md-01738-DGT-RML,1:05-cv-00453-DGT-RML,1:05-cv-06059-DGT-RML,1:06-cv-00149-DGT-RML(Marino, Janine) (Entered: 03/08/2006)

03/10/2006 4 Letter to Judge Orenstein by Hebei Welcome Pharmaceutical Co. Ltd.. AssociatedCases: 1:06-md-01738-DGT-RML,1:05-cv-00453-DGT-RML,1:05-cv-06059-DGT-RML,1:06-cv-00149-DGT-RML(Bailey, James) (Entered: 03/10/2006)

03/13/2006 5 Letter To Hon David G. Trager on behalf of all defendants in response toPlaintiffs' counsel's letter of 3/10/06 by Northeast Pharmaceutical Group Co. Ltd..Associated Cases: 1:06-md-01738-DGT-RML,1:05-cv-00453-DGT-RML,1:05-cv-06059-DGT-RML,1:06-cv-00149-DGT-RML(Serota, James) (Entered:03/13/2006)

03/14/2006 6 ORDER granting 3 Motion for Extension of Time to Answer. The date fordefendants to answer, move or otherwise respond to the complaints shall be set atthe May 3, 2006 conference before Magistrate Judge James Orenstein. Ordered byJudge David G. Trager on 3/14/2006. (Trager, David) (Entered: 03/14/2006)

03/15/2006 Mag. Judge James Orenstein added. Mag. Judge Robert M. Levy no longerassigned to case. (Vaughn, Terry) (Entered: 03/15/2006)

03/24/2006 7 Letter dtd. 3/22/06 from D. Morgan, Deputy Clerk of MDL Panel to Mr.Heinemann, enclosing their certified cond. transfer order (CTO-1), so that EDNYcan now request the attached case (in re Vitamin C Antitrust Litigation) fromTennessee-Eastern for its consolidation into MDL-1738.(Attachments: #(1)Conditional Transfer Order (CTO-1)).***(Forwarded for assignment of newEDNY civil case number). Associated Cases:1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO(Layne,Monique) (Entered: 04/11/2006)

04/27/2006 8 REPORT of Rule 26(f) Planning Meeting. Associated Cases: 1:06-md-01738-

A-24Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page31 of 191

Page 32: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 25/137

DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00988-DGT-RML(Rutherford, Alanna) (Entered: 04/27/2006)

05/01/2006 9 REPORT of Rule 26(f) Planning Meeting. (Attachments: # 1 Exhibit A - Letterfrom W. Isaacson to D. Mason, dated 3/10/06# 2 Exhibit B - Proposed SchedulingOrder# 3 Supplement Proof of Service)Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO,1:06-cv-00988-DGT-RML(Goldstein, Richard) (Entered: 05/01/2006)

05/02/2006 10 NOTICE of Appearance by Kenneth G. Walsh on behalf of Dennis AudetteAssociated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00988-DGT-RML(Walsh,Kenneth) (Entered: 05/02/2006)

05/03/2006 11 Minute Entry for proceedings held before James Orenstein : Initial ConferenceHearing held on 5/3/2006. SCHEDULING: The next status conference will beheld on June 14, 2006, at 2:00 p.m. THE FOLLOWING RULINGS WEREMADE: (1) The parties will submit simultaneous letters on May 12, 2006,regarding the authority for a stay of all discovery pending the resolution ofanticipated motions for dismissal. The defendants' submission will also includeobjections or proposed alternative deadlines in the event discovery is not stayed.(2) The issue of the timing of the defendants' answers was not addressed at today'sconference. The parties' counsel are directed to meet and confer and make either ajoint proposal, or competing proposals for the deadline for each defendant toanswer. In the absence of agreement, the parties should address whether there isany reason to extend any properly served defendant's deadline for answering pastMay 23, 2006. (3) I will enter a separate pretrial order governing other aspects ofpretrial procedures as discussed at today's conference. (4) The law firm of SidleyAustin LLP, by attorney Joel M. Mitnick, was permitted to appear on behalf of theMinistry of Commerce of the People's Republic of China as amicus curiae forpurposes of today's conference. I thank Mr. Mitnick and his client for theirparticipation and assistance, and look forward to their continued participation andassistance as the parties and the court grapple with the practical discovery andlitigation challenges that may arise in this historic case. Accordingly, amicus isinvited to appear through counsel at all future conferences before me in thislitigation, and need not secure permission to do so in advance. To the extentamicus wishes to be heard with respect to the anticipated dispositive motions orother matters before Judge Trager, counsel must seek the court's permission.Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00988-DGT-RML(Orenstein,James) (Entered: 05/03/2006)

05/04/2006 12 PRETRIAL ORDER 1: The attached order consolidates cases for pretrial purposesand provides instructions regarding attorney admissions and electronic filing.(SEE ATTACHED ORDER.) Signed by Judge James Orenstein on 05/04/06.Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00988-DGT-RML(Adams-Ciardullo, Diana) (Entered: 05/04/2006)

05/04/2006 13 Letter Re: Proposed Scheduling Order by Northeast Pharmaceutical Group Co.Ltd.. (Attachments: # 1 Exhibit A# 2 Exhibit B# 3 Exhibit C)Associated Cases:1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-

A-25Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page32 of 191

Page 33: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 26/137

cv-00149-DGT-JO, 1:06-cv-00988-DGT-RML(Izower, Rachel) (Entered:05/04/2006)

05/11/2006 14 NOTICE of Appearance by Daniel Mason on behalf of Defendant(s) in CivilAction Animal Science vs Hebei, 05-CV-453 Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO(Mason, Daniel) (Entered:05/11/2006)

05/11/2006 15 NOTICE of Appearance by Kenneth G. Walsh on behalf of Plaintiff(s) in CivilAction Audette vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-988Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO(Walsh, Kenneth) (Entered: 05/11/2006)

05/12/2006 16 Letter Re Discovery and Timing of Date for Responsive Pleadings byDefendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments:# 1 Exhibit A# 2 Exhibit B# 3 Exhibit C# 4 Service List)Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO(Bomse,Stephen) (Entered: 05/12/2006)

05/12/2006 17 Letter to Judge Orenstein by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453, Plaintiff(s) in Civil Action Cribbs vs Hebei Welcome PharmaceuticalCo. Ltd. 05-CV-6059, Plaintiff(s) in Civil Action Keane vs Hebei WelcomePharmaceutical Co. Ltd. 06-CV-149, Plaintiff(s) in Civil Action Audette vs HebeiWelcome Pharmaceutical Co. Ltd. 06-CV-988. (Attachments: # 1 Exhibit A-C)Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO(Rutherford, Alanna) (Entered: 05/12/2006)

05/15/2006 18 Letter to Judge Trager by Defendant(s) in Civil Action Animal Science vs Hebei,05-CV-453. (Attachments: # 1 Letter to Judge Orenstein Re Discovery andTiming of Date for Responsive Pleadings# 2 Service List)Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO(Bomse,Stephen) (Entered: 05/15/2006)

05/17/2006 19 NOTICE of Appearance by Joseph W. Bell on behalf of Defendant(s) in CivilAction Animal Science vs Hebei, 05-CV-453 Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO(Bell, Joseph) (Entered:05/17/2006)

05/19/2006 20 Proposed Pretrial Order No. 2 by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453, Plaintiff(s) in Civil Action Cribbs vs Hebei WelcomePharmaceutical Co. Ltd. 05-CV-6059, Plaintiff(s) in Civil Action Keane vs HebeiWelcome Pharmaceutical Co. Ltd. 06-CV-149, Plaintiff(s) in Civil Action Audettevs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-988. (Attachments: # 1 Textof Proposed Order)Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO(Rutherford, Alanna) (Entered: 05/19/2006)

05/23/2006 21 NOTICE of Appearance by Jiangxiao Hou on behalf of Defendant(s) in Civil

A-26Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page33 of 191

Page 34: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 27/137

Action Animal Science vs Hebei, 05-CV-453 Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO(Hou, Jiangxiao) (Entered:05/23/2006)

05/25/2006 22 FILING FEE FOR ADMISSION PRO HAC VICE as to David Boies andTimothy D. Battin. $ 50.00, receipt number 325655 Associated Cases: 1:06-md-01738-DGT-JO,1:06-cv-00149-DGT-JO,1:06-cv-00988-DGT-JO(Greene, Donna)(Entered: 05/31/2006)

06/07/2006 23 MEMORANDUM AND ORDER -- For the reasons set forth in the attachedMemorandum and Order, I deny in its entirety the defendants' application for astay of all discovery pending resolution of any dismissal motions, or in thealternative for the entry of a scheduling order that differs from the approachproposed by the plaintiffs. SEE ATTACHED DOCUMENT. Signed by JudgeJames Orenstein on 06/07/06. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO(Adams-Ciardullo, Diana) (Entered: 06/07/2006)

06/07/2006 24 PRETRIAL ORDER 2 -- The attached Order sets forth dates for discoverydeadlines and court appearances and appoints Co-Lead and Liaison Plaintiffs'Counsel. SEE ATTACHED ORDER. Signed by Judge James Orenstein on06/07/06. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO(Adams-Ciardullo, Diana)(Entered: 06/07/2006)

06/08/2006 25 Letter to Magistrate Judge Orenstein with respect to June 14 status conference byDefendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453. AssociatedCases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO(Goldstein, Richard) (Entered: 06/08/2006)

06/09/2006 ORDER re 25 Letter -- The application is granted and the status conferencescheduled for June 14, 2006 is canceled. The next status conference will takeplace on August 9, 2006, at 2:00 p.m. Approved by Judge James Orenstein on06/09/06. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO(Adams-Ciardullo, Diana)(Entered: 06/09/2006)

06/14/2006 26 NOTICE of Appearance by Darrell Prescott on behalf of Hebei WelcomePharmaceutical Co. Ltd. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO(Prescott, Darrell)(Entered: 06/14/2006)

06/14/2006 27 NOTICE of Appearance by Charles Howard Critchlow on behalf of HebeiWelcome Pharmaceutical Co. Ltd. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO,1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-

A-27Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page34 of 191

Page 35: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 28/137

JO(Critchlow, Charles) (Entered: 06/14/2006)

06/26/2006 28 Letter regarding the filing of pre-trial motions by Defendant(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO,1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO(Goldstein, Richard) (Entered: 06/26/2006)

06/28/2006 29 ORDER endorsed on proposed order attached to 28 Letter. Defendants shall servethe motions to dismiss by June 30, 2006. Plaintiffs shall have the opportunity toreview defendants' motions before requesting a date by which to serve theirresponses. Defendants shall then request a date by which to serve their replybriefs. Ordered by Judge David G. Trager on 6/28/2006. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO(Trager, David) (Entered: 06/28/2006)

06/29/2006 30 MOTION for Leave to File Amicus Curiae Brief in Support of Defendants' Motionto Dismiss by Ministry of Commerce for the Peoples Republic of China.(Attachments: # 1 Exhibit A# 2 Exhibit B)Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO(Mitnick, Joel) (Entered: 06/29/2006)

06/29/2006 31 Letter to Judge Trager,re: application to file Amicus Brief by Ministry ofCommerce for the Peoples Republic of China. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO(Mitnick, Joel) (Entered: 06/29/2006)

06/29/2006 32 CERTIFICATE OF SERVICE by Ministry of Commerce for the Peoples Republicof China re 30 MOTION for Leave to File Amicus Curiae Brief in Support ofDefendants' Motion to Dismiss Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO(Mitnick, Joel)(Entered: 06/29/2006)

06/30/2006 33 Letter enclosing payment of pro hac vice admission fee for Jonathan Palmer byDefendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453. AssociatedCases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO(Goldstein, Richard) (Entered: 06/30/2006)

06/30/2006 34 Letter enclosing Notice of Motion to Dismiss and supporting papers (cover letteronly, without enclosures pursuant to Judge Trager's Motion Practices) byDefendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453. AssociatedCases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO(Goldstein, Richard) (Entered: 06/30/2006)

07/05/2006 36 Letter dtd. 6/28/06 from D. Morgan, Deputy Clerk of MDL Panel to Mr.Heinemann, enclosing their certified cond. transfer order (CTO-2), so that EDNYcan now request the attached case (in re Vitamin C Antitrust Litigation) from

A-28Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page35 of 191

Page 36: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 29/137

California-Northern for its consolidation into MDL-1738. (Attachments: #(1)Cond. Transfer Order- (CTO-2)). ***(Forwarded for assignment of new EDNYcivil case number). (Entered: 07/14/2006)

07/06/2006 35 ORDER granting 30 Motion for Leave to File amicus brief. (Order endorsed onproposed order attached to motion.) Ordered by Judge David G. Trager on7/6/2006. (Trager, David) (Entered: 07/06/2006)

07/14/2006 37 Letter to Judge Trager Re Reply Date to Motion to Dismiss by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453, Plaintiff(s) in Civil Action Cribbsvs Hebei Welcome Pharmaceutical Co. Ltd. 05-CV-6059, Plaintiff(s) in CivilAction Keane vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149, Plaintiff(s)in Civil Action Audette vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-988.Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO(Rutherford, Alanna) (Entered: 07/14/2006)

07/20/2006 38 NOTICE of Appearance by Brian A. Ratner on behalf of Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453 Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO(Ratner, Brian) (Entered: 07/20/2006)

07/25/2006 39 TRANSCRIPT of Conference held on May 3, 2006 before Judge James Orenstein.Court Reporter: Gene Rudolph. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Permaul, Jenny) (Entered: 07/25/2006)

08/02/2006 40 Letter seeking to continue August 9, 2006 status conference until September 2006by Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453. AssociatedCases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Goldstein, Richard) (Entered:08/02/2006)

08/08/2006 ORDER re 40 Letter -- The application is granted. The conference scheduled forAugust 9, 2006, is rescheduled for September 12, 2006, at 3:00 p.m. Approved byJudge James Orenstein on 08/08/06. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO,1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Adams-Ciardullo, Diana) (Entered: 08/08/2006)

08/08/2006 41 ORDER endorsed on 37 requesting that the time for responding to defendants'motions to dismiss be set at August 16, 2006, with the exception of the personaljurisdiction motion. Application granted. Ordered by Judge David G. Trager on8/7/2006. (Entered: 08/08/2006)

08/11/2006 42 Letter Re Relief from Page Limit on Brief by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453, Plaintiff(s) in Civil Action Cribbs vs HebeiWelcome Pharmaceutical Co. Ltd. 05-CV-6059, Plaintiff(s) in Civil Action Keanevs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149, Plaintiff(s) in CivilAction Audette vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-988.Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-

A-29Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page36 of 191

Page 37: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 30/137

DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Rutherford, Alanna)(Entered: 08/11/2006)

08/15/2006 43 ORDER endorsed on 42 Letter requesting leave to file a 62-page opposition brief.Application granted. Ordered by Judge David G. Trager on 8/14/2006. (Entered:08/15/2006)

08/15/2006 44 NOTICE of Appearance by Shawn L. Raymond on behalf of Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453 Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Raymond, Shawn) (Entered: 08/15/2006)

08/15/2006 47 FILING FEE: $ 25.00, receipt number 328817 Pro Hac Vice admission as toShawn L. Raymond. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Greene,Donna) (Entered: 08/17/2006)

08/16/2006 45 REPLY in Opposition Defendants' Motion to Dismiss or Strike Ranis's Claims forDamages by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453.(Attachments: # 1 Affidavit of William Isaacson)Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Rutherford, Alanna) (Entered: 08/16/2006)

08/16/2006 46 MEMORANDUM in Opposition to Defendants' Motion to Dismiss by allplaintiffs. (Attachments: # 1 Exhibit A# 2 Exhibit B# 3 Exhibit C# 4 Exhibit D# 5Exhibit E# 6 Exhibit F# 7 Exhibit G# 8 Exhibit H# 9 Exhibit I# 10 Exhibit J# 11Exhibit K# 12 Exhibit L# 13 Exhibit M)Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO,1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Rutherford, Alanna) (Entered: 08/16/2006)

08/17/2006 48 DISCLOSURE of Interested Parties by Plaintiff(s) in Civil Action Audette vsHebei Welcome Pharmaceutical Co. Ltd. 06-CV-988.Associated Cases: 1:06-md-01738-DGT-JO,1:06-cv-00987-DGT-JO(Walsh, Kenneth) (Entered: 08/17/2006)

08/17/2006 50 FILING FEE: $ 25.00, receipt number 328932 for admission for Suyash Agrawalpro hac vice Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Greene,Donna) (Entered: 08/25/2006)

08/21/2006 Email Notification Test - DO NOT REPLY (Greene, Donna) (Entered:08/21/2006)

08/21/2006 49 NOTICE of Appearance by Suyash Agrawal on behalf of Vitamin C AntitrustLitigation Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Agrawal, Suyash) (Entered: 08/21/2006)

09/08/2006 51 Letter NEPG Requesting Permission to File Motion by Defendant(s) in Civil

A-30Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page37 of 191

Page 38: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 31/137

Action Animal Science vs Hebei, 05-CV-453. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO(Izower, Rachel) (Entered: 09/08/2006)

09/08/2006 52 Letter to report on the status of the litigation in advance of the September 12,2006 status conference by Defendant(s) in Civil Action Animal Science vs Hebei,05-CV-453. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Goldstein, Richard) (Entered: 09/08/2006)

09/08/2006 53 Letter NEPG Request for Permission to File Motion by Defendant(s) in CivilAction Animal Science vs Hebei, 05-CV-453. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Izower, Rachel) (Entered: 09/08/2006)

09/08/2006 54 NOTICE of Appearance by Brian C. Baker on behalf of Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453 Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Baker, Brian) (Entered: 09/08/2006)

09/08/2006 55 STATUS REPORT by Plaintiff(s) in Civil Action Audette vs Hebei WelcomePharmaceutical Co. Ltd. 06-CV-988. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO,1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Walsh, Kenneth) (Entered: 09/08/2006)

09/11/2006 56 Letter to Judge Orenstein by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453, Plaintiff(s) in Civil Action Cribbs vs Hebei Welcome PharmaceuticalCo. Ltd. 05-CV-6059, Plaintiff(s) in Civil Action Keane vs Hebei WelcomePharmaceutical Co. Ltd. 06-CV-149, Plaintiff(s) in Civil Action Audette vs HebeiWelcome Pharmaceutical Co. Ltd. 06-CV-988. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Rutherford, Alanna) (Entered: 09/11/2006)

09/12/2006 57 Minute Entry for proceedings held before James Orenstein: Status Conferenceheld on 9/12/2006. SCHEDULING: The next status conference will be held onNovember 7, 2006, at 2:00 p.m. THE FOLLOWING RULINGS WERE MADE:(1) The parties discussed several issues, none of which is yet ripe for my decision.Counsel shall promptly meet and confer in an effort to resolve these issuesindependently and thereafter submit a letter motion with respect to any issue thatrequires my decision. (2) In the event that Judge Trager schedules a hearing inadvance of November 7, counsel shall notify my chambers to reschedule theconference before me for the same date. (Attachments: # 1 Exhibit Appearances)Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Adams-Ciardullo, Diana)(Entered: 09/12/2006)

09/13/2006 58 Letter to join in defendant Northeast Pharmaceutical Group Co., Ltd.'s September

A-31Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page38 of 191

Page 39: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 32/137

8, 2006 pre-motion letter by Defendant(s) in Civil Action Animal Science vsHebei, 05-CV-453. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Goldstein, Richard) (Entered: 09/13/2006)

09/13/2006 59 Letter regarding filing of defendants' dismissal motion by Defendant(s) in CivilAction Animal Science vs Hebei, 05-CV-453. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Goldstein, Richard) (Entered: 09/13/2006)

09/14/2006 60 Letter to Judge Trager regarding filing of reply brief in support of motion todismiss or strike class action allegations by Defendant(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Mason, Daniel) (Entered: 09/14/2006)

09/18/2006 61 ORDER endorsed on 59 Letter requesting that defendants' reply brief in support oftheir motion to dismiss be due September 22, 2006 and that they be given leave tofile a 30-page reply brief. Application granted. Ordered by Judge David G. Trageron 9/18/2006. (Trager, David) (Entered: 09/18/2006)

09/18/2006 62 ORDER endorsed on 60 Letter requesting that defendants' reply brief in support oftheir motion to dismiss The Ranis Co., Inc.'s claim for damages or alternatively, tostrike class action allegations be due September 22, 2006. Application granted.Ordered by Judge David G. Trager on 9/18/2006. (Trager, David) (Entered:09/18/2006)

09/22/2006 63 Notice of MOTION to Dismiss Defendants' Notice of Motion and Motion toDismiss Plaintiff The Ranis Company, Inc.'s Claim for Damages Under theFederal Antitrust Laws or Alternatively, to Strike Class Action Allegations byVitamin C Antitrust Litigation. (Attachments: # 1 Memorandum# 2 Exhibit A toMemorandum# 3 Exhibit B to Memorandum)Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Bell, Joseph) (Entered: 09/22/2006)

09/22/2006 64 MEMORANDUM in Opposition re 63 Notice of MOTION to DismissDefendants' Notice of Motion and Motion to Dismiss Plaintiff The RanisCompany, Inc.'s Claim for Damages Under the Federal Antitrust Laws orAlternatively, to Strike Class Action Allegations by Vitamin C Antitrust Litigation.(Attachments: # 1 Exhibit A to Memorandum in Opposition)Associated Cases:1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Bell, Joseph) (Entered: 09/22/2006)

09/22/2006 65 RESPONSE in Support re 63 Notice of MOTION to Dismiss Defendants' Noticeof Motion and Motion to Dismiss Plaintiff The Ranis Company, Inc.'s Claim forDamages Under the Federal Antitrust Laws or Alternatively, to Strike ClassAction Allegations filed by Vitamin C Antitrust Litigation. Associated Cases:1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-

A-32Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page39 of 191

Page 40: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 33/137

cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Bell, Joseph) (Entered: 09/22/2006)

09/22/2006 66 Notice of MOTION to Dismiss the Complaint with prejudice, pursuant to FederalRule of Civil Procedure 12(b)(1) and (6) by Defendant(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Goldstein, Richard) (Entered: 09/22/2006)

09/22/2006 67 MOTION to Dismiss (Defendants' Memorandum in Support of Motion to Dismiss)by Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453. AssociatedCases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Goldstein, Richard) (Entered:09/22/2006)

09/22/2006 68 MOTION to Dismiss (Declaration of Richard S. Goldstein in Support ofDefendants' Motion to Dismiss) by Defendant(s) in Civil Action Animal Sciencevs Hebei, 05-CV-453. (Attachments: # 1 Exhibit 1# 2 Exhibit 2# 3 Exhibit 3 (part1 of 3)# 4 Exhibit 3 (part 2 of 3)# 5 Exhibit 3 (part 3 of 3)# 6 Exhibit 4# 7 Exhibit5 (part 1 of 6)# 8 Exhibit 5 (part 2 of 6)# 9 Exhibit 5 (part 3 of 6)# 10 Exhibit 5(part 4 of 6)# 11 Exhibit 5 (part 5 of 6)# 12 Exhibit 5 (part 6 of 6)# 13 Exhibit 6#14 Exhibit 7# 15 Exhibit 8)Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Goldstein, Richard) (Entered: 09/22/2006)

09/22/2006 69 MOTION to Dismiss (Brief of Amicus Curiae the Ministry of Commerce of thePeople's Republic of China in Support of the Defendants' Motion to Dismiss theComplaint) by Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Goldstein, Richard)(Entered: 09/22/2006)

09/22/2006 70 MOTION to Dismiss (Declaration of Joel M. Mitnick in Support of the Brief ofAmicus Curiae the Ministry of Commerce of the People's Republic of China) byDefendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments:# 1 Exhibit A# 2 Exhibit B# 3 Exhibit C# 4 Exhibit D# 5 Exhibit E# 6 Exhibit F#7 Exhibit G# 8 Exhibit H# 9 Exhibit I# 10 Exhibit J# 11 Exhibit K)AssociatedCases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Goldstein, Richard) (Entered:09/22/2006)

09/22/2006 71 RESPONSE in Opposition re 67 MOTION to Dismiss (Defendants' Memorandumin Support of Motion to Dismiss) (Plaintiffs' Memorandum in Opposition toDefendants' Motion to Dismiss) filed by Defendant(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit A# 2 Exhibit B# 3Exhibit C# 4 Exhibit D# 5 Exhibit E# 6 Exhibit F# 7 Exhibit G# 8 Exhibit H# 9Exhibit I# 10 Exhibit J# 11 Exhibit K# 12 Exhibit L# 13 Exhibit M)AssociatedCases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-

A-33Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page40 of 191

Page 41: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 34/137

JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Goldstein, Richard) (Entered:09/22/2006)

09/22/2006 72 REPLY to Response to Motion re 67 MOTION to Dismiss (Defendants'Memorandum in Support of Motion to Dismiss) (Defendants' Reply Memorandumin Support of Motion to Dismiss) filed by Defendant(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Goldstein, Richard) (Entered: 09/22/2006)

09/22/2006 73 MOTION to Dismiss (Certificate of Service) by Defendant(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO,1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Goldstein, Richard) (Entered: 09/22/2006)

09/26/2006 74 MOTION to Dismiss (Corrected Certificate of Service to replace DocumentNumber 73) by Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Goldstein, Richard)(Entered: 09/26/2006)

10/06/2006 75 Letter MOTION for Discovery by all defendants. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Prescott, Darrell) (Entered: 10/06/2006)

10/10/2006 ORDER re 75 -- Any party opposing the relief requested may file a writtenresponse of up to seven pages, exclusive of attachments, no later than October 13,2006. In the future, any party seeking discovery relief must either abide by myindividual practice rules, including those regarding the length of submissions, orseek permission to file a motion on notice pursuant to Local Civil Rule 6.1.Ordered by Judge James Orenstein on 10/10/06. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT (Pallak, Michelle) (Entered: 10/10/2006)

10/10/2006 76 Letter by Hebei Welcome Pharmaceutical Co. Ltd.. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Prescott, Darrell) (Entered: 10/10/2006)

10/12/2006 77 Letter dtd. 09/18/2006 from D. Morgan, Deputy Clerk of MDL Panel to Mr.Heinemann, enclosing their certified cond. transfer order (CTO-3), so that EDNYcan now request the attached case (in re Vitamin C Antitrust Litigation) fromKansas its consolidation into MDL-1738.((Marziliano, August) Additionalattachment(s) added on 10/17/2006 (Marziliano, August). (Entered: 10/12/2006)

10/13/2006 78 Letter To Judge Trager from James I. Serota, Esq. on behalf of defendantNortheast Pharmaceutical Group Co., Ltd. and the other defendants requestingapproval of proposed briefing schedule for motions to compel and related stays by

A-34Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page41 of 191

Page 42: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 35/137

Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453. AssociatedCases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Serota, James) (Entered:10/13/2006)

10/16/2006 79 STIPULATION by Hebei Welcome Pharmaceutical Co. Ltd.. Associated Cases:1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Prescott, Darrell) (Entered: 10/16/2006)

10/16/2006 80 ORDER endorsed on 78 Letter proposing briefing schedule for motions to compelarbitration and related stays: defendants will serve their respective motions onOct. 16, 2006 plaintiffs will serve their responses on Nov. 3, 2006, and defendantswill reply on Nov. 10, 2006. Ordered by Judge David G. Trager on 10/16/2006.Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Trager, David) (Entered:10/16/2006)

10/16/2006 81 Letter cover to motion to compel arbitration and stay proceedings byDefendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453. AssociatedCases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Izower, Rachel) (Entered:10/16/2006)

10/16/2006 82 Letter cover to motion to compel arbitration and stay proceedings byDefendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453. AssociatedCases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Goldstein, Richard) (Entered:10/16/2006)

10/20/2006 83 STIPULATION by Hebei Welcome Pharmaceutical Co. Ltd.. Associated Cases:1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Prescott, Darrell) (Entered: 10/20/2006)

10/20/2006 84 ORDER endorsed on letter dated 10/10/06 from James T. Southwick to JudgeTrager. Application for leave to file a three-page sur-reply brief in opposition todefts. motion to dismiss Ranis as a pltf. is granted. Ordered by Judge David G.Trager on 10/11/06. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Greene,Donna) (Entered: 10/20/2006)

10/25/2006 ORDER re 83 -- The stipulation is SO ORDERED. Ordered by Judge JamesOrenstein on 10/25/06. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Pallak, Michelle) (Entered: 10/25/2006)

A-35Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page42 of 191

Page 43: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 36/137

10/25/2006 ORDER re 75 -- The motion is terminated as moot. See October 25, 2006 Order re83 . Ordered by Judge James Orenstein on 10/25/06. (Pallak, Michelle) (Entered:10/25/2006)

11/01/2006 85 AMENDED COMPLAINT against Defendant(s) in Civil Action Keane vs HebeiWelcome Pharmaceutical Co. Ltd. 06-CV-149, filed by Plaintiff(s) in Civil ActionKeane vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149.(Walsh, Kenneth)(Entered: 11/01/2006)

11/02/2006 86 NOTICE of Appearance by Brent W. Landau on behalf of Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453 Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Landau, Brent) (Entered: 11/02/2006)

11/03/2006 87 STATUS REPORT by letter to Judge Orenstein by Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO,1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Southwick, James) (Entered: 11/03/2006)

11/03/2006 88 Letter re November 7, 2006 status conference by Defendant(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO,1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Goldstein, Richard) (Entered: 11/03/2006)

11/03/2006 89 Letter response re November 7, 2006 status conference by Defendant(s) in CivilAction Animal Science vs Hebei, 05-CV-453. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Goldstein, Richard) (Entered: 11/03/2006)

11/06/2006 90 STATUS REPORT by Plaintiff(s) in Civil Action Audette vs Hebei WelcomePharmaceutical Co. Ltd. 06-CV-988. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO,1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Walsh, Kenneth) (Entered: 11/06/2006)

11/07/2006 91 Minute Entry for proceedings held before James Orenstein on 11/7/2006.SCHEDULING: The next status conference will be held on January 10, 2007 at2:00 p.m. THE FOLLOWING RULINGS WERE MADE: The parties report thatthey have resolved on consent their dispute about the extent to which discoveryshould continue pending resolution of the defendants' motions to dismiss andcompel arbitration. The parties will promptly submit a stipulation reflecting theterms of their agreement. Ordered by Judge James Orenstein on 11/07/06.(Attachments: # 1 Exhibit Appearances)Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO,1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT (Pallak, Michelle) Modified on 11/13/2006 (Guy, Alicia).(Entered: 11/07/2006)

11/08/2006 92 Letter MOTION for Extension of Time to File Response/Reply as to 80 Order,,,

A-36Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page43 of 191

Page 44: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 37/137

MOTION for Leave to File Excess Pages Pursuant to Stipulation of All Parties byDefendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453. AssociatedCases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Izower, Rachel) (Entered:11/08/2006)

11/08/2006 93 ORDER granting 92 Motion for Extension of Time to File Response/Reply andgranting 92 Motion for Leave to File Excess Pages. Replies due by 11/17/2006.Ordered by Judge David G. Trager on 11/8/2006. (Trager, David) (Entered:11/08/2006)

11/17/2006 94 MOTION to Compel Arbitration by Defendant(s) in Civil Action Animal Sciencevs Hebei, 05-CV-453. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Serota,James) (Additional attachment(s) added on 12/18/2013: # 1 Motion) (Marziliano,August). (Entered: 11/17/2006)

11/17/2006 95 RESPONSE in Support re 94 MOTION to Compel Arbitration Memorandum ofLaw filed by Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453.Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Serota, James) (Entered:11/17/2006)

11/17/2006 96 AFFIDAVIT in Support re 94 MOTION to Compel Arbitration Declaration ofJames Serota filed by Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit A# 2 Exhibit b# 3 Exhibit C# 4 Exhibit D# 5Exhibit E# 6 Exhibit F# 7 Exhibit G through J coverpage# 8 Exhibit K# 9 ExhibitL# 10 Exhibit M# 11 Exhibit N)Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Serota, James) (Entered: 11/17/2006)

11/17/2006 97 AFFIDAVIT in Support re 94 MOTION to Compel Arbitration Declaration of GeYaping filed by Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit A)Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO,1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Serota, James) (Entered: 11/17/2006)

11/17/2006 98 Notice of MOTION to Compel Arbitration and for a Stay of Litigation byDefendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453. AssociatedCases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Goldstein, Richard) (Entered:11/17/2006)

11/17/2006 99 MEMORANDUM in Support re 98 Notice of MOTION to Compel Arbitrationand for a Stay of Litigation by Defendant(s) in Civil Action Animal Science vsHebei, 05-CV-453. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-

A-37Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page44 of 191

Page 45: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 38/137

JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Goldstein, Richard) (Entered: 11/17/2006)

11/17/2006 100 RESPONSE in Opposition re 98 Notice of MOTION to Compel Arbitration andfor a Stay of Litigation, 94 MOTION to Compel Arbitration - Plaintiffs'Memorandum In Opposition To Defendants' Motions To Compel Arbitration filedby Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453.(Attachments: # 1 Exhibit 1-8 Filed Under Seal Pursuant To Stipulated InterimProtective Order Entered By The Court 10/25/06# 2 Exhibit 9# 3 Exhibit 10# 4Exhibit 11# 5 Exhibit 12# 6 Exhibit 13# 7 Exhibit 14# 8 Exhibit 15# 9 Exhibit16# 10 Exhibit 17# 11 Exhibit 18# 12 Exhibit 19# 13 Exhibit 20# 14 Exhibit 21#15 Exhibit 22# 16 Exhibit 23# 17 Exhibit 24# 18 Exhibit 25# 19 Exhibit 26# 20Exhibit 27# 21 Exhibit 28# 22 Exhibit 29# 23 Exhibit 30# 24 Exhibit 31# 25Exhibit 32)Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Serota,James) (Additional attachment(s) added on 12/18/2013: # 26 Exhibits 1-8)(Marziliano, August). (Additional attachment(s) added on 12/18/2013: # 27Exhibits 1-8 part 2) (Marziliano, August). (Entered: 11/17/2006)

11/17/2006 101 REPLY to Response to Motion re 98 Notice of MOTION to Compel Arbitrationand for a Stay of Litigation filed by Defendant(s) in Civil Action Animal Sciencevs Hebei, 05-CV-453. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Goldstein, Richard) (Entered: 11/17/2006)

11/17/2006 102 CERTIFICATE OF SERVICE by Defendant(s) in Civil Action Animal Science vsHebei, 05-CV-453 re 98 Notice of MOTION to Compel Arbitration and for a Stayof Litigation, 101 Reply to Response to Motion,, 99 Memorandum in Support,Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Goldstein, Richard)(Entered: 11/17/2006)

11/17/2006 103 REPLY to Response to Motion re 94 MOTION to Compel Arbitration filed byDefendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453. AssociatedCases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Izower, Rachel) (Entered:11/17/2006)

11/17/2006 104 AFFIDAVIT in Opposition re 94 MOTION to Compel Arbitration Declaration ofJi Yong filed by Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit A# 2 Exhibit B# 3 Exhibit C# 4 Exhibit D# 5Exhibit E# 6 Exhibit F# 7 Exhibit G# 8 Exhibit H# 9 Exhibit I)Associated Cases:1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Izower, Rachel) (Entered: 11/17/2006)

11/17/2006 105 AFFIDAVIT in Support re 94 MOTION to Compel Arbitration Declaration ofProfessor Le-Ning Liu filed by Defendant(s) in Civil Action Animal Science vs

A-38Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page45 of 191

Page 46: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 39/137

Hebei, 05-CV-453. (Attachments: # 1 Exhibit A)Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Izower, Rachel) (Entered: 11/17/2006)

11/17/2006 106 AFFIDAVIT in Support re 94 MOTION to Compel Arbitration Declaration ofJames I. Serota filed by Defendant(s) in Civil Action Animal Science vs Hebei,05-CV-453. (Attachments: # 1 Exhibit A# 2 Exhibit B# 3 Exhibit C# 4 ExhibitD)Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Izower, Rachel) (Entered:11/17/2006)

11/17/2006 107 AFFIDAVIT in Support re 94 MOTION to Compel Arbitration Declaration ofProfessor Randall Peerenboom filed by Defendant(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit A# 2 Exhibit B# 3Exhibit C# 4 Exhibit D# 5 Exhibit E# 6 Exhibit F# 7 Exhibit G# 8 ExhibitH)Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Izower, Rachel) (Entered:11/17/2006)

11/17/2006 108 AFFIDAVIT in Support re 94 MOTION to Compel Arbitration Declaration ofProfessor Lu Song filed by Defendant(s) in Civil Action Animal Science vsHebei, 05-CV-453. (Attachments: # 1 Exhibit A)Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Izower, Rachel) (Entered: 11/17/2006)

11/17/2006 109 CERTIFICATE OF SERVICE by Defendant(s) in Civil Action Animal Science vsHebei, 05-CV-453 re 94 MOTION to Compel Arbitration, 105 Affidavit inSupport of Motion,, 108 Affidavit in Support of Motion,, 107 Affidavit in Supportof Motion,,, 106 Affidavit in Support of Motion,, 96 Affidavit in Support ofMotion,,, 103 Reply to Response to Motion,, 97 Affidavit in Support of Motion,,95 Response in Support of Motion,, 104 Affidavit in Opposition to Motion,,Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Izower, Rachel) (Entered:11/17/2006)

11/20/2006 110 Letter to Judge Trager by Defendant(s) in Civil Action Animal Science vs Hebei,05-CV-453. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Izower,Rachel) (Entered: 11/20/2006)

11/22/2006 111 Letter To Judge Trager by Defendant(s) in Civil Action Animal Science vs Hebei,05-CV-453. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Serota,James) (Entered: 11/22/2006)

11/22/2006 112 EXHIBIT Replacement Copies of Exhs B, C, D, E, G and H to Ji Yong

A-39Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page46 of 191

Page 47: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 40/137

Declaration by Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453.. Related document: 104 Affidavit in Opposition to Motion,, filed byDefendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453,.(Attachments: # 1 Exhibit C# 2 Exhibit D# 3 Exhibit E# 4 Exhibit G# 5 ExhibitH)Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Serota, James) (Entered:11/22/2006)

11/22/2006 113 NOTICE of Change of Address by Alanna Rutherford Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Rutherford, Alanna) (Entered: 11/22/2006)

11/24/2006 114 EXHIBIT Replacement Exh. I to Declaration of Ji Yong by Defendant(s) in CivilAction Animal Science vs Hebei, 05-CV-453.. Related document: 104 Affidavitin Opposition to Motion,, filed by Defendant(s) in Civil Action Animal Science vsHebei, 05-CV-453,.Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Izower,Rachel) (Entered: 11/24/2006)

11/27/2006 115 Letter to Judge Trager re. Exhibit I to Ji Yong Declaration in Support of Motionto Compel Arbitration by Defendant(s) in Civil Action Animal Science vs Hebei,05-CV-453. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Izower,Rachel) (Entered: 11/27/2006)

12/14/2006 116 STIPULATION AND ORDER REGARDING SCHEDULING AS TO CERTAINPLAINTIFFS ALLEGING INDIRECT PURCHASER CLAIMS by Hebei WelcomePharmaceutical Co. Ltd.. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Prescott, Darrell) (Entered: 12/14/2006)

12/14/2006 117 STIPULATION REGARDING DISCOVERY by Hebei Welcome PharmaceuticalCo. Ltd.. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Prescott, Darrell) (Entered: 12/14/2006)

12/20/2006 ORDER re 116 , 117 -- The stipulations are so ordered. Ordered by Judge JamesOrenstein on 12/20/06. Associated Cases: 1:06-md-01738-DGT-JO,1:05-cv-00453-DGT-JO,1:05-cv-06059-DGT-JO,1:06-cv-00149-DGT-JO, 1:06-cv-00987-DGT-JO,1:06-cv-00988-DGT-JO,1:06-cv-01721-DGT-JO,1:06-cv-03528-DGT(Pallak, Michelle) (Entered: 12/20/2006)

01/03/2007 118 NOTICE of Voluntary Dismissal by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453 of Plaintiff The Ranis Company (Rutherford, Alanna) (Entered:01/03/2007)

01/04/2007 119 Letter to Judge Trager by Plaintiff(s) in Civil Action Audette vs Hebei Welcome

A-40Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page47 of 191

Page 48: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 41/137

Pharmaceutical Co. Ltd. 06-CV-988 (Rutherford, Alanna) (Entered: 01/04/2007)

01/05/2007 120 Letter to Judge Trager by Defendant(s) in Civil Action Animal Science vs Hebei,05-CV-453 (Goldstein, Richard) (Entered: 01/05/2007)

01/05/2007 121 Letter to Magistrate Judge Orenstein requesting continuance of January 10pretrial conference by Vitamin C Antitrust Litigation (Mason, Daniel) (Entered:01/05/2007)

01/08/2007 SCHEDULING ORDER: The application is granted and the conferencepreviously scheduled for January 10, 2007 is rescheduled for March 14, 2007 at11:30 a.m. Ordered by Judge James Orenstein on 1/08/07. (Pallak, Michelle)(Entered: 01/08/2007)

01/11/2007 123 Letter dtd. 01/8/2007 from Denise Morgan, Deputy Clerk of MDL Panel to Mr.Heinemann, enclosing their certified cond. transfer order (CTO-4), so that EDNYcan now request the attached case (in re Vitamin C Antitrust Litigation) fromCalifornia-Northern for its consolidation into MDL-1738.((Marziliano, August)(Marziliano, August) Additional attachment(s) added on 1/17/2007 (Marziliano,August). (Entered: 01/17/2007)

01/16/2007 122 ORDER 119 Letter filed by Plaintiff(s), 120 Letter filed by Defendant(s). PlaintiffThe Ranis Company shall serve and file a brief of no more than ten pages byJanuary 31, 2007, and defendants are directed to serve and file a brief of no morethan ten pages in response by February 14, 2007. Ordered by Judge David G.Trager on 1/16/2007. (Trager, David) (Entered: 01/16/2007)

01/31/2007 124 AMENDED COMPLAINT against all defendants, filed by all plaintiffs.(Rutherford, Alanna) (Entered: 01/31/2007)

01/31/2007 125 RESPONSE to Motion re 94 MOTION to Compel Arbitration and Court Order ofJanuary 16, 2007 filed by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. (Attachments: # 1 Certificate of Service) (Rutherford, Alanna)(Entered: 01/31/2007)

02/07/2007 126 Letter Withdrawing Motion by Hebei Welcome Pharmaceutical Co. Ltd.(Critchlow, Charles) (Entered: 02/07/2007)

02/12/2007 127 STIPULATION regarding discovery by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453 (Rutherford, Alanna) (Entered: 02/12/2007)

02/14/2007 128 STIPULATION Regarding Motion to Dismiss by Hebei Welcome PharmaceuticalCo. Ltd. (Critchlow, Charles) (Entered: 02/14/2007)

02/15/2007 129 NOTICE of Appearance by Daniel C. Hedlund on behalf of Plaintiff(s) in CivilAction Audette vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-988(Attachments: # 1 Certificate of Service) (Hedlund, Daniel) (Entered: 02/15/2007)

02/26/2007 130 NOTICE of Appearance by Michael P. Lehmann on behalf of Melanie FarleyAssociated Cases: 1:06-md-01738-DGT-JO, 1:06-cv-00987-DGT-JO (Lehmann,Michael) (Entered: 02/26/2007)

02/26/2007 131 NOTICE of Appearance by Jon T. King on behalf of Melanie Farley AssociatedCases: 1:06-md-01738-DGT-JO, 1:06-cv-00987-DGT-JO (King, Jon) (Entered:02/26/2007)

A-41Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page48 of 191

Page 49: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 42/137

03/09/2007 132 Letter to Magistrate Judge Orenstein regarding pre-trial conference by HebeiWelcome Pharmaceutical Co. Ltd. (Critchlow, Charles) (Entered: 03/09/2007)

03/12/2007 ORDER re 132 Letter filed by Hebei Welcome Pharmaceutical Co. Ltd. -- Theapplication is granted and the conference shall be rescheduled for a date to bedetermined. No later than March 19, 2007 the parties shall submit jointly aproposal that contemplates a conference no later than April 30, 2007. Ordered byJudge James Orenstein on 3/12/07. (Pallak, Michelle) (Entered: 03/12/2007)

03/14/2007 133 STIPULATION FOR PROTECTIVE ORDER by Hebei Welcome PharmaceuticalCo. Ltd. (Critchlow, Charles) (Additional attachment(s) added on 10/4/2012: # 1Plaintiff's Exhibit 3, # 2 Plaintiff's Exhibit 4, # 3 Plaintiff's Exhibit 5, # 4Plaintiff's Exhibit 6, # 5 Plaintiff's Exhibit 9, # 6 Plaintiff's Exhibit 10, # 7Defendant's Exhibit C, # 8 Defendant's Exhibit E) (Marziliano, August). (Entered:03/14/2007)

03/19/2007 134 Letter Regarding Conference by Hebei Welcome Pharmaceutical Co. Ltd.(Critchlow, Charles) (Entered: 03/19/2007)

03/19/2007 Email Notification Test - DO NOT REPLY (Vaughn, Terry) (Entered:03/19/2007)

03/20/2007 SCHEDULING ORDER re 134 : The application is granted and a conference willbe held on April 25, 2007 at 2:00 p.m. Ordered by Judge James Orenstein on3/20/07. (Pallak, Michelle) (Entered: 03/20/2007)

03/20/2007 ORDER re 133 Stipulation filed by Hebei Welcome Pharmaceutical Co. Ltd. --The stipulation is SO ORDERED. Ordered by Judge James Orenstein on 3/20/07.(Pallak, Michelle) (Entered: 03/20/2007)

04/18/2007 135 ORDER endorsed on 128 Stipulation. Ordered by Judge David G. Trager on4/17/2007. (Trager, David) (Entered: 04/18/2007)

04/23/2007 136 Letter by Hebei Welcome Pharmaceutical Co. Ltd. (Prescott, Darrell) (Entered:04/23/2007)

04/24/2007 137 Letter by Plaintiff(s) in Civil Action Audette vs Hebei Welcome PharmaceuticalCo. Ltd. 06-CV-988 (Walsh, Kenneth) (Entered: 04/24/2007)

04/25/2007 138 ORDER: The Clerk is respectfully directed to issue summonses for the foreigndefendants in Keane, et al. v. Hebei Welcome Pharmaceutical Co. Ltd., et al., CV06-149. Ordered by Judge James Orenstein on 4/25/07. (Movahed, Michelle)(Entered: 04/25/2007)

04/25/2007 139 Minute Entry for proceedings held before James Orenstein: Status Conferenceheld on 4/25/2007. (Court Reporter Henry Shapiro)SCHEDULING: The nextstatus conference will be held on August 1, 2007, at 2:00 p.m. Further conferencesare scheduled as set forth in the attached document. THE FOLLOWINGRULINGS WERE MADE: (1) I denied the defendants' application to adjourn thedeadline for responding to the class certification motion until 60 days after JudgeTrager's ruling on the dismissal motions, and granted the alternate schedulingrelief with the consent of the plaintiffs. (2) Without objection from any party, Igranted the Indirect Purchaser plaintiffs' application for an order directing theClerk to issue summonses for the foreign defendants who are to be servedpursuant to the Hague Convention.(3) With the consent of all parties, I granted the

A-42Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page49 of 191

Page 50: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 43/137

Indirect Purchaser plaintiffs' application to amend the discovery schedule so as toprovide for an additional six-month period for the parties to conduct discoveryunique to the Indirect Purchaser plaintiffs' claims. (4) I will enter a separatepretrial order reflecting the amended deadlines. SEE ATTACHEDDOCUMENT. (Attachments: # 1 Appendix Appearances) (Movahed, Michelle)(Entered: 04/25/2007)

04/25/2007 140 PRETRIAL ORDER 3: The attached order contains amended discovery deadlinesand incorporates by reference certain other deadlines listed in docket entry 136 .In addition, the timing provisions of the Stipulation and Order of December 20,2006, docket entry 116 remain in effect. SEE ATTACHED ORDER. Ordered byJudge James Orenstein on 4/25/07. (Movahed, Michelle) (Entered: 04/25/2007)

05/16/2007 141 MOTION for Extension of Time to File Response/Reply to motion for classcertification for defendants filed by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453. (Rutherford, Alanna) (Entered: 05/16/2007)

05/17/2007 ORDER granting 141 Motion for Extension of Time to File Response/Reply: Theapplication is granted on consent and the proposed briefing schedule is SOORDERED. Ordered by Judge James Orenstein on 5/17/07. (Movahed, Michelle)(Entered: 05/17/2007)

05/30/2007 142 Letter to Judge Trager by Defendant(s) in Civil Action Animal Science vs Hebei,05-CV-453 (Goldstein, Richard) (Entered: 05/30/2007)

05/30/2007 143 EXHIBIT Replacement Copy of Exhibit 8 to Declaration of Richard S. Goldsteinby Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453.(Attachments: # 1 Exhibit 8, pt 2# 2 Exhibit 8, pt 3# 3 Exhibit 8, pt 4) (Goldstein,Richard) (Entered: 05/30/2007)

05/31/2007 144 Letter to Honorable Judge David G.Trager by Ministry of Commerce for thePeoples Republic of China (Attachments: # 1 Un signed Order) Associated Cases:1:06-md-01738-DGT-JO et al. (Mitnick, Joel) (Entered: 05/31/2007)

06/01/2007 145 Letter responding to Ministry of Commerce's letter motion to appear at oralargument by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453(Rutherford, Alanna) (Entered: 06/01/2007)

06/04/2007 146 NOTICE by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453(Attachments: # 1 Exhibit WT/ACC/CHN/49# 2 Exhibit WT/L/432) (Rutherford,Alanna) (Entered: 06/04/2007)

06/05/2007 153 Minute Entry for proceedings held before David G. Trager : Status Conferenceheld on 6/5/2007. Oral argument on the motion to dismiss. (Greene, Donna)(Entered: 06/21/2007)

06/07/2007 147 Letter MOTION to Compel Discovery by Hebei Welcome Pharmaceutical Co.Ltd.. (Attachments: # 1 Exhibit A# 2 Exhibit B# 3 Exhibit C# 4 Exhibit D# 5Exhibit E# 6 Exhibit F# 7 Exhibit G# 8 Certificate of Service) (Prescott, Darrell)(Entered: 06/07/2007)

06/08/2007 148 Letter Pro Hac Vice Admission Letter by Vitamin C Antitrust Litigation(Veenstra, Joseph) (Entered: 06/08/2007)

A-43Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page50 of 191

Page 51: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 44/137

06/08/2007 149 NOTICE of Appearance by Joseph G. Veenstra on behalf of Vitamin C AntitrustLitigation (aty to be noticed) (Veenstra, Joseph) (Entered: 06/08/2007)

06/12/2007 150 Letter To Heinemann Clerk of Court re: Pro hac vice admission by Vitamin CAntitrust Litigation (Attachments: # 1 Pro hac vice admission fees) (Bedwell-Coll,Rebecca) (Entered: 06/12/2007)

06/12/2007 151 RESPONSE in Opposition re 147 Letter MOTION to Compel Discovery filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,James) (Entered: 06/12/2007)

06/13/2007 152 ORDER granting 147 Motion to Compel -- For the reasons stated in the attachedorder, I grant the defendants' motion and direct plaintiff Animal Science toconduct a comprehensive search for documents and information responsive to thedefendants' discovery requests, and to produce all such documents and otherinformation no later than July 6, 2007, in unredacted and electronic form whereappropriate. SEE ATTACHED ORDER. Ordered by Judge James Orenstein onJune 13, 2007. (Movahed, Michelle) (Entered: 06/13/2007)

06/22/2007 154 Letter MOTION for Extension of Time to File Response/Reply to Motion forClass Certification by all defendants. (Prescott, Darrell) (Entered: 06/22/2007)

06/22/2007 155 STIPULATION of Dismissal With Prejudice by Hebei Welcome PharmaceuticalCo. Ltd. (Prescott, Darrell) (Entered: 06/22/2007)

06/25/2007 156 NOTICE of Appearance by Joseph R. Saveri on behalf of Vitamin C AntitrustLitigation (aty to be noticed) (Saveri, Joseph) (Entered: 06/25/2007)

06/25/2007 157 NOTICE of Appearance by Eric B. Fastiff on behalf of Vitamin C AntitrustLitigation (aty to be noticed) (Fastiff, Eric) (Entered: 06/25/2007)

06/25/2007 158 NOTICE of Appearance by Rebecca Bedwell-Coll on behalf of Vitamin CAntitrust Litigation (aty to be noticed) (Bedwell-Coll, Rebecca) (Entered:06/25/2007)

06/25/2007 159 RESPONSE to Motion re 154 Letter MOTION for Extension of Time to FileResponse/Reply to Motion for Class Certification filed by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered:06/25/2007)

06/26/2007 160 NOTICE of Change of Address by Jayne A. Goldstein (Goldstein, Jayne)(Entered: 06/26/2007)

06/26/2007 161 ORDER endorsed on 154 Motion for Extension of Time to File Response/Replyto Motion for Class Certification. Responses due by 8/2/2007. Replies due by10/4/2007. Ordered by Judge David G. Trager on 6/26/2007. (Trager, David)(Entered: 06/26/2007)

06/27/2007 162 Letter to Heinemann Clerk of the Court re: Pro hac vice admission by Vitamin CAntitrust Litigation (Attachments: # 1 Pro Hac Vice Admission Fees) (Quadra,James) (Entered: 06/27/2007)

07/09/2007 163 NOTICE of Appearance by James Quadra on behalf of Vitamin C AntitrustLitigation (aty to be noticed) (Quadra, James) (Entered: 07/09/2007)

A-44Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page51 of 191

Page 52: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 45/137

07/09/2007 164 NOTICE of Appearance by Sylvia Sokol on behalf of Vitamin C AntitrustLitigation (aty to be noticed) (Sokol, Sylvia) (Entered: 07/09/2007)

07/16/2007 165 Letter dated June 28, 2007, from Reginald Terrell to Clerk of the Court, enclosingnotices of appearance. (Abdallah, Fida) (Entered: 07/16/2007)

07/24/2007 166 Letter MOTION for Leave to File Excess Pages in Memorandum of Law inOpposition to the Motion of the Ranis Company for Class Certification byDefendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Prescott,Darrell) (Entered: 07/24/2007)

07/27/2007 167 Letter to Judge Orenstein re continuing the pre-trial conference by Plaintiff(s) inCivil Action Philion vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-987(Rutherford, Alanna) (Entered: 07/27/2007)

07/30/2007 ORDER re 167 Letter filed by Plaintiff(s) in Civil Action Philion vs HebeiWelcome Pharmaceutical Co. Ltd. 06-CV-987 -- The application is granted, andthe status conference previously scheduled for August 1, 2007 is adjourned for adate to be determined. No later than August 6, 2007, the parties shall submit aproposed date for the next status conference. Ordered by Judge James Orensteinon July 30, 2007. (Movahed, Michelle) (Entered: 07/30/2007)

08/02/2007 168 ORDER endorsed on 166 Motion for Leave to File Excess Pages. Applicationgranted. Ordered by Judge David G. Trager on 7/31/2007. (Trager, David)(Entered: 08/02/2007)

08/06/2007 169 Letter re new scheduling conference date by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453 (Rutherford, Alanna) (Entered: 08/06/2007)

08/07/2007 ORDER re 169 Letter filed by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453 -- The application is granted and the next status conference isscheduled for October 2, 2007 at 2:00 p.m. Ordered by Judge James Orenstein onAugust 7, 2007. (Movahed, Michelle) (Entered: 08/07/2007)

08/10/2007 170 Letter dated 8/10/2007 from Joel M. Mitnick, Counsel for Amicus The Ministry ofCommerce of the People's Republic of China to judge David G. Trager.(Attachments: # 1 Certificate of Replacement Copies# 2 Certificate ofReplacement Copies) (Marziliano, August) (Entered: 08/10/2007)

08/20/2007 171 AMENDED COMPLAINT and Motion to File the Amended Complaint against alldefendants, filed by all plaintiffs. (Attachments: # 1 Affidavit # 2 ExhibitAmended Complaint) (Rutherford, Alanna) (Entered: 08/20/2007)

08/22/2007 172 TRANSCRIPT of Proceedings held on 4/25/07 before Judge James Orenstein.Court Reporter: Henry Shapiro. (Guy, Alicia) (Entered: 08/22/2007)

08/27/2007 173 Letter in Response and Opposition to Plaintiffs' Letter Motion to Amend by HebeiWelcome Pharmaceutical Co. Ltd. (Critchlow, Charles) (Entered: 08/27/2007)

09/10/2007 174 Letter in Response to Plaintiffs' Motion to Amend by Hebei WelcomePharmaceutical Co. Ltd. (Critchlow, Charles) (Entered: 09/10/2007)

09/17/2007 175 Letter MOTION to Amend/Correct 173 Letter, 174 Letter motion in opposition toplaintiffs' motion to amend the complaint by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. (Rutherford, Alanna) (Entered: 09/17/2007)

A-45Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page52 of 191

Page 53: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 46/137

09/25/2007 176 ORDER granting 171 letter motion to file a Second Amended Complaint. Thecourt is inclined to grant a reasonable extension of the schedule to accommodatethe issues raised by defendants, but refers the issue of scheduling to MagistrateJudge James Orenstein. Ordered by Judge David G. Trager on 9/25/2007.(Martinez, Mira) (Entered: 09/25/2007)

09/25/2007 Motions terminated: 175 Letter MOTION to Amend/Correct 173 Letter, 174Letter motion in opposition to plaintiffs' motion to amend the complaint filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Greene,Donna) (Entered: 09/26/2007)

09/27/2007 177 AMENDED COMPLAINT against all defendants, filed by all plaintiffs.(Rutherford, Alanna) (Entered: 09/27/2007)

09/27/2007 178 RESPONSE to Motion re 166 Letter MOTION for Leave to File Excess Pages inMemorandum of Law in Opposition to the Motion of the Ranis Company for ClassCertification filed by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered: 09/27/2007)

09/27/2007 179 AMENDED COMPLAINT Second Amended Class Action Complaint. Documentnumber 177 was filed in error against Defendant(s) in Civil Action AnimalScience vs Hebei, 05-CV-453, filed by Plaintiff(s) in Civil Action Animal Sciencevs Hebei, 05-CV-453. (Rutherford, Alanna) (Entered: 09/27/2007)

09/27/2007 180 Letter MOTION for Leave to File Excess Pages in Their Reply Memoranda inSupport of Their Motions for Class Certification by Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered: 09/27/2007)

09/27/2007 181 STATUS REPORT BY LETTER TO JUDGE ORENSTEIN by Animal ScienceProducts, Inc. Associated Cases: 1:06-md-01738-DGT-JO, 1:05-cv-00453-DGT-JO (Southwick, James) (Entered: 09/27/2007)

09/27/2007 182 NOTICE by Plaintiff(s) in Civil Action Cribbs vs Hebei Welcome PharmaceuticalCo. Ltd. 05-CV-6059, Plaintiff(s) in Civil Action Keane vs Hebei WelcomePharmaceutical Co. Ltd. 06-CV-149 OF CHANGE OF LAW FIRM NAMEAssociated Cases: 1:06-md-01738-DGT-JO et al. (Kovel, David) (Entered:09/27/2007)

09/28/2007 183 STATUS REPORT for Indirect Purchaser Plaintiffs by Vitamin C AntitrustLitigation (Walsh, Kenneth) (Entered: 09/28/2007)

09/28/2007 184 Letter re Defendants Non-Opposition to Letter Motion of Plaintiffs The RanisCompany, Inc. and Animal Products, Inc. to file Excess pages in Their ReplyMemoranda in Support of Their Motions for Class Certification [Doc #180] byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 (Agrawal,Suyash) (Entered: 09/28/2007)

09/28/2007 185 Letter Preconference by Hebei Welcome Pharmaceutical Co. Ltd. (Attachments: #1 Exhibit Exhibit A - Trager Order Sept. 25, 2007# 2 Exhibit Exhibit B -Defendants' Sept. 10 Response to Motion to Amend) (Prescott, Darrell) (Entered:09/28/2007)

10/02/2007 186 Minute Entry for proceedings held before James Orenstein : Status Conferenceheld on 10/2/2007. SCHEDULING: The next status conference will be held on

A-46Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page53 of 191

Page 54: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 47/137

December 3, 2007, at 2:00 p.m. Further conferences are scheduled as set forth inthe attached document. THE FOLLOWING RULINGS WERE MADE: Afterdiscussing scheduling matters with the parties, I ordered that, with one exception,merits discovery will be stayed until December 14, 2007 (the deadline for thedefendants to submit their opposition to the submission of new plaintiff Magno-Humphries Laboratories, Inc.). The exception is that the defendants shall timelyrespond to merits discovery requests that were pending as of today's date. In allother respects, I adopted the defendants' proposed amendments to the schedule,and will enter a separate order reflecting those revised deadlines. SEEATTACHED DOCUMENT. (Attachments: # 1 Appendix Appearances)(Kochendorfer, Kate) (Entered: 10/02/2007)

10/02/2007 187 PRETRIAL ORDER 4: The attached order contains amended discovery deadlinesand incorporates by reference certain other deadlines listed in docket entry 185 .In addition, the timing provisions of the Stipulation and Order of December 20,2006, docket entry 116 remain in effect. SEE ATTACHED ORDER. Ordered byJudge James Orenstein on October 2, 2007. (Kochendorfer, Kate) (Entered:10/02/2007)

10/10/2007 188 ORDER endorsed on 180 Motion for Leave to File Excess Pages. Applicationgranted. Ordered by Judge David G. Trager on 10/10/2007. (Trager, David)(Entered: 10/10/2007)

10/15/2007 189 Letter to Judge Orenstein re Service of Process by Plaintiff(s) in Civil ActionPhilion vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-987 (Attachments: # 1Affidavit D. Murphy# 2 Text of Proposed Order) (Rutherford, Alanna) (Entered:10/15/2007)

10/16/2007 ORDER re 189 Letter filed by Plaintiff(s) in Civil Action Philion vs HebeiWelcome Pharmaceutical Co. Ltd. 06-CV-987 -- Any party wishing to be heardon the matter is directed to respond in writing by October 18, 2007. Plaintiffs aredirected to serve their letter and my order on the new defendants. Ordered byJudge James Orenstein on October 16, 2007. (Kochendorfer, Kate) (Entered:10/16/2007)

10/16/2007 190 Letter by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453(Rutherford, Alanna) (Entered: 10/16/2007)

10/18/2007 191 Letter MOTION to Withdraw as Attorney for Shijiazhuang Pharmaceutical (USA)Inc. by Vitamin C Antitrust Litigation. (Mason, Daniel) (Entered: 10/18/2007)

10/22/2007 194 TRANSCRIPT of Proceedings held on 10/2/07 before Mag. Orenstein. CourtReporter: Mickey Brymer. Hebei Welcom - Daniel Prescott,Esq., and Charles H.Critchlow, Esq. Northest - Kenneth A. Lapatine, Esq. and James Ian Serota, Esq.Ranis, Animal Science, MHL - James T. Southwick, Esq. and Brent W. Landau,Esq. Audette - Kenneth Walsh, Esq. Weishang-China - Daniel S. Mason, Esq.(Greene, Donna) (Entered: 10/23/2007)

10/23/2007 192 FILING FEE: $ 25.00, receipt number 344187 received re:Pro Hace ViceAdmission for Ian Otto. (Guy, Alicia) (Entered: 10/23/2007)

10/23/2007 193 Letter to All Counsel of Record re October 25 call with Magistrate JudgeOrenstein re Letter MOTION to Withdraw as Attorney for Shijiazhuang

A-47Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page54 of 191

Page 55: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 48/137

Pharmaceutical (USA) Inc. filed October 18, 2007 191 by Vitamin C AntitrustLitigation (Mason, Daniel) (Entered: 10/23/2007)

10/25/2007 195 Letter MOTION for Extension of Time to File Answer , Move, or OtherwiseRespond to the Amended Consolidated Class Action Complaint to JudgeOrenstein by Jiangsu Jiangshan Pharmaceutical Co., Ltd.. (Goldstein, Richard)(Entered: 10/25/2007)

10/25/2007 196 Proposed Scheduling Order Authorizing Extension of Time to Respond toAmended Consolidated Class Action Complaint by Jiangsu JiangshanPharmaceutical Co., Ltd. (Goldstein, Richard) (Entered: 10/25/2007)

10/25/2007 197 Minute Entry for proceedings held before James Orenstein : TelephoneConference held on 10/25/2007. After hearing from Mr. Mason, counsel for SJZUSA, and representatives of the plaintiffs, I concluded that no disposition of Mr.Mason's pending motion to withdraw will have any effect on the rights orobligations of any party. Accordingly, the motion is moot and is denied on thatbasis. I note in addition that there is no reason to believe that SJZ USA is unableto cure the disability that currently prevents it from allowing its counsel to takeaction on its behalf in these proceedings; for that reason, allowing counsel towithdraw would create the risk of an otherwise unnecessary default. (Orenstein,James) (Entered: 10/25/2007)

10/25/2007 ORDER finding as moot 191 Motion to Withdraw as Attorney. See docket entry197. Ordered by Judge James Orenstein on October 25, 2007. (Orenstein, James)(Entered: 10/25/2007)

10/26/2007 ORDER granting 195 Motion for Extension of Time to Answer -- The applicationis granted. Defendant Jiangsu Jiangshan Pharmaceutical Co., Ltd. shall respond tothe Amended Consolidated Class Action Complaint 30 days after plaintiffs havefiled proof of service of the complaint on all defendants. Ordered by Judge JamesOrenstein on October 26, 2007. (Kochendorfer, Kate) (Entered: 10/26/2007)

10/26/2007 198 Letter enclosing Notice of Supplemental Motion to Dismiss and support papers(cover letter only) by Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453 (Goldstein, Richard) (Entered: 10/26/2007)

10/26/2007 199 Letter MOTION to Compel production of merits-related documents in response todocument production requests served by all plaintiffs. (Attachments: # 1 ExhibitA# 2 Exhibit B# 3 Exhibit C# 4 Exhibit D# 5 Exhibit E# 6 Exhibit F) AssociatedCases: 1:06-md-01738-DGT-JO et al. (Agrawal, Suyash) (Entered: 10/26/2007)

10/29/2007 ORDER denying 199 Motion to Compel -- The application is denied withoutprejudice to renewal in conformity with Rule III.A.1 of my individual practicerequirements. The parties shall meet and confer by November 2, 2007. Ordered byJudge James Orenstein on October 29, 2007. (Kochendorfer, Kate) (Entered:10/29/2007)

10/30/2007 200 Letter Pro Hac Vice Admission Letter by Defendant(s) in Civil Action AnimalScience vs Hebei, 05-CV-453 (Oliver, Patricia) (Entered: 10/30/2007)

10/30/2007 201 NOTICE of Appearance by Patricia K. Oliver on behalf of Vitamin C AntitrustLitigation (aty to be noticed) (Oliver, Patricia) (Entered: 10/30/2007)

A-48Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page55 of 191

Page 56: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 49/137

10/30/2007 202 Letter Motion for Extension of Time to File Answer, Move, or Otherwise Respondto the Second Amended Class-Action Complaint by Legend Ingredients Group,Inc. (Oliver, Patricia) Modified on 10/31/2007 to change this letter to a motion.(Vaughn, Terry). (Entered: 10/30/2007)

10/31/2007 ORDER granting 202 Motion for Extension of Time to Answer -- The applicationis granted; defendant Legend Ingredients Group, Inc., shall answer or otherwiserespond to the complaint by November 20, 2007. Ordered by Judge JamesOrenstein on October 31, 2007. (Kochendorfer, Kate) (Entered: 10/31/2007)

11/02/2007 203 NOTICE of Appearance by Ian Otto on behalf of Vitamin C Antitrust Litigation(aty to be noticed) (Otto, Ian) (Entered: 11/02/2007)

11/02/2007 204 Proposed Pretrial Order modification by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453 (Rutherford, Alanna) (Entered: 11/02/2007)

11/02/2007 205 Letter MOTION to Compel production of documents by all plaintiffs.(Attachments: # 1 Exhibit A# 2 Exhibit B# 3 Exhibit C# 4 Exhibit D# 5 ExhibitE# 6 Exhibit F) (Southwick, James) (Entered: 11/02/2007)

11/05/2007 ORDER re 204 Proposed Pretrial Order filed by Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453 -- The application is granted. I will enter aseparate pretrial order reflecting the amended deadlines. Ordered by Judge JamesOrenstein on November 5, 2007. (Kochendorfer, Kate) (Entered: 11/05/2007)

11/05/2007 206 PRETRIAL ORDER 5: The attached order contains amended discovery deadlinesand incorporates by reference certain other deadlines listed in docket entry 204. Inaddition, the timing provisions of the Stipulation and Order of December 20,2006, docket entry 116 remain in effect. SEE ATTACHED ORDER. Ordered byJudge James Orenstein on November 5, 2007. (Kochendorfer, Kate) (Entered:11/05/2007)

11/05/2007 207 SUMMONS Returned Executed by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453. Legend Ingredients Group, Inc. served on 10/11/2007, answerdue 10/31/2007. (Ratner, Brian) (Entered: 11/05/2007)

11/05/2007 208 SUMMONS Returned Executed by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453. Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453 served on 10/11/2007, answer due 10/31/2007. (Ratner, Brian) (Entered:11/05/2007)

11/05/2007 Reset Deadlines: Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453 answer due 11/20/2007; Legend Ingredients Group, Inc. answer due11/20/2007. See Order of Judge James Orenstein dated 11/5/2007, Document#206. (Lee, Tiffeny) (Entered: 11/06/2007)

11/07/2007 209 RESPONSE in Opposition re 205 Letter MOTION to Compel production ofdocuments filed by Hebei Welcome Pharmaceutical Co. Ltd.. (Attachments: # 1Exhibit A) (Critchlow, Charles) (Entered: 11/07/2007)

11/08/2007 ORDER granting 205 Motion to Compel. The motion is granted; I direct thedefendants immediately to produce all non-privileged records that are responsiveto the outstanding discovery requests, as set forth in the letter motion. To theextent the defendants understood my previous orders to allow them to withholdsuch production until December 14, 2007, they were incorrect. On the assumption

A-49Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page56 of 191

Page 57: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 50/137

that the dispute arose out of a good-faith misunderstanding of my prior orders, Idecline to order the reimbursement of costs pursuant to Federal Rule of CivilProcedure 37(a)(4)(A). Ordered by JudgeJames Orenstein on November 8, 2007.(Orenstein, James) (Entered: 11/08/2007)

11/19/2007 210 NOTICE of Change of Address by Ian Otto (Otto, Ian) (Entered: 11/19/2007)

11/19/2007 211 NOTICE of Change of Firm Affiliation by Ian Otto (Otto, Ian) (Entered:11/19/2007)

11/20/2007 212 NOTICE of Appearance by Richard Scott Goldstein on behalf of JSPC America,Inc. (aty to be noticed) (Goldstein, Richard) (Entered: 11/20/2007)

11/20/2007 213 Letter enclosing Notice of Motion to Dismiss Second Amended Complaint andsupporting papers (cover letter only) by Legend Ingredients Group, Inc., JSPCAmerica, Inc. (Goldstein, Richard) (Entered: 11/20/2007)

11/21/2007 214 NOTICE of Appearance by Stephen V. Bomse on behalf of JSPC America, Inc.(aty to be noticed) (Bomse, Stephen) (Entered: 11/21/2007)

11/28/2007 215 STATUS REPORT on behalf of all parties by Vitamin C Antitrust Litigation(Goldstein, Richard) (Entered: 11/28/2007)

11/29/2007 ORDER re 215 Status Report filed by Vitamin C Antitrust Litigation -- Theapplication is granted and the conference previously scheduled for December 3,2007 is cancelled. The next status conference is scheduled for February 1, 2008.Ordered by Magistrate Judge James Orenstein on November 29, 2007.(Kochendorfer, Kate) (Entered: 11/29/2007)

12/03/2007 216 MOTION for Extension of Time to File Answer to Motion to Dismiss the SecondAmended Complaint by Vitamin C Antitrust Litigation. (Rutherford, Alanna)(Entered: 12/03/2007)

12/04/2007 ORDER granting 216 Motion for Extension of Time to Answer -- The applicationis granted; the Class Plaintiffs shall respond to the motion to dismiss the secondamended complaint by December 5, 2007. Ordered by Magistrate Judge JamesOrenstein on December 4, 2007. (Kochendorfer, Kate) (Entered: 12/04/2007)

12/06/2007 217 Letter enclosing Plaintiffs' Memorandum of Law in Opposition to Defendants'Motions to Dismiss the Second Amended Complaint by Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453 (Ratner, Brian) (Entered: 12/06/2007)

12/12/2007 218 Letter MOTION for Extension of Time to File Response/Reply to Plaintiffs'Supplemental Memorandum in Support of Motion for Class Certification(Damages Class) by Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Goldstein, Richard) (Entered: 12/12/2007)

12/13/2007 ORDER granting 218 Motion for Extension of Time to File Response/Reply --The application is granted. The defendants shall respond to the Plaintiffs'Supplemental Memorandum in Support of Motion for Class Certification(Damages Class) by January 11, 2008. The plaintiffs' reply brief is due on January25, 2008. Ordered by Magistrate Judge James Orenstein on December 13, 2007.(Kochendorfer, Kate) (Entered: 12/13/2007)

12/14/2007 219 Supplemental MOTION to Dismiss Second Amended Complaint by Defendant(s)

A-50Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page57 of 191

Page 58: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 51/137

in Civil Action Animal Science vs Hebei, 05-CV-453. (Goldstein, Richard)(Entered: 12/14/2007)

12/14/2007 220 Supplemental MOTION to Dismiss Memorandum in Support by Defendant(s) inCivil Action Animal Science vs Hebei, 05-CV-453. (Goldstein, Richard) (Entered:12/14/2007)

12/14/2007 221 MOTION to Dismiss by Defendant(s) in Civil Action Animal Science vs Hebei,05-CV-453. (Attachments: # 1 Exhibit 1 Filed Under Seal) (Goldstein, Richard)(Entered: 12/14/2007)

12/14/2007 222 MOTION to Dismiss Second Amended Complaint by Legend Ingredients Group,Inc., JSPC America, Inc.. (Goldstein, Richard) (Entered: 12/14/2007)

12/14/2007 223 MOTION to Dismiss Memorandum in Support by Legend Ingredients Group,Inc., JSPC America, Inc.. (Goldstein, Richard) (Entered: 12/14/2007)

12/14/2007 224 MOTION to Dismiss Declaration by Richard Goldstein by Legend IngredientsGroup, Inc., JSPC America, Inc.. (Attachments: # 1 Exhibit 1) (Goldstein,Richard) (Entered: 12/14/2007)

12/14/2007 225 RESPONSE in Opposition re 219 Supplemental MOTION to Dismiss SecondAmended Complaint, 222 MOTION to Dismiss Second Amended Complaint filedby Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Goldstein,Richard) (Entered: 12/14/2007)

12/14/2007 226 REPLY to Response to Motion re 219 Supplemental MOTION to Dismiss SecondAmended Complaint filed by Defendant(s) in Civil Action Animal Science vsHebei, 05-CV-453. (Goldstein, Richard) (Entered: 12/14/2007)

12/14/2007 227 Supplemental MOTION to Dismiss Certificate of Service by Defendant(s) in CivilAction Animal Science vs Hebei, 05-CV-453. (Goldstein, Richard) (Entered:12/14/2007)

12/14/2007 228 REPLY to Response to Motion re 222 MOTION to Dismiss Second AmendedComplaint filed by Legend Ingredients Group, Inc., JSPC America, Inc..(Goldstein, Richard) (Entered: 12/14/2007)

12/14/2007 229 REPLY to Response to Motion re 222 MOTION to Dismiss Second AmendedComplaint Declaration by Ellen Jalkut filed by Legend Ingredients Group, Inc.,JSPC America, Inc.. (Attachments: # 1 Exhibit 1 Filed Under Seal) (Goldstein,Richard) (Entered: 12/14/2007)

12/14/2007 230 MOTION to Dismiss Certificate of Service by Legend Ingredients Group, Inc.,JSPC America, Inc.. (Goldstein, Richard) (Entered: 12/14/2007)

12/14/2007 231 Letter enclosing courtesy copies of filed motion to dismiss papers by Defendant(s)in Civil Action Animal Science vs Hebei, 05-CV-453 (Goldstein, Richard)(Entered: 12/14/2007)

12/18/2007 Motions terminated, docketed incorrectly: 230 MOTION to Dismiss Certificate ofService filed by JSPC America, Inc., Legend Ingredients Group, Inc., 221MOTION to Dismiss filed by Defendant(s) in Civil Action Animal Science vsHebei, 05-CV-453, 224 MOTION to Dismiss Declaration by Richard Goldstein

A-51Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page58 of 191

Page 59: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 52/137

filed by JSPC America, Inc., Legend Ingredients Group, Inc., 227 SupplementalMOTION to Dismiss Certificate of Service filed by Defendant(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453, 220 Supplemental MOTION to DismissMemorandum in Support filed by Defendant(s) in Civil Action Animal Science vsHebei, 05-CV-453, 223 MOTION to Dismiss Memorandum in Support filed byJSPC America, Inc., Legend Ingredients Group, Inc. THESE DOCUMENTS AREMEMORANDUMS, DECLARATIONS AND CERTIFICATES OF SERVICE.(Guy, Alicia) (Entered: 12/18/2007)

12/27/2007 232 TRANSCRIPT of Civil Cause for Motion Proceedings held on 6/5/07 @10:00a.m. before Judge David G. Trager. Court Reporter: Gene Rudolph. (Drayton,Lorraine) (Entered: 12/27/2007)

01/11/2008 233 Letter accompanying service of supplemental opposition to class certification byDefendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453 (Goldstein,Richard) (Entered: 01/11/2008)

01/14/2008 234 Letter accompanying Amended Supplemental Memorandum in Opposition toClass Certification by Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453 (Goldstein, Richard) (Entered: 01/14/2008)

01/18/2008 235 Letter MOTION for Protective Order by Defendants by Vitamin C AntitrustLitigation. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 ExhibitD, # 5 Exhibit E) (Bomse, Stephen) (Entered: 01/18/2008)

01/22/2008 ORDER re 235 Letter MOTION for Protective Order by Defendants filed byVitamin C Antitrust Litigation -- The plaintiffs shall respond in writing by January24, 2008. By the same date, I invite counsel for amicus curiae the Ministry ofCommerce for the People's Republic of China (the "PRC") to submit a lettersetting forth the extent, if any, to which it will use its good offices to facilitate theability of witnesses who reside in the PRC to provide the testimony to which theparties are entitled without undue burden or delay, either by relaxing theprohibition on conducting depositions within the PRC, by encouraging sisterministries to hasten the process of securing permission to travel abroad, or by anyother appropriate means. Ordered by Magistrate Judge James Orenstein onJanuary 22, 2008. (Kochendorfer, Kate) (Entered: 01/22/2008)

01/22/2008 236 Letter by Ministry of Commerce for the Peoples Republic of China (Mitnick, Joel)(Entered: 01/22/2008)

01/23/2008 237 Letter Plaintiffs' Letter Requesting Extension of Time and Page Limit byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 (Ratner, Brian)(Entered: 01/23/2008)

01/23/2008 238 ORDER endorsed on 237 Letter request for extension of time and page limit.Application granted. Ordered by Senior Judge David G. Trager on 1/23/2008.(Trager, David) (Entered: 01/23/2008)

01/24/2008 239 MEMORANDUM in Opposition re 235 Letter MOTION for Protective Order byDefendants filed by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Rutherford, Alanna) (Entered: 01/24/2008)

01/25/2008 240 MOTION for Leave to File Reply in Support of Defendants' Letter Motion forProtective Order by Vitamin C Antitrust Litigation. (Attachments: # 1 Proposed

A-52Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page59 of 191

Page 60: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 53/137

Reply) (Bomse, Stephen) (Entered: 01/25/2008)

01/29/2008 ORDER: The status conference scheduled for February 1, 2008 is rescheduled forFebruary 12, 2008, at 2:00 p.m. At that time, I will receive oral argument on thedefendants' motion for a protective order. Docket entry 235 . Counsel for amicuscuriae the Ministry of Commerce for the People's Republic of China is invited,but not required, to attend. Ordered by Magistrate Judge James Orenstein onJanuary 29, 2008. (Kochendorfer, Kate) (Entered: 01/29/2008)

02/04/2008 241 Letter to Magistrate Judge Orenstein by Ministry of Commerce for the PeoplesRepublic of China Associated Cases: 1:06-md-01738-DGT-JO et al. (Mitnick,Joel) (Entered: 02/04/2008)

02/07/2008 Email Notification Test - DO NOT REPLY (Fernandez, Erica) (Entered:02/07/2008)

02/07/2008 Email Notification Test - DO NOT REPLY (Fernandez, Erica) (Entered:02/07/2008)

02/08/2008 242 MOTION to Certify Class (Injunction Class) by Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453. (Rutherford, Alanna) (Entered:02/08/2008)

02/08/2008 243 MEMORANDUM in Support re 242 MOTION to Certify Class (Injunction Class)filed by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453.(Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 ExhibitJ) (Rutherford, Alanna) (Entered: 02/08/2008)

02/08/2008 244 REPLY in Support re 242 MOTION to Certify Class (Injunction Class) filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Rutherford,Alanna) (Entered: 02/08/2008)

02/08/2008 245 STATUS REPORT on behalf of all parties by Vitamin C Antitrust Litigation(Prescott, Darrell) (Entered: 02/08/2008)

02/08/2008 246 MOTION to Certify Class (Damages Class) by Plaintiff(s) in Civil Action Philionvs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-987. (Rutherford, Alanna)(Entered: 02/08/2008)

02/08/2008 247 MOTION to Certify Class (Damges Class) by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. (Rutherford, Alanna) (Entered: 02/08/2008)

02/08/2008 248 MEMORANDUM in Support re 247 MOTION to Certify Class (Damges Class)filed by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453.(Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 ExhibitJ) (Rutherford, Alanna) (Entered: 02/08/2008)

02/08/2008 249 MEMORANDUM in Support re 247 MOTION to Certify Class (Damges Class)Supplemental filed by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Rutherford, Alanna) (Entered: 02/08/2008)

02/08/2008 250 AFFIDAVIT/DECLARATION in Support re 247 MOTION to Certify Class(Damges Class) Declaration Of Magno-Humphries Laboratories, Inc. In Support

A-53Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page60 of 191

Page 61: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 54/137

Of Plaintiff's Motion For Class Certification filed by Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453. (Rutherford, Alanna) (Entered:02/08/2008)

02/08/2008 251 Letter addressed to Judge Trager enclosing fully briefed motion for Certificationof Class (Injunction Class) by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453 (Rutherford, Alanna) (Entered: 02/08/2008)

02/08/2008 252 Letter addressed to Judge Trager enclosing fully briefed motion for Certificationof Class (Damages Class) by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453 (Rutherford, Alanna) (Entered: 02/08/2008)

02/12/2008 253 Minute Entry for proceedings held before Magistrate Judge James Orenstein:Status Conference held on 2/12/2008. SCHEDULING: The next status conferencewill be held on April 1, 2008, at 2:00 p.m. THE FOLLOWING RULINGS WEREMADE: (1) For reasons set forth on the record, I denied the Defendants' motion,Docket Entry ("DE") 235, for a protective order with respect to notices ofdeposition for twelve current Chinese employees of the defendants. (2) In light ofthe ruling on the protective order, the parties will confer through counsel andsubmit a letter by March 7, 2008, setting forth either a joint proposal or competingproposals for amending the case management and scheduling order with newspecific deadlines for completing discovery. (Court Reporter Gene Rudolph.)(Attachments: # 1 Appendix Appearances) (Kochendorfer, Kate) (Entered:02/12/2008)

02/13/2008 ORDER denying 235 Motion for Protective Order; granting 240 Motion for Leaveto File. See docket entry 253 . Ordered by Magistrate Judge James Orenstein onFebruary 13, 2008. (Orenstein, James) (Entered: 02/13/2008)

02/13/2008 254 TRANSCRIPT of Proceedings held on February 12, 2008 before Judge JamesOrenstein. Court Reporter: Gene Rudolph. (Kochendorfer, Kate) (Entered:02/13/2008)

03/07/2008 255 Letter To Hon James Orenstein on behalf of defendant Northeast PhamaceuticalGroup as well as all parties advising of adjustment to Court's Case ManagementOrder (Pretrial Order No. 4) by Defendant(s) in Civil Action Animal Science vsHebei, 05-CV-453 (Lapatine, Kenneth) (Entered: 03/07/2008)

03/10/2008 256 PRETRIAL ORDER 6: The attached order contains amended discovery deadlinesand incorporates by reference certain other deadlines listed in docket entry 255 .In addition, the timing provisions of the Stipulation and Order of December 20,2006, docket entry 116 , remain in effect. SEE ATTACHED ORDER. Orderedby Magistrate Judge James Orenstein on March 10, 2008. (Kochendorfer, Kate)(Entered: 03/10/2008)

03/28/2008 257 STATUS REPORT on behalf of all parties by Vitamin C Antitrust Litigation(Goldstein, Richard) (Entered: 03/28/2008)

03/31/2008 SCHEDULING ORDER: The status conference scheduled for April 1, 2008 isrescheduled for June 17, 2008, at 2:00 p.m. Ordered by Magistrate Judge JamesOrenstein on March 31, 2008. (Kochendorfer, Kate) (Entered: 03/31/2008)

04/23/2008 258 MOTION for Leave to Appear Pro Hac Vice by Vitamin C Antitrust Litigation.(Attachments: # 1 Declaration of Charles E. Tompkins, # 2 Affidavit Besrat J.

A-54Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page61 of 191

Page 62: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 55/137

Gebrewold, # 3 Exhibit Proposed Order) (Tompkins, Charles) (Entered:04/23/2008)

04/24/2008 259 MOTION for Leave to File To File A Supplemental Memorandum In OppositionTo Defendants' Motion To Dismiss by Animal Science Products, Inc.. AssociatedCases: 1:06-md-01738-DGT-JO et al. (Rutherford, Alanna) (Entered: 04/24/2008)

04/24/2008 260 ORDER granting 258 Motion for Leave to Appear Pro Hac Vice -- AttorneyBesrat J. Gebrewold ("Gebrewold") is permitted to argue or try this case as co-counsel with Charles E. Tompkins. By May 1, 2008, Gebrewold shall register forECF. Registration is available online at the EDNY's homepage. Once registered,Gebrewold shall file a notice of appearance and ensure that he receives electronicnotification of activity in this case. Gebrewold shall also ensure that the $25admission fee be submitted to the Clerk's Office. Ordered by Magistrate JudgeJames Orenstein on April 24, 2008. (Kochendorfer, Kate) (Entered: 04/24/2008)

04/24/2008 261 Letter to Magistrate Orenstein Re: Removal of Confidentiality Designations byAnimal Science Products, Inc. (Attachments: # 1 Appendix) Associated Cases:1:06-md-01738-DGT-JO et al. (Rutherford, Alanna) Modified on 4/25/2008 tochange this letter to be a motion. (Vaughn, Terry). (Entered: 04/24/2008)

04/24/2008 262 Letter Pursuant to Paragraph 19 of Stipulated Protective Order (D.E. 133)Requesting Conference With Judge Orenstein by Hebei Welcome PharmaceuticalCo. Ltd. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Prescott, Darrell) (Entered: 04/24/2008)

04/24/2008 263 CERTIFICATE OF SERVICE by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453 re 259 MOTION for Leave to File To File A SupplementalMemorandum In Opposition To Defendants' Motion To Dismiss (Ratner, Brian)(Entered: 04/24/2008)

04/25/2008 SCHEDULING ORDER: A conference is scheduled to discuss the ClassPlaintiffs' letter motion, Docket Entry ("DE") 261, on May 8, 2008, at 2:00 p.m.The conference will be conducted in person unless any party shows good causewhy a substantive motion should be argued by telephone. Ordered by MagistrateJudge James Orenstein on April 25, 2008. (Kochendorfer, Kate) (Entered:04/25/2008)

04/29/2008 266 NOTICE of Appearance by Besrat J. Gebrewold on behalf of Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453 (notification declined) (Gebrewold,Besrat) (Entered: 04/29/2008)

04/29/2008 267 Letter MOTION for Extension of Time to File Response/Reply as to 259MOTION for Leave to File To File A Supplemental Memorandum In OppositionTo Defendants' Motion To Dismiss on behalf of all defendants by JiangsuJiangshan Pharmaceutical Co., Ltd., JSPC America, Inc.. (Goldstein, Richard)(Entered: 04/29/2008)

05/01/2008 268 ORDER endorsed on 259 Motion for Leave to File Supplemental Memorandum inOpposition to Defendants' Motion to Dismiss. Application granted. Ordered bySenior Judge David G. Trager on 5/1/2008. (Trager, David) (Greene, Donna).(Entered: 05/01/2008)

05/01/2008 269 ORDER endorsed on 267 Motion for Extension of Time to File Response/Reply

A-55Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page62 of 191

Page 63: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 56/137

to 259 Supplemental Memorandum In Opposition To Defendants' Motion ToDismiss. Application granted. Responses due by 5/28/2008. Ordered by SeniorJudge David G. Trager on 5/1/2008. (Trager, David) (Greene, Donna). (Entered:05/01/2008)

05/02/2008 270 Letter to Honorable James Orenstein by Vitamin C Antitrust Litigation (Mason,Daniel) (Entered: 05/02/2008)

05/02/2008 271 Letter to Honorable James Orenstein re request to appear telephonically at May8, 2008 conference by Legend Ingredients Group, Inc. (Oliver, Patricia) (Entered:05/02/2008)

05/05/2008 ORDER re 271 Letter filed by Legend Ingredients Group, Inc., 270 Letter filed byVitamin C Antitrust Litigation -- The applications are denied without prejudice torenewal upon seeking consent of all counsel. Ordered by Magistrate Judge JamesOrenstein on May 5, 2008. (Kochendorfer, Kate) (Entered: 05/05/2008)

05/05/2008 272 Letter to Honorable James Orenstein renewing request to appear telephonicallyat May 8, 2008 conference by defendants Shijiazhuang Pharma. WeishengPharmaceutical (Shijiazhuang) Co., Ltd. and China Pharmaceutical Group Co.,Ltd. by Vitamin C Antitrust Litigation (Mason, Daniel) (Entered: 05/05/2008)

05/05/2008 273 Letter to the Honorable James Orenstein renewing request to appeartelephonically at May 8, 2008 conference by Legend Ingredients Group, Inc.(Oliver, Patricia) (Entered: 05/05/2008)

05/06/2008 ORDER re 273 Letter filed by Legend Ingredients Group, Inc., 272 Letter, filedby Vitamin C Antitrust Litigation -- The applications are granted. Ordered byMagistrate Judge James Orenstein on May 6, 2008. (Kochendorfer, Kate)(Entered: 05/06/2008)

05/06/2008 274 MOTION to Substitute Attorney for Plaintiff Melanie Farley (N/K/A/ MelanieKing) by Plaintiff(s) in Civil Action Philion vs Hebei Welcome PharmaceuticalCo. Ltd. 06-CV-987. (Saveri, Richard) (Entered: 05/06/2008)

05/06/2008 275 DECLARATION re 274 MOTION to Substitute Attorney for Plaintiff MelanieFarley (N/K/A/ Melanie King) Declaration of Henry A. Cirillo by Plaintiff(s) inCivil Action Philion vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-987(Saveri, Richard) (Entered: 05/06/2008)

05/06/2008 276 DECLARATION re 274 MOTION to Substitute Attorney for Plaintiff MelanieFarley (N/K/A/ Melanie King) Declaration of Melanie Farley by Plaintiff(s) inCivil Action Philion vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-987(Saveri, Richard) (Entered: 05/06/2008)

05/06/2008 277 Proposed Pretrial Order Granting Motion of Melanie Farley to Substitute Counselby Plaintiff(s) in Civil Action Philion vs Hebei Welcome Pharmaceutical Co. Ltd.06-CV-987 (Saveri, Richard) (Entered: 05/06/2008)

05/07/2008 ORDER granting 274 Motion to Substitute Attorney. Added attorney R.Alexander Saveri for Plaintiff(s) in Civil Action Philion vs Hebei WelcomePharmaceutical Co. Ltd. 06-CV-987. Attorney Jon T. King and Michael P.Lehmann terminated. Ordered by Magistrate Judge James Orenstein on May 7,2008. (Kochendorfer, Kate) (Entered: 05/07/2008)

A-56Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page63 of 191

Page 64: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 57/137

05/08/2008 278 Minute Entry for proceedings held before Magistrate Judge James Orenstein:Motion Hearing held on 5/8/2008 re 261 MOTION to Compel filed by AnimalScience Products, Inc. SCHEDULING: The next status conference will be held onJune 17, 2008, at 2:00 p.m. THE FOLLOWING RULINGS WERE MADE: Iheard argument on the Class Plaintiffs' motion to remove the confidentialitydesignations of a group of documents produced by the manufacturer defendants.See DE 261 . After discussing the matter with counsel as set forth in the record, Iruled that, to the extent the information at issue in the motion reflects informationshared between competitors, the defendants failed to meet their burden ofdemonstrating that such information is "of a proprietary or commercially sensitivenature or should otherwise be subject to confidential treatment" simply becausethe information was shared pursuant to a mandate of the Chinese government buthad not otherwise been disseminated. The parties will confer as to whether thatruling applies to all of the information at issue in this motion or whether, instead,there are certain documents as to which the designation of confidentiality rests onsome other basis. If the parties remain in dispute as to such documents, they willsubmit the matter to me by means of letter-motion. (Court Reporter GeneRudolph.) (Attachments: # 1 Appendix Appearances) (Kochendorfer, Kate)(Entered: 05/08/2008)

05/12/2008 279 MOTION for Protective Order Precluding Deposition of Mr. Cai Dong Chen,Chairman of Defendant Shijiazhuang Pharma. Weisheng Pharmaceutical(Shijiazhuang) Co., Ltd. by Vitamin C Antitrust Litigation. (Attachments: # 1Affidavit in Support Declaration of Cai Dong Chen in Support of Motion for aProtective Order) (Mason, Daniel) (Entered: 05/12/2008)

05/15/2008 280 RESPONSE to Motion re 279 MOTION for Protective Order PrecludingDeposition of Mr. Cai Dong Chen, Chairman of Defendant Shijiazhuang Pharma.Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd. MOTION for Protective OrderPrecluding Deposition of Mr. Cai Dong Chen, Chairman of DefendantShijiazhuang Pharma. Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd. filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,James) (Entered: 05/15/2008)

05/15/2008 281 Transcript of Motion held on 2/12/2008, before Judge James Orenstein. CourtReporter: Gene Rudolph, Telephone number: (718) 613-2538. Transcript may beviewed at the court public terminal or purchased through the CourtReporter/Transcriber before the deadline for Release of Transcript Restriction.After that date it may be obtained through PACER. Redaction Request due6/5/2008. Redacted Transcript Deadline set for 6/16/2008. Release of TranscriptRestriction set for 8/13/2008. (Brucella, Michelle) (Entered: 05/15/2008)

05/16/2008 ORDER withdrawing 279 Motion for Protective Order -- See docket entry 280 .Ordered by Magistrate Judge James Orenstein on May 16, 2008. (Kochendorfer,Kate) (Entered: 05/16/2008)

05/20/2008 282 MOTION for Leave to File One Reply Brief to Direct Purchaser Plaintiffs andIndirect Purchaser Plaintiffs Separate Opposition to Defendants ChinaPharmaceutical Group and Shijiazhuang Pharma. Weisheng Pharmaceutical'sMotion to Dismiss for Lack of Personal Jurisdiction by Vitamin C AntitrustLitigation. (Mason, Daniel) (Entered: 05/20/2008)

05/21/2008 283 Letter MOTION for Extension of Time to File Response/Reply as to 269 Order on

A-57Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page64 of 191

Page 65: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 58/137

Motion for Extension of Time to File Response/Reply, on behalf of all Defendantsby Jiangsu Jiangshan Pharmaceutical Co., Ltd.. (Goldstein, Richard) (Entered:05/21/2008)

05/21/2008 284 ORDER endorsed on 282 Motion for Leave to File single reply brief notexceeding 25 substantive pages in length. Application granted. Ordered by SeniorJudge David G. Trager on 5/21/2008. (Trager, David) (Entered: 05/21/2008)

05/21/2008 285 ORDER endorsed on 283 Motion for Extension of Time to File Response/Replyas to 269 . Responses due by 6/9/2008. Application granted. Ordered by SeniorJudge David G. Trager on 5/21/2008. (Trager, David) (Entered: 05/21/2008)

05/27/2008 286 MOTION to Dismiss for Lack of Jurisdiction Notice of Motion and Motion toDismiss for Lack of Personal Jurisdiction by China Pharmaceutical Group Ltd..(Mason, Daniel) (Entered: 05/27/2008)

05/27/2008 287 MEMORANDUM in Support re 286 MOTION to Dismiss for Lack ofJurisdiction Notice of Motion and Motion to Dismiss for Lack of PersonalJurisdiction filed by China Pharmaceutical Group Ltd.. (Attachments: # 1Affidavit Declaration of Jin Yue) (Mason, Daniel) (Entered: 05/27/2008)

05/27/2008 288 Letter to Judge Trager enclosing fully brief Motion to Dismiss for Lack ofPersonal Jurisdiction by China Pharmaceutical Group Ltd. (Mason, Daniel)(Entered: 05/27/2008)

05/28/2008 289 Letter dated 5/27/2008 to the Clerks of court from Jiangxiao Athena Hourequesting case related documents to be filed under seal. (Lagana, Michael)(Entered: 05/29/2008)

05/28/2008 290 Letter dated 4/17/2008 to the Clerks of Court from Suyash Agrawal requestingcase related documents to be filed under seal. (Lagana, Michael) (Entered:05/29/2008)

05/29/2008 291 MEMORANDUM in Opposition re (286 in 1:06-md-01738-DGT-JO) MOTIONto Dismiss for Lack of Jurisdiction Notice of Motion and Motion to Dismiss forLack of Personal Jurisdiction filed by Plaintiff(s) in Civil Action Aminal Sciencevs Hebei, 05-CV-453 Sealed, placed in vault) (Lagana, Michael) Modified on5/30/2008 (Marziliano, August). Modified on 5/30/2008 (Marziliano, August).(Entered: 05/29/2008)

05/29/2008 292 DECLARATION in Opposition re (286 in 1:06-md-01738-DGT-JO) MOTION toDismiss for Lack of Jurisdiction Notice of Motion and Motion to Dismiss for Lackof Personal Jurisdiction filed by Plaintiff(s) in Civil Action Aminal Science vsHebei, 05-CV-453.(Sealed,placed in vault) (Lagana, Michael) Modified on5/30/2008 (Marziliano, August). Modified on 5/30/2008 (Marziliano, August).(Entered: 05/29/2008)

05/29/2008 293 DECLARATION in Opposition re (286 in 1:06-md-01738-DGT-JO) MOTION toDismiss for Lack of Jurisdiction Notice of Motion and Motion to Dismiss for Lackof Personal Jurisdiction filed by Plaintiff(s) in Civil Action Aminal Science vsHebei, 05-CV-453.( Sealed, placed in vault) (Lagana, Michael) Modified on5/30/2008 (Marziliano, August). Modified on 5/30/2008 (Marziliano, August).(Entered: 05/29/2008)

A-58Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page65 of 191

Page 66: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 59/137

05/29/2008 294 DECLARATION in Opposition re (286 in 1:06-md-01738-DGT-JO) MOTION toDismiss for Lack of Jurisdiction Notice of Motion and Motion to Dismiss for Lackof Personal Jurisdiction filed by APlaintiff(s) in Civil Action Aminal Science vsHebei, 05-CV-453. (Sealed,placed in vault) (Lagana, Michael) Modified on5/30/2008 (Marziliano, August). (Entered: 05/29/2008)

05/29/2008 295 Letter dated 4/30/2008 from Ian Otto to counsel regarding case related documentswhich are sealed. (Lagana, Michael) (Entered: 05/29/2008)

05/29/2008 296 MEMORANDUM in Opposition re (286 in 1:06-md-01738-DGT-JO) MOTIONto Dismiss for Lack of Jurisdiction Notice of Motion and Motion to Dismiss forLack of Personal Jurisdiction filed by Vitamin C Antitrust Litigation, Plaintiff(s)in Civil Action Philion vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-987,Plaintiff(s) in Civil Action Keane vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149, Plaintiff(s) in Civil Action Audette vs Hebei Welcome PharmaceuticalCo. Ltd. 06-CV-988. (sealed, placed in vault) (Lagana, Michael) (Entered:05/29/2008)

05/29/2008 297 DECLARATION in Opposition re (286 in 1:06-md-01738-DGT-JO) MOTION toDismiss for Lack of Jurisdiction Notice of Motion and Motion to Dismiss for Lackof Personal Jurisdiction filed by Vitamin C Antitrust Litigation, Plaintiff(s) inCivil Action Philion vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-987,Plaintiff(s) in Civil Action Keane vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149, Plaintiff(s) in Civil Action Audette vs Hebei Welcome PharmaceuticalCo. Ltd. 06-CV-988.( sealed, placed in vault) (Lagana, Michael) (Entered:05/29/2008)

05/29/2008 298 ERRATA re (297 in 1:06-md-01738-DGT-JO, 31 in 1:06-cv-00149-DGT-JO, 37in 1:06-cv-00988-DGT-JO, 34 in 1:06-cv-00987-DGT-JO) Affidavit inOpposition to Motion. (sealed placed in vault) (Lagana, Michael) Modified on5/30/2008 (Marziliano, August). (Entered: 05/29/2008)

05/29/2008 299 MEMORANDUM in Support of Supplemental Opposition to Defendants' Motionto Dismiss (PUBLIC VERSION) filed by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8,# 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, #14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18,# 19 Exhibit 19, # 20 Exhibit 20, # 21 Certificate of Service) (Ratner, Brian)(Entered: 05/29/2008)

05/29/2008 300 REPLY MEMORANDUM in Support re (286 in 1:06-md-01738-DGT-JO)MOTION to Dismiss for Lack of Jurisdiction Notice of Motion and Motion toDismiss for Lack of Personal Jurisdiction filed by China Pharmaceutical Group,Ltd., China Pharmaceutical Group Ltd.( sealed placed in vault) (Lagana, Michael)(Entered: 05/29/2008)

05/29/2008 301 DECLARATION in Support re (286 in 1:06-md-01738-DGT-JO) MOTION toDismiss for Lack of Jurisdiction Notice of Motion and Motion to Dismiss for Lackof Personal Jurisdiction filed by China Pharmaceutical Group LTD(sealed placedin vault) (Lagana, Michael) Modified on 5/30/2008 (Marziliano, August).(Entered: 05/29/2008)

A-59Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page66 of 191

Page 67: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 60/137

06/02/2008 302 Letter to Magistrate Orenstein re: Removal of Confidentiality Designations(Public Version) by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 (Attachments: # 1 Exhibit 1, # 2 Exhibit 2 (part 1), # 3 Exhibit 2 (part 2), # 4Exhibit 2 (part 3), # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)(Rutherford, Alanna) (Entered: 06/02/2008)

06/09/2008 303 MEMORANDUM in Support re 66 Notice of MOTION to Dismiss the Complaintwith prejudice, pursuant to Federal Rule of Civil Procedure 12(b)(1) and(6)Notice of MOTION to Dismiss the Complaint with prejudice, pursuant toFederal Rule of Civil Procedure 12(b)(1) and (6) Defendants' Response toPlaintiffs' Supplemental Memorandum in Opposition to Defendants' Motion toDismiss filed by Jiangsu Jiangshan Pharmaceutical Co., Ltd.. (Attachments: # 1Affidavit of Service) (Goldstein, Richard) (Entered: 06/09/2008)

06/09/2008 304 DECLARATION re 303 Memorandum in Support,, Declaration of Ellen Jalkut inSupport of Defendants' Response to Plaintiffs' Supplemental Memorandum inOpposition to Defendants' Motion to Dismiss by Jiangsu JiangshanPharmaceutical Co., Ltd. (Attachments: # 1 Exhibit 1) (Goldstein, Richard)(Entered: 06/09/2008)

06/09/2008 305 Letter accompanying courtesy copies of supplemental briefing to Judge Trager byJiangsu Jiangshan Pharmaceutical Co., Ltd. (Goldstein, Richard) (Entered:06/09/2008)

06/09/2008 306 Letter to Honorable. David G. Trager by Ministry of Commerce for the PeoplesRepublic of China (Attachments: # 1 Attachment I, # 2 Attachment II) (Mitnick,Joel) (Entered: 06/09/2008)

06/12/2008 307 STATUS REPORT on behalf of all parties Re: June 17, 2008 status conferenceby Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 (Southwick,James) (Entered: 06/12/2008)

06/18/2008 SCHEDULING ORDER: The status conference scheduled for June 17, 2008 isrescheduled for August 5, 2008, at 2:00 p.m. Ordered by Magistrate Judge JamesOrenstein on June 18, 2008. (Kochendorfer, Kate) (Entered: 06/18/2008)

06/20/2008 308 NOTICE of Voluntary Dismissal by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453 of Legend Ingredients Group, Inc. (Ratner, Brian) (Entered:06/20/2008)

06/20/2008 309 NOTICE by Legend Ingredients Group, Inc. OF WITHDRAWAL OF ITSMOTION TO DISMISS AND JOINDER IN DEFENDANTS' OPPOSITION TOMOTION FOR CLASS CERTIFICATION (Oliver, Patricia) (Entered: 06/20/2008)

07/10/2008 310 NOTICE of Change of law firm address by David E. Kovel Associated Cases:1:06-md-01738-DGT-JO et al. (Kovel, David) (Entered: 07/10/2008)

07/11/2008 311 Transcript of Proceedings held on May 8, 2008, before Judge James Orenstein.Court Reporter/Transcriber Gene Rudolph. Transcript may be viewed at the courtpublic terminal or purchased through the Court Reporter/Transcriber before thedeadline for Release of Transcript Restriction. After that date it may be obtainedthrough PACER. Redaction Request due 8/1/2008. Redacted Transcript Deadlineset for 8/11/2008. Release of Transcript Restriction set for 10/9/2008.(Kochendorfer, Kate) (Entered: 07/11/2008)

A-60Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page67 of 191

Page 68: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 61/137

07/11/2008 312 PRETRIAL ORDER 7: I have reminded counsel repeatedly about the importanceof avoiding the multiplication of electronic filings when docketing a submission inthe Master File of this multidistrict litigation. Most recently, I reminded counsel ata conference before me on May 8, 2008. Docket Entry ("DE") 311 at 3 (Transcriptof Proceedings). More thoroughly, I explained the need to avoid spreading text ina memorandum distributed to counsel on August 22, 2006. See Attachment 1. Thisobligation has been imposed on counsel almost since this case's inception. PretrialOrder 1 (Master File docket entry 12 ) requires any attorney docketing asubmission in this case "[t]o avoid duplicate filings and notice of filings [by]select[ing] NO when prompted whether to spread text." Pretrial Order 1 at 2.Counsel is reminded for a final time to make certain to file docket submissionsonly in the MDL Master Docket (06-MD-1738). Do not "spread text" from theMDL to the dockets of individual cases, and do not docket submissions in thoseindividuals cases. Failure to comply with this order will result in an order to showcause why I should not impose sanctions. Ordered by Magistrate Judge JamesOrenstein on July 11, 2008. (Attachments: # 1 Appendix Memorandum)(Kochendorfer, Kate) (Entered: 07/11/2008)

08/01/2008 313 STATUS REPORT Letter to Judge Orenstein Regarding August 5, 2008 StatusConference by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453(Landau, Brent) (Entered: 08/01/2008)

08/04/2008 SCHEDULING ORDER: The status conference scheduled for August 5, 2008 isrescheduled for September 10, 2008, at 2:00 p.m. Ordered by Magistrate JudgeJames Orenstein on August 4, 2008. (Kochendorfer, Kate) (Entered: 08/04/2008)

08/15/2008 314 Letter MOTION for Protective Order by Jiangsu Jiangshan Pharmaceutical Co.,Ltd.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C) (Bomse, Stephen)(Entered: 08/15/2008)

08/18/2008 315 MOTION for Protective Order filed by defendants Northeast PharmaceuticalGroup Co., Ltd and all other defendants except defendant Jiangsu JiangshamPharmaceutical Co., Ltd by Defendant(s) in Civil Action Animal Science vsHebei, 05-CV-453. (Attachments: # 1 Exhibit A, # 2 Exhibit B) (Lapatine,Kenneth) (Entered: 08/18/2008)

08/19/2008 316 RESPONSE in Opposition re 314 Letter MOTION for Protective Order, 315MOTION for Protective Order filed by defendants Northeast PharmaceuticalGroup Co., Ltd and all other defendants except defendant Jiangsu JiangshamPharmaceutical Co., Ltd filed by Vitamin C Antitrust Litigation. (Attachments: #1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4 filed under seal, # 5 Exhibit5 filed Under Seal, # 6 Exhibit 6 Filed Under Seal, # 7 Exhibit 7 Filed Under Seal,# 8 Exhibit 8 Filed Under Seal, # 9 Exhibit 9 Filed Under Seal, # 10 Exhibit 10Filed Under Seal) (Landau, Brent) (Entered: 08/19/2008)

08/20/2008 ORDER denying 314 Motion for Protective Order; denying 315 Motion forProtective Order -- I deny the defendants' motions for a protective order vacatingthe notices for depositions pursuant to Federal Rule of Civil Procedure 30(b)(6).The defendants have not persuaded me that the notices are improper. To the extentthat the defendants invoke a rule pursuant to which I "must," if the rule isapplicable, limit the extent of discovery, I find that they have not met their burden

A-61Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page68 of 191

Page 69: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 62/137

of showing that the discovery the plaintiffs seek is "unreasonably cumulative orduplicative, or can be obtained from some other source that is more convenient,less burdensome, or less expensive[.]" Fed. R. Civ. P. 26(b)(2)(C)(i). Specifically,the type of information the plaintiffs seek is properly discoverable, and cannot becompletely obtained through written questions (which do not allow for immediatefollow-up). As a result, the defendants have not demonstrated that there is a "moreconvenient, less burdensome, or less expensive" way for the plaintiffs to get thefull extent of the information to which they are entitled under Rule 30(b)(6). Evenif it is true, as the defendants argue, that the parties' overall discovery burdenscould have been lessened if the plaintiffs had noticed the Rule 30(b)(6)depositions sooner, that fact would neither establish that there are less burdensomealternatives available now, or that the plaintiffs are solely responsible for the lackof planning that will result in a less efficient course of discovery. Moreover, thedefendants have also failed to demonstrate that the information the plaintiffs seekis "unreasonably cumulative or duplicative" based on the fact that other individualemployees of the defendants have testified. Accordingly, Rule 26(b)(2)(C)(i) doesnot require the relief the defendants seek. Ordered by Magistrate Judge JamesOrenstein on August 20, 2008. (Kochendorfer, Kate) (Entered: 08/20/2008)

08/21/2008 317 Letter MOTION to Compel Documents Withheld by NEPG by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit A)(Landau, Brent) (Entered: 08/21/2008)

08/22/2008 318 NOTICE of Change of Address by Brent W. Landau (Landau, Brent) (Entered:08/22/2008)

08/26/2008 319 Letter from Joel M. Mitnick Counsel for by Ministry of Commerce for the PeoplesRepublic of China (Mitnick, Joel) (Entered: 08/26/2008)

08/26/2008 320 Letter dated August 26, 2008 from Defendant Northeast Pharmaceutical GroupCo., Ltd. by Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453(Lapatine, Kenneth) (Entered: 08/26/2008)

08/26/2008 321 RESPONSE in Opposition re 317 Letter MOTION to Compel DocumentsWithheld by NEPG filed by Defendant(s) in Civil Action Animal Science vsHebei, 05-CV-453. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4Exhibit D, # 5 Appendix Cover Page, # 6 Appendix Exhibit 1, # 7 AppendixExhibit 2, # 8 Appendix Exhibit 3, # 9 Appendix Exhibit 4, # 10 Appendix Exhibit5, # 11 Appendix Exhibit 6, # 12 Appendix Exhibit 7, # 13 Appendix Exhibit 8, #14 Appendix Exhibit 9) (Lapatine, Kenneth) (Entered: 08/26/2008)

08/27/2008 ORDER re 319 Letter filed by Ministry of Commerce for the Peoples Republic ofChina -- Parties are normally required to respond to letter-motions seekingdiscovery relief within three days. The Ministry may file an amicus submission nolater than August 29, 2008. Ordered by Magistrate Judge James Orenstein onAugust 27, 2008. (Kochendorfer, Kate) (Entered: 08/27/2008)

08/29/2008 322 Letter from J. Mitnick by Ministry of Commerce for the Peoples Republic ofChina (Mitnick, Joel) (Entered: 08/29/2008)

09/05/2008 323 Letter MOTION for Extension of Time to Complete Discovery by Vitamin CAntitrust Litigation. (Mason, Daniel) (Entered: 09/05/2008)

09/05/2008 324 STATUS REPORT by Vitamin C Antitrust Litigation (Mason, Daniel) (Entered:

A-62Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page69 of 191

Page 70: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 63/137

09/05/2008)

09/09/2008 325 RESPONSE in Opposition re 323 Letter MOTION for Extension of Time toComplete Discovery filed by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. (Southwick, James) (Entered: 09/09/2008)

09/10/2008 326 Minute Entry for proceedings held before Magistrate Judge James Orenstein:Status Conference held on 9/10/2008. SCHEDULING: The next status conferencewill be held on November 6, 2008, at 2:00 p.m. THE FOLLOWING RULINGSWERE MADE: (1) For the reasons set forth on the record, and in light of the factthat there is no procedural change in the case since I first considered thisapplication for a stay of discovery, see Docket Entry ("DE") 23 , I denied thedefendants' motion to adjourn expert discovery until after the court rendersjudgment on the defendants' motion to dismiss and the plaintiffs' motion for classcertification. DE 323 . (2) I heard argument, and reserved judgment, on theplaintiffs' motion to compel defendant Northeast Pharmaceutical Group Co., Ltd.to produce nine documents the plaintiffs assert are improperly withheld on thebasis of privilege. DE 317 . The Ministry of Commerce of the People's Republicof China was not represented as amicus curiae at the conference, despiterequesting the opportunity to be heard and filing a submission in opposition to themotion. DE 319 , 322 . (Court Reporter Burt Sulzer.) (Attachments: # 1 AppendixAppearances) (Kochendorfer, Kate) (Entered: 09/10/2008)

09/11/2008 327 Letter in further opposition to Plaintiff's motion to compel production by VitaminC Antitrust Litigation (Lapatine, Kenneth) (Entered: 09/11/2008)

09/22/2008 ORDER denying 323 Motion for Extension of Time to Complete Discovery -- Seedocket entry 326 . Ordered by Magistrate Judge James Orenstein on September22, 2008. (Kochendorfer, Kate) (Entered: 09/22/2008)

09/23/2008 328 NOTICE by Vitamin C Antitrust Litigation re Order on Motion for Extension ofTime to Complete Discovery Defendants' Objection to Magistrate Judge's OrderDenying Motion to Continue Dates for Expert Reports (Mason, Daniel) (Entered:09/23/2008)

09/25/2008 329 Transcript of Proceedings held on September 10, 2008, before Judge Orenstein.Court Reporter/Transcriber Burt Sulzer, Telephone number 718 613-2481.Transcript may be viewed at the court public terminal or purchased through theCourt Reporter/Transcriber before the deadline for Release of TranscriptRestriction. After that date it may be obtained through PACER. RedactionRequest due 10/16/2008. Redacted Transcript Deadline set for 10/27/2008.Release of Transcript Restriction set for 12/24/2008. (Sulzer, Burt) (Entered:09/25/2008)

09/26/2008 330 STIPULATION re 328 Notice(Other) Stipulation and [Proposed] OrderRegarding Briefing on Defendants' Objection to Magistrate Judge's OrderDenying Motion to Continue Dates for Expert Reports by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453 (Landau, Brent) (Entered:09/26/2008)

09/29/2008 331 Letter by Ministry of Commerce for the Peoples Republic of China (Mitnick, Joel)(Entered: 09/29/2008)

09/29/2008 332 ORDER endorsed on 330 Stipulation regarding briefing on defendants' objection

A-63Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page70 of 191

Page 71: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 64/137

to Magistrate Judge's orde denying motion to continue dates for expert reports.Plaintiffs' memorandum in opposition shall be served by 10/7/08 and defendants'reply shall be served by 10/14/08. Ordered by Senior Judge David G. Trager on9/29/2008. (Trager, David) (Entered: 09/29/2008)

10/07/2008 333 MEMORANDUM in Opposition re 328 Notice(Other) Plaintiffs' Opposition toDefendants' Objection to Magistrate Judge's Order Denying Motion to ContinueDates for Expert Reports filed by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Certificate of Service)(Landau, Brent) (Entered: 10/07/2008)

10/13/2008 334 REPLY in Support re 328 Notice(Other) Defendants' Reply Memorandum inSupport of Objection to Magistrate Judge's Order Denying Motion to ContnueDates for Expert Reports filed by all defendants. (Mason, Daniel) (Additionalattachment(s) added on 12/18/2013: # 1 Annex A, # 2 Annex B, # 3 Sealing CoverSheet and Cover Letter) (Marziliano, August). (Entered: 10/13/2008)

10/14/2008 335 NOTICE of Change of Firm, Address and Email by Richard Scott Goldstein(Goldstein, Richard) (Entered: 10/14/2008)

10/20/2008 336 NOTICE of Change of Firm Name by Daniel C. Hedlund (Hedlund, Daniel)(Entered: 10/20/2008)

10/30/2008 337 STATUS REPORT on behalf of all parties Re: November 6, 2008 statusconference by Hebei Welcome Pharmaceutical Co. Ltd. (Critchlow, Charles)(Entered: 10/30/2008)

10/31/2008 SCHEDULING ORDER: -- The status conference scheduled for November 6,2008 is rescheduled for January 21, 2009, at 10:30 a.m. Ordered by MagistrateJudge James Orenstein on October 31, 2008. (Fick, Sarah) (Entered: 10/31/2008)

11/06/2008 338 MEMORANDUM AND ORDER denying defendants' motion to dismiss thecomplaints under the act of state doctrine, foreign sovereign compulsion andinternational comity. Defendants' motions to dismiss the second amendedcomplaint are granted. Plaintiffs have 30 days to replead the second amendedcomplaint to make allegations against JSPC and Legend. Ordered by Senior JudgeDavid G. Trager on 11/6/2008. (Trager, David) (Entered: 11/06/2008)

11/07/2008 339 Letter MOTION for Extension of Time to File Expert Reports by Plaintiff(s) inCivil Action Animal Science vs Hebei, 05-CV-453. (Rutherford, Alanna)(Entered: 11/07/2008)

11/10/2008 ORDER granting 339 Motion for Extension of Time to File -- The motion isgranted. Ordered by Magistrate Judge James Orenstein on November 10, 2008.(Turner, Juno) (Entered: 11/10/2008)

11/11/2008 340 STIPULATION of all Counsel and [Proposed] Order Regarding a Stay of theIndirect Purchaser Action by Weisheng Pharmaceutical Co. Ltd. (Mason, Daniel)(Entered: 11/11/2008)

11/13/2008 341 Letter from Richard S. Goldstein to The Honorable David G. Trager, re:Defendants respectfully request a status conference by Jiangsu JiangshanPharmaceutical Co., Ltd., JSPC America, Inc. (Goldstein, Richard) (Entered:

A-64Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page71 of 191

Page 72: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 65/137

11/13/2008)

11/14/2008 342 NOTICE by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453Notice of Firm Name Change and Notice of Appearance (Olson, Steig) (Entered:11/14/2008)

11/14/2008 343 Letter to the Honorable David G. Trager opposing defendants' request for a statusconference and stay by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 (Rutherford, Alanna) (Entered: 11/14/2008)

11/17/2008 Email Notification Test - DO NOT REPLY (Marziliano, August) (Entered:11/17/2008)

11/17/2008 Email Notification Test - DO NOT REPLY (Marziliano, August) (Entered:11/17/2008)

11/17/2008 344 Letter Re Pro Hac Vice Admission by Plaintiff(s) in Civil Action Animal Sciencevs Hebei, 05-CV-453 (Brown, Benjamin) (Entered: 11/17/2008)

11/17/2008 345 NOTICE of Appearance by Benjamin D. Brown on behalf of Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453 (aty to be noticed) (Brown,Benjamin) (Entered: 11/17/2008)

11/17/2008 346 NOTICE by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 re342 Notice(Other) Notice of Firm Name Change (Gebrewold, Besrat) (Entered:11/17/2008)

11/19/2008 SCHEDULING ORDER re 341 , 343 : The Honorable David G. Trager, UnitedStates District Judge, has authorized me to direct the parties' counsel to appearbefore him on December 5, 2008 at 2:30 p.m. The parties shall submit memorandasetting forth their respective views on the matters to be discussed at theconference no later than 12:00 noon on December 1, 2008. The defendants'request to hold further proceedings in abeyance pending the conference is denied;the deadlines set forth in Pretrial Order 6, Docket Entry 256 , remain in effect.Ordered by Magistrate Judge James Orenstein on November 19, 2008. (Turner,Juno) (Entered: 11/19/2008)

11/19/2008 347 STIPULATION and Proposed Order on Expert Discovery by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453 (Attachments: # 1 Proposed Orderon Expert Discovery) (Rutherford, Alanna) (Entered: 11/19/2008)

11/20/2008 ORDER re 347 Stipulation filed by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453 -- So ordered. Ordered by Magistrate Judge James Orensteinon November 20, 2008. (Turner, Juno) (Entered: 11/20/2008)

11/26/2008 348 NOTICE of Change of Firm Affiliation by Michael D. Hausfeld , Brian A. Ratner,Charles E. Tompkins, and Brent W. Landau (Hausfeld, Michael) (Entered:11/26/2008)

11/26/2008 349 NOTICE by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453Notice of Substitution of Counsel (Hausfeld, Michael) (Entered: 11/26/2008)

11/26/2008 350 STIPULATION re 24 Order, Stipulation and [Proposed] Order Substituting Co-Lead Counsel by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453(Attachments: # 1 Proposed Order) (Hausfeld, Michael) (Entered: 11/26/2008)

A-65Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page72 of 191

Page 73: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 66/137

12/01/2008 ORDER re 350 Stipulation filed by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453 -- I will rule on the application to substitute counsel upon thesubmission of some evidence that the relevant clients either do or do not consentto it. Ordered by Magistrate Judge James Orenstein on December 1, 2008.(Turner, Juno) (Entered: 12/01/2008)

12/01/2008 351 STATUS REPORT / Defendants' Statement In Advance Of December 5, 2008Conference by Weisheng Pharmaceutical Co. Ltd., Hebei WelcomePharmaceutical Co. Ltd., Jiangsu Jiangshan Pharmaceutical Co., Ltd., JSPCAmerica, Inc., China Pharmaceutical Group Ltd. (Goldstein, Richard) (Entered:12/01/2008)

12/01/2008 352 STATUS REPORT on Outstanding Matters for December 5, 2008 StatusConference by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453(Southwick, James) (Entered: 12/01/2008)

12/01/2008 353 STATUS REPORT On Outstanding Matters for December 5, 2008 StatusConference by Plaintiff(s) in Civil Action Audette vs Hebei WelcomePharmaceutical Co. Ltd. 06-CV-988 (Attachments: # 1 Exhibit A) (Hedlund,Daniel) (Entered: 12/01/2008)

12/02/2008 354 NOTICE by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 ofFiling Plaintiffs' Declarations (Attachments: # 1 Declaration of Magno-Humphries Laboratories, Inc., # 2 Declaration of Counsel for the Ranis Company,# 3 Declaration of Animal Science Products, Inc.) (Hausfeld, Michael) (Entered:12/02/2008)

12/02/2008 355 AMENDED COMPLAINT Third Amended Class Action Complaint against alldefendants, filed by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Letter to Judge Trager, # 2 Comparison of Second andThird Amended Complaints) (Rutherford, Alanna) (Entered: 12/02/2008)

12/04/2008 356 STATUS REPORT Memorandum on Defendants' Request to File a Motion forInterlocutory Appeal and Related to December 5 Status Conference by Plaintiff(s)in Civil Action Animal Science vs Hebei, 05-CV-453 (Rutherford, Alanna)(Entered: 12/04/2008)

12/05/2008 357 Minute Entry for proceedings held before Senior Judge David G. Trager: StatusConference held on 12/5/2008. (Court Reporter Victoria Torres Butler)(Attachments: # 1 Plaintiff's Sign In, # 2 Defense Sign In) (Siegfried, Evan)(Entered: 12/09/2008)

12/09/2008 358 FILING FEE: $ 25.00, receipt number 360725. Received on motion for PHV byCadio Zirpoli. (Siegfried, Evan) (Entered: 12/09/2008)

12/16/2008 359 NOTICE of Change of Address by Cadio Zirpoli (Zirpoli, Cadio) (Entered:12/16/2008)

01/15/2009 360 STATUS REPORT On Behalf of All Parties to Judge Orenstein RegardingJanuary 21, 2009 Status Conference by Hebei Welcome Pharmaceutical Co. Ltd.(Critchlow, Charles) (Entered: 01/15/2009)

01/16/2009 SCHEDULING ORDER: The status conference previously scheduled for January21, 2009 is rescheduled for March 31, 2009 at 10:30 a.m. Ordered by Magistrate

A-66Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page73 of 191

Page 74: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 67/137

Judge James Orenstein on January 16, 2009. (Turner, Juno) (Entered: 01/16/2009)

01/16/2009 361 NOTICE of Change of Address by Ian P. Otto (Otto, Ian) (Entered: 01/16/2009)

01/16/2009 362 NOTICE of Change of Firm Name by Daniel Mason (Mason, Daniel) (Entered:01/16/2009)

01/22/2009 363 NOTICE of Appearance by Anastasia Angelova Angelova on behalf ofDefendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453 (aty to benoticed) (Angelova, Anastasia) (Entered: 01/22/2009)

01/30/2009 364 Defendant Hebei Welcome Pharmaceutical Co. Ltd.'s ANSWER to 355 AmendedComplaint, by Hebei Welcome Pharmaceutical Co. Ltd.. (Critchlow, Charles)(Entered: 01/30/2009)

01/30/2009 365 Defendant Shijiazhuang Pharma's ANSWER to 355 Amended Complaint, byWeisheng Pharmaceutical Co. Ltd.. (Mason, Daniel) (Entered: 01/30/2009)

01/30/2009 366 ANSWER to 355 Amended Complaint, by Jiangsu Jiangshan Pharmaceutical Co.,Ltd.. (Attachments: # 1 Certificate of Service) (Goldstein, Richard) (Entered:01/30/2009)

01/30/2009 367 ANSWER to 355 Amended Complaint, by JSPC America, Inc.. (Attachments: # 1Certificate of Service) (Goldstein, Richard) (Entered: 01/30/2009)

01/30/2009 368 ANSWER to 355 Amended Complaint, by Defendant(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. (Angelova, Anastasia) (Entered: 01/30/2009)

03/16/2009 369 NOTICE of Change of Address for Jonathan M. Palmer by Richard ScottGoldstein (Goldstein, Richard) (Entered: 03/16/2009)

03/26/2009 370 Letter MOTION for Extension of Time to Complete Discovery on behalf of allparties by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453.(Attachments: # 1 Proposed Order Proposed Stipulated Scheduling Order)(Southwick, James) (Entered: 03/26/2009)

03/27/2009 ORDER granting 370 Motion for Extension of Time to Complete Discovery --The stipulation is so ordered. Ordered by Magistrate Judge James Orenstein on3/27/2009. (Turner, Juno) (Entered: 03/27/2009)

03/27/2009 SCHEDULING ORDER: The status conference previously scheduled for March31, 2009 is rescheduled for June 1, 2009 at 10:30 a.m. Ordered by MagistrateJudge James Orenstein on 3/27/2009. (Turner, Juno) (Entered: 03/27/2009)

03/27/2009 371 Fully Briefed MOTION to Dismiss for Lack of Jurisdiction Cover Letter toHonorable Judge Trager Enclosing Motion Papers Filed Under Seal byDefendants North China Pharmaceutical Group Corp., North ChinaPharmaceutical Co., Ltd., and North China Pharmaceutical Group InternationalTrade Co., Ltd. (f/k/a North China Pharmaceutical Group Import and ExportTrade Co., Ltd.), by Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Prescott, Darrell) (Entered: 03/27/2009)

03/30/2009 372 MOTION to Dismiss by North China Pharmaceutical Group, et al. Memorandumin support of motion to dismiss. Plaintiff's opposition to motion to dismiss.Declaration of support of plaintiff's opposition. Reply memo in support of North

A-67Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page74 of 191

Page 75: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 68/137

China Pharmaceutical. Declaration of Christopher Chin. Documents filed underseal and placed in vault. (Siegfried, Evan) (Entered: 03/30/2009)

05/26/2009 373 MOTION to Adjourn Conference by Plaintiff(s) in Civil Action Animal Sciencevs Hebei, 05-CV-453. (Rutherford, Alanna) (Entered: 05/26/2009)

05/27/2009 ORDER granting 373 Motion to Adjourn Conference -- The motion is granted.The status conference previously scheduled for June 1, 2009 is rescheduled forAugust 5, 2009 at 11:00 a.m. Ordered by Magistrate Judge James Orenstein on5/27/2009. (Turner, Juno) (Entered: 05/27/2009)

07/28/2009 374 Letter MOTION to Adjourn Conference for Two Months by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered:07/28/2009)

07/30/2009 ORDER granting 374 Motion to Adjourn Conference -- The motion is granted andthe status conference previously scheduled for August 5, 2009 is rescheduled forOctober 6, 2009 at 11:00 a.m. Ordered by Magistrate Judge James Orenstein on7/30/2009. (Turner, Juno) (Entered: 07/30/2009)

08/14/2009 375 NOTICE of Appearance by Annabelle Chan on behalf of JSPC America, Inc.,Jiangsu Jiangshan Pharmaceutical Co., Ltd. (aty to be noticed) (Chan, Annabelle)(Entered: 08/14/2009)

08/17/2009 376 Letter MOTION for Leave to File Excess Pages And For Permission To Submit AJoint Memorandum Of Law In Support of Motion For Summary Judgment byHebei Welcome Pharmaceutical Co. Ltd., Jiangsu Jiangshan Pharmaceutical Co.,Ltd., Northeast Pharmaceutical Group Co., Ltd., Shijiazhuang Pharma. WeishengPharmaceutical Co., Ltd.. (Goldstein, Richard) (Entered: 08/17/2009)

08/18/2009 377 ORDER granting 376 Motion for Leave to File Excess Pages. Ordered by SeniorJudge David G. Trager on 8/18/2009. (Siegfried, Evan) (Entered: 08/18/2009)

08/31/2009 378 NOTICE of Appearance by Scott Allan Martin on behalf of NortheastPharmaceutical Group Co., Ltd. (aty to be noticed) (Martin, Scott) (Entered:08/31/2009)

10/01/2009 379 STATUS REPORT by all parties re October 6, 2009 Status Conference byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 (Agrawal,Suyash) (Entered: 10/01/2009)

10/02/2009 ORDER re 350 Stipulation filed by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453 -- So ordered. Ordered by Magistrate Judge James Orensteinon 10/2/2009. (Turner, Juno) (Entered: 10/02/2009)

10/02/2009 SCHEDULING ORDER: re 379 Status Report filed by Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453 -- The status conference previouslyscheduled for October 6, 2009 is rescheduled for January 20, 2010 at 11:00 a.m.Ordered by Magistrate Judge James Orenstein on 10/2/2009. (Turner, Juno)(Entered: 10/02/2009)

10/09/2009 380 Letter MOTION for Leave to File Excess Pages for Plaintiffs' Joint Memorandumof Law in Opposition to Defendants' Motion for Summary Judgment by Plaintiff(s)in Civil Action Animal Science vs Hebei, 05-CV-453. (Ratner, Brian) (Entered:10/09/2009)

A-68Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page75 of 191

Page 76: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 69/137

10/13/2009 381 ORDER in case 1:05-cv-00453-DGT-JO; granting (380) Motion for Leave to FileExcess Pages in case 1:06-md-01738-DGT-JO. Ordered by Senior Judge David G.Trager on 10/11/2009. Associated Cases: 1:06-md-01738-DGT-JO et al.(Siegfried, Evan) (Entered: 10/13/2009)

10/28/2009 382 Letter MOTION for Extension of Time to File Response/Reply Briefs in Supportof Defendants Motions for Summary Judgment, Letter MOTION for Leave to FileExcess Pages by China Pharmaceutical Group Ltd., Hebei WelcomePharmaceutical Co. Ltd., JSPC America, Inc., Jiangsu Jiangshan PharmaceuticalCo., Ltd., Northeast Pharmaceutical Group Co., Ltd., Shijiazhuang Pharma.Weisheng Pharmaceutical Co., Ltd.. (Goldstein, Richard) (Entered: 10/28/2009)

10/28/2009 383 Letter MOTION to Withdraw as Attorney by JSPC America, Inc., JiangsuJiangshan Pharmaceutical Co., Ltd.. (Attachments: # 1 Declaration of AnnabelleChan in Support, # 2 Proposed Order) (Chan, Annabelle) (Entered: 10/28/2009)

10/28/2009 384 NOTICE of Appearance by Steven Robert Newmark on behalf of JSPC America,Inc., Jiangsu Jiangshan Pharmaceutical Co., Ltd. (aty to be noticed) (Newmark,Steven) (Entered: 10/28/2009)

10/29/2009 ORDER granting 383 Motion to Withdraw as Attorney. Attorney Annabelle Chanterminated. Ordered by Magistrate Judge James Orenstein on 10/29/2009. (Stein,Noah) (Entered: 10/29/2009)

10/29/2009 385 ORDER granting 382 Motion for Extension of Time to File Response/Reply ; and,granting 382 Motion for Leave to File Excess Pages. Ordered by Senior JudgeDavid G. Trager on 10/28/2009. (Lee, Tiffeny) (Entered: 10/29/2009)

11/04/2009 386 NOTICE of Appearance by Jennifer Milici on behalf of The Ranis Company, Inc.(aty to be noticed) (Attachments: # 1 PHV Receipt) Associated Cases: 1:06-md-01738-DGT-JO et al. (Siegfried, Evan) (Entered: 11/04/2009)

11/20/2009 387 MOTION for Summary Judgment CHINA PHARMACEUTICAL GROUP LTD.SNOTICE OF MOTION AND ALTERNATIVE MOTION FOR SUMMARYJUDGMENT by China Pharmaceutical Group Ltd.. (Attachments: # 1MEMORANDUM OF LAW IN SUPPORT OF ALTERNATIVE MOTION FORSUMMARY JUDGMENT, # 2 LOCAL RULE 56.1 STATEMENT INSUPPORT OF ALTERNATIVE MOTION FOR SUMMARY JUDGMENT, # 3DECLARATION OF JIANGXIAO HOU IN SUPPORT OF ALTERNATIVEMOTION FOR SUMMARY JUDGMENT, # 4 Exhibit A TO DECLARATIONOF JIANGXIAO HOU ALTERNATIVE MOTION FOR SUMMARYJUDGMENT, # 5 Exhibit B TO DECLARATION OF JIANGXIAO HOUALTERNATIVE MOTION FOR SUMMARY JUDGMENT, # 6 Exhibit C TODECLARATION OF JIANGXIAO HOU ALTERNATIVE MOTION FORSUMMARY JUDGMENT, # 7 Exhibit D TO DECLARATION OF JIANGXIAOHOU ALTERNATIVE MOTION FOR SUMMARY JUDGMENT, # 8 Exhibit ETO DECLARATION OF JIANGXIAO HOU ALTERNATIVE MOTION FORSUMMARY JUDGMENT, # 9 Exhibit F TO DECLARATION OF JIANGXIAOHOU ALTERNATIVE MOTION FOR SUMMARY JUDGMENT, # 10 ExhibitG TO DECLARATION OF JIANGXIAO HOU ALTERNATIVE MOTION FORSUMMARY JUDGMENT) (Mason, Daniel) (Entered: 11/20/2009)

11/20/2009 388 MEMORANDUM in Opposition re 387 MOTION for Summary Judgment

A-69Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page76 of 191

Page 77: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 70/137

CHINA PHARMACEUTICAL GROUP LTD.S NOTICE OF MOTION ANDALTERNATIVE MOTION FOR SUMMARY JUDGMENT PLAINTIFFSOPPOSITION TO CHINA PHARMACEUTICAL GROUP LTD.S MOTION FORSUMMARY JUDGMENT filed by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453. (Attachments: # 1 PLAINTIFFS LOCAL RULE 56.1STATEMENT OF MATERIAL FACTS IN SUPPORT OF THEIR OPPOSITIONTO CHINA PHARMACEUTICAL GROUP LTD.S MOTION FOR SUMMARYJUDGMENT, # 2 DECLARATION OF SUYASH AGRAWAL IN SUPPORT OFPLAINTIFFS OPPOSITION TO CHINA PHARMACEUTICAL GROUP LTD.SMOTION FOR SUMMARY JUDGMENT, # 3 DEPOSITION EXCERPTS OFJIN YUE AS CPG'S RULE 30(B)(6) CORPORATE REPRESENTATIVE ONJURISDICTIONAL ISSUES, # 4 Exhibit 1 TO DECLARATION OF SUYASHAGRAWAL IN SUPPORT OF PLAINTIFFS OPPOSITION TO CHINAPHARMACEUTICAL GROUP LTD.S MOTION FOR SUMMARYJUDGMENT, # 5 Exhibit 5 TO DECLARATION OF SUYASH AGRAWAL INSUPPORT OF PLAINTIFFS OPPOSITION TO CHINA PHARMACEUTICALGROUP LTD.S MOTION FOR SUMMARY JUDGMENT, # 6 Exhibit 7 TODECLARATION OF SUYASH AGRAWAL IN SUPPORT OF PLAINTIFFSOPPOSITION TO CHINA PHARMACEUTICAL GROUP LTD.S MOTIONFOR SUMMARY JUDGMENT, # 7 Exhibit 8 TO DECLARATION OFSUYASH AGRAWAL IN SUPPORT OF PLAINTIFFS OPPOSITION TOCHINA PHARMACEUTICAL GROUP LTD.S MOTION FOR SUMMARYJUDGMENT, # 8 Exhibit 9 TO DECLARATION OF SUYASH AGRAWAL INSUPPORT OF PLAINTIFFS OPPOSITION TO CHINA PHARMACEUTICALGROUP LTD.S MOTION FOR SUMMARY JUDGMENT, # 9 Exhibit 10 TODECLARATION OF SUYASH AGRAWAL IN SUPPORT OF PLAINTIFFSOPPOSITION TO CHINA PHARMACEUTICAL GROUP LTD.S MOTIONFOR SUMMARY JUDGMENT, # 10 Exhibit 11 TO DECLARATION OFSUYASH AGRAWAL IN SUPPORT OF PLAINTIFFS OPPOSITION TOCHINA PHARMACEUTICAL GROUP LTD.S MOTION FOR SUMMARYJUDGMENT, # 11 Exhibit 16 TO DECLARATION OF SUYASH AGRAWALIN SUPPORT OF PLAINTIFFS OPPOSITION TO CHINAPHARMACEUTICAL GROUP LTD.S MOTION FOR SUMMARYJUDGMENT, # 12 Exhibit 18 TO DECLARATION OF SUYASH AGRAWALIN SUPPORT OF PLAINTIFFS OPPOSITION TO CHINAPHARMACEUTICAL GROUP LTD.S MOTION FOR SUMMARYJUDGMENT, # 13 Exhibit 20 TO DECLARATION OF SUYASH AGRAWALIN SUPPORT OF PLAINTIFFS OPPOSITION TO CHINAPHARMACEUTICAL GROUP LTD.S MOTION FOR SUMMARYJUDGMENT, # 14 Exhibit 21 TO DECLARATION OF SUYASH AGRAWALIN SUPPORT OF PLAINTIFFS OPPOSITION TO CHINAPHARMACEUTICAL GROUP LTD.S MOTION FOR SUMMARYJUDGMENT, # 15 Exhibit 23 TO DECLARATION OF SUYASH AGRAWALIN SUPPORT OF PLAINTIFFS OPPOSITION TO CHINAPHARMACEUTICAL GROUP LTD.S MOTION FOR SUMMARYJUDGMENT, # 16 Exhibit 24 TO DECLARATION OF SUYASH AGRAWALIN SUPPORT OF PLAINTIFFS OPPOSITION TO CHINAPHARMACEUTICAL GROUP LTD.S MOTION FOR SUMMARYJUDGMENT, # 17 Exhibit 25 TO DECLARATION OF SUYASH AGRAWALIN SUPPORT OF PLAINTIFFS OPPOSITION TO CHINA

A-70Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page77 of 191

Page 78: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 71/137

PHARMACEUTICAL GROUP LTD.S MOTION FOR SUMMARYJUDGMENT, # 18 Exhibit 26 TO DECLARATION OF SUYASH AGRAWALIN SUPPORT OF PLAINTIFFS OPPOSITION TO CHINAPHARMACEUTICAL GROUP LTD.S MOTION FOR SUMMARYJUDGMENT, # 19 Exhibit 27 TO DECLARATION OF SUYASH AGRAWALIN SUPPORT OF PLAINTIFFS OPPOSITION TO CHINAPHARMACEUTICAL GROUP LTD.S MOTION FOR SUMMARYJUDGMENT, # 20 Exhibit 28 TO DECLARATION OF SUYASH AGRAWALIN SUPPORT OF PLAINTIFFS OPPOSITION TO CHINAPHARMACEUTICAL GROUP LTD.S MOTION FOR SUMMARYJUDGMENT, # 21 Exhibit A TO DECLARATION OF SUYASH AGRAWALIN SUPPORT OF PLAINTIFFS OPPOSITION TO CHINAPHARMACEUTICAL GROUP LTD.S MOTION FOR SUMMARYJUDGMENT, # 22 Exhibit B TO DECLARATION OF SUYASH AGRAWALIN SUPPORT OF PLAINTIFFS OPPOSITION TO CHINAPHARMACEUTICAL GROUP LTD.S MOTION FOR SUMMARYJUDGMENT, # 23 Exhibit C TO DECLARATION OF SUYASH AGRAWALIN SUPPORT OF PLAINTIFFS OPPOSITION TO CHINAPHARMACEUTICAL GROUP LTD.S MOTION FOR SUMMARYJUDGMENT, # 24 Exhibit D TO DECLARATION OF SUYASH AGRAWALIN SUPPORT OF PLAINTIFFS OPPOSITION TO CHINAPHARMACEUTICAL GROUP LTD.S MOTION FOR SUMMARYJUDGMENT, # 25 Exhibit E TO DECLARATION OF SUYASH AGRAWAL INSUPPORT OF PLAINTIFFS OPPOSITION TO CHINA PHARMACEUTICALGROUP LTD.S MOTION FOR SUMMARY JUDGMENT, # 26 Exhibit F TODECLARATION OF SUYASH AGRAWAL IN SUPPORT OF PLAINTIFFSOPPOSITION TO CHINA PHARMACEUTICAL GROUP LTD.S MOTIONFOR SUMMARY JUDGMENT, # 27 Exhibit G TO DECLARATION OFSUYASH AGRAWAL IN SUPPORT OF PLAINTIFFS OPPOSITION TOCHINA PHARMACEUTICAL GROUP LTD.S MOTION FOR SUMMARYJUDGMENT, # 28 Exhibit H TO DECLARATION OF SUYASH AGRAWALIN SUPPORT OF PLAINTIFFS OPPOSITION TO CHINAPHARMACEUTICAL GROUP LTD.S MOTION FOR SUMMARYJUDGMENT, # 29 Exhibit I TO DECLARATION OF SUYASH AGRAWAL INSUPPORT OF PLAINTIFFS OPPOSITION TO CHINA PHARMACEUTICALGROUP LTD.S MOTION FOR SUMMARY JUDGMENT, # 30 Exhibit J TODECLARATION OF SUYASH AGRAWAL IN SUPPORT OF PLAINTIFFSOPPOSITION TO CHINA PHARMACEUTICAL GROUP LTD.S MOTIONFOR SUMMARY JUDGMENT, # 31 Exhibit K TO DECLARATION OFSUYASH AGRAWAL IN SUPPORT OF PLAINTIFFS OPPOSITION TOCHINA PHARMACEUTICAL GROUP LTD.S MOTION FOR SUMMARYJUDGMENT, # 32 Exhibit L TO DECLARATION OF SUYASH AGRAWAL INSUPPORT OF PLAINTIFFS OPPOSITION TO CHINA PHARMACEUTICALGROUP LTD.S MOTION FOR SUMMARY JUDGMENT) (Mason, Daniel)(Entered: 11/20/2009)

11/20/2009 389 REPLY in Support re 387 MOTION for Summary Judgment CHINAPHARMACEUTICAL GROUP LTD.S NOTICE OF MOTION ANDALTERNATIVE MOTION FOR SUMMARY JUDGMENT REPLYMEMORANDUM IN SUPPORT OF CHINA PHARMACEUTICAL GROUPLTD.S ALTERNATIVE MOTION FOR SUMMARY JUDGMENT filed by China

A-71Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page78 of 191

Page 79: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 72/137

Pharmaceutical Group Ltd.. (Attachments: # 1 DECLARATION OF JIANGXIAOHOU IN SUPPORT OF REPLY MEMORANDUM IN SUPPORT OFDEFENDANT CHINA PHARMACEUTICAL GROUP LTD.S ALTERNATIVEMOTION FOR SUMMARY JUDGMENT, # 2 Exhibit A TO DECLARATIONOF JIANGXIAO HOU IN SUPPORT OF REPLY MEMORANDUM INSUPPORT OF DEFENDANT CHINA PHARMACEUTICAL GROUP LTD.SALTERNATIVE MOTION FOR SUMMARY JUDGMENT, # 3 Exhibit B TODECLARATION OF JIANGXIAO HOU IN SUPPORT OF REPLYMEMORANDUM IN SUPPORT OF DEFENDANT CHINAPHARMACEUTICAL GROUP LTD.S ALTERNATIVE MOTION FORSUMMARY JUDGMENT) (Mason, Daniel) (Entered: 11/20/2009)

11/20/2009 390 Letter to the Honorable David G. Trager by China Pharmaceutical Group Ltd.(Mason, Daniel) (Entered: 11/20/2009)

11/23/2009 391 MOTION for Summary Judgment by Hebei Welcome Pharmaceutical Co. Ltd.,Jiangsu Jiangshan Pharmaceutical Co., Ltd., Northeast Pharmaceutical Group Co.,Ltd., Shijiazhuang Pharma. Weisheng Pharmaceutical Co., Ltd.. (Goldstein,Richard) (Entered: 11/23/2009)

11/23/2009 392 RULE 56.1 STATEMENT re 391 MOTION for Summary Judgment or, in theAlternative, for Determination of Foreign Law and Entry of Judgment Pursuant toRule 44.1, Fed. R. Civ. P. filed by Hebei Welcome Pharmaceutical Co. Ltd.,Jiangsu Jiangshan Pharmaceutical Co., Ltd., Northeast Pharmaceutical Group Co.,Ltd., Shijiazhuang Pharma. Weisheng Pharmaceutical Co., Ltd.. (Goldstein,Richard) (Entered: 11/23/2009)

11/23/2009 393 MEMORANDUM in Support re 391 MOTION for Summary Judgment or, in theAlternative, for Determination of Foreign Law and Entry of Judgment Pursuant toRule 44.1, Fed. R. Civ. P. filed by Hebei Welcome Pharmaceutical Co. Ltd.,Jiangsu Jiangshan Pharmaceutical Co., Ltd., Northeast Pharmaceutical Group Co.,Ltd., Shijiazhuang Pharma. Weisheng Pharmaceutical Co., Ltd.. (Goldstein,Richard) (Entered: 11/23/2009)

11/23/2009 394 AFFIDAVIT/DECLARATION in Support re 391 MOTION for SummaryJudgment or, in the Alternative, for Determination of Foreign Law and Entry ofJudgment Pursuant to Rule 44.1, Fed. R. Civ. P. filed by Hebei WelcomePharmaceutical Co. Ltd., Jiangsu Jiangshan Pharmaceutical Co., Ltd., NortheastPharmaceutical Group Co., Ltd., Shijiazhuang Pharma. Weisheng PharmaceuticalCo., Ltd.. (Attachments: # 1 Exhibits 1-5, # 2 Exhibits 6-12, # 3 Exhibits 13-22, #4 Exhibits 23-39, # 5 Exhibits 40-44, # 6 Exhibits 45-48, # 7 Exhibit 49, # 8Exhibits 50-52, # 9 Exhibits 53-59) (Goldstein, Richard) (Additionalattachment(s) added on 11/30/2009: # 10 Exhibit 35) (Marziliano, August).(Entered: 11/23/2009)

11/23/2009 395 MEMORANDUM in Opposition re 391 MOTION for Summary Judgment or, inthe Alternative, for Determination of Foreign Law and Entry of JudgmentPursuant to Rule 44.1, Fed. R. Civ. P. filed by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. (Goldstein, Richard) (Entered: 11/23/2009)

11/23/2009 396 RULE 56.1 STATEMENT re 391 MOTION for Summary Judgment or, in theAlternative, for Determination of Foreign Law and Entry of Judgment Pursuant to

A-72Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page79 of 191

Page 80: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 73/137

Rule 44.1, Fed. R. Civ. P. filed by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453. (Goldstein, Richard) (Entered: 11/23/2009)

11/23/2009 397 AFFIDAVIT/DECLARATION in Opposition re 391 MOTION for SummaryJudgment or, in the Alternative, for Determination of Foreign Law and Entry ofJudgment Pursuant to Rule 44.1, Fed. R. Civ. P. filed by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit A, # 2Exhibit B, # 3 Exhibits C-G, # 4 Exhibit H, # 5 Exhibit I, # 6 Exhibits J-M, # 7Exhibit N (Part 1 of 2), # 8 Exhibit N (Part 2 of 2), # 9 Exhibits O-R, # 10Exhibits S-U, # 11 Exhibits V-X, # 12 Exhibits Y-CC, # 13 Exhibits DD-II, # 14Exhibit JJ, # 15 Exhibits KK-MM, # 16 Exhibits NN-RR, # 17 Exhibits SS-VV, #18 Exhibits WW-YY, # 19 Exhibit 21, # 20 Exhibits 37,38,40,42, # 21 Exhibits43,47,49, # 22 Exhibits 50,51,52,53,54,56, # 23 Exhibits 57,58,59,61,64, # 24Exhibits 65,72,74, # 25 Exhibits 76,79,81,83, # 26 Exhibits 85,86,87,88,92, # 27Exhibits 111,119,135, # 28 Exhibits 136,137,138,139, # 29 Exhibits 141,142, # 30Exhibits 144,149,150, # 31 Exhibits 154,159,160,162,164,176,233) (Goldstein,Richard) (Additional attachment(s) added on 11/30/2009: # 32 Exhibit B, # 33Exhibit E, # 34 Exhibit F, # 35 Errata H) (Marziliano, August). (Additionalattachment(s) added on 11/30/2009: # 36 Exhibit 56, # 37 Errata 59 61 and 64, #38 Exhibit 65 and 74, # 39 76 79 81 and 83, # 40 Exhibit 85 86 and 88, # 41Exhibit 11 119 and 135, # 42 136 137 138 and 139, # 43 Exhibit 141, # 44 Exhibit149 and 150, # 45 Exhibit 176) (Marziliano, August). (Entered: 11/23/2009)

11/23/2009 398 REPLY in Support re 391 MOTION for Summary Judgment or, in theAlternative, for Determination of Foreign Law and Entry of Judgment Pursuant toRule 44.1, Fed. R. Civ. P. filed by Hebei Welcome Pharmaceutical Co. Ltd.,Jiangsu Jiangshan Pharmaceutical Co., Ltd., Northeast Pharmaceutical Group Co.,Ltd., Shijiazhuang Pharma. Weisheng Pharmaceutical Co., Ltd.. (Goldstein,Richard) (Entered: 11/23/2009)

11/23/2009 399 AFFIDAVIT/DECLARATION in Support re 391 MOTION for SummaryJudgment or, in the Alternative, for Determination of Foreign Law and Entry ofJudgment Pursuant to Rule 44.1, Fed. R. Civ. P. filed by Hebei WelcomePharmaceutical Co. Ltd., Jiangsu Jiangshan Pharmaceutical Co., Ltd., NortheastPharmaceutical Group Co., Ltd., Shijiazhuang Pharma. Weisheng PharmaceuticalCo., Ltd.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4,# 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12) (Goldstein, Richard) (Entered:11/23/2009)

11/23/2009 400 Letter from Richard S. Goldstein to the Honorable David G. Trager by HebeiWelcome Pharmaceutical Co. Ltd., Jiangsu Jiangshan Pharmaceutical Co., Ltd.,Northeast Pharmaceutical Group Co., Ltd., Shijiazhuang Pharma. WeishengPharmaceutical Co., Ltd. (Attachments: # 1 Statement Of The Ministry OfCommerce of the PRC, dated 8/31/09) (Goldstein, Richard) (Entered: 11/23/2009)

11/23/2009 401 MOTION for Summary Judgment by JSPC America, Inc.. (Goldstein, Richard)(Entered: 11/23/2009)

11/23/2009 402 RULE 56.1 STATEMENT re 401 MOTION for Summary Judgment filed byJSPC America, Inc.. (Goldstein, Richard) (Entered: 11/23/2009)

11/23/2009 403 MEMORANDUM in Support re 401 MOTION for Summary Judgment filed by

A-73Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page80 of 191

Page 81: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 74/137

JSPC America, Inc.. (Goldstein, Richard) (Entered: 11/23/2009)

11/23/2009 404 AFFIDAVIT/DECLARATION in Support re 401 MOTION for SummaryJudgment filed by JSPC America, Inc.. (Attachments: # 1 Exhibits 1-8, # 2Exhibits 9-17) (Goldstein, Richard) (Additional attachment(s) added on11/30/2009: # 3 Exhibit 8, # 4 Exhibit 10, # 5 Exhibit 11, # 6 Exhibit 12)(Marziliano, August). (Entered: 11/23/2009)

11/23/2009 405 MEMORANDUM in Opposition re 401 MOTION for Summary Judgment filedby Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453.(Attachments: # 1 Certificate of Service) (Goldstein, Richard) (Entered:11/23/2009)

11/23/2009 406 RULE 56.1 STATEMENT re 401 MOTION for Summary Judgment filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Goldstein,Richard) (Entered: 11/23/2009)

11/23/2009 407 AFFIDAVIT/DECLARATION in Opposition re 401 MOTION for SummaryJudgment filed by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibits 1-7) (Goldstein, Richard) (Additionalattachment(s) added on 11/30/2009: # 2 Exhibit 3,4 and 5) (Marziliano, August).(Entered: 11/23/2009)

11/23/2009 408 REPLY in Support re 401 MOTION for Summary Judgment filed by JSPCAmerica, Inc.. (Goldstein, Richard) (Entered: 11/23/2009)

11/23/2009 409 RULE 56.1 STATEMENT re 401 MOTION for Summary Judgment filed byJSPC America, Inc.. (Goldstein, Richard) (Entered: 11/23/2009)

11/23/2009 410 AFFIDAVIT/DECLARATION in Support re 401 MOTION for SummaryJudgment filed by JSPC America, Inc.. (Attachments: # 1 Exhibit 1) (Goldstein,Richard) (Entered: 11/23/2009)

12/07/2009 411 Plaintiffs' Opposition to China Pharmaceutical Group Ltd.'s Motion for SummaryJudgment; Plaintiffs' Local Rule 56.1 Statement; Declaration of Suyash Agrawalin Support of Plaintiffs' Opposition and confidential exhibits. Documents sealedand placed in vault. (Manuel, Germaine) (Entered: 12/07/2009)

01/13/2010 412 STATUS REPORT by all parties for Jan. 20, 2010 conference by Plaintiff(s) inCivil Action Animal Science vs Hebei, 05-CV-453 (Agrawal, Suyash) (Entered:01/13/2010)

01/14/2010 SCHEDULING ORDER: re 412 Status Report filed by Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453 -- The application is granted; the statusconference previously scheduled for January 20, 2010 is rescheduled for May 20,2010 at 10:30 a.m. Ordered by Magistrate Judge James Orenstein on 1/14/2010.(Stein, Noah) (Entered: 01/14/2010)

01/14/2010 413 Letter MOTION for Leave to File Sur-Reply in Opposition to Defendants' Motionfor Summary Judgment or Determination of Foreign Law (Doc #391) byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments: #1 Memorandum in Opposition Sur-Reply) (Agrawal, Suyash) (Entered:01/14/2010)

01/15/2010 414 Letter MOTION to Withdraw as Attorney by JSPC America, Inc., Jiangsu

A-74Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page81 of 191

Page 82: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 75/137

Jiangshan Pharmaceutical Co., Ltd.. (Attachments: # 1 Declaration of Jonathan M.Palmer in Support, # 2 Proposed Order) (Goldstein, Richard) (Entered:01/15/2010)

01/19/2010 415 ORDER granting 413 Motion for Leave to File. Ordered by Senior Judge DavidG. Trager on 1/15/2010. (Siegfried, Evan) (Entered: 01/19/2010)

01/19/2010 416 REPLY in Opposition re 391 MOTION for Summary Judgment (sur-replypermitted by D.E. 415) filed by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453. (Agrawal, Suyash) (Entered: 01/19/2010)

01/19/2010 ORDER granting 414 Motion to Withdraw as Attorney -- The application isgranted; attorney Jonathan M. Palmer terminated. Ordered by Magistrate JudgeJames Orenstein on 1/19/2010. (Stein, Noah) (Entered: 01/19/2010)

02/01/2010 417 Letter Motion From Richard S. Goldstein To The Honorable James OrensteinRequesting Defendant's Name Change From "Jiangsu Jiangshan PharmaceuticalCo., Ltd." To "Aland (Jiangsu) Nutraceutical Co., Ltd." by Jiangsu JiangshanPharmaceutical Co., Ltd. (Goldstein, Richard) (Entered: 02/01/2010)

02/02/2010 ORDER re 417 Letter, filed by Jiangsu Jiangshan Pharmaceutical Co., Ltd. -- Theapplication is granted. The Clerk is respectfully directed to change the party nameJiangsu Jiangshan Pharmaceutical Co., Ltd. to Aland (Jiangsu) Nutraceutical Co.,Ltd. in the caption in this case and in the cases with the following docket numbers:05-cv-0453, 06-cv-0987, and 06-cv-0988. Ordered by Magistrate Judge JamesOrenstein on 2/2/2010. (Stein, Noah) (Entered: 02/02/2010)

02/05/2010 418 Letter To The Honorable David G. Trager by Aland (Jiangsu) Nutraceutical Co.,Ltd (Goldstein, Richard) (Entered: 02/05/2010)

02/05/2010 419 REPLY in Opposition re 391 MOTION for Summary Judgment /Defendants'Response To Plaintiffs' Sur-Reply Opposing Summary Judgment AndDetermination Of Foreign Law (Response to D.E. 416) filed by Aland (Jiangsu)Nutraceutical Co., Ltd. (Goldstein, Richard) (Entered: 02/05/2010)

04/20/2010 420 NOTICE of Change of Address of Orrick, Herrington & Sutcliffe LLP to 51 West52nd Street, New York, New York 10019 by Steven Robert Newmark (Newmark,Steven) (Entered: 04/20/2010)

05/04/2010 421 Letter to Judge Trager Regarding Opinion by Hebei Welcome PharmaceuticalCo. Ltd. (Attachments: # 1 Appendix Opinion Part 1, # 2 Appendix Opinion Part2, # 3 Appendix Opinion Part 3) (Prescott, Darrell) (Entered: 05/04/2010)

05/13/2010 422 STATUS REPORT on behalf of all parties re May 20, 2010 Status Conference byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 (Agrawal,Suyash) (Entered: 05/13/2010)

05/13/2010 ORDER re 422 Status Report -- The application is granted; the status conferencepreviously scheduled for May 20, 2010 is adjourned without date pendingresolution of the motions for summary judgment. Ordered by Magistrate JudgeJames Orenstein on 5/13/2010. (Stein, Noah) (Entered: 05/13/2010)

01/19/2011 423 JPMDL Order reassigning litigation to the Honorable Brian Cogan. AssociatedCases: 1:06-md-01738-DGT-JO et al. (Marziliano, August) (Entered: 01/19/2011)

A-75Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page82 of 191

Page 83: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 76/137

01/19/2011 Judge Brian M. Cogan added. Senior Judge David G. Trager no longer assigned tocase. Associated Cases: 1:06-md-01738-DGT-JO et al. (Marziliano, August)(Entered: 01/19/2011)

01/20/2011 424 MEMORANDUM AND ORDER granting in part and denying in part 317 Motionto Compel -- For the reasons set forth in the attached memorandum and order, Igrant in part and deny in part the motion to compel; specifically, I order defendantNortheast Pharmaceutical Group Co., Ltd. to produce documents numbered 1, 3,4, 6, 7, 8, 13, and 43 in its Privilege Log but deny similar relief with respect todocument number 17. SEE ATTACHED MEMORANDUM AND ORDER.Ordered by Magistrate Judge James Orenstein on 1/20/2011. (Lardo, Melissa)(Entered: 01/20/2011)

02/03/2011 425 Letter Requesting Permission to submit documents ex parte for in camera reviewby Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453 (Cohen,Philip) (Entered: 02/03/2011)

02/03/2011 ORDER granting 425 Letter permitting to submit documents ex parte for incamera review filed by Defendant(s) in Civil Action Animal Science vs Hebei,05-CV-453. Ordered by Judge Brian M. Cogan on 2/3/2011. (Clarke, Melonie)(Entered: 02/03/2011)

02/03/2011 426 DECLARATION re 424 Order on Motion to Compel,, of Philip H. Cohen inSupport of Objectioin to Discovery Order of the Magistrate by NortheastPharmaceutical Group Co., Ltd. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3Exhibit C, # 4 Exhibit D, # 5 Appendix Cover Page, # 6 Ex 1, # 7 Ex 2, # 8 Ex 3,# 9 Ex 4, # 10 Ex 5, # 11 Ex 6, # 12 Ex 7, # 13 Ex 8, # 14 Ex 9) (Cohen, Philip)(Entered: 02/03/2011)

02/03/2011 427 MEMORANDUM in Opposition re 424 Order on Motion to Compel,, Objectionto Magistrate Orenstein's January 20, 2011 Memorandum and Order filed byNortheast Pharmaceutical Group Co., Ltd.. (Cohen, Philip) (Entered: 02/03/2011)

02/03/2011 428 DECLARATION re 424 Order on Motion to Compel,, of Philip H. Cohen inSupport of Objection to Discovery Order of the Magistrate by NortheastPharmaceutical Group Co., Ltd. (Attachments: # 1 Exhibit A - Redacted, # 2Exhibit B - Redacted, # 3 Exhibit C - Redacted, # 4 Exhibit D - Redacted, # 5Appendix Cover Sheet, # 6 Ex 1 - Redacted, # 7 Ex 2 - Redacted, # 8 Ex 3 -Redacted, # 9 Ex 4 - Redacted, # 10 Ex 5 - Redacted, # 11 Ex 6 - Redacted, # 12Ex 7 Redacted, # 13 Ex 8 - Redacted, # 14 Ex 9 - Redacted) (Cohen, Philip)(Entered: 02/03/2011)

02/03/2011 429 REDACTION to 427 Exparte, Memorandum in Opposition NortheastPharmaceutical's Objection to Magistrate Orenstein's January 20, 2011Memorandum and Order by Northeast Pharmaceutical Group Co., Ltd. (Cohen,Philip) (Entered: 02/03/2011)

02/07/2011 430 REPLY in Opposition re 427 Exparte, Memorandum in Opposition re Order onMotion to Compel, Objection to Magistrate Orenstein's January 20, 2011Memorandum and Order filed by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453. (Attachments: # 1 Declaration Declaration of Brent W.Landau, # 2 Exhibit A, # 3 Certificate of Service Certificate of Service) (Landau,Brent) (Entered: 02/07/2011)

A-76Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page83 of 191

Page 84: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 77/137

02/10/2011 431 REPLY in Support re 427 Exparte, Memorandum in Opposition ReplyDeclaration of Philip H. Cohen in Support of Objection To Judge Orenstein'sJanuary 20, 2011 Memorandum and Order filed by Northeast PharmaceuticalGroup Co., Ltd.. (Attachments: # 1 Exhibit A) (Cohen, Philip) (Entered:02/10/2011)

02/10/2011 432 MEMORANDUM in Support re 427 Exparte, Memorandum in Opposition Replyin Support of Objection to Judge Orenstein's January 20, 2011 Memorandum andOrder filed by Northeast Pharmaceutical Group Co., Ltd.. (Cohen, Philip)(Entered: 02/10/2011)

03/25/2011 433 Letter To The Honorable Brian M. Cogan, re: supplemental authority by Aland(Jiangsu) Nutraceutical Co., Ltd, JSPC America, Inc. (Attachments: # 1 ExhibitA) (Goldstein, Richard) (Entered: 03/25/2011)

06/23/2011 434 MOTION for Summary Judgment Originally filed on 11/23/2009 as Docket Entry96, 96-1 & 96-2 in case number 05-cv-00453. by Northeast Pharmaceutical GroupCo., Ltd.. (Attachments: # 1 Exhibit Cover Letter, # 2 Rule 56.1 Statement)(Serota, James) (Entered: 06/23/2011)

06/23/2011 435 MEMORANDUM in Support re 434 MOTION for Summary JudgmentOriginally filed on 11/23/2009 as Docket Entry 96, 96-1 & 96-2 in case number05-cv-00453. Dkt Entry No. 97 in 05-cv-00453 filed by Northeast PharmaceuticalGroup Co., Ltd.. (Serota, James) (Entered: 06/23/2011)

06/23/2011 436 AFFIDAVIT/DECLARATION in Support re 434 MOTION for SummaryJudgment Originally filed on 11/23/2009 as Docket Entry 96, 96-1 & 96-2 in casenumber 05-cv-00453. Dkt Entry 98 & 98-1 in 05-cv-00453 filed by NortheastPharmaceutical Group Co., Ltd.. (Attachments: # 1 Exhibit A) (Serota, James)(Entered: 06/23/2011)

06/23/2011 437 MEMORANDUM in Opposition re 434 MOTION for Summary JudgmentOriginally filed on 11/23/2009 as Docket Entry 96, 96-1 & 96-2 in case number05-cv-00453. Dkt Entry 99, 99-1, 99-2 & 99-3 in 05-cv-00453 filed by Plaintiff(s)in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 ExhibitCover Letter, # 2 Rule 56.1 Statement Response to R56.1 Statement, # 3Certificate of Service) (Serota, James) (Entered: 06/23/2011)

06/23/2011 438 AFFIDAVIT/DECLARATION in Opposition re 434 MOTION for SummaryJudgment Originally filed on 11/23/2009 as Docket Entry 96, 96-1 & 96-2 in casenumber 05-cv-00453. Dkt Entry 100 in 05-cv-00453 filed by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453. (Serota, James) (Entered:06/23/2011)

06/23/2011 439 REPLY in Support re 434 MOTION for Summary Judgment Originally filed on11/23/2009 as Docket Entry 96, 96-1 & 96-2 in case number 05-cv-00453. DktEntry 101 and 101-1 in 05-cv-00453 filed by Northeast Pharmaceutical GroupCo., Ltd.. (Attachments: # 1 Rule 56.1 Statement Rule 56.1 Statement Summaryon Reply) (Serota, James) (Entered: 06/23/2011)

09/06/2011 440 ORDER denying 391 Motion for Summary Judgment. Ordered by Judge Brian M.Cogan on 9/1/2011. (Marziliano, August) (Entered: 09/06/2011)

09/06/2011 SCHEDULING ORDER: In light of the Memorandum Decision and Order 440

A-77Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page84 of 191

Page 85: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 78/137

denying defendants' motion for summary judgment, a Status Conference will beheld on 10/4/2011 at 2:15 PM in Courtroom 8D South. Ordered by Judge BrianM. Cogan on 9/6/2011. (Weisberg, Peggy) (Entered: 09/06/2011)

09/23/2011 441 Letter MOTION to Adjourn Conference on consent of all defendants from 10/4/11to on or after 11/3/11 by Northeast Pharmaceutical Group Co., Ltd.. (Serota,James) (Entered: 09/23/2011)

09/23/2011 ORDER granting 441 Motion to Adjourn Conference to 11/3 at 2:15 pm inCourtroom 8D. Ordered by Judge Brian M. Cogan on 9/23/2011. (Weisberg,Peggy) (Entered: 09/23/2011)

11/03/2011 442 Letter to Judge Cogan enclosing Plaintiffs' Proposed Schedule by Plaintiff(s) inCivil Action Animal Science vs Hebei, 05-CV-453 (Attachments: # 1 Plaintiffs'Proposed Schedule) (Landau, Brent) (Entered: 11/03/2011)

11/03/2011 443 Proposed Scheduling Order List of Pending Motions and Proposed Schedule byNortheast Pharmaceutical Group Co., Ltd. (Martin, Scott) (Entered: 11/03/2011)

11/04/2011 Minute Entry for Status Conference held before Judge Brian M. Cogan on11/3/11. All parties present. The Court stated that it will set a schedule for expertdiscovery upon determination of the class certification motion. The Court also setthe following dates. Defendants' 1292(b) motion is due 11/11. Plaintiffs'opposition due 11/25. Reply, if any, due 12/2. See transcript for details. (Courtreporter Marsha Diamond). (Weisberg, Peggy) (Entered: 11/04/2011)

11/07/2011 444 NOTICE of Appearance by Catharine Louise Zurbrugg on behalf of Aland(Jiangsu) Nutraceutical Co., Ltd, JSPC America, Inc. (aty to be noticed)(Zurbrugg, Catharine) (Entered: 11/07/2011)

11/11/2011 445 MOTION for Leave to Appeal by Aland (Jiangsu) Nutraceutical Co., Ltd, HebeiWelcome Pharmaceutical Co. Ltd., JSPC America, Inc., Northeast PharmaceuticalGroup Co., Ltd., Shijiazhuang Pharma. Weisheng Pharmaceutical Co., Ltd..(Attachments: # 1 Memorandum in Support Of Defendants' Motion ForCertification Of The Court's September 1, 2011 Order For Interlocutory AppealPursuant To 28 U.S.C. § 1292(b)) (Bomse, Stephen) (Entered: 11/11/2011)

11/16/2011 446 MOTION for Extension of Time to File Brief Opposing Defendants' Motion forCertification of Court's 9-1-11 Order by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. (Southwick, James) (Entered: 11/16/2011)

11/16/2011 ORDER granting 446 Motion for Extension of Time to File Brief OpposingDefendants' Motion for Certification. Plaintiffs' opposition due by 11/30;defendants' reply due by 12/7. Ordered by Judge Brian M. Cogan on 11/16/2011.(Weisberg, Peggy) (Entered: 11/16/2011)

11/17/2011 447 Letter MOTION for Extension of Time to File Response/Reply In Support ofMotion for Certification of Court's 9-1-11 Order by Defendant(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453. (Mason, Daniel) (Entered: 11/17/2011)

11/17/2011 ORDER granting (447) Motion for Extension of Time to File Reply to motion tocertify order for appeal to 12/12/11. Ordered by Judge Brian M. Cogan on11/17/2011. Associated Cases: 1:06-md-01738-BMC-JO et al. (Cogan, Brian)(Entered: 11/17/2011)

A-78Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page85 of 191

Page 86: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 79/137

11/30/2011 448 MEMORANDUM in Opposition re 445 MOTION for Leave to Appeal filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments: #1 Affidavit of Service) (Landau, Brent) (Entered: 11/30/2011)

12/08/2011 449 ORDER. NEPG's objections are denied in part and sustained in part. NEPG mustproduce the Ministry Report Documents, but may withhold the Report toGovernment Agencies Documents. Ordered by Judge Brian M. Cogan on12/7/2011. (Siegfried, Evan) (Entered: 12/08/2011)

12/12/2011 450 REPLY in Support re 445 MOTION for Leave to Appeal filed by Aland (Jiangsu)Nutraceutical Co., Ltd, Hebei Welcome Pharmaceutical Co. Ltd., JSPC America,Inc., Northeast Pharmaceutical Group Co., Ltd., Shijiazhuang Pharma. WeishengPharmaceutical Co., Ltd.. (Bomse, Stephen) (Entered: 12/12/2011)

12/12/2011 451 Letter Dated December 12, 2012 from Joel M. Mitnick to Judge Cogan byMinistry of Commerce for the Peoples Republic of China (Mitnick, Joel)(Entered: 12/12/2011)

12/28/2011 452 Memorandum Decision and Order granting (401) Motion for SummaryJudgment in case 1:06-md-01738-BMC-JO. Ordered by Judge Brian M. Cogan on12/27/2011. Forwarded for judgment. (Siegfried, Evan) (Entered: 12/28/2011)

01/26/2012 453 MEMORANDUM DECISION AND ORDER denying 63 Motion to Dismiss;granting 242 Motion to Certify Class; granting 247 Motion to Certify Class.Ordered by Judge Brian M. Cogan on 1/25/2012. (Siegfried, Evan) (Entered:01/26/2012)

02/02/2012 SCHEDULING ORDER: The Court will hold a Telephonic Status Conference on2/7/12 at 2:15 pm. All parties will jointly call Chambers at 718-613-2230.Parties on the stayed actions are not required to participate in the telephoneconference. Ordered by Judge Brian M. Cogan on 2/2/2012. (Weisberg, Peggy)(Entered: 02/02/2012)

02/03/2012 454 Letter MOTION to Compel production of document by Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2,# 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5) (Landau, Brent) (Entered: 02/03/2012)

02/06/2012 ORDER re 454 Letter MOTION to Compel production of document filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 -- DefendantAland (Jiangsu) Nutraceutical Co., Ltd shall respond to the motion to compel byFebruary 9, 2012. The response must include an affidavit from a person withauthority on behalf of Aland stating whether the company asserts an attorney-client privilege with respect to communications between itself and Sidley Austin.If Aland does assert such a privilege, it must provide sufficient information, suchas contemporaneous documents establishing the relationship, to allow the court todetermine that the privilege existed at the time the document at issue was created;such documents may, if necessary, be submitted in camera. In addition, counselfor amicus curiae Ministry of Commerce is invited to submit an affidavitspecifying whether it also serves as counsel to Aland for any purpose. Ordered byMagistrate Judge James Orenstein on 2/6/2012. (Konkoly, Antonia) (Entered:02/06/2012)

02/07/2012 MINUTE ENTRY for status conference held before Judge Brian M. Cogan on2/7/2012 via telephone. The Court discussed outstanding discovery. By 2/28/2012,

A-79Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page86 of 191

Page 87: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 80/137

the parties shall jointly submit a proposed schedule for the completion of expertdiscovery and for class notice to be submitted. See transcript for details. (Courtreporter: Michelle Nardone) (Weisberg, Peggy) (Entered: 02/07/2012)

02/09/2012 455 MEMORANDUM DECISION AND ORDER denying 445 Motion for Leave toAppeal. Ordered by Judge Brian M. Cogan on 2/8/2012. (Siegfried, Evan)(Entered: 02/09/2012)

02/09/2012 456 RESPONSE to Motion re 454 Letter MOTION to Compel production ofdocument filed by Aland (Jiangsu) Nutraceutical Co., Ltd. (Attachments: # 1Declaration of Wang Qiang, # 2 Exhibit A) (Goldstein, Richard) (Entered:02/09/2012)

02/09/2012 457 Letter to Magistrate Judge James Orenstein dated 2/9/2012 by Ministry ofCommerce for the Peoples Republic of China (Mitnick, Joel) (Entered:02/09/2012)

02/09/2012 458 DECLARATION re Order,,,, dated 02/06/2012 by Ministry of Commerce for thePeoples Republic of China (Attachments: # 1 Appendix A (Redacted in Full), # 2Appendix B (Redacted in Full)) (Mitnick, Joel) (Entered: 02/09/2012)

02/28/2012 459 Letter Submitting Proposed Schedule by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453 (Southwick, James) (Entered: 02/28/2012)

02/28/2012 460 Letter to Judge Brian M. Cogan by Defendant(s) in Civil Action Animal Sciencevs Hebei, 05-CV-453 (Mason, Daniel) (Entered: 02/28/2012)

02/29/2012 ORDER re 459 Letter Submitting Proposed Schedule. The time for filingdispositive motions on liability was previously set and has passed. In order todecide whether to allow defendants to file additional dispositive motions, theCourt needs more information. Defendants therefore must file a letter by 3/7/2012describing in detail the proposed dispositive motion. Ordered by Judge Brian M.Cogan on 2/29/2012. (Weisberg, Peggy) (Entered: 02/29/2012)

03/02/2012 SCHEDULING ORDER: re 454 Letter MOTION to Compel production ofdocument -- A telephone conference to discuss the motion will be held on March16, 2012, at 4:00 p.m. Counsel for Aland shall coordinate the call and conferencein chambers when all parties are on the line. Ordered by Magistrate Judge JamesOrenstein on 3/2/2012. (Konkoly, Antonia) (Entered: 03/02/2012)

03/07/2012 461 Letter to Judge Brian M. Cogan in Response to the Court's Order of February 29,2012 by Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453(Mason, Daniel) (Entered: 03/07/2012)

03/09/2012 ORDER adopting the proposed schedule set forth at 459 . Expert discovery to becomplete by 9/7/12; Daubert motions and non-liability dispositive motions by9/14/12; trial in October, 2012. Ordered by Judge Brian M. Cogan on 3/9/2012.(Weisberg, Peggy) (Entered: 03/09/2012)

03/16/2012 462 Minute Entry for proceedings held before Magistrate Judge JamesOrenstein:Telephone Conference held on 3/16/2012. THE FOLLOWINGRULINGS WERE MADE: I asked the plaintiff and amicus curiae for certainsupplemental submissions on the pending motion to compel discovery. Theplaintiff will submit a letter specifying the bases for contending the document at

A-80Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page87 of 191

Page 88: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 81/137

issue is discoverable in the absence of any privilege, and the amicus, as well as thelaw firm that serves as its counsel, will submit declarations or affidavits providingfurther information as to the relationship between the law firm and defendantAland at the time the document at issue was created. I did not set a deadline forthe submissions during the call but hereby request that the submissions describedabove be made no later than March 30, 2012. If any party seeks to alter thatschedule, the parties shall confer and jointly propose an alternative. (Konkoly,Antonia) (Entered: 03/16/2012)

03/30/2012 463 Letter to Judge James Orenstein with Declaration of Joel M. Mitnick attached, byMinistry of Commerce for the Peoples Republic of China (Attachments: # 1Declaration Declaration of Joel M. Mitnick) (Mitnick, Joel) (Entered: 03/30/2012)

03/30/2012 464 Letter to Judge James Orenstein in Response to Order (Dkt. 462) of March 16,2012 by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453(Landau, Brent) (Entered: 03/30/2012)

04/04/2012 465 Letter MOTION to Withdraw as Attorney by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. (Attachments: # 1 Declaration, # 2 ProposedOrder) (Gebrewold, Besrat) (Entered: 04/04/2012)

04/05/2012 ORDER granting 465 Motion to Withdraw as Attorney. Attorney Besrat J.Gebrewold terminated -- The motion is granted and the proposed order so ordered.Ordered by Magistrate Judge James Orenstein on 4/5/2012. (Konkoly, Antonia)(Entered: 04/05/2012)

04/12/2012 466 NOTICE of Appearance by Melinda R. Coolidge on behalf of All Plaintiffs (aty tobe noticed) (Coolidge, Melinda) (Entered: 04/12/2012)

05/04/2012 467 NOTICE OF FILING OF OFFICIAL TRANSCRIPT of Proceedings held on 1103 2011, before Judge BRIAN M. COGAN. Court Reporter/TranscriberMARSHA DIAMOND, Telephone number 718 613-2489. Email address:[email protected]. Transcript may be viewed atthe court public terminal or purchased through the Court Reporter/Transcriberbefore the deadline for Release of Transcript Restriction. After that date it may beobtained through PACER. Redaction Request due 5/25/2012. Redacted TranscriptDeadline set for 6/4/2012. Release of Transcript Restriction set for 8/2/2012.(Diamond, Marsha) (Entered: 05/04/2012)

05/08/2012 468 Copy of receipt for fee paying PHV due by Melinda R. Coolidge. (Siegfried,Evan) (Entered: 05/08/2012)

05/10/2012 469 Letter MOTION to Amend/Correct/Supplement Schedule entered by the Court onMarch 9, 2012 by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Coolidge, Melinda) (Entered: 05/10/2012)

05/16/2012 ORDER granting 469 motion to amend the discovery schedule. The revisedschedule set forth in the plaintiffs' letter is hereby adopted. Ordered by JudgeBrian M. Cogan on 5/16/2012. (Weisberg, Peggy) (Entered: 05/16/2012)

05/21/2012 470 Notice of MOTION for Settlement Preliminary Approval of Settlements withDefendant Aland (Jiangsu) Nutraceutical Co., Ltd. by Plaintiff(s) in Civil ActionPhilion vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-987, Plaintiff(s) inCivil Action Animal Science vs Hebei, 05-CV-453, Plaintiff(s) in Civil Action

A-81Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page88 of 191

Page 89: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 82/137

Audette vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-988, Plaintiff(s) inCivil Action Keane vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149.(Attachments: # 1 Memorandum in Support, # 2 Declaration of Michael D.Hausfeld in Support of Certified Classes Settlement Agreement, # 3 Exhibit A, # 4Declaration of Daniel C. Hedlund in Support of Indirect Purchaser SettlementAgreement, # 5 Exhibit A, # 6 Exhibit B, # 7 Exhibit C, # 8 Exhibit D, # 9Proposed Order) (Coolidge, Melinda) (Entered: 05/21/2012)

05/21/2012 471 Letter to the Honorable Brian M. Cogan enclosing courtesy copies by Plaintiff(s)in Civil Action Philion vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-987,Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453, Plaintiff(s) inCivil Action Audette vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-988,Plaintiff(s) in Civil Action Keane vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149 (Coolidge, Melinda) Modified on 5/22/2012 to change filer. (Chee,Alvin). (Entered: 05/21/2012)

05/23/2012 SCHEDULING ORDER. The Court will hold a telephone conference on5/30/2012 at 5:00 pm. Plaintiffs' counsel is directed to arrange and initiate the calland will call Chambers at 718-613-2230. It is further Ordered that lawyers whoare signatories to the settlement agreement 470 must attend. All other parties mayparticipate if they wish. Ordered by Judge Brian M. Cogan on 5/23/2012.(Weisberg, Peggy) (Entered: 05/23/2012)

05/24/2012 472 Letter to Judge Brian M. Cogan Regarding Class Notice Proposal byDefendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453 (Mason,Daniel) (Entered: 05/24/2012)

05/25/2012 473 Notice of MOTION for Settlement Direct and Indirect Purchaser Plaintiffs'Notice of Joint Motion for Approval of Notice Plan, Form of Notice, and ClaimForm by Plaintiff(s) in Civil Action Philion vs Hebei Welcome PharmaceuticalCo. Ltd. 06-CV-987, Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453, Plaintiff(s) in Civil Action Audette vs Hebei Welcome PharmaceuticalCo. Ltd. 06-CV-988, Plaintiff(s) in Civil Action Keane vs Hebei WelcomePharmaceutical Co. Ltd. 06-CV-149. (Attachments: # 1 Memorandum in Support,# 2 Declaration of Katherine Kinsella, # 3 Exhibit 1 to Kinsella Decl., # 4 Exhibit2 to Kinsella Decl., # 5 Exhibit 3 to Kinsella Decl., # 6 Exhibit 4 to KinsellaDecl., # 7 Exhibit 5 to Kinsella Decl., # 8 Declaration of Brent W. Landau, # 9Exhibit 1 to Landau Decl., # 10 Exhibit 2 to Landau Decl., # 11 Exhibit 3 toLandau Decl., # 12 Exhibit 4 to Landau Decl., # 13 Proposed Order) (Coolidge,Melinda) (Entered: 05/25/2012)

05/25/2012 474 Letter to the Honorable Brian M. Cogan by Plaintiff(s) in Civil Action Philion vsHebei Welcome Pharmaceutical Co. Ltd. 06-CV-987, Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453, Plaintiff(s) in Civil Action Audette vsHebei Welcome Pharmaceutical Co. Ltd. 06-CV-988, Plaintiff(s) in Civil ActionKeane vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149 (Coolidge,Melinda) (Entered: 05/25/2012)

05/29/2012 475 RESPONSE to Motion re 473 Notice of MOTION for Settlement Direct andIndirect Purchaser Plaintiffs' Notice of Joint Motion for Approval of Notice Plan,Form of Notice, and Claim Form , RESPONSE in Opposition re 470 Notice ofMOTION for Settlement Preliminary Approval of Settlements with DefendantAland (Jiangsu) Nutraceutical Co., Ltd. filed by Hebei Welcome Pharmaceutical

A-82Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page89 of 191

Page 90: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 83/137

Co. Ltd., Weisheng Pharmaceutical Co. Ltd.. (Attachments: # 1 Declaration ofGina M. Intrepido-Bowden) (Mason, Daniel) (Entered: 05/29/2012)

05/29/2012 476 Letter to the Honorable Brian M. Cogan by Hebei Welcome Pharmaceutical Co.Ltd., Weisheng Pharmaceutical Co. Ltd. (Mason, Daniel) (Entered: 05/29/2012)

05/30/2012 477 Letter to Judge Cogan Regarding the Expert Report of B. Douglas Bernheim byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 (Landau, Brent)(Entered: 05/30/2012)

05/31/2012 MINUTE ENTRY for status conference held before Judge Brian M. Cogan viatelephone on May 30, 2012. Counsel for various plaintiffs and defendants present.The Court discussed the parties' motion for preliminary approval of theirsettlement. See transcript for details. (Court reporter: Charisse Kitt) (Weisberg,Peggy) (Entered: 05/31/2012)

05/31/2012 SCHEDULING ORDER: The Court will hold a status conference in Courtroom8D on July 10, 2012, at 11:00 AM. Parties on the stayed actions are not requiredto attend. Ordered by Judge Brian M. Cogan on 5/31/2012. (Weisberg, Peggy)(Entered: 05/31/2012)

06/01/2012 478 REPLY in Support re 473 Notice of MOTION for Settlement Direct and IndirectPurchaser Plaintiffs' Notice of Joint Motion for Approval of Notice Plan, Form ofNotice, and Claim Form filed by Plaintiff(s) in Civil Action Philion vs HebeiWelcome Pharmaceutical Co. Ltd. 06-CV-987, Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453, Plaintiff(s) in Civil Action Audette vs HebeiWelcome Pharmaceutical Co. Ltd. 06-CV-988, Plaintiff(s) in Civil Action Keanevs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149. (Attachments: # 1Declaration of Brent W. Landau, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8) (Coolidge,Melinda) (Entered: 06/01/2012)

06/01/2012 479 Letter to the Honorable Brian M. Cogan by Plaintiff(s) in Civil Action Philion vsHebei Welcome Pharmaceutical Co. Ltd. 06-CV-987, Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453, Plaintiff(s) in Civil Action Audette vsHebei Welcome Pharmaceutical Co. Ltd. 06-CV-988, Plaintiff(s) in Civil ActionKeane vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149 (Coolidge,Melinda) (Entered: 06/01/2012)

06/04/2012 480 MEMORANDUM DECISION AND ORDER denying 434 Motion forSummary Judgment. Ordered by Judge Brian M. Cogan on 6/1/2012. (Siegfried,Evan) (Entered: 06/04/2012)

06/08/2012 481 Letter dated 6/4/2012 to Judge Brian M. Cogan from counsel James I. Serota RE:counsel informs the Court that several attorneys from Greenberg Traurig are nolonger working on this case. (Siegfried, Evan) (Entered: 06/08/2012)

06/08/2012 482 DECLARATION Of Service Of Notice Of Class Action Settlement Pursuant To28 U.S.C. § 1715 by Aland (Jiangsu) Nutraceutical Co., Ltd (Attachments: # 1Exhibit A, # 2 Exhibit B) (Goldstein, Richard) (Entered: 06/08/2012)

06/11/2012 483 NOTICE of Voluntary Dismissal by Plaintiff(s) in Civil Action Carroll vs. ChinaPharmaceuticals Group, 07-CV-0226, Plaintiff(s) in Civil Action Cribbs vs HebeiWelcome Pharmaceutical Co. Ltd. 05-CV-6059, Plaintiff(s) in Civil Action Keane

A-83Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page90 of 191

Page 91: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 84/137

vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149, Jabo's Pharmacy, Inc.,Niall Vignoles, Hunt & Behrens, Inc. (Battin, Timothy) (Entered: 06/11/2012)

06/11/2012 484 Letter to Judge Cogan Regarding Status of Indirect Purchaser Complaints byPlaintiff(s) in Civil Action Keane vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149 (Battin, Timothy) (Entered: 06/11/2012)

06/14/2012 485 ORDER. Ordered by Judge Brian M. Cogan on 6/13/2012. Associated Cases:1:06-md-01738-BMC-JO et al. (Siegfried, Evan) (Entered: 06/14/2012)

06/14/2012 486 ORDER. Please see attached order for details. Ordered by Judge Brian M. Coganon 6/14/2012. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-06059-BMC-JO, 1:06-cv-00897-BMC-JO, 1:06-cv-05561-BMC-JO (Siegfried, Evan) (MainDocument 486 replaced on 6/14/2012) (Siegfried, Evan). (Entered: 06/14/2012)

06/14/2012 487 ORDER. Please see attached order for details. Ordered by Judge Brian M. Coganon 6/14/2012. Associated Cases: 1:06-md-01738-BMC-JO, 1:06-cv-01721-BMC-JO, 1:06-cv-03528-BMC-JO, 1:07-cv-00226-BMC-JO (Siegfried, Evan) (Entered:06/14/2012)

06/15/2012 488 MEMORANDUM DECISION AND ORDER regarding 473 Direct and IndirectPurchaser Plaintiffs' Notice of Joint Motion for Approval of Notice Plan, Form ofNotice, and Claim Form. Fairness Hearing set for 10/17/2012 at 02:00 PM inCourtroom 8D South. Ordered by Judge Brian M. Cogan on 6/14/2012. (Lee,Tiffeny) (Entered: 06/15/2012)

07/03/2012 489 NOTICE by Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453NON-SETTLING DEFENDANTS STATEMENT OF RULE 16 CONFERENCE(Mason, Daniel) (Entered: 07/03/2012)

07/06/2012 490 NOTICE by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 re489 Notice(Other) DIRECT PURCHASER AND INJUNCTION CLASSPLAINTIFFS' STATEMENT OF ISSUES FOR STATUS CONFERENCE ANDRESPONSE TO NON-SETTLING DEFENDANTS' STATEMENT OF RULE 16CONFERENCE (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4Exhibit 4, # 5 Certificate of Service) (Landau, Brent) (Entered: 07/06/2012)

07/10/2012 MINUTE ENTRY AND ORDER for Status Conference held before Judge BrianM. Cogan on July 10, 2012. Counsel for both sides present. By July 12, 2012, theparties shall jointly submit a proposed briefing schedule for defendants' motion inlimine regarding statements of the Ministry of Commerce. The parties are requiredto file a Joint Pretrial Order using the form posted on the Court's website bySeptember 26, 2012. The parties are to simultaneously deliver to Chambers a setof those exhibits to which objection has been made, and those portions ofdeposition testimony that a party intends to offer and to which the adversaryobjects, both as reflected in the Joint Pretrial Order, so that the Court can rule onthe objections at the Final Pretrial Conference to the extent practicable. Exhibitsand deposition testimony which the parties may use solely for the purposes ofimpeachment or rebuttal should be omitted from the Joint Pretrial Order. FinalPretrial Conference is set for 10/10/2012 at 10:00 A.M. in Courtroom 8D South.The Court heard argument regarding whether Qiao Haili should be precluded fromtestifying at trial; the Court reserved decision on this issue. Trial will begin onNovember 5, 2012. See transcript for details. (Court Reporter: Fred Guerino)

A-84Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page91 of 191

Page 92: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 85/137

(Weisberg, Peggy) (Entered: 07/10/2012)

07/11/2012 ORDER regarding plaintiffs' motion to preclude defense witness Qiao Haili fromtestifying at trial. As an initial step to resolving this inquiry, defendants must filean affidavit of Mr. Qiao with this Court, by August 8, 2012, setting forth inexacting detail the substance of Mr. Qiao's anticipated direct testimony. The Courtwill then determine whether to rule on plaintiffs' motion based on this affidavit orconduct further proceedings to determine what, if any, prejudice plaintiffs wouldsuffer as a result of Mr. Qiao's testimony. Ordered by Judge Brian M. Cogan on7/11/2012. (Weisberg, Peggy) (Entered: 07/11/2012)

07/12/2012 491 Letter to Honorable Brian M. Cogan by Hebei Welcome Pharmaceutical Co. Ltd.,Northeast Pharmaceutical Group Co., Ltd., Shijiazhuang Pharma. WeishengPharmaceutical Co., Ltd. (Mason, Daniel) (Entered: 07/12/2012)

07/12/2012 492 Letter to Honorable Brian M. Cogan by Hebei Welcome Pharmaceutical Co. Ltd.,Northeast Pharmaceutical Group Co., Ltd., Shijiazhuang Pharma. WeishengPharmaceutical Co., Ltd. (Mason, Daniel) (Entered: 07/12/2012)

07/13/2012 ORDER adopting 492 proposed scheduling order. Defendants' motion in liminedue by August 15, 2012; opposition by September 7, 2012; reply, if any, bySeptember 21, 2012. Ordered by Judge Brian M. Cogan on 7/13/2012. (Weisberg,Peggy) (Entered: 07/13/2012)

07/13/2012 493 MOTION to Withdraw as Attorney by Plaintiff(s) in Civil Action Animal Sciencevs Hebei, 05-CV-453. (Agrawal, Suyash) (Entered: 07/13/2012)

07/13/2012 ORDER granting 493 Motion to Withdraw as Attorney. Attorney Suyash Agrawalterminated. Ordered by Judge Brian M. Cogan on 7/13/2012. (Weisberg, Peggy)(Entered: 07/13/2012)

07/18/2012 494 MEMORANDUM DECISION AND ORDER denying (387) Motion forSummary Judgment; denying (286) Motion to Dismiss for Lack of Jurisdiction.See attached order for further details. Ordered by Judge Brian M. Cogan on7/17/2012. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO,1:06-cv-00149-BMC-JO, 1:06-cv-00987-BMC-JO, 1:06-cv-00988-BMC-JO(Siegfried, Evan) (Entered: 07/18/2012)

08/01/2012 495 DEFENDANT CHINA PHARMACEUTICAL GROUP LTD.'S ANSWER to 355Amended Complaint, by China Pharmaceutical Group Ltd.. (Mason, Daniel)(Entered: 08/01/2012)

08/08/2012 496 MEMORANDUM DECISION AND ORDER. The NCPC defendants' 371motion to dismiss is granted in part and denied in part. Defendants North ChinaPharmaceutical Co. Limited and North China Pharmaceutical Group InternationalTrade Co., Ltd. are dismissed from this case for lack of personal jurisdiction. Themotion to dismiss is denied insofar as it seeks dismissal of defendant North ChinaPharmaceutical Group Corp. See attached order for further details. Ordered byJudge Brian M. Cogan on 8/7/2012. Associated Cases: 1:06-md-01738-BMC-JO,1:05-cv-00453-BMC-JO (Siegfried, Evan) (Entered: 08/08/2012)

08/08/2012 497 NOTICE by Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453,Northeast Pharmaceutical Group Co., Ltd., Weisheng Pharmaceutical Co. Ltd.NON-SETTLING DEFENDANTS NOTICE OF FILING OF AFFIDAVIT OF

A-85Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page92 of 191

Page 93: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 86/137

QIAO HAILI PURSUANT TO THE COURTS ORDER OF JULY 11, 2012 ANDSTATEMENT THEREON (Attachments: # 1 Exhibit A, # 2 Exhibit B) (Mason,Daniel) (Entered: 08/08/2012)

08/10/2012 498 ORDER. Please see attached order for details. Ordered by Judge Brian M. Coganon 8/9/2012. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Siegfried, Evan) (Entered: 08/10/2012)

08/14/2012 499 Letter supplementing March 30, 2012 letter to Magistrate Judge Orensteinregarding pending motion to compel by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453 (Landau, Brent) (Entered: 08/14/2012)

08/15/2012 500 NOTICE by Hebei Welcome Pharmaceutical Co. Ltd., Northeast PharmaceuticalGroup Co., Ltd., Weisheng Pharmaceutical Co. Ltd. NON-SETTLINGDEFENDANTS MEMORANDUM REGARDING THE ADMISSIBILITY AT TRIALOF CERTAIN STATEMENTS BY THE MINISTRY OF COMMERCE OF THEPEOPLES REPUBLIC OF CHINA AND APPENDIX A (Mason, Daniel) (Entered:08/15/2012)

08/16/2012 501 Letter TO JUDGE COGAN by Hebei Welcome Pharmaceutical Co. Ltd.,Northeast Pharmaceutical Group Co., Ltd., Weisheng Pharmaceutical Co. Ltd.(Mason, Daniel) (Entered: 08/16/2012)

08/16/2012 ORDER re 501 Letter filed by Northeast Pharmaceutical Group Co., Ltd., HebeiWelcome Pharmaceutical Co. Ltd., Weisheng Pharmaceutical Co. Ltd. Defendantsmay deem their letter to constitute their motion for reconsideration, or they maychoose to file a formal motion. Ordered by Judge Brian M. Cogan on 8/16/2012.(Cogan, Brian) (Entered: 08/16/2012)

08/17/2012 502 Notice of MOTION for Reconsideration OF THE COURTS AUGUST 9, 2012ORDER REQUIRING AN ADVERSE INFERENCE INSTRUCTION INCONNECTION WITH DEFENDANTS WITNESS QIAO HAILI by HebeiWelcome Pharmaceutical Co. Ltd., Northeast Pharmaceutical Group Co., Ltd.,Weisheng Pharmaceutical Co. Ltd.. (Attachments: # 1 Memorandum in Support, #2 Certificate of Service) (Mason, Daniel) (Entered: 08/17/2012)

08/17/2012 503 Letter by Northeast Pharmaceutical Group Co., Ltd. (Serota, James) (Entered:08/17/2012)

08/21/2012 504 Letter TO HONORABLE BRIAN M. COGAN by Weisheng Pharmaceutical Co.Ltd. (Mason, Daniel) (Entered: 08/21/2012)

08/22/2012 ORDER re 504 Letter. Joint Pretrial Order due 10/3/2012. Pretrial Conference andTrial date will remain as previously scheduled. Ordered by Judge Brian M. Coganon 8/22/2012. (Weisberg, Peggy) (Entered: 08/22/2012)

08/22/2012 505 ANSWER to 355 Amended Complaint, by North China Pharmaceutical GroupCorp.. (Prescott, Darrell) (Entered: 08/22/2012)

08/22/2012 506 ORDER denying 454 Motion to Compel -- For the reasons set forth in theattached document, I deny the motion to compel. Ordered by Magistrate JudgeJames Orenstein on 8/22/2012. (Orenstein, James) (Entered: 08/22/2012)

08/31/2012 507 Notice of MOTION for Settlement Final Approval of Settlements with DefendantAland (Jiangsu) Nutraceutical Co., Ltd. by Plaintiff(s) in Civil Action Philion vs

A-86Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page93 of 191

Page 94: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 87/137

Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-987, Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453, Plaintiff(s) in Civil Action Audette vsHebei Welcome Pharmaceutical Co. Ltd. 06-CV-988, Plaintiff(s) in Civil ActionKeane vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149. (Attachments: # 1Memorandum in Support of Motion for Final Approval, # 2 Declaration ofMichael D. Hausfeld in Support of Motions for Final Approval, # 3 Exhibit Ex. Ato Hausfeld Decl., # 4 Declaration of R. Alexander Saveri in Support of Motionsfor Final Approval, # 5 Exhibit Ex. A to Saveri Decl., # 6 Affidavit Aff. ofCharlene Young, # 7 Certificate of Service) (Coolidge, Melinda) (Entered:08/31/2012)

08/31/2012 508 Letter to the Honorable Brian M. Cogan by Plaintiff(s) in Civil Action Philion vsHebei Welcome Pharmaceutical Co. Ltd. 06-CV-987, Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453, Plaintiff(s) in Civil Action Audette vsHebei Welcome Pharmaceutical Co. Ltd. 06-CV-988, Plaintiff(s) in Civil ActionKeane vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149 (Coolidge,Melinda) (Entered: 08/31/2012)

08/31/2012 509 RESPONSE in Opposition re 502 Notice of MOTION for Reconsideration OFTHE COURTS AUGUST 9, 2012 ORDER REQUIRING AN ADVERSEINFERENCE INSTRUCTION IN CONNECTION WITH DEFENDANTSWITNESS QIAO HAILI filed by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453. (Southwick, James) (Entered: 08/31/2012)

08/31/2012 510 Notice of MOTION for Attorney Fees and Expenses by Plaintiff(s) in Civil ActionPhilion vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-987, Plaintiff(s) inCivil Action Audette vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-988,Plaintiff(s) in Civil Action Keane vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149. (Attachments: # 1 Memorandum in Support of Indirect PurchaserPlaintiffs' Motion for an Interim Reimbursement of Expenses, # 2 Declaration ofDaniel C. Hedlund, Timothy D. Battin, and R. Alexander Saveri in Support ofIndirect Purchaser Plaintiffs' Motion for an Interim Reimbursement of Expenses, #3 Exhibit : Indirect Purchaser Plaintiffs' Compendium in Support of Lead CounselDeclaration, # 4 Certificate of Service) (Battin, Timothy) (Entered: 08/31/2012)

08/31/2012 511 Notice of MOTION for Attorney Fees and Expenses by Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453. (Attachments: # 1 Memorandum inSupport Class Counsel's Application for an Award of Attorneys' Fees andReimbursement of Expenses, # 2 Declaration Benjamin D. Brown, # 3 DeclarationJames T. Southwick, # 4 Declaration Michael D. Hausfeld, # 5 Declaration TanyaS. Chutkin) (Southwick, James) (Entered: 08/31/2012)

09/06/2012 512 Letter MOTION for Extension of Time to File Letter regarding Re-DeposingWitnesses by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453.(Coolidge, Melinda) (Entered: 09/06/2012)

09/06/2012 ORDER granting 512 Motion for Extension of Time to File Letter regarding Re-Deposing Witnesses to 9/12. Ordered by Judge Brian M. Cogan on 9/6/2012.(Cogan, Brian) (Entered: 09/06/2012)

09/07/2012 513 REPLY in Support re 502 Notice of MOTION for Reconsideration OF THECOURTS AUGUST 9, 2012 ORDER REQUIRING AN ADVERSE INFERENCEINSTRUCTION IN CONNECTION WITH DEFENDANTS WITNESS QIAO HAILI

A-87Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page94 of 191

Page 95: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 88/137

AND APPENDIX A filed by Hebei Welcome Pharmaceutical Co. Ltd., NortheastPharmaceutical Group Co., Ltd., Weisheng Pharmaceutical Co. Ltd.. (Mason,Daniel) (Entered: 09/07/2012)

09/07/2012 514 MEMORANDUM in Opposition re 500 Notice(Other), Direct Purchaser andInjunction Class Plaintiffs' Memorandum in Response to Non-Settling Defendants'Memorandum Regarding the Admissibility at Trial of Certain Statements of theMinistry of Commerce of the People's Republic of China filed by Plaintiff(s) inCivil Action Animal Science vs Hebei, 05-CV-453. (Landau, Brent) (Entered:09/07/2012)

09/12/2012 515 MOTION for Leave to Electronically File Document under Seal by Plaintiff(s) inCivil Action Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 LetterMotion to Re-Depose Defense Witnesses, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8)(Coolidge, Melinda) (Entered: 09/12/2012)

09/12/2012 516 Letter to the Honorable Brian M. Cogan by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453 (Coolidge, Melinda) (Entered: 09/12/2012)

09/13/2012 517 ORDER in case 1:05-cv-00453-BMC-JO; denying 502 . See attached order forfurther details. Ordered by Judge Brian M. Cogan on 9/12/2012. AssociatedCases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Siegfried, Evan)(Entered: 09/13/2012)

09/14/2012 ORDER granting in part and denying in part 515 plaintiffs' motion for leave to fileunder seal. Plaintiffs' letter does not contain any confidential, proprietary, orcommercially sensitive information. Nor do the attached exhibits, except forExhibit 8. The Clerk of the Court is directed to unseal plaintiffs' motion, letter,and exhibits, except for Exhibit 8 [515-9] which shall remain sealed. The Courtappreciates that many of the exhibits to plaintiffs' letter are excerpts of largerdeposition transcripts. This Order is limited to the documents as filed. The Courthas made no ruling on whether any portions of these transcripts which are notcurrently before the Court may be appropriately designated as confidential.Ordered by Judge Brian M. Cogan on 9/14/2012. (Weisberg, Peggy) (Entered:09/14/2012)

09/17/2012 518 NOTICE /Objection to Proposed Settlement by movant Bradford L. Edwards.(Fernandez, Erica) (Entered: 09/17/2012)

09/17/2012 521 Letter dated 9/17/12 from P.C. Holland to Judge Cogan, objecting to the proposedsettlement for the Indirect Purchaser Damages Class. (Brucella, Michelle)(Entered: 09/19/2012)

09/18/2012 519 Letter MOTION for Extension of Time to File Response/Reply TO PLAINTIFFS'LETTER REGARDING RE-DEPOSING CERTAIN WITNESSES by HebeiWelcome Pharmaceutical Co. Ltd., Northeast Pharmaceutical Group Co., Ltd.,Weisheng Pharmaceutical Co. Ltd.. (Mason, Daniel) (Entered: 09/18/2012)

09/18/2012 520 Letter to the Honorable Brian M. Cogan by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453 (Coolidge, Melinda) (Entered: 09/18/2012)

09/19/2012 ORDER granting 519 Motion for Extension of Time to File Response/Reply to9/20/2012. Ordered by Judge Brian M. Cogan on 9/19/2012. (Weisberg, Peggy)

A-88Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page95 of 191

Page 96: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 89/137

(Entered: 09/19/2012)

09/19/2012 ORDER as to 520 plaintiffs' letter. The Clerk of the Court is directed to unsealExhibit 8 to Plaintiffs' Letter Motion to Re-Depose Defense Witnesses [515-9].Ordered by Judge Brian M. Cogan on 9/19/2012. (Weisberg, Peggy) (Entered:09/19/2012)

09/20/2012 522 REPLY in Support NON-SETTLING DEFENDANTS REPLY MEMORANDUMREGARDING THE ADMISSIBILITY AT TRIAL OF CERTAIN STATEMENTS BYTHE MINISTRY OF COMMERCE OF THE PEOPLES REPUBLIC OF CHINA re500 NOTICE filed by Hebei Welcome Pharmaceutical Co. Ltd., NortheastPharmaceutical Group Co., Ltd., Weisheng Pharmaceutical Co. Ltd.. (Mason,Daniel) (Entered: 09/20/2012)

09/20/2012 523 REPLY in Opposition TO PLAINTIFFS' REQUEST FOR "SPOLIATION"DEPOSITIONS OF EVERY NON-SETTLING DEFENDANT filed by HebeiWelcome Pharmaceutical Co. Ltd., Northeast Pharmaceutical Group Co., Ltd.,Weisheng Pharmaceutical Co. Ltd.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, #3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G) (Mason,Daniel) (Entered: 09/20/2012)

09/21/2012 524 Letters from individuals requesting claim forms. (Siegfried, Evan) (Entered:09/21/2012)

09/21/2012 525 ORDER. See attached order for further details. Ordered by Judge Brian M. Coganon 9/21/2012. (Siegfried, Evan) (Entered: 09/21/2012)

09/24/2012 526 Letter MOTION to Amend/Correct/Supplement SEPTEMBER 21, 2012 COURTORDER [DE 525] by Hebei Welcome Pharmaceutical Co. Ltd., NortheastPharmaceutical Group Co., Ltd., Weisheng Pharmaceutical Co. Ltd.. (Mason,Daniel) (Entered: 09/24/2012)

09/25/2012 ORDER granting 526 defendant Weisheng's letter motion to amend the September21, 2012 Order. The depositions provided for by the September 21st Order mustbe completed by October 19, 2012. The depositions shall be conducted either byvideo or in Hong Kong, at plaintiffs' option. Ordered by Judge Brian M. Cogan on9/25/2012. (Weisberg, Peggy) (Entered: 09/25/2012)

09/25/2012 527 NOTICE of Appearance by Katherine H. Kunz on behalf of Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453 (aty to be noticed) (Kunz,Katherine) (Entered: 09/25/2012)

09/26/2012 528 Letters from individuals requesting claim forms. (Siegfried, Evan) (Entered:09/26/2012)

09/26/2012 529 Letters from individuals requesting claim forms. (Siegfried, Evan) (Entered:09/26/2012)

09/28/2012 530 MOTION to Strike Defendants' Expert Testimony by Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered: 09/28/2012)

09/28/2012 531 Notice of MOTION for Judgment on the Pleadings or Summary Judgment, andDetermination of Foreign Law by China Pharmaceutical Group Ltd..(Attachments: # 1 Memorandum in Support, # 2 Affidavit in Support EnglishVersion, # 3 Affidavit in Support Chinese Version, # 4 Rule 56.1 Statement, # 5

A-89Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page96 of 191

Page 97: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 90/137

Certificate of Service) (Mason, Daniel) (Entered: 09/28/2012)

09/28/2012 532 MEMORANDUM in Support re 530 MOTION to Strike Defendants' ExpertTestimony filed by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Southwick, James) (Entered: 09/28/2012)

09/28/2012 533 MOTION to Dismiss Notice of Motion by Hebei Welcome Pharmaceutical Co.Ltd.. Responses due by 10/12/2012 (Prescott, Darrell) (Entered: 09/28/2012)

09/28/2012 534 MOTION to Dismiss Foreign Purchases From Plaintiffs' Claims for Lack ofSubject Matter Jurisdiction and to Exclude Certain Other Claims as WithoutEvidentiary Support ( Responses due by 10/12/2012) by Hebei WelcomePharmaceutical Co. Ltd.. (Attachments: # 1 Exhibit 1 through 9) (Prescott,Darrell) (Entered: 09/28/2012)

10/01/2012 535 Letter to Judge Cogan dated October 1, 2012 Re Courtesy Copies of Defendants'Motion to Exclude Foreign Purchases by Hebei Welcome Pharmaceutical Co.Ltd. (Prescott, Darrell) (Entered: 10/01/2012)

10/01/2012 536 MEMORANDUM DECISION AND ORDER: For reasons set forth below, theCourt concludes that the Ministry Statements are relevant but are nonethelessinadmissible since they do not fall into either exception to the hearsay rule andshould, in any case, be excluded under Rule 403; For these reasons, the MinistryStatements are excluded. Ordered by Judge Brian M. Cogan on 9/27/2012.Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Fernandez,Erica) (Entered: 10/01/2012)

10/01/2012 541 Objection to Certification of Indirect Purchaser Settlement Class and InjunctionClass and Objection to Plaintiffs' Motion for Final Approval of Settlements withDefendant Aland (Jiangsu) Nutraceutical Co., Ltd. And Objection to Certificationof the Settlement Class (Marziliano, August) (Entered: 10/05/2012)

10/02/2012 537 Letter MOTION for Protective Order (JOINT PRE-MOTION LETTERREGARDING CPG'S MOTION FOR PROTECTIVE ORDER CONCERNINGDEPOSITION OF CAI DONG CHEN) by China Pharmaceutical Group Ltd..(Attachments: # 1 Exhibit Defendant Ex. A-G, # 2 Exhibit Plaintiff Ex. 1-21)(Mason, Daniel) (Entered: 10/02/2012)

10/03/2012 ORDER granting 537 Motion for Protective Order. Plaintiffs have made aninsufficient showing to warrant this deposition. Ordered by Judge Brian M. Coganon 10/3/2012. (Weisberg, Peggy) (Entered: 10/03/2012)

10/03/2012 538 [Proposed] Joint Pretrial Order; filed by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. W/Attachments: # 1 Plaintiffs' Exhibit List, # 2Defendants' Exhibit List. (Coolidge, Melinda) (Modified: Attachment # 2 has beenreplaced.) (Entered: 10/03/2012)

10/04/2012 Set/Reset Hearing: Final Pretrial Conference previously set for 10/10/2012 is resetto 10/12/2012 at 3:30 pm in Courtroom 8D South. (Weisberg, Peggy) (Entered:10/04/2012)

10/04/2012 539 Letter to Judge Cogan regarding enclosed set of Defendants' trial exhibits byHebei Welcome Pharmaceutical Co. Ltd. (Prescott, Darrell) (Entered: 10/04/2012)

A-90Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page97 of 191

Page 98: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 91/137

10/04/2012 540 Letter to the Honorable Brian M. Cogan enclosing courtesy copies by Plaintiff(s)in Civil Action Animal Science vs Hebei, 05-CV-453 (Coolidge, Melinda)(Entered: 10/04/2012)

10/05/2012 ORDER. In light of the recent motions filed in this case, the number ofevidentiary objections contained in the parties' proposed Joint Pretrial Order, andthe parties' estimate of the length of the trial, the trial date is continued to 1/14/13with jury selection to be conducted by a MagistrateJudge. All other dates remainunchanged, including the Pretrial Conference on 10/10/12 (which may be the firstof several such conferences before trial). Additionally, the parties are remindedthat therequirements of Local Civil Rule 6.1 apply to their recently-filed motions[530, 531, 533]. Ordered by Judge Brian M. Cogan on 10/5/2012. AssociatedCases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO, 1:06-cv-00149-BMC-JO, 1:06-cv-00987-BMC-JO, 1:06-cv-00988-BMC-JO (Cogan, Brian) (Entered:10/05/2012)

10/05/2012 ORDER revising the Court's Order of earlier today. The Pretrial Conference isscheduled for October 12, 2012 at 3:30 pm in Courtroom 8D South. Ordered byJudge Brian M. Cogan on 10/5/2012. Associated Cases: 1:06-md-01738-BMC-JO,1:05-cv-00453-BMC-JO, 1:06-cv-00149-BMC-JO, 1:06-cv-00987-BMC-JO,1:06-cv-00988-BMC-JO (Clarke, Melonie) (Entered: 10/05/2012)

10/08/2012 542 Letter to the Honorable Brian M. Cogan by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453 (Attachments: # 1 Plaintiffs' Exhibit List)(Coolidge, Melinda) (Entered: 10/08/2012)

10/09/2012 543 Letter from individual requesting claim form. (Siegfried, Evan) (Entered:10/09/2012)

10/09/2012 544 Notice of MOTION to Amend/Correct/Supplement (Motion to Extend ClaimsDeadline and Mail Additional Notice) by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. (Attachments: # 1 Memorandum in Support, # 2Exhibit 1, # 3 Declaration of Charlene Young, # 4 Exhibit A, # 5 Proposed Order)(Coolidge, Melinda) (Entered: 10/09/2012)

10/10/2012 545 ORDER REGARDING NOTICE AND EXTENSION OF CLAIMSDEADLINE. See attached order for further details. Ordered by Judge Brian M.Cogan on 10/9/2012. (Siegfried, Evan) (Entered: 10/10/2012)

10/11/2012 546 Letter MOTION to Compel Joint Letter Regarding Plaintiffs' Motion to CompelCPG Documents by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit Plaintiffs Exhibits A-I, # 2 Exhibit DefendantsExhibits 1-4) (Raymond, Shawn) (Entered: 10/11/2012)

10/11/2012 MOTIONS REFERRED: 546 Letter MOTION to Compel Joint Letter RegardingPlaintiffs' Motion to Compel CPG Documents. Motion referred to MagistrateJudge James Orenstein. (Weisberg, Peggy) (Entered: 10/11/2012)

10/11/2012 SCHEDULING ORDER: re 546 Letter MOTION to Compel Joint LetterRegarding Plaintiffs' Motion to Compel CPG Documents filed by Plaintiff(s) inCivil Action Animal Science vs Hebei, 05-CV-453 -- A status conference todiscuss the motion will be held on October 25, 2012 at 11:00 a.m. Ordered byMagistrate Judge James Orenstein on 10/11/2012. (Tarpey, Clare) (Entered:10/11/2012)

A-91Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page98 of 191

Page 99: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 92/137

10/11/2012 547 NOTICE by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 re546 Letter MOTION to Compel Joint Letter Regarding Plaintiffs' Motion toCompel CPG Documents CPG Exhibit 1 to Joint Letter Regarding Plaintiffs'Motion to Compel CPG Documents (Attachments: # 1 Exhibit CPG 1) (Raymond,Shawn) (Entered: 10/11/2012)

10/12/2012 548 RESPONSE in Opposition re 531 Notice of MOTION for Judgment on thePleadings or Summary Judgment, and Determination of Foreign Law filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Raymond,Shawn) (Entered: 10/12/2012)

10/12/2012 549 RESPONSE in Opposition re 530 MOTION to Strike Defendants' ExpertTestimony filed by Hebei Welcome Pharmaceutical Co. Ltd.. (Attachments: # 1Declaration of Dr. Lawrence Wu) (Prescott, Darrell) (Entered: 10/12/2012)

10/12/2012 550 RESPONSE in Opposition re 533 MOTION to Dismiss Notice of Motion toDismiss Foreign Purchases From Plaintiffs' Claims for Lack of Subject MatterJurisdiction and to Exclude Certain Other Claims as Without Evidentiary Supportfiled by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453.(Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I) (Coolidge,Melinda) (Entered: 10/12/2012)

10/15/2012 MINUTE ENTRY for Pretrial Conference held before Judge Brian M. Cogan onOctober 12, 2012. Both sides present. Certain evidentiary rulings made. Seetranscript for details. (Court Reporter: Marie Foley). Plaintiffs and defendantsshall simultaneously file any motions in limine by October 29, 2012 and theirresponses to the motions in limine by November 12, 2012. Plaintiffs anddefendants shall each submit revised exhibit lists with their motions in limine.NEPG's motion for summary judgment, if it chooses to make one, shall be filed byNovember 12, 2012. Plaintiffs' opposition to NEPG's motion is due on December3, 2012, and NEPG's reply is due on December 10, 2012. If plaintiffs choose tomake a motion concerning NCPG's document production, such motion shall befiled by November 12, 2012, with opposition due by November 19, 2012, andreply due by November 21, 2012. The parties may not file any pretrial motionsother than those listed in this Minute Entry without first obtaining the Court'spermission. The Court will hold another pretrial conference on November 19,2012 at 10:00 am in Courtroom 8D South. The trial date is continued to February25, 2013, with jury selection to be conducted by a Magistrate Judge. (Weisberg,Peggy) (Entered: 10/15/2012)

10/15/2012 551 Letter MOTION for Extension of Time to File Response/Reply and Other ReliefRegarding Scheduling by Hebei Welcome Pharmaceutical Co. Ltd.. (Prescott,Darrell) (Entered: 10/15/2012)

10/16/2012 552 ORDER granting 551 Motion for Extension of Time to File Response/Reply.Ordered by Judge Brian M. Cogan on 10/15/2012. (Siegfried, Evan) (Entered:10/16/2012)

10/16/2012 553 Letter from individual requesting claim forms. (Siegfried, Evan) (Entered:10/16/2012)

10/16/2012 554 Letter Motion to Appear by Telephone by China Pharmaceutical Group Ltd..

A-92Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page99 of 191

Page 100: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 93/137

(Mason, Daniel) (Entered: 10/16/2012)

10/17/2012 MINUTE ENTRY for Fairness Hearing held before Judge Brian M. Cogan onOctober 17, 2012. Counsel for the Direct Purchaser Damages Class, the InjunctionClass, the Indirect Purchaser Damages Settlement Class, and settling defendantAland (Jiangsu) Nutraceutical Co., Ltd. appeared. No objectors or class membersappeared. Plaintiffs' motion for final approval of the settlements with Aland 507 isgranted, as are plaintiffs' motions for fees and expenses [510 and 511]. Seetranscript for details. (Court Reporter: Charisse Kitt). A written decision will beentered shortly. (Weisberg, Peggy) (Entered: 10/17/2012)

10/18/2012 ORDER granting 554 Motion to Appear by Telephone -- The application isgranted; defendants China Pharmaceutical Group Co., Ltd. and WeishengPharmaceutical (Shijiazhuang) Co., Ltd. may appear by telephone for the statusconference previously scheduled on October 25, 2012 at 11:00 a.m. Ordered byMagistrate Judge James Orenstein on 10/18/2012. (Tarpey, Clare) (Entered:10/18/2012)

10/19/2012 555 Letter Re Aland Settlement Direct Purchaser Claims by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453 (Milici, Jennifer) (Entered:10/19/2012)

10/19/2012 556 REPLY in Support re 531 Notice of MOTION for Judgment on the Pleadings orSummary Judgment, and Determination of Foreign Law filed by ChinaPharmaceutical Group Ltd.. (Mason, Daniel) (Entered: 10/19/2012)

10/19/2012 557 REPLY in Support re (534 in 1:06-md-01738-BMC-JO, 534 in 1:06-md-01738-BMC-JO) MOTION to Dismiss Foreign Purchases From Plaintiffs' Claims forLack of Subject Matter Jurisdiction and to Exclude Certain Other Claims asWithout Evidentiary Support, (114 in 1:05-cv-00453-BMC-JO, 114 in 1:05-cv-00453-BMC-JO) MOTION to Dismiss Foreign Purchases from Plaintiffs' Claimsfor Lack of Subject Matter Jurisdiction and to Exclude Certain Other Claims asWithout Evidentiary Support filed by Hebei Welcome Pharmaceutical Co. Ltd..(Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Prescott,Darrell) (Entered: 10/19/2012)

10/22/2012 558 Letter to Judge Cogan regarding enclosed courtesy copies of Defendants' October19, 2012 Reply Memorandum in Support of Motion to Exclude Foreign Purchasesby Hebei Welcome Pharmaceutical Co. Ltd. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Prescott, Darrell) (Entered: 10/22/2012)

10/22/2012 559 REPLY in Support re 530 MOTION to Strike Defendants' Expert Testimony filedby Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,James) (Entered: 10/22/2012)

10/23/2012 560 MEMORANDUM DECISION AND ORDER. Plaintiffs' motion for finalapproval of the Aland settlements 507 is granted. The Court also grants plaintiffs'motions for fees and expenses ( 510 and [51l]). See attached order for furtherdetails. Ordered by Judge Brian M. Cogan on 10/22/2012. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO, 1:06-cv-00149-BMC-JO, 1:06-cv-00987-BMC-JO, 1:06-cv-00988-BMC-JO (Siegfried, Evan) (Entered:10/23/2012)

A-93Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page100 of 191

Page 101: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 94/137

10/24/2012 561 FINAL JUDGMENT. Please see attached document for further details. Orderedby Judge Brian M. Cogan on 10/24/2012. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Siegfried, Evan) (Entered: 10/24/2012)

10/24/2012 562 FINAL JUDGMENT. Please see attached document for further details. Orderedby Judge Brian M. Cogan on 10/24/2012. Associated Cases: 1:06-md-01738-BMC-JO, 1:06-cv-00149-BMC-JO, 1:06-cv-00987-BMC-JO, 1:06-cv-00988-BMC-JO (Siegfried, Evan) (Entered: 10/24/2012)

10/25/2012 563 EXHIBIT A Amended [dkt 546] by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453. Related document: 546 Letter MOTION to Compel JointLetter Regarding Plaintiffs' Motion to Compel CPG Documents filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Raymond,Shawn) (Entered: 10/25/2012)

10/25/2012 564 EXHIBIT J [Additional Exhibit to dkt 546] by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. Related document: 546 Letter MOTION to CompelJoint Letter Regarding Plaintiffs' Motion to Compel CPG Documents filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Raymond,Shawn) (Entered: 10/25/2012)

10/25/2012 565 Minute Entry for proceedings held before Magistrate Judge JamesOrenstein:Status Conference held on 10/25/2012. SCHEDULING: There are nofurther conferences scheduled before me at this time. THE FOLLOWINGRULINGS WERE MADE: For the reasons set forth on the record, I granted themotion to compel in its entirety, with the exception that CPG shall have 30 days,rather than 10 days, to discharge its obligations. I denied CPG's request to shift tothe plaintiffs the cost of having an ESI specialist assist CPG in discharging itsdiscovery obligations. The plaintiffs shall submit a proposed order by October 29,2012 (Court Reporter Mary Agnes Drury x2615.) (Tarpey, Clare) (Entered:10/25/2012)

10/25/2012 ORDER granting in part and denying in part 546 Motion to Compel -- as set forthon the record and in docket entry 565 , I granted the motion to compel in itsentirety, with the exception that CPG shall have 30 days, rather than 10 days, todischarge its obligations. Ordered by Magistrate Judge James Orenstein on10/25/2012. (Orenstein, James) (Entered: 10/25/2012)

10/29/2012 566 MOTION in Limine (omnibus) by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453. (Attachments: # 1 Exhibits 1-13) (Coolidge, Melinda)(Entered: 10/29/2012)

10/29/2012 567 Letter to Judge Cogan pursuant to the Court's request at the 10/12/2012 PretrialConference and 10/15/2012 Minute Entry to provide a Revised Trial Exhibit Listby Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453(Attachments: # 1 Exhibit Plaintiffs' Revised Trial Exhibit List) (Kunz, Katherine)(Entered: 10/29/2012)

10/29/2012 568 Letter to Judge Orenstein pursuant to the Court's ruling at the 10/25/2012 statusconference [dkt 565] by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 (Attachments: # 1 Exhibit A - Proposed Order) (Raymond, Shawn)(Entered: 10/29/2012)

10/29/2012 569 MOTION in Limine DEFENDANTS MOTION IN LIMINE TO EXCLUDE ANY

A-94Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page101 of 191

Page 102: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 95/137

REFERENCE TO OTHER VITAMINS LITIGATION OR ANTITRUSTINVESTIGATIONS OR PROSECUTIONS by China Pharmaceutical Group Ltd.,Hebei Welcome Pharmaceutical Co. Ltd., North China Pharmaceutical GroupCorp., Weisheng Pharmaceutical Co. Ltd.. (Attachments: # 1 Certificate ofService) (Mason, Daniel) (Entered: 10/29/2012)

10/29/2012 570 MOTION in Limine DEFENDANTS MOTION IN LIMINE TO EXCLUDEDOCUMENTS OF SETTLING DEFENDANT ALAND (FILED UNDER SEAL) byChina Pharmaceutical Group Ltd., Hebei Welcome Pharmaceutical Co. Ltd.,North China Pharmaceutical Group Corp., Weisheng Pharmaceutical Co. Ltd..(Attachments: # 1 Exhibit, # 2 Exhibit, # 3 Certificate of Service) (Mason, Daniel)(Additional attachment(s) added on 5/16/2013: # 4 SEALING COVER SHEET)(Barrett, C). (Entered: 10/29/2012)

10/29/2012 571 MOTION in Limine DEFENDANTS MOTION IN LIMINE TO EXCLUDEPLAINTIFFS PROPOSED TRIAL EXHIBIT 18 [DEPOSITION EX. 72] (FILEDUNDER SEAL) by Hebei Welcome Pharmaceutical Co. Ltd., NortheastPharmaceutical Group Co., Ltd., Weisheng Pharmaceutical Co. Ltd..(Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5Exhibit E, # 6 Exhibit F, # 7 Certificate of Service) (Mason, Daniel) (Entered:10/29/2012)

10/29/2012 572 MOTION in Limine DEFENDANTS MOTION IN LIMINE TO EXCLUDESTATEMENTS BY THE CHINESE GOVERNMENT IN UNRELATEDPROCEEDINGS, INCLUDING FOR IMPEACHMENT PURPOSES (FILEDUNDER SEAL) by China Pharmaceutical Group Ltd., Hebei WelcomePharmaceutical Co. Ltd., Northeast Pharmaceutical Group Co., Ltd., WeishengPharmaceutical Co. Ltd.. (Attachments: # 1 Exhibit A, # 2 Certificate of Service)(Mason, Daniel) (Entered: 10/29/2012)

10/29/2012 573 Letter TO HONORABLE BRIAN M. COGAN AND DEFENDANTS REVISEDTRIAL EXHIBIT LIST by China Pharmaceutical Group Ltd., Hebei WelcomePharmaceutical Co. Ltd., Northeast Pharmaceutical Group Co., Ltd., WeishengPharmaceutical Co. Ltd. (Mason, Daniel) (Entered: 10/29/2012)

10/29/2012 574 MOTION in Limine to Exclude Chinese Laws and Regulations and OpinionTestimony and to Correct Discovery Orders by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3Exhibit 3, # 4 Exhibit 4 FILED SEPARATELY UNDER SEAL) (Southwick,James) (Entered: 10/29/2012)

10/29/2012 575 REDACTION to 574 MOTION in Limine to Exclude Chinese Laws andRegulations and Opinion Testimony and to Correct Discovery Orders byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 (Attachments: #1 Exhibit 4 FILED UNDER SEAL) (Southwick, James) (Entered: 10/29/2012)

10/29/2012 576 AFFIDAVIT/AFFIRMATION PROFFER OF TESTIMONY OF QIAO HAILIPURSUANT TO THE COURT ORDER OF OCTOBER 12, 2012 by ChinaPharmaceutical Group Ltd., Hebei Welcome Pharmaceutical Co. Ltd., NorthChina Pharmaceutical Group Corp., Weisheng Pharmaceutical Co. Ltd.(Attachments: # 1 Certificate of Service) (Mason, Daniel) (Entered: 10/29/2012)

10/29/2012 577 MOTION in Limine Briefing on Admissibility of Aland Documents by Plaintiff(s)

A-95Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page102 of 191

Page 103: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 96/137

in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick, James)(Entered: 10/29/2012)

10/29/2012 578 MOTION in Limine DEFENDANTS MOTION IN LIMINE TO EXCLUDEINCORRECT TRANSLATIONS OF PLAINTIFFS TRIAL EXHIBITS by ChinaPharmaceutical Group Ltd., Hebei Welcome Pharmaceutical Co. Ltd., NorthChina Pharmaceutical Group Corp., Weisheng Pharmaceutical Co. Ltd..(Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 ExhibitJ, # 11 Exhibit K, # 12 Certificate of Service) (Mason, Daniel) (Entered:10/29/2012)

10/30/2012 579 Letter LETTER TO HONORABLE JAMES ORENSTEIN RE: CPG'SOBJECTIONS TO PLAINTIFFS' PROPOSED ORDER [D.E. 567] by ChinaPharmaceutical Group Ltd. (Attachments: # 1 Exhibit A, # 2 Exhibit B) (Mason,Daniel) (Entered: 10/30/2012)

11/02/2012 580 Letter to Judge Cogan regarding the delivery of courtesy copies of Defendants'trial exhibits by Hebei Welcome Pharmaceutical Co. Ltd. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Prescott, Darrell) (Entered:11/02/2012)

11/08/2012 ORDER re 579 Letter filed by China Pharmaceutical Group Ltd., 568 Letter filedby Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 -- Havingreviewed the parties' submissions, I am satisfied that the substance of proposedorder submitted by the plaintiffs, docket entry [568-1], aptly reflects the oralruling I made on October 25, 2012, see docket entry 565 . I therefore adopt thatorder in its entirety, notwithstanding the defendant's objections, with the provisothat I extend the time for the parties to meet and confer and reach an agreement asto search terms to November 16, 2012. Ordered by Magistrate Judge JamesOrenstein on 11/8/2012. (Orenstein, James) (Entered: 11/08/2012)

11/08/2012 581 MOTION to Set Aside DEFENDANT CHINA PHARMACEUTICAL GROUPLTD.S OBJECTION TO MAGISTRATE JUDGE JAMES ORENSTEINSOCTOBER 25, 2012 ORDER COMPELLING THE PRODUCTION OFDELOITTES WORK FILES by China Pharmaceutical Group Ltd.. (Mason,Daniel) (Entered: 11/08/2012)

11/12/2012 582 NOTICE of Appearance by Eric Buetzow on behalf of China PharmaceuticalGroup Ltd., Vitamin C Antitrust Litigation, Weisheng Pharmaceutical Co. Ltd.(aty to be noticed) (Buetzow, Eric) (Entered: 11/12/2012)

11/12/2012 583 RESPONSE in Opposition re 577 MOTION in Limine Briefing on Admissibilityof Aland Documents filed by Hebei Welcome Pharmaceutical Co. Ltd..(Attachments: # 1 Exhibit A) (Prescott, Darrell) (Entered: 11/12/2012)

11/12/2012 584 RESPONSE to Motion re 566 MOTION in Limine (omnibus) filed by ChinaPharmaceutical Group Ltd., Hebei Welcome Pharmaceutical Co. Ltd., NorthChina Pharmaceutical Group Corp., Weisheng Pharmaceutical Co. Ltd..(Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Certificate of Service)(Mason, Daniel) (Entered: 11/12/2012)

11/12/2012 585 RESPONSE to Motion re 574 MOTION in Limine to Exclude Chinese Laws andRegulations and Opinion Testimony and to Correct Discovery Orders filed by

A-96Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page103 of 191

Page 104: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 97/137

China Pharmaceutical Group Ltd., Hebei Welcome Pharmaceutical Co. Ltd.,Northeast Pharmaceutical Group Co., Ltd., Weisheng Pharmaceutical Co. Ltd..(Attachments: # 1 Certificate of Service) (Mason, Daniel) (Entered: 11/12/2012)

11/12/2012 586 MEMORANDUM in Opposition re 571 MOTION in Limine DEFENDANTSMOTION IN LIMINE TO EXCLUDE PLAINTIFFS PROPOSED TRIAL EXHIBIT18 [DEPOSITION EX. 72] (FILED UNDER SEAL) filed by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit 1 Filedunder seal, # 2 Exhibit 2 Filed under seal, # 3 Exhibit 3 Filed under seal, # 4Exhibit 4 filed under seal) (Milici, Jennifer) (Entered: 11/12/2012)

11/12/2012 587 MOTION for Summary Judgment ( Responses due by 12/3/2012) by North ChinaPharmaceutical Group Corp.. (Attachments: # 1 Memorandum in Support, # 2Rule 56.1 Statement, # 3 Declaration of James D. Bailey, # 4 Exhibit A, # 5Exhibit B, # 6 Exhibit C, # 7 Exhibit D, # 8 Exhibit E, # 9 Exhibit F, # 10 ExhibitG, # 11 Exhibit H, # 12 Exhibit I, # 13 Exhibit J, # 14 Exhibit K, # 15 Exhibit L, #16 Exhibit M, # 17 Exhibit N, # 18 Exhibit O, # 19 Exhibit P) (Prescott, Darrell)(Entered: 11/12/2012)

11/12/2012 588 EXHIBIT 1- 4 by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. Related document: 586 Memorandum in Opposition, filed by Plaintiff(s) inCivil Action Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit 1, #2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4) (Milici, Jennifer) (Entered: 11/12/2012)

11/12/2012 589 MEMORANDUM in Opposition re 576 Affidavit, Proffer of Testimony of QiaoHaili filed by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453.(Attachments: # 1 Exhibit 1 (filed separately under seal), # 2 Exhibit 2) (Milici,Jennifer) (Entered: 11/12/2012)

11/12/2012 590 EXHIBIT 1 to Plaintiffs' Response to Proffer of Testimony of Qiao Haili byPlaintiff(s) in Civil Action Philion vs Hebei Welcome Pharmaceutical Co. Ltd.06-CV-987. Related document: 589 Memorandum in Opposition, filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments: #1 Exhibit 1) (Milici, Jennifer) (Entered: 11/12/2012)

11/12/2012 591 MEMORANDUM in Opposition re 570 MOTION in Limine DEFENDANTSMOTION IN LIMINE TO EXCLUDE DOCUMENTS OF SETTLINGDEFENDANT ALAND (FILED UNDER SEAL) filed by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit 1 (filedspearately under seal)) (Milici, Jennifer) (Entered: 11/12/2012)

11/12/2012 592 EXHIBIT 1 to Plaintiffs' Opposition to Defendants' Motion to Exclude AlandDocuments by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453.(Attachments: # 1 Exhibit 1) (Milici, Jennifer) (Entered: 11/12/2012)

11/12/2012 593 RESPONSE in Opposition re 578 MOTION in Limine DEFENDANTS MOTIONIN LIMINE TO EXCLUDE INCORRECT TRANSLATIONS OF PLAINTIFFSTRIAL EXHIBITS (filed under seal) filed by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. (Attachments: # 1 Exhibits 1-14, # 2 Declaration ofShiqi Liao) (Coolidge, Melinda) (Entered: 11/12/2012)

11/12/2012 594 RESPONSE in Opposition re 569 MOTION in Limine DEFENDANTS MOTIONIN LIMINE TO EXCLUDE ANY REFERENCE TO OTHER VITAMINSLITIGATION OR ANTITRUST INVESTIGATIONS OR PROSECUTIONS (filed

A-97Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page104 of 191

Page 105: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 98/137

under seal) filed by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibits 1-6) (Coolidge, Melinda) (Entered: 11/12/2012)

11/12/2012 595 MOTION to Compel by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit A - PX 124, # 2 Exhibit B - May 2008 RFP, #3 Exhibit C - June 2008 Response to RFP, # 4 Exhibit D - August 2008 MeritsRFP, # 5 Exhibit E - August 2012 Email, # 6 Exhibit F - September 2012Response to RFP, # 7 Exhibit G - September 2012 Email, # 8 Exhibit H -September 2012 ROG Request, # 9 Exhibit I - September 2012 ROG Response, #10 Exhibit J - FILED SEPARATELY UNDER SEAL, # 11 Exhibit K - FILEDSEPARATELY UNDER SEAL, # 12 Exhibit L - FILED SEPARATELYUNDER SEAL, # 13 Exhibit M - FILED SEPARATELY UNDER SEAL)(Southwick, James) (Entered: 11/12/2012)

11/12/2012 596 EXHIBIT J, K, L & M by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. Related document: 595 MOTION to Compel filed by Plaintiff(s) inCivil Action Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit J -Jianfu Yang Depo Pages - FILED SEPARATELY UNDER SEAL, # 2 Exhibit K -PX 433 - FILED SEPARATELY UNDER SEAL, # 3 Exhibit L - PX 306 - FILEDSEPARATELY UNDER SEAL, # 4 Exhibit M - PX 119 - FILED SEPARATELYUNDER SEAL) (Southwick, James) (Entered: 11/12/2012)

11/12/2012 597 RESPONSE in Opposition re 572 MOTION in Limine DEFENDANTS MOTIONIN LIMINE TO EXCLUDE STATEMENTS BY THE CHINESE GOVERNMENTIN UNRELATED PROCEEDINGS, INCLUDING FOR IMPEACHMENTPURPOSES (FILED UNDER SEAL) filed by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. (Coolidge, Melinda) (Entered: 11/12/2012)

11/14/2012 598 Notice of MOTION for Disbursement of Funds (Motion to Authorize Payment ofNotice and Claims Administration Costs) by Plaintiff(s) in Civil Action Philion vsHebei Welcome Pharmaceutical Co. Ltd. 06-CV-987, Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453, Plaintiff(s) in Civil Action Audette vsHebei Welcome Pharmaceutical Co. Ltd. 06-CV-988, Plaintiff(s) in Civil ActionKeane vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149. (Attachments: # 1Memorandum in Support, # 2 Exhibit A, # 3 Proposed Order) (Coolidge, Melinda)(Entered: 11/14/2012)

11/15/2012 599 MOTION for Leave to File REPLY MEMO IN SUPPORT OF DEFENDANTS'MOTION IN LIMINE TO EXCLUDE STATEMENTS BY THE CHINESEGOVERNMENT IN UNRELATED PROCEEDINGS [D.E. 572] by ChinaPharmaceutical Group Ltd., Hebei Welcome Pharmaceutical Co. Ltd., NortheastPharmaceutical Group Co., Ltd., Weisheng Pharmaceutical Co. Ltd..(Attachments: # 1 [PROPOSED] REPLY MEMORANDUM, # 2 Certificate ofService) (Mason, Daniel) (Entered: 11/15/2012)

11/15/2012 600 RESPONSE in Opposition re 581 MOTION to Set Aside DEFENDANT CHINAPHARMACEUTICAL GROUP LTD.S OBJECTION TO MAGISTRATE JUDGEJAMES ORENSTEINS OCTOBER 25, 2012 ORDER COMPELLING THEPRODUCTION OF DELOITTES WORK FILES filed by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit A, # 2Exhibit B) (Raymond, Shawn) (Entered: 11/15/2012)

11/16/2012 NOTICE TO ALL PARTIES. Final Pretrial Conference previously set for

A-98Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page105 of 191

Page 106: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 99/137

November 19, 2012 at 10:00 am is CANCELLED. The Court will reschedulethe conference in a subsequent Order. Ordered by Judge Brian M. Cogan on11/16/2012. (Weisberg, Peggy) (Entered: 11/16/2012)

11/16/2012 ORDER as to 599 defendants' motion for leave to file a reply memorandum. Themotion is granted and the reply memorandum is deemed filed. Ordered by JudgeBrian M. Cogan on 11/16/2012. (Weisberg, Peggy) (Entered: 11/16/2012)

11/16/2012 601 Letter from C. Critchlow to Judge Cogan regarding cancellation of the November19 Pretrial Conference and defense counsel's availability for a rescheduledconference by Hebei Welcome Pharmaceutical Co. Ltd. (Prescott, Darrell)(Entered: 11/16/2012)

11/16/2012 602 Letter from James D. Bailey to Judge Cogan regarding delivery of courtesy copiesof November 12 filings by Hebei Welcome Pharmaceutical Co. Ltd. (Prescott,Darrell) (Entered: 11/16/2012)

11/16/2012 603 REPLY in Support re 581 MOTION to Set Aside DEFENDANT CHINAPHARMACEUTICAL GROUP LTD.S OBJECTION TO MAGISTRATE JUDGEJAMES ORENSTEINS OCTOBER 25, 2012 ORDER COMPELLING THEPRODUCTION OF DELOITTES WORK FILES AND CERTIFICATE OFSERVICE filed by China Pharmaceutical Group Ltd.. (Buetzow, Eric) (Entered:11/16/2012)

11/19/2012 604 MEMORANDUM DECISION AND ORDER. Defendants' motion to dismissthe foreign purchaser claims, strike evidence related to the foreign purchaserclaims, and strike evidence of purchases from Hualong and Tiger 533 is denied.Ordered by Judge Brian M. Cogan on 11/16/2012. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Siegfried, Evan) (Entered:11/19/2012)

11/19/2012 605 Letter to Judge Cogan Regarding North China Pharmaceutical Group Corp.'sOpposition to Plaintiffs' Motion to Compel by North China Pharmaceutical GroupCorp. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Prescott,Darrell) (Entered: 11/19/2012)

11/21/2012 606 MEMORANDUM AND ORDER dated 11/19/12 that CPG's objection 581 issustained and Magistrate Judge Orenstein's Orders are reversed to the extent setforth above. ( Ordered by Judge Brian M. Cogan on 11/19/2012 ) AssociatedCases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Guzzi, Roseann)(Entered: 11/21/2012)

11/21/2012 607 REPLY to Response to Motion re 595 MOTION to Compel filed by Plaintiff(s) inCivil Action Animal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered:11/21/2012)

11/21/2012 608 EXHIBIT A by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453.Related document: 607 Reply to Response to Motion filed by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered:11/21/2012)

11/21/2012 609 EXHIBIT B by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453.Related document: 607 Reply to Response to Motion filed by Plaintiff(s) in Civil

A-99Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page106 of 191

Page 107: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 100/137

Action Animal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered:11/21/2012)

11/21/2012 610 EXHIBIT C by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453.Related document: 607 Reply to Response to Motion filed by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered:11/21/2012)

11/21/2012 611 MOTION for Leave to File Reply Memorandum in Support of Plaintiffs' Motion inLimine No. 1 (ECF No. 566) by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453. (Attachments: # 1 [Proposed] Reply Memorandum, # 2Exhibit A, # 3 Exhibit B) (Coolidge, Melinda) (Entered: 11/21/2012)

11/21/2012 612 REPLY to Response to Motion re 595 MOTION to Compel [Corrected] filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,James) (Entered: 11/21/2012)

11/21/2012 ORDER in case 1:05-cv-00453-BMC-JO; granting (611) Motion for Leave to Filein case 1:06-md-01738-BMC-JO. Ordered by Judge Brian M. Cogan on11/21/2012. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Cogan, Brian) (Entered: 11/21/2012)

11/21/2012 613 REPLY in Support re 566 MOTION in Limine (omnibus) No. 1 filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments: #1 Exhibit A, # 2 Exhibit B) (Coolidge, Melinda) (Entered: 11/21/2012)

12/03/2012 614 Notice of MOTION for Reconsideration of the Court's November 19, 2012 Orderby Hebei Welcome Pharmaceutical Co. Ltd.. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Prescott, Darrell) (Entered: 12/03/2012)

12/03/2012 615 MOTION for Reconsideration (Memorandum of Law in Support of) by HebeiWelcome Pharmaceutical Co. Ltd.. Associated Cases: 1:06-md-01738-BMC-JO,1:05-cv-00453-BMC-JO (Prescott, Darrell) (Entered: 12/03/2012)

12/03/2012 616 MEMORANDUM in Opposition re 587 MOTION for Summary Judgment filedby Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,James) (Entered: 12/03/2012)

12/03/2012 617 AFFIDAVIT/DECLARATION in Opposition re 587 MOTION for SummaryJudgment filed by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit A - FILED UNDER SEAL, # 2 Exhibit B - FILEDUNDER SEAL, # 3 Exhibit C - FILED UNDER SEAL, # 4 Exhibit D - FILEDUNDER SEAL, # 5 Exhibit E - FILED UNDER SEAL, # 6 Exhibit F - FILEDUNDER SEAL, # 7 Exhibit G - FILED UNDER SEAL, # 8 Exhibit H - FILEDUNDER SEAL, # 9 Exhibit I - FILED UNDER SEAL, # 10 Exhibit J - FILEDUNDER SEAL, # 11 Exhibit K - FILED UNDER SEAL, # 12 Exhibit L - FILEDUNDER SEAL, # 13 Exhibit M - FILED UNDER SEAL, # 14 Exhibit N - FILEDUNDER SEAL, # 15 Exhibit O - FILED UNDER SEAL, # 16 Exhibit P - FILEDUNDER SEAL) (Southwick, James) (Entered: 12/03/2012)

12/03/2012 618 RULE 56.1 STATEMENT re 587 MOTION for Summary Judgment filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,James) (Entered: 12/03/2012)

12/04/2012 619 Letter to Judge Cogan regarding enclosed courtesy copies of Defendants' Motion

A-100Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page107 of 191

Page 108: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 101/137

for Reconsideration by Hebei Welcome Pharmaceutical Co. Ltd. AssociatedCases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Prescott, Darrell)(Entered: 12/04/2012)

12/04/2012 620 DECLARATION OF EDDIE CHAK REGARDING DEFENDANT CHINAPHARMACEUTICAL GROUP LTD.S CONTACT OF FORMER EMPLOYEESAND EXECUTIVE DIRECTORS Pursuant to the November 8, 2012 MagistrateJudge Order by China Pharmaceutical Group Ltd. (Mason, Daniel) (Entered:12/04/2012)

12/10/2012 621 REPLY in Support re 587 MOTION for Summary Judgment filed by North ChinaPharmaceutical Group Corp.. (Attachments: # 1 Exhibit A) (Prescott, Darrell)(Entered: 12/10/2012)

12/10/2012 622 AFFIDAVIT/DECLARATION in Support re 587 MOTION for SummaryJudgment James Bailey filed by North China Pharmaceutical Group Corp..(Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5Exhibit E, # 6 Exhibit F, # 7 Exhibit G) (Prescott, Darrell) (Entered: 12/10/2012)

12/10/2012 623 AFFIDAVIT/DECLARATION in Support re 587 MOTION for SummaryJudgment by Sarah Hu filed by North China Pharmaceutical Group Corp..(Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Prescott, Darrell) (Entered: 12/10/2012)

12/11/2012 624 Letter to Judge Cogan regarding hand-delivery of courtesy copies of December10, 2012 Reply by North China Pharmaceutical Group Corp. Associated Cases:1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Prescott, Darrell) (Entered:12/11/2012)

12/14/2012 625 RESPONSE in Opposition re 614 Notice of MOTION for Reconsideration of theCourt's November 19, 2012 Order filed by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. (Coolidge, Melinda) (Entered: 12/14/2012)

12/18/2012 626 REPLY in Support re 614 Notice of MOTION for Reconsideration of the Court'sNovember 19, 2012 Order filed by China Pharmaceutical Group Ltd., HebeiWelcome Pharmaceutical Co. Ltd., North China Pharmaceutical Group Corp.,Weisheng Pharmaceutical Co. Ltd.. (Attachments: # 1 Certificate of Service)(Buetzow, Eric) (Entered: 12/18/2012)

12/21/2012 627 MEMORANDUM DECISION AND ORDER. Plaintiffs' motion to exclude thetestimony of Dr. Wu 530 is denied. Please see attached order for further details.Ordered by Judge Brian M. Cogan on 12/20/2012. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Siegfried, Evan) (Entered:12/21/2012)

12/21/2012 628 ORDER REGARDING PAYMENT OF NOTICE AND CLAIMSADMINISTRATION COSTS. Please see attached order for further details.Ordered by Judge Brian M. Cogan on 12/20/2012. (Siegfried, Evan) (Entered:12/21/2012)

01/10/2013 629 NOTICE of Change of Firm Address by Darrell Prescott Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Prescott, Darrell) (Entered:01/10/2013)

A-101Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page108 of 191

Page 109: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 102/137

01/10/2013 630 NOTICE of Change of Firm Address by Darrell Prescott (Charles H. Critchlow)Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Prescott,Darrell) (Entered: 01/10/2013)

01/24/2013 631 Letter TO HONORABLE BRIAN M. COGAN REGARDING PRETRIALCONFERENCE AVAILABILITY by China Pharmaceutical Group Ltd., WeishengPharmaceutical Co. Ltd. (Mason, Daniel) (Entered: 01/24/2013)

01/31/2013 632 Letter dated 1/21/2013 from Hayes Barker to Clerk of Court RE: Mr. Barkerrequests to be added to the action. (Siegfried, Evan) (Entered: 01/31/2013)

01/31/2013 633 SCHEDULING ORDER: This case has been referred to me for purposes ofselecting a trial jury, which I will do on February 25, 2013, beginning promptly at9:30 a.m in courtroom 8D, South. I direct counsel for each party to submit, nolater than February 19, 2013, any questions the party wishes me to ask ofprospective jurors during voir dire. Only questions specifically addressing theissues to be tried should be submitted; routine questions are not necessary. Ifurther direct each party to include within its submission a list of the names of allpersons, entities, and locations that the party expects to be mentioned during thetrial. Ordered by Magistrate Judge James Orenstein on 1/31/2013. (Guy, Alicia)(Entered: 01/31/2013)

02/01/2013 634 NOTICE of Appearance by Catherine Yunie Stillman on behalf of HebeiWelcome Pharmaceutical Co. Ltd. (aty to be noticed) Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO, 1:06-cv-00149-BMC-JO, 1:06-cv-00987-BMC-JO, 1:06-cv-00988-BMC-JO (Stillman, Catherine) (Entered:02/01/2013)

02/08/2013 635 MEMORANDUM DECISION AND ORDER denying (587) Motion forSummary Judgment; granting in part and denying in part (595) Motion to Compel.See attached order for further details. Ordered by Judge Brian M. Cogan on2/8/2013. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO(Siegfried, Evan) (Entered: 02/08/2013)

02/11/2013 636 Letter MOTION for Extension of Time to Complete Discovery by North ChinaPharmaceutical Group Corp.. (Stillman, Catherine) (Entered: 02/11/2013)

02/15/2013 ORDER granting 636 Motion for Extension of Time to Complete Discovery.NCPG's time to produce any responsive documents is extended to 2/25/2013.Ordered by Judge Brian M. Cogan on 2/15/2013. (Weisberg, Peggy) (Entered:02/15/2013)

02/19/2013 637 Letter to the Honorable Brian M. Cogan by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453 (Coolidge, Melinda) (Entered: 02/19/2013)

02/19/2013 638 Proposed Voir Dire by Hebei Welcome Pharmaceutical Co. Ltd. (Attachments: #1 Jury Questionnaire, # 2 List of Names, Entities, Locations, # 3 Proposed BriefCase Summary) (Stillman, Catherine) (Entered: 02/19/2013)

02/19/2013 639 Letter to the Honorable Brian M. Cogan (revised) by Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453 (Coolidge, Melinda) (Entered: 02/19/2013)

02/19/2013 640 Proposed Voir Dire by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 (Coolidge, Melinda) (Entered: 02/19/2013)

A-102Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page109 of 191

Page 110: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 103/137

02/20/2013 641 Letter Responding to 638 Defendants' Proposed Jury Questionnaire, CaseSummary, and List of Names by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453 (Landau, Brent) (Entered: 02/20/2013)

02/20/2013 ORDER re 638 Proposed Voir Dire filed by Hebei Welcome Pharmaceutical Co.Ltd., 641 Letter filed by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 -- I deny the defendants' request to conduct voir dire by means of awritten questionnaire. Using a questionnaire would impose needless burdens onthe parties and the court, and would make it impossible for the parties to completejury selection on February 25, 2013, as previously scheduled. The parties shouldbe prepared to make their opening statements immediately after the jury has beenselected, no later than the afternoon of February 25, 2013. To the extent that theparties have not agreed on a proposed description of the case, I respectfullyrequest that the parties meet and confer and submit by noon on February 21, 2013,either a joint proposal or competing proposals for a short, and non argumentativecase description. Ordered by Magistrate Judge James Orenstein on 2/20/2013.(Orenstein, James) (Entered: 02/20/2013)

02/20/2013 642 MEMORANDUM DECISION AND ORDER. CPG's motion for adetermination of foreign law and judgment on the pleadings or, in the alternative,for summary judgment 531 is denied as untimely. Ordered by Judge Brian M.Cogan on 2/20/2013. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Siegfried, Evan) (Entered: 02/20/2013)

02/21/2013 643 Proposed Voir Dire by Hebei Welcome Pharmaceutical Co. Ltd. (Attachments: #1 Proposed Brief Case Summary) (Stillman, Catherine) (Entered: 02/21/2013)

02/21/2013 644 Proposed Voir Dire by Hebei Welcome Pharmaceutical Co. Ltd. (Attachments: #1 Defendants' Proposed Voir Dire Questions) (Stillman, Catherine) (Entered:02/21/2013)

02/21/2013 645 Letter Regarding Original Apostiled Documents Attached as Exhibits to MitnickDeclaration in Support of the Brief of Amicus Curiae of the Ministry of Commerceof the People's Republic of China by Hebei Welcome Pharmaceutical Co. Ltd.(Stillman, Catherine) (Entered: 02/21/2013)

02/21/2013 646 Proposed Jury Instructions by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453 (Coolidge, Melinda) (Entered: 02/21/2013)

02/21/2013 647 Letter to Magistrate Judge James Orenstein regarding objections to ECF 644(proposed voir dire) by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 (Coolidge, Melinda) (Entered: 02/21/2013)

02/22/2013 648 Letter to the Honorable Brian M. Cogan by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453 (Coolidge, Melinda) (Entered: 02/22/2013)

02/23/2013 649 Letter to Judge Cogan Regarding Resolution of Plaintiffs' Motion in Limine No. 1566 by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 (Landau,Brent) (Entered: 02/23/2013)

02/23/2013 650 Proposed Jury Instructions by Hebei Welcome Pharmaceutical Co. Ltd. (Stillman,Catherine) (Entered: 02/23/2013)

02/23/2013 651 Letter to the Honorable Judge James Orenstein by Hebei Welcome

A-103Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page110 of 191

Page 111: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 104/137

Pharmaceutical Co. Ltd. (Attachments: # 1 Recent Publicity About China ForPossible Use In Connection with Voir Dire) (Stillman, Catherine) (Entered:02/23/2013)

02/23/2013 652 Letter regarding Plaintiffs' Qiao Deposition Designations by Hebei WelcomePharmaceutical Co. Ltd. (Stillman, Catherine) (Entered: 02/23/2013)

02/24/2013 653 ORDER in case 1:06-cv-00149-BMC-JO; granting in part and denying in partMotions in Limine; granting in part and denying in part (566)(569) (570) (571)(572) (574) (577) (578) Motion in Limine in case 1:06-md-01738-BMC-JO. Seeattached Order. Ordered by Judge Brian M. Cogan on 2/24/2013. AssociatedCases: 1:06-md-01738-BMC-JO, 1:06-cv-00149-BMC-JO (Cogan, Brian)(Entered: 02/24/2013)

02/24/2013 654 Letter to the Honorable Brian M. Cogan by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453 (Attachments: # 1 Exhibit 1) (Coolidge, Melinda)(Entered: 02/24/2013)

02/24/2013 655 Letter to Magistrate Judge Orenstein regarding Defendants' proposed list ofnames for voir dire 638 by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453 (Landau, Brent) (Entered: 02/24/2013)

02/24/2013 656 Proposed Jury Instructions by Defendant(s) in Civil Action Animal Science vsHebei, 05-CV-453, Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 (Landau, Brent) (Entered: 02/24/2013)

02/25/2013 657 Letter to Honorable Brian M. Cogan by China Pharmaceutical Group Ltd.,Weisheng Pharmaceutical Co. Ltd. (Mason, Daniel) (Entered: 02/25/2013)

02/25/2013 658 Minute Entry for proceedings held before Judge Brian M. Cogan: Jury Selectionheld on 2/25/2013.(Court Reporter Charleane Heading) (Lee, Tiffeny) (Entered:02/26/2013)

02/25/2013 Minute Entry for Jury Trial begun on 2/25/2013 before Judge Brian M. Cogan. Allparties present. Opening statements. Jury Trial continued to 2/26/2013 at 9:30 AMin Courtroom 8D South. (Court Reporter Marsha Diamond.) Associated Cases:1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Clarke, Melonie) Modified.(Entered: 02/26/2013)

02/26/2013 Minute Entry for Jury Trial held on 2/26/2013 before Judge Brian M. Cogan. Allparties present. Evidence entered; testimony heard. Jury Trial cont'd to 2/27/2013at 9:30 AM in Courtroom 8D South. (Court Reporter Marsha Diamond.)Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Clarke,Melonie) (Entered: 02/26/2013)

02/27/2013 Minute Entry for Jury Trial held on 2/27/2013 before Judge Brian M. Cogan. Allparties present. Evidence entered; testimony heard. Jury Trial cont'd to 2/28/2013at 9:30 AM in Courtroom 8D South.(Court Reporter Marsha Diamond.)Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Clarke,Melonie) (Entered: 02/27/2013)

02/28/2013 Minute Entry for Jury Trial held on 2/28/2013 before Judge Brian M. Cogan. Allparties present. Evidence entered; testimony heard. Jury Trial cont'd to 3/4/2013 at9:30 AM in Courtroom 8D South. (Court Reporter Anthony Mancuso.) Associated

A-104Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page111 of 191

Page 112: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 105/137

Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Clarke, Melonie)(Entered: 02/28/2013)

03/01/2013 NOTICE TO COUNSEL: Jury Trial will continue on 3/4/2013 at 10:30 AM inCourtroom 8D South. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Clarke, Melonie) (Entered: 03/01/2013)

03/02/2013 ORDER. Any party wishing to submit proposed jury charges shall do so by closeof business on 3/8/13. The Court generally does not need standard charges, e.g.,weighing of the evidence, evaluation of witness credibility, expert witnessinstruction, mechanism of jury deliberations, unless the parties are so inclined, butis interested in proposed substantive instructions if the parties wish to submitthem. Ordered by Judge Brian M. Cogan on 3/2/2013. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Cogan, Brian) (Entered: 03/02/2013)

03/03/2013 659 Letter to Judge Cogan regarding objections to deposition designations byPlaintiff(s) in Civil Action Audette vs Hebei Welcome Pharmaceutical Co. Ltd.06-CV-988 (Landau, Brent) (Entered: 03/03/2013)

03/04/2013 Minute Entry for Jury Trial held on 3/4/2013 before Judge Brian M. Cogan. Allparties present. Evidence entered; testimony heard. Jury Trial cont'd to 3/5/2013 at9:30 AM in Courtroom 8D South. (Court Reporter Mary Agnes Drury.)Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Clarke,Melonie) (Entered: 03/04/2013)

03/04/2013 660 Letter to Judge Cogan withdrawing objection to DX 105 by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453 (Landau, Brent) (Entered:03/04/2013)

03/05/2013 Minute Order for proceedings before Judge Brian M. Cogan: All parties present.Motions for Reconsideration 125 and 614 are denied on the record. Jury Trial heldon 3/5/2013. Evidence entered; testimony heard. Plaintiffs rests. Jury Trial cont'dto 3/6/2013 at 9:30 AM in Courtroom 8D South. (Court Reporter Mary AgnesDrury.) Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO(Clarke, Melonie) (Entered: 03/05/2013)

03/05/2013 661 Letter to Judge Cogan regarding the cross-examination of Qiao Haili byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 (Landau, Brent)(Entered: 03/05/2013)

03/06/2013 662 Proposed Jury Instructions by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453 (Coolidge, Melinda) (Entered: 03/06/2013)

03/06/2013 663 NOTICE by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453(Proposed Verdict Form) (Coolidge, Melinda) (Entered: 03/06/2013)

03/06/2013 Minute Entry for Jury Trial held on 3/6/2013 before Judge Brian M. Cogan. Allparties present. Evidence entered; testimony heard. Jury Trial cont'd to 3/7/2013 at9:30 AM in Courtroom 8D South. (Court Reporter Mary Agnes Drury.)Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Clarke,Melonie) (Entered: 03/06/2013)

03/06/2013 664 Proposed Jury Instructions by Hebei Welcome Pharmaceutical Co. Ltd. (Stillman,Catherine) (Entered: 03/06/2013)

A-105Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page112 of 191

Page 113: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 106/137

03/06/2013 665 Letter to the Honorable Brian M. Cogan by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453 (Coolidge, Melinda) (Entered: 03/06/2013)

03/07/2013 666 MOTION in Limine to Exclude Exhibit PX 72 by Hebei Welcome PharmaceuticalCo. Ltd.. (Attachments: # 1 Exhibit A, # 2 Exhibit B) (Stillman, Catherine)(Entered: 03/07/2013)

03/07/2013 Minute Order for proceedings before Judge Brian M. Cogan: All parties present.Motion in Limine 666 is granted on the record. Jury Trial held on 3/7/2013.Evidence entered; testimony heard. Jury Trial cont'd to 3/11/2013 at 9:30 AM inCourtroom 8D South. (Court Reporter Mary Agnes Drury.) Associated Cases:1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO(Clarke, Melonie) (Entered:03/07/2013)

03/08/2013 667 Letter to Judge Cogan by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453 (Attachments: # 1 Exhibit A, # 2 Exhibit B) (Southwick, James)(Entered: 03/08/2013)

03/08/2013 ORDER re (667 in 1:06-md-01738-BMC-JO) Letter filed by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453. The Court will withhold ruling onplaintiff's motion in limine pending receipt of defendant's response, but defendantsshould have Dr. Wu prepared to proceed without the material (and accompanyingtestimony) to which plaintiffs have objected. Ordered by Judge Brian M. Coganon 3/8/2013. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Cogan, Brian) (Entered: 03/08/2013)

03/09/2013 668 NOTICE by Hebei Welcome Pharmaceutical Co. Ltd. (Defendants' ProposedSpecial Verdict Form) (Stillman, Catherine) (Entered: 03/09/2013)

03/09/2013 669 Letter to Judge Cogan by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453 (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 ExhibitD, # 5 Exhibit E, # 6 Exhibit F) (Southwick, James) (Entered: 03/09/2013)

03/10/2013 670 Letter to Judge Cogan Regarding Plaintiffs' Objections to Dr. Wu'sDemonstratives by China Pharmaceutical Group Ltd., Hebei WelcomePharmaceutical Co. Ltd., North China Pharmaceutical Group Corp., WeishengPharmaceutical Co. Ltd. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 ExhibitC, # 4 Exhibit D, # 5 Exhibit E) (Prescott, Darrell) (Entered: 03/10/2013)

03/10/2013 671 MEMORANDUM in Opposition re 668 Notice(Other) Defendants' ProposedSpecial Verdict Form filed by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453. (Milici, Jennifer) (Entered: 03/10/2013)

03/10/2013 672 Letter to Judge Cogan Regarding Dr. Wu's Demonstratives by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453 (Coolidge, Melinda) (Entered:03/10/2013)

03/10/2013 673 MEMORANDUM in Opposition re 664 Proposed Jury Instructions filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Landau, Brent)(Entered: 03/10/2013)

03/11/2013 Minute Entry for Jury Trial held on 3/11/2013 before Judge Brian M. Cogan. Allparties present. Evidence entered; testimony heard. Defendants'rests. ChargingConference set for 3/12/2013 at 10:30 AM in Courtroom 8D South. (Court

A-106Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page113 of 191

Page 114: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 107/137

Reporter Victoria Butler.) Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Clarke, Melonie) (Entered: 03/11/2013)

03/12/2013 674 MOTION in Limine and proposed jury instruction by Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453. (Attachments: # 1 Proposed JuryInstruction) (Milici, Jennifer) (Entered: 03/12/2013)

03/12/2013 Minute Order for proceedings held before Judge Brian M. Cogan. All partiespresent. Motion in Limine(674) granting in part on the record. ChargingConference held on 3/12/2013. Jury Trial cont'd to 3/13/2013 at 10:30 AM inCourtroom 8D South. (Court Reporter Victoria Butler.) Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO(Clarke, Melonie) (Entered:03/12/2013)

03/13/2013 Minute Entry for Jury Trial held on 3/13/2013 before Judge Brian M. Cogan. Allparties present. Closing arguments. Jury charged. Deliberations will resume3/14/2013 at 9:30 AM in Courtroom 8D South. (Court Reporter Victoria Butler.)Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Clarke,Melonie) (Entered: 03/13/2013)

03/13/2013 ORDER OF SUSTENANCE: It is hereby Ordered that the Marshal supply propersustenance to the seven jurors empaneled in the above action. Ordered by JudgeBrian M. Cogan on 3/13/2013. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Clarke, Melonie) (Entered: 03/15/2013)

03/14/2013 Minute Entry for Jury Trial completed on 3/14/2013 before Judge Brian M.Cogan. All parties present. The jury deliberated and returned a verdict in favor ofplaintiffs. The jurors were polled and excused. On motion of plaintiffs, the Courtdirected entry of judgment in favor of plaintiffs and against defendants in theamount of $162,300,000. (Court Reporter Victoria Butler.) Associated Cases:1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Clarke, Melonie) (Entered:03/14/2013)

03/14/2013 675 JURY VERDICT Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Clarke, Melonie) (Entered: 03/14/2013)

03/14/2013 676 JUDGMENT: The jury having rendered its verdict in this case in favor ofplaintiff, the Ranis Company, Inc., as representative of the Direct Purchaser Class,in the amount of $54,100,000.00, and the Court, upon motion of plaintiff, havingdirected entry of judgment upon trebling the damage award pursuant to 15U.S.C.§ 15(a), less $9,000,000 received from former defendants, it is herebyORDERED and ADJUDGED, that the Ranis Company, as class representative,take judgment against defendants, Hebei Welcome Pharmaceutical Co., Ltd. andNorth China Pharmaceutical Group Corp., jointly and severally, in the amount of$153,300,000. Ordered by Judge Brian M. Cogan on 3/14/2013. AssociatedCases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Clarke, Melonie)(Entered: 03/14/2013)

03/14/2013 ORDER OF SUSTENANCE: It is hereby Ordered that the Marshal supply propersustenance to the seven jurors empaneled in the above action. Ordered by JudgeBrian M. Cogan on 3/14/2013. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Clarke, Melonie) (Entered: 03/15/2013)

03/15/2013 ORDER: The Court directs counsel for all parties in the MDL and associated

A-107Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page114 of 191

Page 115: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 108/137

cases that have not been adjudicated or fully settled to file with the Court by3/25/2013 a joint status report. The parties may submit one joint report for eachpending case or they may submit one report for all pending cases. These reportsshould contain counsels' proposal or proposals (if there is disagreement) as to howto proceed to dispose of the open cases. The reports need not encompass actionsthat are awaiting settlement approval or where a settlement has been placed on therecord. Ordered by Judge Brian M. Cogan on 3/15/2013. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO, 1:06-cv-00149-BMC-JO, 1:06-cv-00987-BMC-JO, 1:06-cv-00988-BMC-JO (Clarke, Melonie) (Entered:03/15/2013)

03/25/2013 677 MOTION for Extension of Time to File Petitions for Attorney Fees &Reimbursable Costs by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered: 03/25/2013)

03/25/2013 ORDER granting 677 Motion. Plaintiffs time to file their petitions for attorneyfees and reimbursable costs extended to 4/11/2013. Ordered by Judge Brian M.Cogan on 3/25/2013. (Weisberg, Peggy) (Entered: 03/25/2013)

03/25/2013 678 Notice of MOTION for Settlement with Defendant Northeast Pharmaceutical Co.,Ltd. by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453.(Attachments: # 1 Memorandum in Support, # 2 Declaration of Michael D.Hausfeld, # 3 Exhibit A, # 4 Proposed Order) (Coolidge, Melinda) (Entered:03/25/2013)

03/25/2013 679 Notice of MOTION for Settlement with Defendants Weisheng PharmaceuticalCo., Ltd. and China Pharmaceutical Group, Ltd. by Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453. (Attachments: # 1 Memorandum inSupport, # 2 Declaration of Michael D. Hausfeld, # 3 Exhibit A, # 4 ProposedOrder) (Coolidge, Melinda) (Entered: 03/25/2013)

03/25/2013 680 Letter to the Honorable Brian M. Cogan enclosing courtesy copies by Plaintiff(s)in Civil Action Animal Science vs Hebei, 05-CV-453 (Coolidge, Melinda)(Entered: 03/25/2013)

03/25/2013 681 STATUS REPORT Joint Status Report by China Pharmaceutical Group Ltd.,Weisheng Pharmaceutical Co. Ltd. (Mason, Daniel) (Entered: 03/25/2013)

03/28/2013 682 ORDER re 678 motion for settlement. Please see attached order for further detailsand modifications made by the Court. Ordered by Judge Brian M. Cogan on3/28/2013. (Siegfried, Evan) (Entered: 03/28/2013)

03/28/2013 683 ORDER regarding 679 Motion for Settlement. Please see attached order forfurther details and modifications made by the Court. Ordered by Judge Brian M.Cogan on 3/28/2013. (Siegfried, Evan) (Entered: 03/28/2013)

04/01/2013 ORDER as to 681 joint status report. The stay in the Indirect Purchaser Actionsshall remain in place except that (1) defendants may file their motion to dismissthe underlying complaints for lack of service, (2) plaintiffs may file their motionto amend their pleadings, and (3) plaintiffs may file their motion on the preclusiveeffect of the judgment in the Direct Purchaser Action. The motions must be madeby 5/1/2013. Opposition briefs shall be filed by 5/15/2013 and reply briefs shall befiled by 5/22/2013. Ordered by Judge Brian M. Cogan on 4/1/2013. Associated

A-108Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page115 of 191

Page 116: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 109/137

Cases: 1:06-md-01738-BMC-JO, 1:06-cv-00149-BMC-JO, 1:06-cv-00987-BMC-JO, 1:06-cv-00988-BMC-JO (Weisberg, Peggy) (Entered: 04/01/2013)

04/01/2013 684 Notice of MOTION for Settlement with NEPG by Plaintiff(s) in Civil ActionPhilion vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-987, Plaintiff(s) inCivil Action Audette vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-988,Plaintiff(s) in Civil Action Keane vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149. (Attachments: # 1 Memorandum in Support, # 2 Declaration of TimothyD. Battin, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Exhibit D, # 7 ProposedOrder) (Battin, Timothy) (Entered: 04/01/2013)

04/01/2013 685 Letter to the Honorable Brian M. Cogan enclosing courtesy copies by Plaintiff(s)in Civil Action Philion vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-987,Plaintiff(s) in Civil Action Audette vs Hebei Welcome Pharmaceutical Co. Ltd.06-CV-988, Plaintiff(s) in Civil Action Keane vs Hebei Welcome PharmaceuticalCo. Ltd. 06-CV-149 (Battin, Timothy) (Entered: 04/01/2013)

04/03/2013 686 ORDER re 684 Motion for Settlement. Please see attached order for further detailsand modifications made by the Court. Ordered by Judge Brian M. Cogan on4/1/2013. (Siegfried, Evan) (Entered: 04/03/2013)

04/08/2013 687 MOTION for Extension of Time to File Motions for Attorneys' Fees and Costs byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,James) (Entered: 04/08/2013)

04/09/2013 ORDER granting 687 . Plaintiffs' time to file their motions for attorneys' fees andcosts is extended to 5/2/2013. Ordered by Judge Brian M. Cogan on 4/9/2013.(Weisberg, Peggy) (Entered: 04/09/2013)

04/11/2013 688 MOTION for Judgment as a Matter of Law to Reduce Damages by $7.5 Million(Before Trebling) Due to Speculation, Guess and Surmise as to Co-ConspiratorSales by Hebei Welcome Pharmaceutical Co. Ltd.. Responses due by 4/25/2013(Attachments: # 1 Memorandum in Support of Defendants' Renewed Motion forJudgment as as Matter of Law to Reduce Damages by $7.5 Million (BeforeTrebling) Due to Speculation, Guess and Surmise as to Co-Conspirator Sales, # 2Exhibit A, # 3 Exhibit B) (Stillman, Catherine) (Entered: 04/11/2013)

04/11/2013 689 MOTION for Judgment as a Matter of Law (Renewed) Under Fed. R. Civ. P.50(b) by North China Pharmaceutical Group Corp.. Responses due by 4/25/2013(Attachments: # 1 Memorandum in Support, # 2 Exhibit A, # 3 Exhibit B, # 4Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 ExhibitH, # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M,# 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, #20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25Exhibit X, # 26 Exhibit Y, # 27 Exhibit Z, # 28 Exhibit AA, # 29 Exhibit BB, # 30Exhibit CC, # 31 Exhibit DD, # 32 Exhibit EE, # 33 Exhibit FF, # 34 Exhibit GG,# 35 Exhibit HH, # 36 Exhibit II) (Stillman, Catherine) (Entered: 04/11/2013)

04/11/2013 690 DECLARATION OF JIANGXIAO ATHENA HOU CERTIFYING COMPLIANCEWITH NOTICE REQUIREMENTS OF 28 U.S.C. § 1715 by China PharmaceuticalGroup Ltd., Weisheng Pharmaceutical Co. Ltd. (Attachments: # 1 Exhibit A, # 2Exhibit B) (Hou, Jiangxiao) (Entered: 04/11/2013)

04/11/2013 691 MOTION for Judgment as a Matter of Law (Renewed) Based on Act of State,

A-109Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page116 of 191

Page 117: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 110/137

Foreign Sovereign Compulsion, and International Comity by Hebei WelcomePharmaceutical Co. Ltd.. Responses due by 4/25/2013 (Attachments: # 1Memorandum in Support, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 ExhibitD, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I, # 11Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Exhibit X, # 26Exhibit Y) (Stillman, Catherine) (Entered: 04/11/2013)

04/12/2013 ORDER in case 1:05-cv-00453-BMC-JO; terminating (689) Motion for Judgmentas a Matter of Law; terminating (691) Motion for Judgment as a Matter of Law incase 1:06-md-01738-BMC-JO. Rule 50(b) provides that a party may file "a"renewed motion for judgment as a matter of law; it does not provide that a partymay file three motions for judgment as a matter of law. It is unclear whydefendants felt the need to file three motions instead of one motion with theirdifferent grounds for relief. The latter two motions are therefore terminated. Thecourt will consider the grounds raised in those motions as part of its determinationof motion 688. Defendant is directed not to refile. Ordered by Judge Brian M.Cogan on 4/12/2013. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Cogan, Brian) (Entered: 04/12/2013)

04/12/2013 692 Letter to Honorable Judge Cogan re Courtesy Copies of Defendants' April 11,2013 Motions [D.E. 688, D.E. 689, D.E. 691] by Hebei Welcome PharmaceuticalCo. Ltd., North China Pharmaceutical Group Corp. (Stillman, Catherine)(Entered: 04/12/2013)

04/12/2013 693 Notice of MOTION for Permanent Injunction by Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453. Responses due by 4/29/2013 (Attachments:# 1 Memorandum in Support, # 2 Exhibit 1, # 3 Proposed Order) (Coolidge,Melinda) (Modified) (Entered: 04/12/2013)

04/22/2013 694 Letter MOTION for Extension of Time to File Response/Reply as to 688MOTION for Judgment as a Matter of Law to Reduce Damages by $7.5 Million(Before Trebling) Due to Speculation, Guess and Surmise as to Co-ConspiratorSales, 693 Notice of MOTION for Permanent Injunction by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453. (Milici, Jennifer) (Entered:04/22/2013)

04/24/2013 ORDER granting 694 the parties' request for an extension. Plaintiffs' opposition to688 , defendants' Rule 50(b) motion shall be filed by 5/10/2013 and defendants'reply shall be submitted by 5/31/2013. Defendants' opposition to 693 plaintiffs'motion for a permanent injunction shall be filed by 5/13/2013. Ordered by JudgeBrian M. Cogan on 4/24/2013. (Weisberg, Peggy) (Entered: 04/24/2013)

04/29/2013 695 Notice of MOTION for Settlement Direct and Indirect Purchaser Plaintiffs'Notice of Joint Motion for Approval of Notice Plan and Form of Notice byPlaintiff(s) in Civil Action Philion vs Hebei Welcome Pharmaceutical Co. Ltd.06-CV-987, Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453,Plaintiff(s) in Civil Action Audette vs Hebei Welcome Pharmaceutical Co. Ltd.06-CV-988, Plaintiff(s) in Civil Action Keane vs Hebei Welcome PharmaceuticalCo. Ltd. 06-CV-149. (Attachments: # 1 Memorandum in Support, # 2 Declarationof Daniel C. Hedlund, # 3 Exhibit A to Hedlund Declaration, # 4 Exhibit B toHedlund Declaration, # 5 Exhibit C to Hedlund Declaration, # 6 Proposed Order,

A-110Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page117 of 191

Page 118: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 111/137

# 7 Exhibit 1 to Proposed Order (Proposed Detailed Notice), # 8 Exhibit 2 toProposed Order (Proposed Publication Notice)) (Coolidge, Melinda) (Entered:04/29/2013)

04/30/2013 696 ORDER in case 1:05-cv-00453-BMC-JO; granting (695) Motion for an ORDERAPPROVING DIRECT AND INDIRECT PURCHASER PLAINTIFFS NOTICEPLAN AND FORM OF NOTICE in case 1:06-md-01738-BMC-JO. Ordered byJudge Brian M. Cogan on 4/30/2013. Associated Cases: 1:06-md-01738-BMC-JO,1:05-cv-00453-BMC-JO, 1:06-cv-00149-BMC-JO, 1:06-cv-00987-BMC-JO,1:06-cv-00988-BMC-JO (Marziliano, August) (Entered: 04/30/2013)

04/30/2013 697 Letter MOTION for Extension of Time to File Motions for Attorneys' Fees andCosts by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453.(Landau, Brent) (Entered: 04/30/2013)

04/30/2013 ORDER granting 697 . Plaintiffs' time to file their motions for attorneys' fees andcosts is extended to 5/16/2013. Ordered by Judge Brian M. Cogan on 4/30/2013.(Weisberg, Peggy) (Entered: 04/30/2013)

05/01/2013 698 Letter by Hebei Welcome Pharmaceutical Co. Ltd. (Prescott, Darrell) (Entered:05/01/2013)

05/01/2013 699 Letter by Plaintiff(s) in Civil Action Cribbs vs Hebei Welcome PharmaceuticalCo. Ltd. 05-CV-6059 (Hedlund, Daniel) (Entered: 05/01/2013)

05/01/2013 ORDER re: 699 . If plaintiffs do not want to file their preclusion motion now, theymay wait for the Court to set a new schedule after disposition of the post-trialmotions. Ordered by Judge Brian M. Cogan on 5/1/2013. (Weisberg, Peggy)(Entered: 05/01/2013)

05/01/2013 700 MOTION to Amend/Correct/Supplement Indirect Purchaser Complaints byPlaintiff(s) in Civil Action Keane vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149. (Attachments: # 1 Memorandum in Support of Motion to Amend, # 2Exhibit A) (Battin, Timothy) (Entered: 05/01/2013)

05/08/2013 701 Letter MOTION for Leave to File Excess Pages by Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453. (Kunz, Katherine) (Entered: 05/08/2013)

05/09/2013 ORDER granting plaintiffs' 701 Motion for Leave to File Excess Pages, up to fiftypages. Ordered by Judge Brian M. Cogan on 5/9/2013. (Weisberg, Peggy)(Entered: 05/09/2013)

05/10/2013 702 MEMORANDUM in Opposition re 688 MOTION for Judgment as a Matter ofLaw to Reduce Damages by $7.5 Million (Before Trebling) Due to Speculation,Guess and Surmise as to Co-Conspirator Sales filed by Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit A, # 2 ExhibitB, # 3 Exhibit C, # 4 PX 21 to PX 165, # 5 PX 173 to PX 320, # 6 PX 386 to PX386A, # 7 PX 425 part 1, # 8 PX 425 part 2, # 9 PX 425 part 3, # 10 PX 425A, #11 PX 426 part 1, # 12 PX 426 part 2, # 13 PX 426 part 3, # 14 PX 426A, # 15 PX427, # 16 PX 427A to PX 442, # 17 DTX 28 to DTX 68, # 18 Video Exhibit 1 toVideo Exhibit 6) (Milici, Jennifer) (Entered: 05/10/2013)

05/13/2013 703 EXHIBIT Exhibit A (corrected) to Plaintiffs Memorandum in Opposition toDefendants' Renewed Motion by Plaintiff(s) in Civil Action Animal Science vs

A-111Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page118 of 191

Page 119: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 112/137

Hebei, 05-CV-453. Related document: 702 Memorandum in Opposition,, filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Milici,Jennifer) (Entered: 05/13/2013)

05/13/2013 704 Letter enclosing courtesy copies by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453 (Milici, Jennifer) (Entered: 05/13/2013)

05/13/2013 705 MEMORANDUM in Opposition to Injunction Class Plaintiffs' Motion forPermanent Injunction filed by Hebei Welcome Pharmaceutical Co. Ltd..(Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Stillman, Catherine) (Entered: 05/13/2013)

05/14/2013 708 Letter to Judge Cogan Regarding Courtesy Copies of Defendants' Memorandumof Law in Opposition to Injunction Class Plaintiffs' Motion for PermanentInjunction by Hebei Welcome Pharmaceutical Co. Ltd., North ChinaPharmaceutical Group Corp. (Stillman, Catherine) (Entered: 05/14/2013)

05/15/2013 723 MEMORANDUM in Opposition re 700 MOTION to Amend/Correct/SupplementIndirect Purchaser Complaints filed by Hebei Welcome Pharmaceutical Co. Ltd..(Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3) (Prescott, Darrell)(Entered: 05/15/2013)

05/16/2013 724 Letter to Judge Cogan regarding courtesy copies of Defendant's May 15 filing(D.E. 723) by Hebei Welcome Pharmaceutical Co. Ltd. (Stillman, Catherine)(Entered: 05/16/2013)

05/16/2013 725 MOTION for Attorney Fees by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453. (Southwick, James) (Entered: 05/16/2013)

05/16/2013 726 MEMORANDUM in Support re 725 MOTION for Attorney Fees , Costs & Post-Judgment Interest filed by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit4, # 5 Exhibit 5) (Southwick, James) (Entered: 05/16/2013)

05/16/2013 727 AFFIDAVIT/DECLARATION in Support re 725 MOTION for Attorney Fees ofJames T. Southwick filed by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. (Attachments: # 1 Exhibit 1, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Exhibit 12, # 10Exhibit 13, # 11 Exhibit 14, # 12 Exhibit 15, # 13 Exhibit 16, # 14 Exhibit 17)(Southwick, James) (Entered: 05/16/2013)

05/16/2013 728 EXHIBIT 2 (part 1 of 2) by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. Related document: 727 Affidavit in Support of Motion, filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,James) (Entered: 05/16/2013)

05/16/2013 729 EXHIBIT 2 (part 2 of 2) by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. Related document: 727 Affidavit in Support of Motion, filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,James) (Entered: 05/16/2013)

05/16/2013 730 EXHIBIT 5 (part 1 of 2) by Defendant(s) in Civil Action Animal Science vsHebei, 05-CV-453. Related document: 727 Affidavit in Support of Motion, filedby Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,

A-112Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page119 of 191

Page 120: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 113/137

James) (Entered: 05/16/2013)

05/16/2013 731 EXHIBIT 5 (part 2 of 2) by Defendant(s) in Civil Action Animal Science vsHebei, 05-CV-453. Related document: 727 Affidavit in Support of Motion, filedby Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,James) (Entered: 05/16/2013)

05/16/2013 732 EXHIBIT 6 by Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453. Related document: 727 Affidavit in Support of Motion, filed by Plaintiff(s) inCivil Action Animal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered:05/16/2013)

05/16/2013 733 AFFIDAVIT/DECLARATION in Support re 725 MOTION for Attorney Fees byWilliam A. Isaacson filed by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. (Attachments: # 1 Exhibit 1, # 2 Exhibit 3, # 3 Exhibit 4) (Southwick,James) (Entered: 05/16/2013)

05/16/2013 734 EXHIBIT 2 (part 1 of 2) by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. Related document: 733 Affidavit in Support of Motion, filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,James) (Entered: 05/16/2013)

05/16/2013 735 EXHIBIT 2 (part 2 of 2) by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. Related document: 733 Affidavit in Support of Motion, filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,James) (Entered: 05/16/2013)

05/16/2013 736 EXHIBIT 5 (part 1 of 6) by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. Related document: 733 Affidavit in Support of Motion, filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,James) (Entered: 05/16/2013)

05/16/2013 737 EXHIBIT 5 (part 2 of 6) by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. Related document: 733 Affidavit in Support of Motion, filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,James) (Entered: 05/16/2013)

05/16/2013 738 EXHIBIT 5 (part 3 of 6) by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. Related document: 733 Affidavit in Support of Motion, filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,James) (Entered: 05/16/2013)

05/16/2013 739 EXHIBIT 5 (part 4 of 6) by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. Related document: 733 Affidavit in Support of Motion, filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,James) (Entered: 05/16/2013)

05/16/2013 740 EXHIBIT 5 (part 5 of 6) by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. Related document: 733 Affidavit in Support of Motion, filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,James) (Entered: 05/16/2013)

05/16/2013 741 EXHIBIT 5 (part 6 of 6) by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. Related document: 733 Affidavit in Support of Motion, filed by

A-113Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page120 of 191

Page 121: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 114/137

Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,James) (Entered: 05/16/2013)

05/16/2013 742 EXHIBIT 6 (part 1 of 4) by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. Related document: 733 Affidavit in Support of Motion, filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,James) (Entered: 05/16/2013)

05/16/2013 743 EXHIBIT 6 (part 2 of 4) by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. Related document: 733 Affidavit in Support of Motion, filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,James) (Entered: 05/16/2013)

05/16/2013 744 EXHIBIT 6 (3 of 4) by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. Related document: 733 Affidavit in Support of Motion, filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,James) (Entered: 05/16/2013)

05/16/2013 745 EXHIBIT 6 (part 4 of 4) by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. Related document: 733 Affidavit in Support of Motion, filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick,James) (Entered: 05/16/2013)

05/16/2013 746 AFFIDAVIT/DECLARATION in Support re 725 MOTION for Attorney Fees byMichael D. Hausfeld filed by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453. (Attachments: # 1 Exhibit 1, # 2 Exhibit 3, # 3 Exhibit 5, # 4Exhibit 7, # 5 Exhibit 9, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 14, # 9 Exhibit15) (Southwick, James) (Entered: 05/16/2013)

05/16/2013 747 EXHIBIT 2 by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453.Related document: 746 Affidavit in Support of Motion, filed by Plaintiff(s) inCivil Action Animal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered:05/16/2013)

05/16/2013 748 EXHIBIT 4 by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453.Related document: 746 Affidavit in Support of Motion, filed by Plaintiff(s) inCivil Action Animal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered:05/16/2013)

05/16/2013 749 EXHIBIT 6 by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453.Related document: 746 Affidavit in Support of Motion, filed by Plaintiff(s) inCivil Action Animal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered:05/16/2013)

05/16/2013 750 EXHIBIT 8 by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453.Related document: 746 Affidavit in Support of Motion, filed by Plaintiff(s) inCivil Action Animal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered:05/16/2013)

05/16/2013 751 EXHIBIT 10a by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. Related document: 746 Affidavit in Support of Motion, filed by Plaintiff(s) inCivil Action Animal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered:05/16/2013)

05/16/2013 752 EXHIBIT 10b by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-

A-114Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page121 of 191

Page 122: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 115/137

453. Related document: 746 Affidavit in Support of Motion, filed by Plaintiff(s) inCivil Action Animal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered:05/16/2013)

05/16/2013 753 EXHIBIT 13a by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. Related document: 746 Affidavit in Support of Motion, filed by Plaintiff(s) inCivil Action Animal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered:05/16/2013)

05/16/2013 754 EXHIBIT 13b by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. Related document: 746 Affidavit in Support of Motion, filed by Plaintiff(s) inCivil Action Animal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered:05/16/2013)

05/16/2013 755 EXHIBIT 13c by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. Related document: 746 Affidavit in Support of Motion, filed by Plaintiff(s) inCivil Action Animal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered:05/16/2013)

05/16/2013 756 EXHIBIT 13d by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. Related document: 746 Affidavit in Support of Motion, filed by Plaintiff(s) inCivil Action Animal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered:05/16/2013)

05/17/2013 757 Letter MOTION for Extension of Time to File Response/Reply as to 705Memorandum in Opposition, 693 Notice of MOTION for Permanent Injunctionby Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Coolidge,Melinda) (Entered: 05/17/2013)

05/17/2013 ORDER granting 757 Motion for Extension of Time to File Reply to 693 to6/6/13. Ordered by Judge Brian M. Cogan on 5/17/2013. (Cogan, Brian) (Entered:05/17/2013)

05/22/2013 759 REPLY in Support re 700 MOTION to Amend/Correct/Supplement IndirectPurchaser Complaints filed by All Plaintiffs. (Hedlund, Daniel) (Entered:05/22/2013)

05/23/2013 760 Letter to Judge Cogan re Courtesy Copies of Plaintiffs' May 22, 2013 filing(Doc.Entry 759) by All Plaintiffs by Hunt & Behrens, Inc., Jabo's Pharmacy, Inc.,One or more Plaintiffs in 06-cv-05561, Diana Kitch v. Hebei WelcomePharmaceutical Co et al, Plaintiff(s) in Civil Action Philion vs Hebei WelcomePharmaceutical Co. Ltd. 06-CV-987, Plaintiff(s) in Civil Action Animal Sciencevs Hebei, 05-CV-453, Plaintiff(s) in Civil Action Audette vs Hebei WelcomePharmaceutical Co. Ltd. 06-CV-988, Plaintiff(s) in Civil Action Carroll vs. ChinaPharmaceuticals Group, 07-CV-0226, Plaintiff(s) in Civil Action Cribbs vs HebeiWelcome Pharmaceutical Co. Ltd. 05-CV-6059, Plaintiff(s) in Civil Action Keanevs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149, Niall Vignoles (Hedlund,Daniel) (Entered: 05/23/2013)

05/23/2013 761 REPLY in Opposition re 700 MOTION to Amend/Correct/Supplement IndirectPurchaser Complaints filed by Hebei Welcome Pharmaceutical Co. Ltd..(Attachments: # 1 Exhibit 1) (Prescott, Darrell) (Entered: 05/23/2013)

05/24/2013 762 Letter MOTION for Extension of Time to File Response/Reply as to 725

A-115Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page122 of 191

Page 123: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 116/137

MOTION for Attorney Fees by Hebei Welcome Pharmaceutical Co. Ltd..(Stillman, Catherine) (Entered: 05/24/2013)

05/28/2013 ORDER granting 762 defendants' Motion for Extension of Time to File Responseto plaintiffs' motion for attorneys' fees and costs to 7/15/2013. Ordered by JudgeBrian M. Cogan on 5/28/2013. (Weisberg, Peggy) (Entered: 05/28/2013)

05/29/2013 763 Letter MOTION for Leave to File Excess Pages by Hebei WelcomePharmaceutical Co. Ltd.. (Stillman, Catherine) (Entered: 05/29/2013)

05/30/2013 ORDER granting 763 Motion for Leave to File reply in excess of page limit up to22 pages. Ordered by Judge Brian M. Cogan on 5/30/2013. (Weisberg, Peggy)(Entered: 05/30/2013)

05/31/2013 764 REPLY in Support of Defendants' Renewed Motion for Judgment as a Matter ofLaw filed by Hebei Welcome Pharmaceutical Co. Ltd.. (Attachments: # 1 ExhibitA, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D) (Stillman, Catherine) (Entered:05/31/2013)

06/03/2013 765 Letter to Judge Cogan Regarding Courtesy Copies of Defendants' May 31 Filingby Hebei Welcome Pharmaceutical Co. Ltd., North China Pharmaceutical GroupCorp. (Stillman, Catherine) (Entered: 06/03/2013)

06/06/2013 766 REPLY in Support re 693 Notice of MOTION for Permanent Injunction filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments: #1 Proposed Order (Amended)) (Coolidge, Melinda) (Entered: 06/06/2013)

06/26/2013 767 MOTION for Attorney Fees Notice of Class Counsel's Application for an Awardof Attorneys' Fees and Reimbursement of Expenses by Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered: 06/26/2013)

06/26/2013 768 MEMORANDUM in Support re 767 MOTION for Attorney Fees Notice of ClassCounsel's Application for an Award of Attorneys' Fees and Reimbursement ofExpenses filed by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Southwick, James) (Entered: 06/26/2013)

06/26/2013 769 AFFIDAVIT/DECLARATION in Support re 767 MOTION for Attorney FeesNotice of Class Counsel's Application for an Award of Attorneys' Fees andReimbursement of Expenses (Declaration of James T. Southwick) filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments: #1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4) (Southwick, James)(Entered: 06/26/2013)

06/26/2013 770 AFFIDAVIT/DECLARATION in Support re 767 MOTION for Attorney FeesNotice of Class Counsel's Application for an Award of Attorneys' Fees andReimbursement of Expenses (Tanya S. Chutkan) filed by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit 1, # 2Exhibit 2) (Southwick, James) (Entered: 06/26/2013)

06/26/2013 771 AFFIDAVIT/DECLARATION in Support re 767 MOTION for Attorney FeesNotice of Class Counsel's Application for an Award of Attorneys' Fees andReimbursement of Expenses (Michael D. Hausfeld) filed by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit 1, # 2Exhibit 2) (Southwick, James) (Entered: 06/26/2013)

A-116Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page123 of 191

Page 124: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 117/137

07/15/2013 772 MEMORANDUM in Opposition to Class Plaintiffs' Motion for Attorneys' Fees,Costs, and Post-Judgment Interest filed by Hebei Welcome Pharmaceutical Co.Ltd., North China Pharmaceutical Group Corp.. (Attachments: # 1 Exhibit A, # 2Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 ExhibitG, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, #13 Exhibit M) (Stillman, Catherine) (Entered: 07/15/2013)

07/16/2013 773 Letter to Judge Cogan Regarding Delivery of Courtesy Copies of Defendants' July15 Filing by Hebei Welcome Pharmaceutical Co. Ltd., North ChinaPharmaceutical Group Corp. (Stillman, Catherine) (Entered: 07/16/2013)

07/17/2013 774 Letter MOTION for Extension of Time to File Response/Reply as to 772 Sealed,Memorandum in Opposition,, to Class Plaintiffs' Motion for Attorneys' Fees,Costs, and Post-Judgment Interest by Plaintiff(s) in Civil Action Animal Sciencevs Hebei, 05-CV-453. (Kunz, Katherine) (Entered: 07/17/2013)

07/17/2013 ORDER granting 774 Motion for Extension of Time to File Response to sealedmemorandum in opposition to 8/9/2013. Ordered by Judge Brian M. Cogan on7/17/2013. (Weisberg, Peggy) (Entered: 07/17/2013)

07/18/2013 RESCHEDULING ORDER: The Fairness Hearing currently scheduled for8/29/2013 at 2:30 PM is rescheduled to 8/30/2013 at 11:00 AM in Courtroom 8DSouth. In accordance with 696 the Court's Order approving the class notice plan,class counsel is instructed to reflect the new date and time for the FairnessHearing on the www.vitaminCantitrust.com website. The Court will also post thenew date and time for the Fairness Hearing on its public calendar and at thecourthouse. Additionally, class counsel is instructed to mail actual notice of therescheduling of the Fairness Hearing to any members of the Settlement Classeswho timely file objections. Ordered by Judge Brian M. Cogan on 7/18/2013.(Weisberg, Peggy) (Entered: 07/18/2013)

07/19/2013 775 Notice of MOTION for Settlement Final Approval of Settlement with NortheastPharmaceutical Group Co., Ltd. by Plaintiff(s) in Civil Action Philion vs HebeiWelcome Pharmaceutical Co. Ltd. 06-CV-987, Plaintiff(s) in Civil Action Audettevs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-988, Plaintiff(s) in CivilAction Keane vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149.(Attachments: # 1 Memorandum in Support of Final Approval of Settlement withDefendant NEPG, # 2 Declaration of Charlene Young, # 3 Declaration of James I.Serota) (Battin, Timothy) (Entered: 07/19/2013)

07/19/2013 776 Letter to the Honorable Brian M. Cogan by Plaintiff(s) in Civil Action Philion vsHebei Welcome Pharmaceutical Co. Ltd. 06-CV-987, Plaintiff(s) in Civil ActionAudette vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-988, Plaintiff(s) inCivil Action Keane vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149(Battin, Timothy) (Entered: 07/19/2013)

07/19/2013 777 Notice of MOTION for Settlement Final Approval of Settlements with DefendantsNortheast Pharmaceutical Co., Ltd., Weisheng Pharmaceutical Co., Ltd., andChina Pharmaceutical Group, Ltd. and for Payment of Notice Costs byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments: #1 Memorandum in Support, # 2 Declaration of Michael D. Hausfeld and Exs. Aand B, # 3 Declaration of Charlene Young and Exs. 1-9, # 4 Declaration of James

A-117Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page124 of 191

Page 125: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 118/137

I. Serota and Ex. A) (Coolidge, Melinda) (Entered: 07/19/2013)

07/19/2013 778 Letter to the Honorable Brian M. Cogan by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453 (Coolidge, Melinda) (Entered: 07/19/2013)

08/02/2013 779 Letter from Michael Blackwell RE: status of case (Siegfried, Evan) (Entered:08/02/2013)

08/05/2013 780 MOTION for Joinder by Julius Anderson. (Greene, Donna) (Entered: 08/09/2013)

08/05/2013 781 Plaintiffs Notice to Stay in the Class Lawsuit after August 29,2013. (Greene,Donna) (Entered: 08/09/2013)

08/05/2013 785 Notice of MOTION for Joinder and Motion for Appointment of Counsel; filed byDion D. Lee, dated 8/1/2013. (Latka-Mucha, Wieslawa) (Entered: 08/12/2013)

08/05/2013 786 "Notice to Stay in the Lawsuit After August 29, 2013" filed by Dion D. Lee, dated7/31/2013. (Latka-Mucha, Wieslawa) (Entered: 08/12/2013)

08/08/2013 787 Notice of MOTION for Joinder "and Identification to Class Counsel for Purposeof Settlement" filed by Mauricio Ajanel, dated 8/4/2013. (Latka-Mucha,Wieslawa) (Entered: 08/12/2013)

08/09/2013 RESCHEDULING ORDER: The Fairness Hearing currently scheduled for8/30/2013 at 11:00 AM is rescheduled to 9/11/2013 at 2:15 PM in Courtroom 8DSouth. In accordance with 696 the Court's Order approving the class notice plan,class counsel is instructed to reflect the new date and time for the FairnessHearing on the www.vitaminCantitrust.com website. The Court will also post thenew date and time for the Fairness Hearing on its public calendar and at thecourthouse. Additionally, class counsel is instructed to mail actual notice of therescheduling of the Fairness Hearing to any members of the Settlement Classeswho timely file objections. Ordered by Judge Brian M. Cogan on 8/9/2013(Weisberg, Peggy) (Entered: 08/09/2013)

08/09/2013 782 REPLY in Support re 725 MOTION for Attorney Fees , Costs, and Post-Judgment Interest filed by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 ExhibitD, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N)(Southwick, James) (Entered: 08/09/2013)

08/09/2013 783 AFFIDAVIT/DECLARATION in Support re 725 MOTION for Attorney FeesDeclaration of Tanya S. Chutkan in Support of Reply Memorandum for Attorney'sFees, Costs, and Post-Judgment Interest filed by Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Southwick, James) (Entered: 08/09/2013)

08/09/2013 784 AFFIDAVIT/DECLARATION in Support re 725 MOTION for Attorney FeesDeclaration of James T. Southwick in Support of Reply Memorandum forAttorney's Fees, Costs, and Post-Judgment Interest filed by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit 1)(Southwick, James) (Entered: 08/09/2013)

08/13/2013 788 NOTICE of Motion to Permit Joinder filed by Andie' West (Siegfried, Evan)(Entered: 08/13/2013)

A-118Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page125 of 191

Page 126: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 119/137

08/20/2013 789 Letter to the Honorable Brian M. Cogan by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453 (Coolidge, Melinda) (Entered: 08/20/2013)

08/20/2013 ORDER granting 789 Letter request to adjourn. Fairness Hearing is adjourned to10/2/2013 at 10:00 am in Courtroom 8D South. Ordered by Judge Brian M. Coganon 8/20/2013. (Weisberg, Peggy) (Entered: 08/20/2013)

08/20/2013 790 Notice of MOTION for Disbursement of Funds (Motion to Authorize Distributionof the Aland Direct Purchaser Settlement Fund and to Pay Costs of ClaimsAdministration) by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Memorandum in Support, # 2 Declaration of CharleneYoung and Exhibits, # 3 Proposed Order) (Coolidge, Melinda) (Entered:08/20/2013)

08/21/2013 791 Letter to the Court from David Sellers RE: Mr. Sellers indicates that he willexercise his option to receive settlement. (Siegfried, Evan) (Entered: 08/21/2013)

09/12/2013 792 ORDER Authorizing the Distribution of the Aland Direct Purchaser SettlementFund. See attached document for further details. Ordered by Judge Brian M.Cogan on 9/10/2013. (Siegfried, Evan) (Entered: 09/12/2013)

09/13/2013 793 Letter dated 9/7/2013 from Clem L. Davis RE: Mr. Davis gives notice ofplaintiff's agreement to accept settlement. (Siegfried, Evan) (Entered: 09/13/2013)

10/02/2013 Minute Entry and Order for Fairness Hearing held before Judge Brian M. Coganon 10/2/2013. Counsel for the Direct Purchaser Damages Class, the InjunctionClass, the Indirect Purchaser Damages Settlement Class, and settling defendantsNortheast Pharmaceutical Co., Ltd., Weisheng Pharmaceutical Co., Ltd., andChina Pharmaceutical Group, Ltd. appeared. No objectors or class membersappeared. Plaintiffs' motions for final approval of the settlements with thesedefendants 775 777 is granted, as is plaintiffs' motion for fees and expenses 767 .Parties to submit proposed form of judgment. See transcript for details. (Courtreporter: Alan Sherman). (Weisberg, Peggy) (Entered: 10/02/2013)

10/10/2013 794 Letter to the Honorable Brian M. Cogan enclosing courtesy copy of ProposedFinal Judgment for IPP Settlement with NEPG by Plaintiff(s) in Civil ActionPhilion vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-987, Plaintiff(s) inCivil Action Audette vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-988,Plaintiff(s) in Civil Action Keane vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149 (Attachments: # 1 Proposed Judgment re: NEPG Settlement) (Battin,Timothy) (Entered: 10/10/2013)

10/11/2013 Order re: Letter to the Honorable Brian M. Cogan enclosing courtesy copy ofProposed Final Judgment for IPP Settlement with NEPG at 794 . This letter doesnot indicate whether the settling defendants consent to the form of the ProposedFinal Judgment. The Court will assume they do absent advice to the contrary bytoday. Ordered by Judge Brian M. Cogan on 10/11/2013. (Clarke, Melonie)(Entered: 10/11/2013)

10/11/2013 795 Letter to the Honorable Brian M. Cogan enclosing courtesy copies of ProposedFinal Judgments by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 (Attachments: # 1 Proposed Judgment re CPG and Weisheng, # 2 ProposedJudgment re NEPG) (Milici, Jennifer) (Entered: 10/11/2013)

A-119Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page126 of 191

Page 127: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 120/137

10/16/2013 796 Final Judgment as to Direct Purchaser Damages Class and Defendants CPG andWeisheng. The Court finds that there is no just reasons for delay and herebydirects the entry of this final judgment of dismissal forthwith as the the ReleasedParties. See attached order for further details. Ordered by Judge Brian M. Coganon 10/16/2013. (Siegfried, Evan) (Entered: 10/16/2013)

10/16/2013 797 Final Judgment as to Indirect Purchaser Settlement Class and Defendant NEPG.The Court finds that there is no just reason for delay and hereby directs the entryof this final judgment of dismissal forthwith as the the Releasees. See attachedorder for further details. Ordered by Judge Brian M. Cogan on 10/16/2013.(Siegfried, Evan) (Entered: 10/16/2013)

10/21/2013 798 Final Judgment as to Injunction Class and Defendant NEPG. See attached orderfor further details. Ordered by Judge Brian M. Cogan on 10/16/2013. (Siegfried,Evan) (Entered: 10/21/2013)

10/24/2013 799 NOTICE OF FILING OF OFFICIAL TRANSCRIPT of Proceedings held on10/02/2013, before Judge BRIAN M COGAN. Court Reporter/TranscriberALLAN R SHERMAN, Telephone number 718-613-2529. Email address:[email protected]. Transcript may be viewed at the court public terminal orpurchased through the Court Reporter/Transcriber before the deadline for Releaseof Transcript Restriction. After that date it may be obtained through PACER.Redaction Request due 11/14/2013. Redacted Transcript Deadline set for11/25/2013. Release of Transcript Restriction set for 1/22/2014. (Sherman, Allan)(Entered: 10/24/2013)

11/26/2013 800 MEMORANDUM DECISION AND ORDER. Defendants' renewed motion forjudgment as a matter of law 688 is denied and the Injunction Class's motion for apermanent injunction 693 is granted. An Amended Judgment and Decree willissue by separate order. Ordered by Judge Brian M. Cogan on 11/25/2013.Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Siegfried,Evan) (Entered: 11/26/2013)

11/27/2013 801 AMENDED JUDGMENT AND FINAL DECREE: The Ranis Company, as classrepresentative, will take damages of defendants Hebei Welcome PharmaceuticalCo., Ltd. and North China Pharmaceutical Group Corp. jointly and severally, inthe amount of One Hundred Fifty Three Million Three Hundred Thousand Dollars($153,300,000).. Ordered by Judge Brian M. Cogan on 11/27/2013. AssociatedCases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Marziliano, August)Modified on 11/27/2013 (Marziliano, August). Modified on 11/27/2013(Marziliano, August). (Entered: 11/27/2013)

12/06/2013 802 NOTICE of Appearance by Jonathan Mitchell Jacobson on behalf of HebeiWelcome Pharmaceutical Co. Ltd., North China Pharmaceutical Group Corp. (atyto be noticed) (Jacobson, Jonathan) (Entered: 12/06/2013)

12/06/2013 803 NOTICE of Appearance by Daniel Paul Weick on behalf of Hebei WelcomePharmaceutical Co. Ltd., North China Pharmaceutical Group Corp. (aty to benoticed) (Weick, Daniel) (Entered: 12/06/2013)

12/13/2013 804 NOTICE of Appearance by Zachary Bennett Grendi on behalf of QualChem, LLCd/b/a Great Earth Chemical (aty to be noticed) (Grendi, Zachary) (Entered:12/13/2013)

A-120Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page127 of 191

Page 128: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 121/137

12/13/2013 805 NOTICE of Appearance by Douglas A Gross on behalf of QualChem, LLC d/b/aGreat Earth Chemical (aty to be noticed) (Gross, Douglas) (Entered: 12/13/2013)

12/13/2013 806 Letter Request for Scheduling of Pre-Motion Conference by QualChem, LLCd/b/a Great Earth Chemical (Gross, Douglas) (Entered: 12/13/2013)

12/13/2013 ORDER re 806 Letter Request for Scheduling of Pre-Motion Conference.Premotion Conference is waived. QualChem is directed to file its motion by12/20/13; opposition, if any, is due 1/3/14; reply by 1/10/14. Ordered by JudgeBrian M. Cogan on 12/13/2013. (Weisberg, Peggy) (Entered: 12/13/2013)

12/13/2013 807 Notice of MOTION for Settlement Preliminary Approval of Settlement withDefendants Weisheng Pharmaceutical Co., Ltd and CSPC Pharmaceutical GroupLimited by Defendant(s) in Civil Action Philion vs Hebei WelcomePharmaceutical Co. Ltd. 06-CV-987, Defendant(s) in Civil Action Audette vsHebei Welcome Pharmaceutical Co. Ltd. 06-CV-988, Defendant(s) in CivilAction Keane vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149.(Attachments: # 1 Memorandum in Support, # 2 Declaration with Exhibits A-G, #3 Proposed Order) (Hedlund, Daniel) (Entered: 12/13/2013)

12/16/2013 808 Letter to Judge Cogan Regarding Enclosed Courtesy Copies of Defendant'sOpposition to Class Counsels' Motion for Attorneys' Fees, Costs, and Post-Judgment Interest by Hebei Welcome Pharmaceutical Co. Ltd. (Prescott, Darrell)(Entered: 12/16/2013)

12/19/2013 809 MOTION for Disbursement of Funds to Claimant QualChem, LLC d/b/a GreatEarth Chemical by QualChem, LLC d/b/a Great Earth Chemical. (Grendi,Zachary) (Entered: 12/19/2013)

12/19/2013 810 MEMORANDUM in Support re 809 MOTION for Disbursement of Funds toClaimant QualChem, LLC d/b/a Great Earth Chemical filed by QualChem, LLCd/b/a Great Earth Chemical. (Grendi, Zachary) (Entered: 12/19/2013)

12/19/2013 811 AFFIDAVIT/AFFIRMATION re 809 MOTION for Disbursement of Funds toClaimant QualChem, LLC d/b/a Great Earth Chemical by QualChem, LLC d/b/aGreat Earth Chemical (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, #4 Exhibit 4, # 5 Exhibit 5) (Grendi, Zachary) (Entered: 12/19/2013)

12/19/2013 812 AFFIDAVIT/AFFIRMATION re 809 MOTION for Disbursement of Funds toClaimant QualChem, LLC d/b/a Great Earth Chemical by QualChem, LLC d/b/aGreat Earth Chemical (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, #4 Exhibit 4, # 5 Exhibit 5) (Grendi, Zachary) (Entered: 12/19/2013)

12/20/2013 813 DECLARATION of Jiangxiao Athena Hou Certifying Compliance with NoticeRequirements of 28 U.S.C. § 1715 by China Pharmaceutical Group, Ltd.,Weisheng Pharmaceutical Group Co. Ltd. (Attachments: # 1 Exhibit A, # 2Exhibit B) Associated Cases: 1:06-md-01738-BMC-JO, 1:06-cv-00149-BMC-JO,1:06-cv-00987-BMC-JO, 1:06-cv-00988-BMC-JO (Hou, Jiangxiao) (Entered:12/20/2013)

12/23/2013 814 NOTICE OF APPEAL as to 801 Judgment,, by Hebei Welcome PharmaceuticalCo. Ltd., North China Pharmaceutical Group Corp.. Filing fee $ 505, receiptnumber 0207-6632038. (Jacobson, Jonathan) (Entered: 12/23/2013)

12/23/2013 Electronic Index to Record on Appeal sent to US Court of Appeals. (814 in 1:06-

A-121Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page128 of 191

Page 129: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 122/137

md-01738-BMC-JO) Notice of Appeal (McGee, Mary Ann) (Entered:12/23/2013)

12/30/2013 815 ORDER in case 1:05-cv-00453-BMC-JO; granting in part and denying in part(725) Motion for Attorney Fees in case 1:06-md-01738-BMC-JO. Ordered byJudge Brian M. Cogan on 12/30/2013. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Cogan, Brian) (Entered: 12/30/2013)

12/30/2013 816 SECOND AMENDED JUDGMENT AND FINAL DECREE: ORDERED,ADJUDGED AND DECREED, that The Ranis Company, as class representative,will take of defendants Hebei Welcome Pharmaceutical Co., Ltd. and North ChinaPharmaceutical Group Corp., jointly and severally, damages in the amount of OneHundred Fifty Three Million Three Hundred Dollars ($153,300,000) plusattorneys fees in the amount of $4,903,163.35, for a total judgment amount of OneHundred Fifty Eight Million Two Hundred Three Thousand One Hundred SixtyThree Dollars and 35/100 ($158,203,163.35) with post judgment interest thereonpursuant to 28 U.S.C. § 1961 nunc pro tunc to March 14, 2013. Ordered by Clerkof Court, by Michele Gapinski, on 12/30/2013. (Barrett, C) (Entered: 12/30/2013)

01/02/2014 817 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 25, receipt number0207-6644515. by North American World Trade Group, Inc., Great EarthChemical, LLC. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Nelson, Philip) (Entered: 01/02/2014)

01/02/2014 818 NOTICE of Appearance by Philip J. Nelson on behalf of Great Earth Chemical,LLC, North American World Trade Group, Inc. (notification declined or alreadyon case) Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO(Nelson, Philip) (Entered: 01/02/2014)

01/02/2014 ORDER granting 817 Motion for Philip J. Nelson to appear pro hac vice ascounsel for Great Earth Chemical, LLC and North American World Trade Group,Inc. Ordered by Judge Brian M. Cogan on 1/2/2014. (Weisberg, Peggy) (Entered:01/02/2014)

01/03/2014 819 RESPONSE in Opposition re (809 in 1:06-md-01738-BMC-JO) MOTION forDisbursement of Funds to Claimant QualChem, LLC d/b/a Great Earth Chemicalfiled by Great Earth Chemical, LLC, North American World Trade Group, Inc..Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Nelson,Philip) (Entered: 01/03/2014)

01/03/2014 820 AFFIDAVIT/DECLARATION in Opposition re (809 in 1:06-md-01738-BMC-JO) MOTION for Disbursement of Funds to Claimant QualChem, LLC d/b/aGreat Earth Chemical filed by Great Earth Chemical, LLC, North AmericanWorld Trade Group, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 ExhibitC, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F) Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Nelson, Philip) (Entered: 01/03/2014)

01/06/2014 821 DECLARATION re (819 in 1:06-md-01738-BMC-JO, 145 in 1:05-cv-00453-BMC-JO) Response in Opposition to Motion, QualChem, LLC's Motion forDistribution of Class Action Proceeds by Great Earth Chemical, LLC, NorthAmerican World Trade Group, Inc. Associated Cases: 1:06-md-01738-BMC-JO,1:05-cv-00453-BMC-JO (Nelson, Philip) (Entered: 01/06/2014)

01/06/2014 822 Subsequent/Amended NOTICE OF APPEAL as to 816 Clerk's Judgment,,, 801

A-122Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page129 of 191

Page 130: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 123/137

Judgment,,by Defendant(s) in Civil Action Animal Science vs Hebei, 05-CV-453,North China Pharmaceutical Group Corp. No fee for an Amended Notice ofAppeal. Service done electronically. Associated cases: 06-md-1738-BMC-JO and05-cv-453-BMC-JO (McGee, Mary Ann) (Entered: 01/06/2014)

01/07/2014 First Supplemental Electronic Index to Record on Appeal sent to US Court ofAppeals. 822 Subsequent/Amended Notice of Appeal (McGee, Mary Ann)(Entered: 01/07/2014)

01/10/2014 823 REPLY in Support re 809 MOTION for Disbursement of Funds to ClaimantQualChem, LLC d/b/a Great Earth Chemical filed by QualChem, LLC d/b/aGreat Earth Chemical. (Grendi, Zachary) (Entered: 01/10/2014)

01/13/2014 824 MOTION for Reconsideration re 815 Order on Motion for Attorney Fees, byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments: #1 Notice of Motion to Partially Reconsider) (Kunz, Katherine) (Entered:01/13/2014)

01/15/2014 825 MOTION to Withdraw As Counsel by Hebei Welcome Pharmaceutical Co. Ltd.,North China Pharmaceutical Group Corp.. (Stillman, Catherine) (Entered:01/15/2014)

01/16/2014 ORDER REFERRING MOTION: Motion 809 for Disbursement of Funds isreferred to Magistrate Judge Orenstein for a Report and Recommendation.Ordered by Judge Brian M. Cogan on 1/16/2014. (Weisberg, Peggy) (Entered:01/16/2014)

01/16/2014 826 Letter to Honorable Judge Cogan Regarding Courtesy Copy of Motion toWithdraw as Counsel by Hebei Welcome Pharmaceutical Co. Ltd., North ChinaPharmaceutical Group Corp. (Stillman, Catherine) (Entered: 01/16/2014)

01/16/2014 827 ORDER granting Indirect Purchaser Plaintiffs' 807 Motion for PreliminaryApproval of Settlement with Defendants Weisheng Pharmaceutical Co. Ltd. andCSPC Pharmaceutical Group Limited and Approval of Notice Plan and Form ofNotice. Ordered by Judge Brian M. Cogan, on 1/16/2014. Associated Cases: 1:06-md-01738-BMC-JO, 1:06-cv-00149-BMC-JO, 1:06-cv-00987- BMC-JO, 1:06-cv-00988-BMC-JO (Barrett, C) (Entered: 01/16/2014)

01/17/2014 ORDER re 809 MOTION for Disbursement of Funds to Claimant QualChem,LLC d/b/a Great Earth Chemical filed by QualChem, LLC d/b/a Great EarthChemical, Order Referring Motion -- Any claimant or other party seeking to beheard in opposition to the motion shall file a response no later than January 31,2014. Ordered by Magistrate Judge James Orenstein on 1/17/2014. (Pollock,David) (Entered: 01/17/2014)

01/17/2014 828 ORDER granting 825 Motion to Withdraw As Counsel in 06-MDL-1738, byHebei Welcome Pharmaceutical Co. Ltd., North China Pharmaceutical GroupCorp.: This matter, having come before the Court on a motion for an ordergranting leave for Charles H. Critchlow, Darrell Prescott and Catherine Y.Stillman ("Movants") of the law firm Baker & McKenzie LLP to withdraw fromrepresentation of Defendants Hebei Welcome Pharmaceutical Co., Ltd. and NorthChina Pharmaceutical Group Corp. in this matter and all of the actions subsumedunder the above-captioned MDL number, and the Court, having considered the

A-123Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page130 of 191

Page 131: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 124/137

papers filed in support thereof, hereby orders that the motion is GRANTED, andMovants may withdraw and hereby do withdraw from representation of HebeiWelcome Pharmaceutical Co., Ltd. and North China Pharmaceutical Group Corp.in this matter and all of the actions subsumed under the above-captioned MDLnumber. Ordered by Judge Brian M. Cogan, on 1/17/2014. Associated Cases:1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO, 1:06-cv-00149-BMC-JO,1:06-cv-00987-BMC-JO, 1:06-cv-00988-BMC-JO (Barrett, C) (Entered:01/17/2014)

01/27/2014 829 Letter to Judge Cogan Enclosing Replacement Documents re: Dckt. Entry 807-3by Plaintiff(s) in Civil Action Philion vs Hebei Welcome Pharmaceutical Co. Ltd.06-CV-987, Plaintiff(s) in Civil Action Audette vs Hebei WelcomePharmaceutical Co. Ltd. 06-CV-988, Plaintiff(s) in Civil Action Keane vs HebeiWelcome Pharmaceutical Co. Ltd. 06-CV-149 (Attachments: # 1 Proposed Order)(Hedlund, Daniel) (Entered: 01/27/2014)

01/27/2014 830 AMENDED ORDER granting Indirect Purchaser Plaintiffs' 807 Motion forPreliminary Approval of Settlement with Defendants Weisheng PharmaceuticalCo. Ltd. and CSPC Pharmaceutical Group Limited and Approval of Notice Planand Form of Notice. Ordered by Judge Brian M. Cogan, on 1/27/2014. AssociatedCases: 1:06-md-01738-BMC-JO, 1:06-cv-00149-BMC-JO, 1:06-cv-00987- BMC-JO, 1:06-cv-00988-BMC-JO. (Barrett, C) (Entered: 01/27/2014)

01/30/2014 831 MEMORANDUM in Opposition re 824 MOTION for Reconsideration re 815Order on Motion for Attorney Fees, filed by Hebei Welcome Pharmaceutical Co.Ltd., North China Pharmaceutical Group Corp.. (Jacobson, Jonathan) (Entered:01/30/2014)

01/31/2014 832 MEMORANDUM DECISION AND ORDER granting in part and denying in part(700) Motion to Amend/Correct/Supplement Indirect Purchaser Complaints incase 1:06-md-01738-BMC-JO: Plaintiffs' motion to amend is denied to the extentthat it would add claims against North China under the laws of any state otherthan Massachusetts, and granted in all other respects. The Second AmendedConsolidated Complaint, as modified consistent with this decision, shall be filedwithin 14 days. Ordered by Judge Brian M. Cogan, on 1/31/2014. AssociatedCases: 1:06-md-01738-BMC-JO, 1:06-cv-00149-BMC-JO, 1:06-cv-00987- BMC-JO, 1:06-cv-00988-BMC-JO (Barrett, C) (Entered: 01/31/2014)

02/06/2014 833 REPLY in Support re 824 MOTION for Reconsideration re 815 Order on Motionfor Attorney Fees, filed by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. (Southwick, James) (Entered: 02/06/2014)

02/06/2014 SCHEDULING ORDER: re 809 MOTION for Disbursement of Funds -- OralArgument on the motion will take place before the undersigned on March 6, 2014,at 10:30 a.m. Ordered by Magistrate Judge James Orenstein on 2/6/2014.(Pollock, David) (Entered: 02/06/2014)

02/12/2014 834 ORDER granting 824 Motion for Reconsideration: The motion for reconsiderationis granted. Plaintiffs have now belatedly made clear that the fee award theyrequested was not to be paid to Class Counsel, but to the Direct Purchasersthemselves. Because the full amount of each settlement will already be offsetagainst the total damages owed by defendants, off-setting the portion of thosesettlements paid as fees to Class Counsel money already included in the settlement

A-124Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page131 of 191

Page 132: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 125/137

totals would be double counting. The Clerk is therefore directed to enter a ThirdAmended Judgment and Final Decree in the amount of $147,831,471.03 withinterest nunc pro tunc to March 14, 2013. Ordered by Judge Brian M. Cogan, on2/11/2014. (Barrett, C) (Entered: 02/12/2014)

02/12/2014 835 THIRD AMENDED JUDGMENT AND FINAL DECREE that The RanisCompany, as class representative, will take of defendants Hebei WelcomePharmaceutical Co., Ltd. and North China Pharmaceutical Group Corp., jointlyand severally, damages in the amount of One Hundred Forty Seven Million EightHundred Thirty One Thousand Four Hundred Seventy One Dollars and 03/100($147,831,471.03) with post judgment interest thereon pursuant to 28 U.S.C.§1961 nunc pro tunc to March 14, 2013 Signed Douglas C. Palmer, Clerk of Courtby Michele Gapinski, Chief Deputy Clerk on 2/12/2014. (Lee, Tiffeny) (Entered:02/12/2014)

02/14/2014 836 AMENDED COMPLAINT Second Amended Consolidated Complaint againstChina Pharmaceutical Group Ltd., Hebei Welcome Pharmaceutical Co. Ltd.,North China Pharmaceutical Group Corp., Northeast Pharmaceutical Group Co.,Ltd., Shijiazhuang Pharma. Weisheng Pharmaceutical Co., Ltd., WeishengPharmaceutical Co. Ltd., filed by Plaintiff(s) in Civil Action Philion vs HebeiWelcome Pharmaceutical Co. Ltd. 06-CV-987, Plaintiff(s) in Civil Action Keanevs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149, Plaintiff(s) in CivilAction Audette vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-988. (Battin,Timothy) (Entered: 02/14/2014)

02/18/2014 837 Subsequent NOTICE OF APPEAL by Hebei Welcome Pharmaceutical Co. Ltd.,North China Pharmaceutical Group Corp. SECOND AMENDED NOTICE OFAPPEAL as to 835 THIRD AMENDED JUDGMENT AND FINAL DECREE, 816SECOND AMENDED JUDGMENT AND FINAL DECREE, and 801 AMENDEDJUDGMENT AND FINAL DECREE. (Jacobson, Jonathan) (Entered: 02/18/2014)

02/18/2014 Second Supplemental Electronic Index to Record on Appeal sent to US Court ofAppeals. 837 Subsequent/Amended Notice of Appeal. (McGee, Mary Ann)(Entered: 02/18/2014)

02/18/2014 838 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 25, receipt number0207-6738189. by Great Earth Chemical, LLC, North American World TradeGroup, Inc.. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO, 1:06-cv-00149-BMC-JO, 1:06-cv-00987-BMC-JO, 1:06-cv-00988-BMC-JO(Pitt, Keith) (Entered: 02/18/2014)

02/19/2014 839 ORDER granting 838 Motion for Leave to Appear Pro Hac Vice -- Attorney KeithA. Pitt, Esq. is permitted to argue or try this case in whole or in part as counsel oradvocate. By February 26, 2014, Mr. Pitt shall register for ECF. Registration isavailable online at the EDNY's homepage. Once registered, Mr. Pitt shall file anotice of appearance and ensure that he receives electronic notification of activityin this case. Mr. Pitt shall also ensure that the $25 admission fee be submitted tothe Clerk's Office. Ordered by Magistrate Judge James Orenstein on 2/19/2014.(Pollock, David) (Entered: 02/19/2014)

02/19/2014 840 NOTICE of Appearance by Keith A. Pitt on behalf of Great Earth Chemical, LLC,North American World Trade Group, Inc. (notification declined or already on

A-125Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page132 of 191

Page 133: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 126/137

case) Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO, 1:06-cv-00149-BMC-JO, 1:06-cv-00987-BMC-JO, 1:06-cv-00988-BMC-JO (Pitt,Keith) (Entered: 02/19/2014)

02/20/2014 841 Letter to The Honorable Brian M. Cogan respectfully requesting an extension oftime to respond to the Second Amended Consolidated Complaint by HebeiWelcome Pharmaceutical Co. Ltd., North China Pharmaceutical Group Corp.(Weick, Daniel) (Entered: 02/20/2014)

02/20/2014 ORDER granting 841 defendants Hebei Welcome Pharmaceutical Corp. andNorth China Pharmaceutical Group Corp.'s request for an extension of time to filetheir response to the Second Amended Consolidated complaint to 3/28/2014.Ordered by Judge Brian M. Cogan on 2/20/2014. (Weisberg, Peggy) (Entered:02/20/2014)

02/21/2014 SCHEDULING ORDER: re 836 Amended Complaint -- There will be a StatusConference on March 13, 2014, at 2:00 p.m. in Courtroom 11D South beforeMagistrate Judge James Orenstein. Ordered by Magistrate Judge James Orensteinon 2/21/2014. (Pollock, David) (Entered: 02/21/2014)

02/25/2014 842 MOTION for Leave to Appear Pro Hac Vice of Dean C. Eyler Filing fee $ 25,receipt number 0207-6753638. by QualChem, LLC d/b/a Great Earth Chemical.Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Smith,Gary) (Entered: 02/25/2014)

02/26/2014 843 ORDER granting 842 Motion for Leave to Appear Pro Hac Vice -- Attorney DeanC. Eyler, Esq. is permitted to argue or try this case in whole or in part as counselor advocate. By March 5, 2014, Mr. Eyler shall register for ECF. Registration isavailable online at the EDNY's homepage. Once registered, Mr. Eyler shall file anotice of appearance and ensure that he receives electronic notification of activityin this case. Mr. Eyler shall also ensure that the $25 admission fee be submitted tothe Clerk's Office. Ordered by Magistrate Judge James Orenstein on 2/26/2014.(Pollock, David) (Entered: 02/26/2014)

02/26/2014 844 Letter MOTION to Stay Indirect Purchaser Action as to Settling Defendants byChina Pharmaceutical Group Ltd., Plaintiff(s) in Civil Action Keane vs HebeiWelcome Pharmaceutical Co. Ltd. 06-CV-149, Weisheng Pharmaceutical Co.Ltd.. (Attachments: # 1 Proposed Order & Stipulation) (Battin, Timothy)(Entered: 02/26/2014)

02/27/2014 ORDER granting 844 Motion to Stay -- The motion is granted and the proposedstipulation is so ordered; all non-settlement proceedings as between the signingparties are stayed pending the court's consideration of the proposed settlement.Ordered by Magistrate Judge James Orenstein on 2/27/2014. (Pollock, David)(Entered: 02/27/2014)

03/06/2014 845 Minute Entry for proceedings held before Magistrate Judge JamesOrenstein:Motion Hearing held on 3/6/2014 re 809 MOTION for Disbursement ofFunds to Claimant QualChem, LLC d/b/a Great Earth Chemical filed byQualChem, LLC d/b/a Great Earth Chemical. SCHEDULING: The next statusconference will be held on March 13, 2014, at 2:00 p.m. SUMMARY: (1)NorthAmerican will promptly file on the docket copies of all declarations of CliffChulos and Ruth Yien to which the previously filed submissions refer. (2)QualChem and North American are seeking to resolve their dispute on consent.

A-126Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page133 of 191

Page 134: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 127/137

They will confer through counsel and promptly contact chambers to schedule asettlement conference. All parties other than QualChem and North American areexcused from attending any such settlement conference, although all are welcome.(Orenstein, James) (Main Document 845 replaced on 3/6/2014) (Guy, Alicia).(Entered: 03/06/2014)

03/06/2014 846 Letter to The Honorable James Orenstein respectfully requesting that allproceedings in the Indirect-Purchaser Actions as to Defendants Hebei and NorthChina Pharmaceutical Group Corporation are stayed until the issuance of themandate of the U.S. Court of Appeals for the Second Circuit in the currently-pending appeal, In re Vitamin C Antitrust Litigation, No. 13-4791 by HebeiWelcome Pharmaceutical Co. Ltd., North China Pharmaceutical Group Corp.(Attachments: # 1 Proposed Order) (Weick, Daniel) (Entered: 03/06/2014)

03/07/2014 847 DECLARATION of Phil Nelson by Great Earth Chemical, LLC, North AmericanWorld Trade Group, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 ExhibitC, # 4 Exhibit D) (Pitt, Keith) (Entered: 03/07/2014)

03/12/2014 848 Letter Requesting Telephone Appearance by North American World Trade Group,Inc., Great Earth Chemical, LLC Associated Cases: 1:06-md-01738-BMC-JO,1:05-cv-00453-BMC-JO, 1:06-cv-00149-BMC-JO, 1:06-cv-00987-BMC-JO,1:06-cv-00988-BMC-JO (Pitt, Keith) (Entered: 03/12/2014)

03/12/2014 ORDER re 848 Letter, filed by Great Earth Chemical, LLC, North AmericanWorld Trade Group, Inc. -- The application is granted. Counsel for NorthAmerican World Trade Group is permitted to appear by telephone at the statusconference scheduled for March 13, 2014, at 2:00 p.m. Counsel is respectfullydirected to send a direct dial number in advance of the conference [email protected]. Ordered by Magistrate Judge JamesOrenstein on 3/12/2014. (Pollock, David) (Entered: 03/12/2014)

03/13/2014 849 Minute Entry for proceedings held before Magistrate Judge JamesOrenstein:Status Conference held on 3/13/2014. The parties will confer and byMarch 21, 2014, will submit a joint proposal as to the discovery that can becompleted without undue burden pending the resolution of the appellate review ofthe judgment on the direct purchaser plaintiffs' claims. Upon reviewing the parties'submission I will schedule further proceedings as appropriate. (Orenstein, James)(Entered: 03/13/2014)

03/20/2014 850 WAIVER OF SERVICE Returned Executed by North China PharmaceuticalGroup Corp.. North China Pharmaceutical Group Corp. waiver sent on 2/28/2014,answer due 5/29/2014. (Battin, Timothy) (Entered: 03/20/2014)

03/21/2014 851 Letter to The Honorable James Orenstein enclosing joint proposal regardingdiscovery by Hebei Welcome Pharmaceutical Co. Ltd., North ChinaPharmaceutical Group Corp. (Attachments: # 1 Proposed Order) (Weick, Daniel)(Entered: 03/21/2014)

03/24/2014 ORDER re 851 Letter filed by Hebei Welcome Pharmaceutical Co. Ltd., NorthChina Pharmaceutical Group Corp. -- The proposed scheduling order is SoOrdered. The parties shall complete the limited discovery specified in the order nolater than August 29, 2014. Proceedings in the Indirect Purchaser Actions as to thenon-settling defendants are otherwise stayed until resolution of the pendingappeal. The non-settling defendants shall answer or otherwise respond to the

A-127Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page134 of 191

Page 135: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 128/137

second amended consolidated complaint no later than 30 days following aresolution of the pending appeal. Ordered by Magistrate Judge James Orenstein on3/24/2014. (Pollock, David) (Entered: 03/24/2014)

03/25/2014 852 NOTICE of Appearance by Michael S Kim on behalf of Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453, Vitamin C Antitrust Litigation (atyto be noticed) Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Kim, Michael) (Entered: 03/25/2014)

03/25/2014 853 NOTICE of Appearance by Carrie Ann Tendler on behalf of Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453, Vitamin C Antitrust Litigation (atyto be noticed) Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Tendler, Carrie) (Entered: 03/25/2014)

03/25/2014 854 Letter to Judge Cogan re Pre-Motion Conference Request by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453 Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Kim, Michael) (Entered: 03/25/2014)

03/25/2014 ORDER re 854 in 1:06-md-01738-BMC-JO; 156 in 1:05-cv-00453-BMC-JOLetter re Pre-Motion Conference Request. The premotion conference is waived.Plaintiff may file the motion described in this letter, and may file such portions ofthat motion (not the entire motion) under seal as is required by the currentprotective order. Ordered by Judge Brian M. Cogan on 3/25/2014. AssociatedCases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Weisberg, Peggy)(Entered: 03/25/2014)

03/26/2014 855 NOTICE of Appearance by John Han on behalf of Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453, Vitamin C Antitrust Litigation (aty to benoticed) Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO(Han, John) (Entered: 03/26/2014)

03/26/2014 856 MOTION to Enforce Judgment Motion for Turnover Orders, Restraining Orders,and Discovery in Aid of Execution Against Defendants North ChinaPharmaceutical Group Corporation and Hebei Welcome Pharmaceutical Co.,Ltd. by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453.Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Kim,Michael) (Entered: 03/26/2014)

03/26/2014 857 MEMORANDUM in Support re (158 in 1:05-cv-00453-BMC-JO, 856 in 1:06-md-01738-BMC-JO) MOTION to Enforce Judgment Motion for TurnoverOrders, Restraining Orders, and Discovery in Aid of Execution AgainstDefendants North China Pharmaceutical Group Corporation and Hebei WelcomePharmaceutical Co., Ltd. Memorandum of Law filed by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Proposed Order)Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Kim,Michael) (Entered: 03/26/2014)

03/26/2014 858 AFFIDAVIT/DECLARATION in Support re (158 in 1:05-cv-00453-BMC-JO,856 in 1:06-md-01738-BMC-JO) MOTION to Enforce Judgment Motion forTurnover Orders, Restraining Orders, and Discovery in Aid of Execution AgainstDefendants North China Pharmaceutical Group Corporation and Hebei WelcomePharmaceutical Co., Ltd. Declaration and Exhibits filed by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit A, # 2

A-128Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page135 of 191

Page 136: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 129/137

Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E) Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Kim, Michael) (Entered:03/26/2014)

03/26/2014 859 MOTION to Enforce Judgment Motion for Leave to Register the Judgment inOther Judicial Districts Pursuant to 28 U.S.C. § 1963 by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Kim, Michael) (Entered: 03/26/2014)

03/26/2014 860 MEMORANDUM in Support re (161 in 1:05-cv-00453-BMC-JO, 859 in 1:06-md-01738-BMC-JO) MOTION to Enforce Judgment Motion for Leave to Registerthe Judgment in Other Judicial Districts Pursuant to 28 U.S.C. § 1963Memorandum of Law filed by Plaintiff(s) in Civil Action Animal Science vsHebei, 05-CV-453. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Kim, Michael) (Entered: 03/26/2014)

03/26/2014 861 AFFIDAVIT/DECLARATION in Support re (161 in 1:05-cv-00453-BMC-JO,859 in 1:06-md-01738-BMC-JO) MOTION to Enforce Judgment Motion forLeave to Register the Judgment in Other Judicial Districts Pursuant to 28 U.S.C.§ 1963 Declaration and Exhibits filed by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3Exhibit C, # 4 Exhibit D) Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Kim, Michael) (Entered: 03/26/2014)

03/26/2014 862 MEMORANDUM in Support re (161 in 1:05-cv-00453-BMC-JO, 859 in 1:06-md-01738-BMC-JO) MOTION to Enforce Judgment Motion for Leave to Registerthe Judgment in Other Judicial Districts Pursuant to 28 U.S.C. § 1963Memorandum of Law filed Under Seal filed by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Kim, Michael) (Entered: 03/26/2014)

03/26/2014 863 AFFIDAVIT/DECLARATION in Support re (161 in 1:05-cv-00453-BMC-JO,859 in 1:06-md-01738-BMC-JO) MOTION to Enforce Judgment Motion forLeave to Register the Judgment in Other Judicial Districts Pursuant to 28 U.S.C.§ 1963 Declaration and Exhibits filed Under Seal filed by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit C, # 2Exhibit D) Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO(Kim, Michael) (Entered: 03/26/2014)

04/01/2014 864 MOTION for Extension of Time to File Response/Reply re [Dkt. Nos. 856-63] byHebei Welcome Pharmaceutical Co. Ltd., North China Pharmaceutical GroupCorp.. (Weick, Daniel) (Entered: 04/01/2014)

04/01/2014 865 RESPONSE in Opposition re (864 in 1:06-md-01738-BMC-JO) MOTION forExtension of Time to File Response/Reply re [Dkt. Nos. 856-63] filed byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. AssociatedCases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Tendler, Carrie)(Entered: 04/01/2014)

04/02/2014 866 REPLY in Support re 864 MOTION for Extension of Time to FileResponse/Reply re [Dkt. Nos. 856-63] filed by Hebei Welcome PharmaceuticalCo. Ltd., North China Pharmaceutical Group Corp.. (Weick, Daniel) (Entered:04/02/2014)

A-129Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page136 of 191

Page 137: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 130/137

04/02/2014 867 MEMORANDUM DECISION AND ORDER denying (158) MOTION to EnforceJudgment Motion for Turnover Orders, Restraining Orders, and Discovery in Aidof Execution Against Defendants North China Pharmaceutical Group Corporationand Hebei Welcome Pharmaceutical Co., Ltd. in case 1:05-cv-00453-BMC-JO;denying (856) MOTION to Enforce Judgment Motion for Turnover Orders,Restraining Orders, and Discovery in Aid of Execution Against Defendants NorthChina Pharmaceutical Group Corporation and Hebei Welcome PharmaceuticalCo., Ltd. in case 1:06-md-01738-BMC-JO; granting in part and denying in part(864) Motion for Extension of Time to File Response/Reply re (Dkt. Nos. 856-63in 1:06-md-01738-BMC-JO); Response to 859 MOTION to Enforce JudgmentMotion for Leave to Register the Judgment in Other Judicial Districts Pursuant to28 U.S.C. § 1963 in case 1:06-md-01738-BMC-JO and 161 MOTION to EnforceJudgment Motion for Leave to Register the Judgment in Other Judicial DistrictsPursuant to 28 U.S.C. § 1963 in case 1:05-cv-00453- BMC-JO due by 5/5/2014.Ordered by Judge Brian M. Cogan, on 4/2/2014. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO. (Barrett, C) (Entered: 04/02/2014)

04/07/2014 868 Notice of MOTION for Disbursement of Funds Motion to Authorize Distributionof the Weisheng Direct Purchaser Settlement Fund and to Pay Costs of ClaimsAdministration by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Memorandum in Support, # 2 Declaration of CharleneYoung and Exhibits, # 3 Proposed Order) (Coolidge, Melinda) (Entered:04/07/2014)

04/16/2014 869 NOTICE by Neil Freedman of Objections (Siegel, Edward) (Entered: 04/16/2014)

04/16/2014 870 NOTICE by Neil Freedman of objections to the fairness and reasonableness ofClass Counsels' requested attorneys' fees. (Attachments: # 1 Exhibit A, # 2Certificate of Service) (Barrett, C) (Entered: 04/22/2014)

04/17/2014 ORDER re 809 MOTION for Disbursement of Funds, 845 Motion Hearing --Counsel for claimants QualChem, LLC, and North American World Trade Group,Inc., shall file a joint status report no later than April 24, 2014. Ordered byMagistrate Judge James Orenstein on 4/17/2014. (Pollock, David) (Entered:04/17/2014)

04/22/2014 871 Letter to Judge Cogan re Pre-Motion Conference Request by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453 Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Kim, Michael) (Entered: 04/22/2014)

04/22/2014 ORDER re 871 . Plaintiff is granted leave to file whatever motion it wants, but theCourt's preliminary take on this is that if the bank is holding the money, then thebank is the respondent in the turnover proceeding, not the debtor, as plaintiffpresumably has served a restraining notice on the bank to prevent withdrawals.Ordered by Judge Brian M. Cogan on 4/22/2014. (Weisberg, Peggy) (Entered:04/22/2014)

04/22/2014 872 ORDER AUTHORIZING THE DISTRIBUTION of the Weisheng/CPG DirectPurchaser Settlement Fund, granting (868) Motion for Disbursement of Funds incase 1:06- md-01738-BMC-JO. Ordered by Judge Brian M. Cogan on 4/22/2014.Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Barrett, C)(Entered: 04/22/2014)

04/24/2014 873 STATUS REPORT by North American World Trade Group, Inc. (Nelson, Philip)

A-130Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page137 of 191

Page 138: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 131/137

(Entered: 04/24/2014)

04/25/2014 874 MOTION to Enforce Judgment Renewed Motion for Turnover Orders Pursuant toFederal Rule 69 and N.Y. CPLR §§ 5225 & 5226 by Plaintiff(s) in Civil ActionAnimal Science vs Hebei, 05-CV-453. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Kim, Michael) (Entered: 04/25/2014)

04/25/2014 875 MEMORANDUM in Support re (874 in 1:06-md-01738-BMC-JO, 171 in 1:05-cv-00453-BMC-JO) MOTION to Enforce Judgment Renewed Motion forTurnover Orders Pursuant to Federal Rule 69 and N.Y. CPLR §§ 5225 & 5226filed by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453.(Attachments: # 1 Proposed Order) Associated Cases: 1:06-md-01738-BMC-JO,1:05-cv-00453-BMC-JO (Kim, Michael) (Entered: 04/25/2014)

04/25/2014 876 AFFIDAVIT/DECLARATION in Support re (874 in 1:06-md-01738-BMC-JO,171 in 1:05-cv-00453-BMC-JO) MOTION to Enforce Judgment Renewed Motionfor Turnover Orders Pursuant to Federal Rule 69 and N.Y. CPLR §§ 5225 & 5226filed by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453.(Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5Exhibit E, # 6 Exhibit F, # 7 Exhibit G) Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Kim, Michael) (Entered: 04/25/2014)

04/25/2014 877 Notice of MOTION for Settlement with Defendants Weisheng PharmaceuticalCo., Ltd. and CSPC Pharmaceutical Group Limited by Plaintiff(s) in Civil ActionPhilion vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-987, Plaintiff(s) inCivil Action Audette vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-988,Plaintiff(s) in Civil Action Keane vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149. (Attachments: # 1 Memorandum in Support, # 2 Declaration Declarationof April Hyduk, # 3 Declaration Declaration of R. Alexander Saveri) (Saveri,Richard) (Entered: 04/25/2014)

04/25/2014 878 MOTION for Attorney Fees and reimbursement of expenses by Plaintiff(s) inCivil Action Philion vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-987,Plaintiff(s) in Civil Action Audette vs Hebei Welcome Pharmaceutical Co. Ltd.06-CV-988, Plaintiff(s) in Civil Action Keane vs Hebei Welcome PharmaceuticalCo. Ltd. 06-CV-149. (Attachments: # 1 Memorandum in Support, # 2 Declarationof Timothy Battin, Daniel Hedlund, and R. Alexander Saveri, # 3 Exhibit A -Compendium, # 4 Exhibit B - Hyduk Declaration, # 5 Exhibit C) (Battin,Timothy) (Entered: 04/25/2014)

05/05/2014 879 MEMORANDUM in Opposition re 859 MOTION to Enforce Judgment Motionfor Leave to Register the Judgment in Other Judicial Districts Pursuant to 28U.S.C. § 1963 filed by Hebei Welcome Pharmaceutical Co. Ltd., North ChinaPharmaceutical Group Corp.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Jacobson, Jonathan) (Entered: 05/05/2014)

05/05/2014 880 Letter to The Honorable Brian M. Cogan respectfully requesting a pre-motionconference by Hebei Welcome Pharmaceutical Co. Ltd., North ChinaPharmaceutical Group Corp. (Weick, Daniel) (Entered: 05/05/2014)

05/05/2014 Order re: 880 . Premotion conference is waived. Defendants may file their motion.Ordered by Judge Brian M. Cogan on 5/5/2014. (Clarke, Melonie) (Entered:05/05/2014)

A-131Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page138 of 191

Page 139: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 132/137

05/07/2014 881 NOTICE of Appearance by William J. Heye on behalf of Plaintiff(s) in CivilAction Philion vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-987,Plaintiff(s) in Civil Action Audette vs Hebei Welcome Pharmaceutical Co. Ltd.06-CV-988, Plaintiff(s) in Civil Action Keane vs Hebei Welcome PharmaceuticalCo. Ltd. 06-CV-149 (aty to be noticed) (Heye, William) (Entered: 05/07/2014)

05/07/2014 882 FILING FEE: $ 25 (pro hac vice admission fee), receipt number 4653073782.Related document: 881 Notice of Appearance by William J. Heye. (Attachments:# 1 Cover Letter) (Barrett, C) (Entered: 05/08/2014)

05/09/2014 883 Letter to The Honorable Brian M. Cogan enclosing Declaration of ZhangWencheng as further support for Defendants' Memorandum in Opposition toPlaintiffs' Motion for Leave to Register the Judgment Pursuant to 28 U.S.C. §1963 re Dkt. 879 by Hebei Welcome Pharmaceutical Co. Ltd., North ChinaPharmaceutical Group Corp. (Attachments: # 1 Declaration of Zhang Wencheng)(Weick, Daniel) (Entered: 05/09/2014)

05/09/2014 884 MOTION to Stay DEFENDANTS' NOTICE OF MOTION AND MOTION TODISSOLVE RESTRAINING NOTICES AND PARTIALLY STAY ENFORCEMENTPROCEEDINGS AND OPPOSITION TO PLAINTIFFS' RENEWED MOTIONFOR TURNOVER ORDERS (Dkt. 874) by Hebei Welcome Pharmaceutical Co.Ltd., North China Pharmaceutical Group Corp.. (Jacobson, Jonathan) (Entered:05/09/2014)

05/09/2014 885 MEMORANDUM in Support re 884 MOTION to Stay DEFENDANTS' NOTICEOF MOTION AND MOTION TO DISSOLVE RESTRAINING NOTICES ANDPARTIALLY STAY ENFORCEMENT PROCEEDINGS AND OPPOSITION TOPLAINTIFFS' RENEWED MOTION FOR TURNOVER ORDERS (Dkt. 874) filedby Hebei Welcome Pharmaceutical Co. Ltd., North China Pharmaceutical GroupCorp.. (Jacobson, Jonathan) (Entered: 05/09/2014)

05/09/2014 886 AFFIDAVIT/DECLARATION in Support re 884 MOTION to StayDEFENDANTS' NOTICE OF MOTION AND MOTION TO DISSOLVERESTRAINING NOTICES AND PARTIALLY STAY ENFORCEMENTPROCEEDINGS AND OPPOSITION TO PLAINTIFFS' RENEWED MOTIONFOR TURNOVER ORDERS (Dkt. 874) [DECLARATION OF DANIEL P.WEICK] filed by Hebei Welcome Pharmaceutical Co. Ltd., North ChinaPharmaceutical Group Corp.. (Attachments: # 1 Exhibits A through I, # 2 ExhibitsJ through S, # 3 Exhibits T through Z, # 4 Exhibits AA through MM) (Jacobson,Jonathan) (Entered: 05/09/2014)

05/09/2014 887 EXHIBIT G TO THE DECLARATION OF DANIEL P. WEICK [FILED UNDERSEAL] by Hebei Welcome Pharmaceutical Co. Ltd., North China PharmaceuticalGroup Corp.. Related document: 886 Affidavit in Support of Motion,, filed byHebei Welcome Pharmaceutical Co. Ltd., North China Pharmaceutical GroupCorp.. (Jacobson, Jonathan) (Entered: 05/09/2014)

05/12/2014 888 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 25, receipt number0207-6920148. by Plaintiff(s) in Civil Action Keane vs Hebei WelcomePharmaceutical Co. Ltd. 06-CV-149. (Le, Christopher) (Entered: 05/12/2014)

05/12/2014 889 REPLY in Support re (859 in 1:06-md-01738-BMC-JO) MOTION to EnforceJudgment Motion for Leave to Register the Judgment in Other Judicial Districts

A-132Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page139 of 191

Page 140: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 133/137

Pursuant to 28 U.S.C. § 1963 filed by Plaintiff(s) in Civil Action Animal Sciencevs Hebei, 05-CV-453. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Kim, Michael) (Entered: 05/12/2014)

05/13/2014 890 ORDER granting 888 Motion for Leave to Appear Pro Hac Vice -- AttorneyChristopher Le, Esq., is permitted to argue or try this case in whole or in part ascounsel or advocate. By May 20, 2014, Mr. Le shall register for ECF. Registrationis available online at the EDNY's homepage. Once registered, Mr. Le shall file anotice of appearance and ensure that he receives electronic notification of activityin this case. Mr. Le shall also ensure that the $25 admission fee be submitted tothe Clerk's Office. Ordered by Magistrate Judge James Orenstein on 5/13/2014.(Pollock, David) (Entered: 05/13/2014)

05/13/2014 891 NOTICE of Appearance by Christopher V. Le on behalf of Plaintiff(s) in CivilAction Keane vs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149(notification declined or already on case) (Le, Christopher) (Entered: 05/13/2014)

05/16/2014 Minute Entry and Order for Fairness Hearing held before Judge Brian M. Coganon 5/16/2014. Counsel for the Indirect Purchaser Damages Settlement Class andsettling defendants Weisheng Pharmaceutical Co., Ltd. and CSPC PharmaceuticalGroup, Ltd. appeared. No objectors or class members appeared. For the reasonsstated on the record, the sole objection is overruled, and plaintiffs' motion for finalapproval of the settlement at 877 is granted, as is plaintiffs' motion for fees andexpenses at 878 . Parties to submit proposed final judgment in Microsoft Wordformat to [email protected]. See transcript for details. (CourtReporter Charleane Heading.) Associated Cases: 1:06-md-01738-BMC-JO, 1:06-cv-00149-BMC-JO, 1:06-cv-00987-BMC-JO, 1:06-cv-00988-BMC-JO(Clarke,Melonie) (Entered: 05/16/2014)

05/16/2014 892 MEMORANDUM in Support re (874 in 1:06-md-01738-BMC-JO, 171 in 1:05-cv-00453-BMC-JO) MOTION to Enforce Judgment Renewed Motion forTurnover Orders Pursuant to Federal Rule 69 and N.Y. CPLR §§ 5225 & 5226Reply Memorandum in Further Support of Renewed Turnover Motion AgainstJudgment Debtors filed by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Kim, Michael) (Entered: 05/16/2014)

05/16/2014 893 AFFIDAVIT/DECLARATION in Support re (171 in 1:05-cv-00453-BMC-JO)MOTION to Enforce Judgment Renewed Motion for Turnover Orders Pursuant toFederal Rule 69 and N.Y. CPLR §§ 5225 & 5226 filed by Plaintiff(s) in CivilAction Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit A, # 2Exhibit B, # 3 Exhibit C, # 4 Exhibit D) Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Kim, Michael) (Entered: 05/16/2014)

05/21/2014 894 Letter to the Honorable Brian M. Cogan enclosing courtesy copy of ProposedFinal Judgment by Plaintiff(s) in Civil Action Philion vs Hebei WelcomePharmaceutical Co. Ltd. 06-CV-987, Plaintiff(s) in Civil Action Audette vs HebeiWelcome Pharmaceutical Co. Ltd. 06-CV-988, Plaintiff(s) in Civil Action Keanevs Hebei Welcome Pharmaceutical Co. Ltd. 06-CV-149 (Heye, William)(Entered: 05/21/2014)

05/22/2014 ORDER as to plaintiffs' 894 Letter enclosing courtesy copy of Proposed Final

A-133Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page140 of 191

Page 141: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 134/137

Judgment. The filing does not indicate whether defendants have a position withrespect to this form of judgment. The Court will endorse the judgment whendefendants indicate their consent. Ordered by Judge Brian M. Cogan on5/22/2014. (Weisberg, Peggy) (Entered: 05/22/2014)

05/22/2014 895 Letter to Honorable Brian M. Cogan consenting to entry of proposed finaljudgment by Weisheng Pharmaceutical Co. Ltd. (Mason, Daniel) (Entered:05/22/2014)

05/23/2014 896 MEMORANDUM in Opposition re (884 in 1:06-md-01738-BMC-JO) MOTIONto Stay DEFENDANTS' NOTICE OF MOTION AND MOTION TO DISSOLVERESTRAINING NOTICES AND PARTIALLY STAY ENFORCEMENTPROCEEDINGS AND OPPOSITION TO PLAINTIFFS' RENEWED MOTIONFOR TURNOVER ORDERS (Dkt. 874) filed by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Kim, Michael) (Entered: 05/23/2014)

05/23/2014 897 AFFIDAVIT/DECLARATION in Opposition re (884 in 1:06-md-01738-BMC-JO) MOTION to Stay DEFENDANTS' NOTICE OF MOTION AND MOTION TODISSOLVE RESTRAINING NOTICES AND PARTIALLY STAY ENFORCEMENTPROCEEDINGS AND OPPOSITION TO PLAINTIFFS' RENEWED MOTIONFOR TURNOVER ORDERS (Dkt. 874) filed by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 ExhibitH, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, #14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24Exhibit X, # 25 Exhibit Y, # 26 Exhibit Z) Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Kim, Michael) (Entered: 05/23/2014)

05/27/2014 898 NOTICE of Appearance by Marcus Johnson Green on behalf of Plaintiff(s) inCivil Action Animal Science vs Hebei, 05-CV-453 (aty to be noticed) AssociatedCases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Green, Marcus)(Entered: 05/27/2014)

05/29/2014 899 Final Judgment as to Indirect Purchaser Settlement Class ("Settlement Class") andDefendants Weisheng Pharmaceutical Co. Ltd. ("Weisheng") and CSPCPharmaceutical Group Limited, formerly China Pharmaceutical Group Ltd.("CSPC"). Pursuant to Fed. R. Civ. P. 54(b), the Court finds that there is no reasonfor delay and hereby directs the entry of this final judgment of dismissal forthwithas to the Releasees. Ordered by Judge Brian M. Cogan on 5/28/2014. AssociatedCases: 1:06-md-01738-BMC-JO, 1:06-cv-00149-BMC-JO, 1:06-cv-00987- BMC-JO, 1:06-cv-00988-BMC-JO (Barrett, C) (Entered: 05/29/2014)

05/29/2014 902 MOTION to Intervene " as Plaintiffs Under Rule 24(A) 2, Rule 24(B)" byChristopher Donnelly, Christopher Wirth, Jimmy Thule, Jonathan Rich, TerryNichols, John Lindh, James Holmes. (Barrett, C) (Entered: 06/02/2014)

05/30/2014 900 REPLY in Support re 884 MOTION to Stay DEFENDANTS' NOTICE OFMOTION AND MOTION TO DISSOLVE RESTRAINING NOTICES ANDPARTIALLY STAY ENFORCEMENT PROCEEDINGS AND OPPOSITION TOPLAINTIFFS' RENEWED MOTION FOR TURNOVER ORDERS (Dkt. 874) filedby Hebei Welcome Pharmaceutical Co. Ltd., North China Pharmaceutical Group

A-134Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page141 of 191

Page 142: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 135/137

Corp.. (Jacobson, Jonathan) (Entered: 05/30/2014)

05/30/2014 901 AFFIDAVIT/DECLARATION in Support re 884 MOTION to StayDEFENDANTS' NOTICE OF MOTION AND MOTION TO DISSOLVERESTRAINING NOTICES AND PARTIALLY STAY ENFORCEMENTPROCEEDINGS AND OPPOSITION TO PLAINTIFFS' RENEWED MOTIONFOR TURNOVER ORDERS (Dkt. 874) [[REPLY DECLARATION OF DANIEL P.WEICK IN SUPPORT OF DEFENDANTS MOTION TO DISSOLVERESTRAINING NOTICES AND PARTIALLY STAY ENFORCEMENTPROCEEDINGS]] filed by Hebei Welcome Pharmaceutical Co. Ltd., North ChinaPharmaceutical Group Corp.. (Attachments: # 1 Exhibits A through J, # 2 ExhibitsK through T, # 3 Exhibits U through Z, # 4 Exhibit AA) (Jacobson, Jonathan)(Entered: 05/30/2014)

06/03/2014 903 ORDER denying 902 Motion to Intervene. No adequate grounds have been statedand the motion is untimely. Ordered by Judge Brian M. Cogan on 6/3/2014.Chambers mailed copies to the following intervenors: Donnelly, Wirth, Thule,Rich, Nichols, Lindh, and Holmes. (Barrett, C) (Entered: 06/03/2014)

06/18/2014 904 Mail Returned as Undeliverable. A copy of the 903 Order was sent to John Lindhat 5880 Highway 67, Florence, CO 81226. Returned with postal notations:"Return to Sender," "Insufficient Address," "Unable to Forward." (Barrett, C)(Entered: 06/26/2014)

06/18/2014 905 Mail Returned as Undeliverable. A copy of the 903 Order was sent to TerryNichols at 5880 Highway 67, Florence, CO 81226. Returned with postalnotations: "Return to Sender," "Insufficient Address," "Unable to Forward."(Barrett, C) (Entered: 06/26/2014)

06/26/2014 906 STIPULATION re 809 MOTION for Disbursement of Funds to ClaimantQualChem, LLC d/b/a Great Earth Chemical, 819 Response in Opposition toMotion, INCLUDING PROPOSED ORDER by QualChem, LLC d/b/a Great EarthChemical (Gross, Douglas) (Entered: 06/26/2014)

06/26/2014 ORDER re 906 STIPULATION, finding as moot 809 Motion for Disbursement ofFunds -- The parties' stipulation and proposed order are So Ordered; in light of theparties' agreement, the motion 809 is moot. Ordered by Magistrate Judge JamesOrenstein on 6/26/2014. (Pollock, David) (Entered: 06/26/2014)

07/03/2014 907 NOTICE of Change of Address for Brent W. Landau by Melinda R. Coolidge(Coolidge, Melinda) (Entered: 07/03/2014)

07/07/2014 908 NOTICE by Animal Science Products, Inc., The Ranis Company, Inc., Plaintiff(s)in Civil Action Animal Science vs Hebei, 05-CV-453 of Withdrawal of AttorneyTanya S. Chutkan as attorney for Plaintiffs Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Isaacson, William) (Entered: 07/07/2014)

07/21/2014 909 Letter to Judge Cogan re Pre-Motion Requirement for Discovery Disputes byPlaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453 AssociatedCases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Kim, Michael)(Entered: 07/21/2014)

07/29/2014 ORDER re: pre-motion letter at 909 in 1:06-md-01738-BMC-JO. Plaintiffs mayfile their motion by 8/5/2014. Opposition due 8/12/2014. Ordered by Judge Brian

A-135Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page142 of 191

Page 143: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 136/137

M. Cogan on 7/29/2014. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Weisberg, Peggy) (Entered: 07/29/2014)

08/05/2014 910 Letter MOTION to Compel Discovery by Plaintiff(s) in Civil Action AnimalScience vs Hebei, 05-CV-453. Associated Cases: 1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Kim, Michael) (Entered: 08/05/2014)

08/12/2014 911 RESPONSE to Motion re 910 Letter MOTION to Compel Discovery filed byHebei Welcome Pharmaceutical Co. Ltd., North China Pharmaceutical GroupCorp.. (Weick, Daniel) (Entered: 08/12/2014)

08/12/2014 912 AFFIDAVIT/DECLARATION in Opposition re 910 Letter MOTION to CompelDiscovery DECLARATION OF DANIEL P. WEICK IN SUPPORT OFDEFENDANTS' OPPOSITION TO PLAINTIFFS' MOTION TO COMPEL filed byHebei Welcome Pharmaceutical Co. Ltd., North China Pharmaceutical GroupCorp.. (Attachments: # 1 Exhibits A through K, # 2 Exhibits L through U) (Weick,Daniel) (Entered: 08/12/2014)

10/08/2014 913 Letter dated 10/3/14 from Tamara A. Brady, Chief Trial Deputy Office of theState Public Defender, I am legal counsel for James Holmes in a criminal case inColorado re: to advise that Mr. James Holmes is not involved in the EasternDistrict class action, we are not sure how his name became associated with yourcase. (Guzzi, Roseann) (Entered: 10/14/2014)

10/23/2014 914 MEMORANDUM DECISION AND ORDER dated 10/22/14 that plaintiff'srenewed motion for turnover orders 874 is granted as to Hebei and denied as toNCPG. Defendants' motion to stay enforcement proceedings and dissolverestraining notices 884 is granted in part and denied in part; specifically, themotion to dissolve restraining notices is granted as to NCPG, but denied as toHebei, and their motion for an unsecured stay is denied. Plaintiffs' motion tocompel discovery 910 is granted. Finally, plaintiffs' motion for leave to registerthe judgment in other districts 859 is denied without prejudice to renewal afterdiscovery. ( Ordered by Judge Brian M. Cogan on 10/22/2014 ) Associated Cases:1:06-md-01738-BMC-JO, 1:05-cv-00453-BMC-JO (Guzzi, Roseann) (Entered:10/23/2014)

11/13/2014 915 Notice of MOTION for Disbursement of Funds (Motion to Authorize Distributionof the Weisheng Direct Purchaser Settlement Fund and to Pay Costs of ClaimsAdministration) by Plaintiff(s) in Civil Action Animal Science vs Hebei, 05-CV-453. (Attachments: # 1 Memorandum in Support, # 2 Declaration of April Hydukre: Final Weisheng and CPG Distribution, and Exhibits, # 3 Proposed Order)(Coolidge, Melinda) (Entered: 11/13/2014)

11/21/2014 916 NOTICE OF APPEAL as to (183 in 1:05-cv-00453-BMC-JO, 183 in 1:05-cv-00453-BMC-JO, 183 in 1:05-cv-00453-BMC-JO, 183 in 1:05-cv-00453-BMC-JO) Order on Motion to Stay, Order on Motion to Enforce Judgment,, Order onMotion to Compel,,,,,,,,,,,, by Plaintiff(s) in Civil Action Animal Science vs Hebei,05-CV-453. Filing fee $ 505, receipt number 0207-7353363. Appeal Record dueby 12/5/2014. (Attachments: # 1 Exhibit A) (Kim, Michael) (Entered: 11/21/2014)

11/24/2014 Electronic Index to Record on Appeal sent to US Court of Appeals. (916 in 1:06-md-01738-BMC-JO, 184 in 1:05-cv-00453-BMC-JO) Notice of Appeal,Documents are available via Pacer. For docket entries without a hyperlink or for

A-136Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page143 of 191

Page 144: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1/12/2015 Eastern District of New York - LIVE Database V6.1

https://ecf.nyed.uscourts.gov/cgi-bin/DktRpt.pl?26401853377615-L_1_1-1 137/137

documents under seal, contact the court and we'll arrange for the document(s) tobe made available to you. (McGee, Mary Ann) (Entered: 11/24/2014)

11/24/2014 917 NOTICE OF APPEAL as to 914 Order on Motion to Enforce Judgment,, Order onMotion to Stay, Order on Motion to Compel,,,,,,,,,,,, by Hebei WelcomePharmaceutical Co. Ltd.. Filing fee $ 505, receipt number 0207-7354295.(Jacobson, Jonathan) (Entered: 11/24/2014)

11/24/2014 First Supplemental Electronic Index to Record on Appeal sent to US Court ofAppeals. (917 in 1:06-md-01738-BMC-JO) Notice of Appeal, Documents areavailable via Pacer. For docket entries without a hyperlink or for documents underseal, contact the court and we'll arrange for the document(s) to be made availableto you. (McGee, Mary Ann) (Entered: 11/24/2014)

12/15/2014 918 ORDER AUTHORIZING THE SECOND DISTRIBUTION OF THEWEISHENG DIRECT PURCHASER SETTLEMENT FUND re: 915 Motion forDisbursement of Funds in case 1:06-md-01738-BMC-JO. ( Ordered by JudgeBrian M. Cogan on 12/12/2014 ) Associated Cases: 1:06-md-01738-BMC-JO,1:05-cv-00453-BMC-JO (Guzzi, Roseann) (Entered: 12/15/2014)

PACER Service CenterTransaction Receipt

01/12/2015 13:12:51

PACERLogin: Stephaniehsu6299:3789663:3936994 Client

Code: 763.001

Description: Docket Report SearchCriteria:

1:06-md-01738-BMC-JO

BillablePages: 30 Cost: 3.00

A-137Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page144 of 191

Page 145: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

A-138Case 1:06-md-01738-BMC-JO Document 676 Filed 03/14/13 Page 1 of 2 PagelD #: 19262

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK

IN RE VITAMIN C ANTITRUST LITIGATION

This document relates to:

ANIMAL SCIENCE PRODUCTS, INC., et al.,

Plaintiffs,

v.

HEBEi WELCOME PHARMACEUTICAL CO. LTD., et al.,

Defendants.

x

--------------------------------------------------------------- x

JUDGMENT

06-MD-1738 (BMC) (JO)

05-CV-0453

The jury having rendered its verdict in this case in favor of plaintiff, the Ranis Company,

Inc., as representative of the Direct Purchaser Class, 1 in the amount of Fifty Four Million One

Hundred Thousand Dollars ($54, 100,000.00), and the Court, upon motion of plaintiff, having

directed entry of judgment upon trebling the damage award pursuant to 15 U.S.C. § I 5(a), less

Nine Million Dollars ($9,000,000) received from former defendants, it is hereby

ORDERED AND ADJUDGED, that the Ranis Company, as class representative, take

judgment against defendants, Hebei Welcome Pharmaceutical Co., Ltd. and North China

1 The Direct Purchaser Damages Class consists of all persons or entities, or assignees of such persons or entities, who directly purchased vitamin C for delivery in the United States, other than pursuant to a contract containing an arbitration clause, from any of Defendants or their co­conspirators, other than Northeast Pharmaceutical (Group) Co. Ltd., from December 1, 200 I to June 30, 2006. Excluded from this class are all governmental entities, defendants, their co­conspirators, and their respective subsidiaries or affiliates.

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page145 of 191

Page 146: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

A-139Case 1:06-md-01738-BMC-JO Document 676 Filed 03/14/13 Page 2 of 2 PagelD #: 19263

Pharmaceutical Group Corp., jointly and severally, in the amount of One Hundred Fifty Three

Million Three Hundred Thousand Dollars ($153,300,000).

Date: Brooklyn, New York March 14, 2013

J i

, ;

s_,4Mc. HON. BRIAN M. cotjAN / UNITED STATES D}STRict JUDGE

l'

2

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page146 of 191

Page 147: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

UNITED STATES DISTRICT COURTEASTERN DISTRICT OF NEW YORK------------------------------------------------------------- X

IN RE VITAMIN C ANTITRUST LITIGATION

------------------------------------------------------------

This document relates to:

ANIMAL SCIENCE PRODUCTS, INC., et al.,

Plaintiffs,

v.

HEBEI WELCOME PHARMACEUTICAL CO.LTD., et al.,

Defendants.

:::::::::::::::::

MASTER FILE06-MD-1738 (BMC) (JO)

05-CV-0453

--------------------------------------------------------------- X

AMENDED JUDGMENT AND FINAL DECREE

The jury having rendered its verdict in this case in favor of plaintiff, the Ranis Company,

Inc., as representative of the Direct Purchaser Class,1 in the amount of Fifty Four Million One

Hundred Thousand Dollars ($54,100,000.00), and in favor of plaintiff, Animal Science Products,

Inc., as representative of the Injunction Class,2 and the Court, upon motion of plaintiff, having

1 The Direct Purchaser Damages Class consists of all persons or entities, or assignees of such persons or entities, who directly purchased vitamin C for delivery in the United States, other than pursuant to a contract containing an arbitration clause, from any of Defendants or their co-conspirators, other than Northeast Pharmaceutical (Group) Co. Ltd., from December 1, 2001 to June 30, 2006. Excluded from this class are all governmental entities, defendants, their co-conspirators, and their respective subsidiaries or affiliates. 2 The Injunction Class consists of all persons or entities, or assignees of such persons or entities, who purchased vitamin C manufactured by Defendants for delivery in the United States, other than pursuant to a contract with a Defendant containing an arbitration clause, from December 1, 2001 to the present, requiring injunctive relief against Defendants to end Defendants’ antitrust violations.

Case 1:05-cv-00453-BMC-JO Document 140 Filed 11/27/13 Page 1 of 3 PageID #: 1635

A-140Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page147 of 191

Page 148: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

2

directed entry of judgment upon trebling the damage award pursuant to 15 U.S.C. § 15(a), less

Nine Million Dollars ($9,000,000) received from former defendants, and the Court, having

entered its Memorandum Decision and Order of November 26, 2013, granting the motion of the

Injunctive Class for a permanent injunction, it is hereby:

ORDERED AND ADJUDGED, that The Ranis Company, as class representative, will

take damages of defendants – Hebei Welcome Pharmaceutical Co., Ltd. and North China

Pharmaceutical Group Corp. – jointly and severally, in the amount of One Hundred Fifty Three

Million Three Hundred Thousand Dollars ($153,300,000); and it is further

ORDERED, ADJUDGED AND DECREED, as follows:

1. Defendants, their officers, directors, agents, servants, employees, successors, assigns

and those persons acting in concert with them who receive actual notice of this injunction, are

each ENJOINED and RESTRAINED from agreeing, directly or indirectly, to fix the price or

limit the supply of vitamin C sold in the United States in violation of Section 1 of the Sherman

Act, 15 U.S.C. § 1.

2. Any party may seek modification of this Order, at any time, by written motion and for

good cause based on changed circumstances or otherwise.

3. This Court shall retain jurisdiction to enforce this Order. In the event that any part of

this Order is violated by the parties named herein or other persons, Plaintiffs may, by motion

with notice to the attorneys for the defendants, apply for sanctions or other relief that may be

appropriate.

Case 1:05-cv-00453-BMC-JO Document 140 Filed 11/27/13 Page 2 of 3 PageID #: 1636

A-141Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page148 of 191

Page 149: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

3

4. Unless this Court grants an extension, the injunction will expire without further action

of this Court ten years from the date of its entry, or if timely appealed, ten years after the final

order of the highest-level appellate court.

SO ORDERED.

___________________________________ U.S.D.J.

Dated: Brooklyn, New York November 27, 2013

Case 1:05-cv-00453-BMC-JO Document 140 Filed 11/27/13 Page 3 of 3 PageID #: 1637

gitally signed by Brian M.

A-142Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page149 of 191

Page 150: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

UNITED STATES DISTRICT COURT

EASTERN DISTRICT OF NEW YORK

------------------------------------------------------------X

IN RE: VITAMIN C ANTITRUST LITIGATION SECOND AMENDED JUDGMENT

AND FINAL DECREE

-----------------------------------------------------------

MASTER FILE

This document relates to: 06-MD-1738 (BMC) (JO)

ANIMAL SCIENCE PRODUCTS, INC., et al.,

Plaintiffs, 05-CV-0453

v.

HEBEI WELCOME PHARMACEUTICAL CO.

LTD., et al.,

Defendants.

----------------------------------------------------------X

The jury having rendered its verdict in this case in favor of plaintiff, The Ranis Company,

Inc., as representative of the Direct Purchaser Class,1 in the amount of Fifty Four Million One

Hundred Thousand Dollars ($54,100,000.00), and in favor of plaintiff, Animal Science Products,

Inc., as representative of the Injunction Class,2 and the Court, upon motion of plaintiff having

directed entry of judgment upon trebling the damage award pursuant to 15 U.S.C. § 15(a), less Nine

Million Dollars ($9,000,000) received from former defendants, and the Court having entered its

1 The Direct Purchaser Damages Class consists of all personas or entities, or assignees of

such persons or entities, who directly purchased vitamin C for delivery in the United States, other

than pursuant to a contract containing an arbitration clause, from any of Defendants or their co-

conspirators, other than Northeast Pharmaceutical (Group) Co. Ltd., from December 1, 2001 to

June 30, 2006. Excluded from this class are governmental entities, defendants, their co-

conspirators, and their respective subsidiaries or affiliates.

2 The Injunction Class consists of all persons or entities, or assignees of such persons or

entities, who purchase vitamin C manufactured by Defendants for delivery in the United States,

other than pursuant to a contract with a Defendant containing an arbitration clause, from

December 1, 2001 to the present, requiring injunctive relief against Defendants to end

Defendants antitrust violations.

1

Case 1:06-md-01738-BMC-JO Document 816 Filed 12/30/13 Page 1 of 3 PageID #: 27586

A-143Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page150 of 191

Page 151: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

SECOND AMENDED JUDGMENT AND FINAL DECREE 06-MD-1738; 05-CV-0453

Memorandum Decision and Order of November 26, 2013, granting the motion of the Injunctive

Class for a permanent injunction and the Court having entered its Decision and Order dated

December 30, 2013 awarding plaintiffs attorneys’ fees in the amount of $4,903,163.35 and directing

the Clerk to enter a Second Amended Judgment and Final Decree adding said amount to plaintiffs’

recovery, with interest nunc pro tunc to March 14, 2013, it is hereby:

ORDERED, ADJUDGED AND DECREED, that The Ranis Company, as class

representative, will take of defendants Hebei Welcome Pharmaceutical Co., Ltd. and

North China Pharmaceutical Group Corp., jointly and severally, damages in the amount of One

Hundred Fifty Three Million Three Hundred Dollars ($153,300,000) plus attorneys’ fees in the

amount of $4,903,163.35, for a total judgment amount of One Hundred Fifty Eight Million Two

Hundred Three Thousand One Hundred Sixty Three Dollars and 35/100 ($158,203,163.35) with

post judgment interest thereon pursuant to 28 U.S.C. § 1961 nunc pro tunc to March 14, 2013; and

it is further

ORDERED, ADJUDGED AND DECREED, as follows:

1. Defendants, their officers, directors, agents, servants, employees, successors, assigns and

those persons acting in concert with them who receive actual notice of this injunction, are each

ENJOINED and RESTRAINED from agreeing, directly or indirectly, to fix the price or limit the

supply of vitamin C sold in the United States in violation of Section 1 of the Sherman Act, 15

U.S.C. § 1.

2. Any party may seek modification of this Order, at any time, by written motion and for

good cause based on changed circumstances or otherwise.

3. The Court shall retain jurisdiction to enforce this Order. In the event that any part of this

2

Case 1:06-md-01738-BMC-JO Document 816 Filed 12/30/13 Page 2 of 3 PageID #: 27587

A-144Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page151 of 191

Page 152: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

SECOND AMENDED JUDGMENT AND FINAL DECREE 06-MD-1738; 05-CV-0453

Order is violated by the parties named herein or other persons, Plaintiffs may, by motion with notice

to the attorneys for the defendants, apply for sanctions or other relief that may be appropriate.

4. Unless the Court grants an extension, the injunction will expire without further action

of the Court ten years from the date of its entry, or if timely appealed, ten years after the final order

of the highest-level appellate court.

Dated: Brooklyn, New York Douglas C. Palmer

December 30, 2013 Clerk of Court

by:

Michele Gapinski

Chief Deputy

3

Case 1:06-md-01738-BMC-JO Document 816 Filed 12/30/13 Page 3 of 3 PageID #: 27588

lly signed by Michele Gapinski n=Michele Gapinski

A-145Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page152 of 191

Page 153: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

A-146Case 1:06-md-01738-BMC-JO Document 835 Filed 02/12/14 Page 1of3 PagelD #: 27771

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK -------------------------------X

IN RE: VITAMIN C ANTITRUST LITIGATION

This document relates to:

ANIMAL SCIENCE PRODUCTS, INC., et al.,

Plaintiffs, v.

HEBEi WELCOME PHARMACEUTICAL CO. LTD., et al.,

Defendants.

-------------------------------X

TIDRD AMENDED JUDGMENT AND FINAL DECREE

MASTER FILE 06-MD-1738 (BMC) (JO)

05-CV-0453

The jury having rendered its verdict in this case in favor of plaintiff, The Ranis Company,

Inc., as representative of the Direct Purchaser Class, 1 in the amount of Fifty Four Million One

Hundred Thousand Dollars ($54,100,000.00), and in favor of plaintiff, Animal Science Products,

Inc., as representative of the Injunction Class;2 and the Court, upon motion of plaintiff having

directed entry of judgment upon trebling the damage award pursuant to 15 U.S.C. § 15(a), less Nine

Million Dollars ($9,000,000) received from former defendants; and the Court having entered its

1 The Direct Purchaser Damages Class consists of all personas or entities, or assignees of such persons or entities, who directly purchased vitamin C for delivery in the United States, other than pursuant to a contract containing an arbitration clause, from any of Defendants or their co­conspirators, other than Northeast Pharmaceutical (Group) Co. Ltd., from December 1, 2001 to June 30, 2006. Excluded from this class are governmental entities, defendants, their co­conspirators, and their respective subsidiaries or affiliates.

2 The Injunction Class consists of all persons or entities, or assignees of such persons or entities, who purchase vitamin C manufactured by Defendants for delivery in the United States, other than pursuant to a contract with a Defendant containing an arbitration clause, from December 1, 2001 to the present, requiring injunctive relief against Defendants to end Defendants anti1rust violations.

1

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page153 of 191

Page 154: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

A-147Case 1:06-md-01738-BMC-JO Document 835 Filed 02/12/14 Page 2 of 3 PagelD #: 27772

TIDRD AMENDED JUDGMENT AND FINAL DECREE 06-MD-1738; 05-CV-0453

Memorandum Decision and Order of November 26, 2013, granting the motion of the Injunctive

Class for a permanent injunction and the Court having entered its Decision and Order dated

December 30, 2013 awarding plaintiffs attorneys' fees in the amount of $4,903, 163 .35 and directing

the Clerk to enter a Second Amended Judgment and Final Decree adding said amount to plaintiffs'

recovery, with interest nunc pro tune to March 14, 2013; and a further Order of Honorable Brian

M. Cogan, United States District Judge, having been filed on February 12, 2014, granting the

motion for reconsideration; ordering that Plaintiffs have now belatedly made clear that the fees

award they requested was not to be paid to Class Counsel, but to the Direct Purchasers themselves;

directing that the full amount of each settlement will already be offset against the total damages

owed by Defendants, off-setting the portion of those settlements paid as fees to Class Counsel­

money already included in the settlement total- would be double counting; and further, directing the

Clerk of Court to enter a Third Amended Judgment and Final Decree in the amount of

$147,831,471.03 with interest nunc pro tune to March 14, 2013 it is hereby:

ORDERED, ADJUDGED AND DECREED, that The Ran.is Company, as class

representative, will take of defendants Hebei Welcome Phannaceutical Co., Ltd. and

North China Pharmaceutical Group Corp., jointly and severally, damages in the amount of One

Hundred Forty Seven Million Eight Hundred Thirty One Thousand Four Hundred Seventy One

Dollars and 03/100 ($14 7 ,831,4 71.03) with post judgment interest thereon pursuant to 28 U.S.C.

§ 1961 nunc pro tune to March 14, 2013; and it is further

ORDERED, ADJUDGED AND DECREED, as follows:

1. Defendants, their officers, directors, agents, servants, employees, successors, assigns and

those persons acting in concert with them who receive actual notice of this injunction, are each

2

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page154 of 191

Page 155: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

A-148Case 1:06-md-01738-BMC-JO Document 835 Filed 02/12/14 Page 3 of 3 PagelD #: 27773

TIDRD AMENDED JUDGMENT AND FINAL DECREE 06-MD-1738; 05-CV-0453

ENJOINED and RESTRAINED from agreeing, directly or indirectly, to fix the price or limit the

supply of vitamin C sold in the United States in violation of Section 1 of the Sherman Act, 15

U.S.C. § 1.

2. Any party may seek modification of this Order, at any time, by written motion and for

good cause based on changed circumstances or otherwise.

3. The Court shall retain jurisdiction to enforce this Order. In the event that any part of this

Order is violated by the parties named herein or other persons, Plaintiffs may, by motion with notice

to the attorneys for the defendants, apply for sanctions or other relief that may be appropriate.

4. Unless the Court grants an extension, the injunction will expire without further action

of the Court ten years from the date of its entry, or if timely appealed, ten years after the final order

of the highest-level appellate court.

Dated: Brooklyn, New York February 12, 2014

by:

3

Douglas C. Palmer Clerk of Court

Digitally signed by Michele Gapinski DN: cn=Mlchele Gapinski, ou=Federal Judiciary, a=US.Government, e=US

Michele Gapinski Chief Deputy

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page155 of 191

Page 156: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

A-149

TRANSPERFECT

City of New York, State of New York, County of New York

I, Caroline Mikumo Lee, hereby affirm that the following is to the best of my knowledge and belief, a true and accurate Translation from Chinese to English of the document "North China Pharmaceutical Group Corporation Website".

Caroline Mikumo Lee TransPerfect Translations International, Inc.

Sworn to before me this Tuesday, March 11, 2014

Sign.Z~ -...J":i:.IC~~-41'1---~-.-....'~-~

~RYA i ' ALEXANDER DROSl 1

Notary Publlc"Sta~ of New York I Nu. 01 DR6202048

Quellfled in NEW YORK County MyComm1ssion Expires MAY 21, 2016

Stamp. Notary Public

LANGUAGE AND TECHNOLOGY SOLUTIONS FOR GLOBAL BUSINESS

THREE PARK AVENUE, 39TH FLOOR, NEW YORK, NY 10016 I T 212.689.5555 I F 212.689.1059 I WWWTRANSPERFECT.COM

OFFICES IN 80 CITIES WORLDWIDE

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page156 of 191

Page 157: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

A-150Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page157 of 191

Page 158: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

A-151Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page158 of 191

Page 159: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

A-1522/19"2014

lilp:/Jwww.ncpc.cxm'imulim

.. ~ #~ ~~$~ M~*~ ~&~D4 ~m~~

:fl>:~-~

EN GUSH

$J!i•111•~M:IR*1¥J.ft~JJ!i:t-il-, ~:rl'iiI~t~fi'~li•~1P. tt:!if$jtJWBir :.lelj;I

RI "-1i." TI"i!IMJ'iU1¥rt~ftJ;i~. 1953~JHfM•Jt, 1958:¥6J.1Jl.lilt~f'. 7ft217ftai::kNt

~-1¥J.Ui.t.. j;j~~ll~~!J>ff~iiittlll7Ujitt,. 1992¥1Ulii!t:Il:$jt!Wal!'i~;ff

Pll*iil' l~UJ:rlf. 199~1J.I, $~ttiJiiliriE1-ta$!J~ll;ff4l!~HHiJ-$~t!Wi!;

•m;ffP!ljlt.fH}ii], W.Ali~Jl(7~~JLtt1¥i:Ir$!J. 2009:¥6~. Ql'iiJ~t11t~~m~. •lj;lftS•

lii~$~•W;rt(i70. $1$•1I'l~Jt.sooD:fl>::i&l¥J~rlff*'iJ·

$~*· $J9•WH~tJMf, aug. il1J7:ttj;:. !UfM~/l'tfffiJi, ~·Q~N'ttllt • .£ ~~H..,Mt~&!trll~frilff:ftiirJ~. ~012•~· $f!i#!OOiiff',~tli158£7G, ~I27.7~A.

-~~+$~~(~)*~·~f'&s~~~~.lilt~--~~tt*f!j~,~~a~f!j,

it!:EIUf#1itlUlr- 1'1J11!J51'-JAJ~700$1'-dU+. Blff:9'JS, flJ111J~ft*l¥1iii;rK~ g 1¥11!.liltti

~.~~-~fli•m7f~7n~m~~m1f..-~~~fli•m1¥Jfi•#.

ff~~-l!'l:

~**llll;.l;t.j!i4jgQ, ~U, .!ilitU.fUtflif#U, U~•Wf:!it~msoo*~*®~tt

~~GI:ft~fi.JIJ,fU !fl 1!1*1Jl.Jiilit:lll!.llt+4!i, %mM'.W~ldt~~ "16*~Am liil1t$h:fl>:

.:i&" , "aD•t.-IJ~" , "~mm.riu~:i& .. , ·i::iim+::kilA#r~lll!." , "~llMA:'f8.Jll

Mil" , "~~~hAfii~" , "~~-M~~~,fUil~lll!." , "~11-llk%t!~

.ft" ~*D-iJ. "~t" Jltitti~:tE~f!i.frilJil4iAjj!~i:f!llUM!lit5~ • .Ait <•w$1> lj;ll~Ui

:«ift~Ri,..z-.

*+tttt*

$1i.lllfl:j;Jll~*ii*t!!~~:fl>:il-,fUll* "863" ilUitt*if1tj:Jitt:t.IAU~f"'llk

~~.-:«-x~A~~lkti*A~~~. ~.£~~~nQ..@~~tt~.M;ffai*•~llktt

113

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page159 of 191

Page 160: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

A-1532/19"2014

lilp:/Jwww.ncpc.cxm'imulim

$~ttKf1•iil~lllljtff~iil

.;fttfi•tl, "ftfA$!t/711nfilff~if!·t..." , "~-f*$H$1Jll*ll~~9i~" , :JI! "m*Ottiilr

m~"- "m~~~~v~mtt~~6•~~m•~-"- "W~'4tt~~~

~"- "ftfA~~~~~~-£·~~~~~",ildf7"~--~~*~~

~,, , "iflligi3:.i1J~fmj.JU-~.illll-" , "11Jii:Ji~f"'~if~~~ti~" ~!llHHt:-iJ, ~

~1£1i~-~~ff·~-~···-~m••·~1t•SB.#ey···~#···~#··

••D·*•&n~••·•~~,£PO¥+*f+1"~.#1am~#m*£OO~s~,m*'4tt~~

~19J»i.

J:iftA:.ft*

~*•muo~•· giJ\.#tt~:w~tHt.fr~w•••• <TQM). •S£71Gfflf~BIJetA:

'lfil-f*~, ~tf!'J~~itlftltGMl';fi(~tM'r. 1fll'pgM-11f~J:AlfttitiBIJ!li&ta#. 1986~

1f~fin'H$'.ff "l!lUA:~" • 2000~ili:ltIS0900l!li&'lil.1*1'.iAiiE, 2003~ll1:lt

IS01400UfU:Ji-f*~Y.iiE. :fi5-t'Uf"ilr~l5*Uf'<dl~. 401'f'<dl1£'1fit~J:f'<dlAfiQ\,f~

'*'~· f!llltr, e~liFDA;>.iiE, dUCOSiiE~f'<dl231', 49af'tlltllJ:ltfifiiGMPiJ.iiE, ~

*lli1iGMPiiE 't5179if, ;E :tE Tti'lklltr11J.

~Rll&IG

*.*n~.$ff•m~~*~~w.~m~.~"A~••~J: • .Jtt;Jc~m-"BIJ~~

*~.itlft"~-~3:.~fi.re.ft71-•-•••B"BIJ&Ji~-.M~~-"=~;E",~

JR. "-.=2" ~~ (~~. ~20ll~ff~lOO.fZ..Ja1 $=1Ji, ~2013~Mffitk>dtsJ1J200

.fl..Ja, •=~· JJJ201s~-tJ~sOOfWC> , ~M~=flln~BIJ•~· ~~)!kJtiblt~ "M

n~. •~1161\t. *M•- ~it•~" 1¥1Ji$f!i, •i!t.i&~nm, it6~tt- ey~•1¥Jml"i~

~11tJt.-~BfJJJf.ftflltJfi#!!'ll.

ti: tij~l;~~l(S:iti-f(:~J&~~*·388.li}

111111: 050015

!iii: (0311)85993999

.ft.J(:: (0311)86672430

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page160 of 191

Page 161: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF NEW YORK

IN RE VITAMIN C ) ANTITRUST LITIGATION ) ECF Case ) This Document Relates to: ) Case No.: 1:06-md-01738-BMC-JO ) All Indirect-Purchaser Actions ) )

DECLARATION OF LIU RONGLIANG

I, Liu Rongliang, declare as follows:

1. I am the Deputy General Manager of Hebei Welcome Pharmaceutical Co. Ltd.

(“Hebei Welcome”) and have been with Hebei Welcome since June 2011. In this capacity, I

have the right to review the books, records, and operations of Hebei Welcome. I make this

declaration on the basis of my personal knowledge and my review of Hebei Welcome’s records.

2. Hebei Welcome currently has no assets in any state or territory of the United

States of America.

3. In particular, Hebei Welcome has not had accounts receivable in the U.S. since

January 2010.

4. I declare under penalty of perjury that the foregoing is true and correct to the best

of my knowledge.

In witness whereof, I have executed this declaration on this 17th day of April, 2014, by

signing or affixing my personal Chop.

[Liu Rongliang’s Signature]

Case 1:06-md-01738-BMC-JO Document 879-1 Filed 05/05/14 Page 2 of 4 PageID #: 28871

A-154Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page161 of 191

Page 162: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 879-1 Filed 05/05/14 Page 3 of 4 PageID #: 28872

A-155

,v~D Wilson Sonsini Goodrich & Rosati WV' PROl l 'i'ilONAl CORPORATION

Unit !901. .!'JJ.. To\\cr( . Bt:ijinf! Yim.u <:t..·mrt· No . .! J1.1U!!UOll1("1\W:1i A\"("llUt·

C.l1.K1y~11~ D 1Mric1. l\eiji11g 10001.?

l'n>pl<'> Repuhlic of Chin.i

itit1rnit.ni ~J11rn". mlilr J ~xm21; * ;t•t>.C:''1'f: ttiCJ'El91,i2901 ~ ilif>ifj:~f!}: I 00022

Certificate of Accuracy

l'llO!'ll 86-10.6)2'1-8 ICKI

rAX !!(>· I CJ.6~!11-IU'J'J www.wtgr.com

•l!. i.'i: 8(>- 10 ·6529-8.100 l'ili: 8(>· 1 0·6~2'1·8.l')')

1111 iii: www.wsgr.com

I, Ke Li, am fluent in Chinese and Engl ish and certify that the attached trans lation, w hich I have made, is a true and co rrect trans lation of the orig inal document.

I certify under penalty of perj ury under the laws of the United States of America that the foregoing is true and correct.

Executed on May 2, 20 14

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page162 of 191

Page 163: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 879-1 Filed 05/05/14 Page 4 of 4 PageID #: 28873

A-156

}.:+

-T~~J~.g.Affil±t!i, IR~~

fil!.~*IR

)

~il: /~:. % c Jj_~ Wf i/f i!~ ft!, T~ ~* tJE;t1Lf )

4. I J . • I I I . " · /'/ '· . • 1 ·1 l ).,: I':;

) ~14%: 1:06-md-01738-BMC-.JO ) )

, 11

.. l • J, ; , !~~1. ~1 ~ •11•

A A f 1 ··20 1 4 / 1:4JJJ7IJ'' 1 ~'°'' '. ,l~ o'('.f·/ "'·;'• .l' :'.J''•" '~~- J.· ·,l.·111 ] f>j~f,~· 1~1 1 1 1 / I').. l ' 1 - ~' ,,;-: f D.X.d tJtJj'l \ 111- J J \.,. n'f: -fl / j>. -' 1 ~ ' V.,A "!J.!. ~J _ ') 11

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page163 of 191

Page 164: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 879-2 Filed 05/05/14 Page 2 of 12 PageID #: 28875

A-157

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK

INRE VITAMIN C ANTITRUST LITIGATION

This Document Relates The Following Case:

• Animal Science Products, Inc., et al v. Hebei Welcome Pharmaceutical Co., Ltd., et al, Case No. 1:05-CV-00453 (DGT)(JO) (E.D.N.Y.)

Yang Jianfu hereby declares as follows:

MASTER FILE 1:06-MD-1738 (DGT)(JO)

DECLARATION OF

YANGJIANFU

IN SUPPORT OF MOTION OF

NORTH CHINA PHARMACEUTICAL GROUP CORP.

TO DISMISS THE COMPLAINT

1. I am the Deputy General Manager of North China Pharmaceutical Group

Corporation (hereinafter ''NCP Group Corp."), and have been with NCP Group Corp. since 1996.

In this capacity I have knowledge of the books, records, and operations of NCP Group Corp. I

have read the Second Amended Complaint in the above-captioned action and submit this

declaration in support ofNCP Group Corp.'s motion to dismiss.

2. My statements made in this declaration are based upon my personal knowledge,

my review of documents prepared and maintained by NCP Group Corp. in the ordinary course of

business, and upon information provided by NCP Group Corp. employees responsible for and

with knowledge of the business or accounting records ofNCP Group Corp.

CONFIDENTIAL AND LA WYERS ONLY

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page164 of 191

Page 165: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 879-2 Filed 05/05/14 Page 3 of 12 PageID #: 28876

A-158

3. NCP Group Corp. is an investment holding company, formerly known as North

China Phannaceutical Factory, organized in 1953 under the laws of the People's Republic of

China. Its one and only office is located at 388 Heping East Road, Shijiazhuang, Hebei, China.

4. NCP Group Corp. is owned by the State-Owned Assets Supervision and

Administration Commission of Hebei Province ("SASAC"). Although there are other minority

ownerships in NCP Group Corp., it is a state-owned company established under the laws of the

People's Republic of China.

5. NCP Group Corp. owns directly or indirectly predominant stakes in defendants

North China Pharmaceutical Co., Ltd. ("NCPC Limited") and in North China Pharmaceutical

Group International Trade Co., Ltd., (formerly known as North China Phannaceutical Group

Corporation Import and Export Trade Co., Ltd) ("NCPC I&E"). Although others own smaller

numbers of shares in these entities, the predominant stake is held by NCP Group Corp., and all

these entities are separate legal entities indirectly state-owned by SASAC.

6. Defendant NCPC Limited owns defendant Hebei Welcome Pharmaceutical Co.,

Ltd. ("Hebei Welcome"), in which it holds a majority share, although there are other owners with

minority interests, thereby making NCP Group Corp. an indirect owner in Hebei Welcome as

well.

7. In essence, NCP Group Corp. is an investment vehicle whereby SASAC holds

interest in a variety of corporate business entities. NCP Group Corp. itself does not engage in

the production, manufacture or sale of any products itself, leaving such activities to these various

separate corporate subsidiary entities.

8. Specifically as regards the various entities named as defendants in this litigation,

NCP Group Corp., NCPC I&E, NCPC Limited and Hebei Welcome are all separate legal entities,

CONFIDENTIAL AND LA WYERS ONLY 2

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page165 of 191

Page 166: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 879-2 Filed 05/05/14 Page 4 of 12 PageID #: 28877

A-159

.-··-..

each with its own corporate staff, management, officers and directors. Each functions separately

with separate responsibility for its day to day business activities. In particular, NCP Group Corp.

does not involve itself in the day to day activities of any of the three other entities, relating to

them solely .in the manner that a predominant shareholder normally relates to a subsidiary

corporation, observing all necessary corporate formalities and requirements. None of these

companies interjects itself in the day-to-day business of any other, and each maintains its own

separate records, assets and accounts.

9. Specifically as regards defendant Hebei Welcome, where NCP Group Corp. has

an indirect ownership interest, NCP Group Corp. relates ·to it only in the general way a

predominant shareholder would relate to a subsidiary, nominates directors of Hebei Welcome as

a shareholder would in accordance with applicable laws, but strictly maintains a corporate ·

separation. NCP Group Corp. does not participate in, control, manage, administer, coordinate, or

otherwise directly involve itself in any of Hebei Welcome's business decisions related to the

production, pricing, marketing, and sale ofHebei Welcome's Vitamin C products.

10. The officers of Hebei Welcome have been entirely separate and distinct from

those of NCP Group Corp., with the limited exception that the President ofHebei Welcome is

also an officer of NCP Group Corp. Prior to 2003, another individual was the General Manager

ofNCP Group Corp. and also a director of Hebei Welcome. However, these individuals have at

all times kept and performed their functions entirely separately, always acting solely in their

capacity with Hebei Welcome when involving themselves in the day to day business activities of

Hebei Welcome.

11. NCP Group Corp. has never been qualified, authorized or registered to do

business in New York, let alone anywhere else in the United States. NCP Group Corp. has never

CONFIDENTIAL AND.LA WYERS ONLY 3

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page166 of 191

Page 167: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 879-2 Filed 05/05/14 Page 5 of 12 PageID #: 28878

A-160

-: /

had or maintained a registered agent for service of process in New York, let alone anywhere else

in the United States.

12. NCP Group Corp. does not own or lease any real property in New York, let alone

anywhere else in the United States.

13. NCP Group Corp. does not have any offices, manufacturing plants, distribution

centers, facilities or any other place of business in New York, let alone anywhere else in the

United States. NCP Group Corp. has never maintained any inventory of products for sale in

New York, let alone anywhere else in the United States.

14. NCP Group Corp. does not have a bank account, post office box, a telephone

listing, a facsimile listi9g or electronic mail listing anywhere in New York, let alone anywhere

else in the United States.

15. To my knowledge, since January 1, 2000, no NCP Group Corp. employees have

made business travels to the United States to conduct manufacture, production, sale or marketing

of vitamin C. Only few people made isolated trips to the United States on unrelated matters~

16. NCP Group Corp. has never filed, nor been required to file, any income tax

returns or filings in New York or anywhere else in the United States.

17. NCP Group Corp. has never commenced any lawsuit in any court in New York or

anywhere else in the United States. Indeed, the only litigation in which it is involved is the

instant case.

18. NCP Group Corp. has never directly sold, solicited sales of, or marketed any

vitamin C products in New York or anywhere else in the United States.

CONFIDENTIAL AND LA WYERS ONLY 4

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page167 of 191

Page 168: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 879-2 Filed 05/05/14 Page 6 of 12 PageID #: 28879

A-161

19. NCP Group Corp. has not entered into any business contracts with any resident or

business located in New York or anywhere else in the United States or conducted any regular

commercial business in New York or anywhere else in the United States.

20. Specifically as regards the allegations in the Second Amended Complaint, NCP

Group Corp~ has never participated in any meeting of the Western Medicine Department of the

Association of Importers and Exporters of Medicines and Health Products of China as alleged

therein, nor has it participated in any conspiracy as alleged therein. Without limiting the

foregoing, no NCP Group Corp. agent, officer or employee has ever participated in that capacity

in any meeting as alleged in paragraphs 49, 52-54 or 60-62 of the Second Amended Complaint.

No one from NCP Group Corp., including specifically the sole person in NCP Group Corp. who

has also held an officer position in Hebei Welcome since 2003, has ever been elected Vice

President of a subcommittee as alleged in paragraph 54.

21. I declare under penalty of perjury under the laws of the United States of America

that the foregoing is true and correct to the best of my knowledge.

In witness whereof, I have executed this declaration on this 11th day of April, 2008, by

signing or affixing my personal Chop.

[Yang Jianfu's signature]

CONFIDENTIAL AND LA WYERS ONLY 5

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page168 of 191

Page 169: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 879-2 Filed 05/05/14 Page 7 of 12 PageID #: 28880

A-162

.PIE~t;JiOliJlmnM;:itf I -Ii} ai!J!j;:Lt I !US ~ 11!~~-il} . 100004

35/F, China World Tower l No. 1, Jian Guo Men Wai Avenue Beijing 100004, PRC

"jj' it. ~* ffr1l $. $1 ?if

F ANGDA PARTNERS J:l!i Shanghai • :!t'Jl( Beijing • tm Shenzhen

http://www.l!ngdlllaw.com

il!'f-.ifl' E·mail: ema!l@fengdalawcom il! ifi Toi.: 86-I0-6SOS-SSS7 it Jt Fax: 86-10-6SOS-8997 :t -I} Ref.: 07DR028

Certificate of Accuracy

I, Wang Xiaomeng, am fluent in Chinese and English and certify that the attached translation which l have made is a true and correct translation of the original document.

I certify under penalty of perjury under the laws of the United States of America that the foregoing is true and correct.

Executed onApril 14, 2008

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page169 of 191

Page 170: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 879-2 Filed 05/05/14 Page 8 of 12 PageID #: 28881

A-163

~ltllUi~f&IK·mWG m~*TK

~~ tt4:~ c &~lfiWi'~

* :iC f tf~JIFf W-r ;t11f:

• F;!Jfl!J#~/tfJJlrz1."ffJ~A Viliifjtiflff<Jiirti/ !!i1f/lliz}·iii}~,A, ~#~: 1:05-CV-

.. ---- ----00453(DGT)(JO) (E.D.N.Y.) -

CONFIDENTIAL AND LA WYERS ONLY

iiJ1*.tiJ~ 1:06-MD-1738 (DGT)(JO)

~~m

:J-ix*$~tft!J~~m:ff~iJfff0ii.1~@1~ i)f ~Z;IJi-.Sl.1¥J :?5 IYJ ·~

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page170 of 191

Page 171: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 879-2 Filed 05/05/14 Page 9 of 12 PageID #: 28882

A-164

3. ft! !'ii~ Iii* ~ ~ - ~ r,t ti ff. mu~ J;] ' 'ft(;jf.!} i:p if-A f\; ~~D ~ Y*W PX..ll:-f- 1953

{f. • ~ lltr 3l Ji: f~ it*"~ r · • Jt fi _u ix n- -:?.t 1:H-~ J:~1 Nr . 1~ -r- r.p kfil ~iiJ it~, 1:1:~ 1-1m.flJ1¥ * ~ 388~.

4. ~!1:i~OO~'RJ:JiJfnJit~'IE:fr~P':illr'li'jg;:JJR~m~ ( "IE~~" ) Jijfff. !i~

Ja!fi'&it~~~~HJ'.JJJiffi-:*J;Jtftl?.A:i':i'ff. :1~1'1~1il£1~tf& i:p:t~ A ~j:t~ll !Ei*tf /JX.ll:a<J IE ff

5.

fil" ) fiH~it\M~~rn ~ !ftF'ffl ~ff l\lQ -2 iiJ < :!t rrir 51 /g <r:dtfu1JFJ~lll:itt w P 'Fi. ?JJ'ff ~~Ja1f0

'a'J ) c " i~!'iiitt 1:11 P " ) ~ff ::t tlidt:il! ffi: l'fJ H!HX. " ki ~if fHt!!.A :Fr ff :iS: ~ 1' ~ f<iq'f~ , 5.i {f! Fi

~ ffi1} 'ii.J ;ffi X>J" ~it*li ~!&& B<J /Nill' , :<~ ~1 tU ltl 0 ;;'] .#.f f'l. ~ fff31' 0 ·ciJ A f-f 3t ~~ft!! W: 8~ I& tx. .

Jiffff~®~1*·-~-~~-~~~~~#~~~A.

6. ~15-rilJ~t~~''**1JI14:ff PR i~ GJ < "1nr ~t~ft /f\fflt" ) :1i1 *1St ~:ff !'4 HQ:f~} JiJT1r. £n.

~ff 9>ii:fli;f;}(.;}91t.ftltA.WTff' {IJ.1¥i ~ JNf)f # 1HiiJ ~t tiHKJM a~$ J&JRtt' Mm} 1! fij.$! ~~ m

£-fiJ fflt/9m~trl~:.~Ffll ~m mf1 ~"

7. ~ISl'F I., i~ ~ tR !~ 0 -BJ ;;If: Ii lli .~{~ l;J. tr:~ "i'" iffl ~IV. 0·ti'J~1-* i:p ~~ff ~J.ful '(t1 :ti~

IA. :f:~~j~III 0 ii'J *51 ff~ JA·~-ff: {ilJ -,..·c it'1t'f.J 1JJ•'., fhtlifu.EOC r~ {!}. mi· :;'i::J~~ ®¥fi #J~ rn ~

l'~!h:llff.JT~ iJJ ~1*illfr Q

8. Ai*~T-:tE*=iffi'~ 41 :tJ9:f1J /;i-Mz.15-8~ .e--t-~11>-ff!~Jtk: !fl i~ flJ, Jf'.!F:i3t!:lli

Cl, f~~JN:ffi'~7"J~t~$/ji=m~M.t:\.l.(f.J¥1;A3k1*· rt1fJ-e- 81 tf .(j. g !'.fJ0 iIJ h~ I, "Et;J£ffi,

ft•A~~••.&1-*~•n~ilitr. •~~.e-~~B~~~m~mmo~m£~fi•

ffl0'~*~ tf:~~*~jU§J~r -1'3k1*r+1 f-f-·1"8~ El ~r;rfii;l] r:f, EirtifJZ.f1'l] a<J~~ fX 1X~

2

CONFIDENTIAL AND LA WYERS ONLY

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page171 of 191

Page 172: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 879-2 Filed 05/05/14 Page 10 of 12 PageID #: 28883

A-165Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page172 of 191

Page 173: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 879-2 Filed 05/05/14 Page 11 of 12 PageID #: 28884

A-166Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page173 of 191

Page 174: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 879-2 Filed 05/05/14 Page 12 of 12 PageID #: 28885

A-167Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page174 of 191

Page 175: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

1301 Avenue of the Americas, 40th FloorNew York, NY 10019-6022

PHONE 212.999.5800FAX 212.999.5899www.wsgr.com

AUSTIN BEIJING BRUSSELS GEORGETOWN, DE HONG KONG LOS ANGELES NEW YORKPALO ALTO SAN DIEGO SAN FRANCISCO SEATTLE SHANGHAI WASHINGTON, DC

May 9, 2014

Via CM/ECF

The Honorable Brian M. CoganUnited States District JudgeEastern District of New York225 Cadman Plaza EastBrooklyn, New York 11201

Re: In re Vitamin C Antitrust Litigation, 06-MD-1738 (E.D.N.Y.)

Dear Judge Cogan:

I write on behalf of Defendants Hebei Welcome Pharmaceutical Co., Ltd. (“HebeiWelcome”) and North China Pharmaceutical Group Corp. (“NCPG,” collectively, “Defendants”) torequest leave to file the enclosed Declaration of Zhang Wencheng as further support for Defendants’Memorandum in Opposition to Plaintiffs’ Motion for Leave to Register the Judgment Pursuant to 28U.S.C. § 1963. See Dkt. 879. Mr. Zhang’s declaration confirms that NCPG does not have and hasnever had any assets in any state or territory of the United States. See Zhang Decl. ¶ 4. Filing of thisdeclaration was delayed due to NCPG’s need to obtain approval of this declaration from the Hebeiprovincial government, which had not been granted as of the May 5, 2014 filing deadline. See Dkt.879 at 2 n.2. Plaintiffs will suffer no prejudice from this filing as it simply confirms that nothing haschanged between the 2008 Declaration of Yang Jianfu and today. See Dkt. 879-2 ¶¶ 11-19.Defendants therefore respectfully request that the Court allow filing of the enclosed declaration andconsider it in connection with its resolution of Plaintiffs’ Motion for Leave to Register the Judgment,Dkt. 859.

Respectfully,

WILSON SONSINI GOODRICH & ROSATIProfessional Corporation

s/ Daniel P. Weick

Daniel P. Weick

Attorneys for Defendants Hebei WelcomePharmaceutical Co., Ltd. and North ChinaPharmaceutical Group Corp.

Enclosure

Cc: All counsel of record (via CM/ECF)

Case 1:06-md-01738-BMC-JO Document 883 Filed 05/09/14 Page 1 of 1 PageID #: 28892

A-168Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page175 of 191

Page 176: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF NEW YORK

IN RE VITAMIN C ) ANTITRUST LITIGATION ) ECF Case ) ) Case No.: 1:06-md-01738-BMC-JO ) ) )

DECLARATION OF ZHANG WENCHENG

I, Zhang Wencheng, declare as follows:

1. I am the Deputy Chief Accountant of North China Pharmaceutical Group

Corporation (“NCPG”). In this capacity, I have the right to review the books, records, and

operations of NCPG. I make this declaration on the basis of my personal knowledge and my

review of NCPG’s records.

2. NCPG is organized as a state-owned company under the laws of the People’s

Republic of China. It is under the indirect ownership of the State-Owned Assets Supervision and

Administration Commission of the Hebei Province (“SASAC”), subject to its supervision and

management, and operates as a subsidiary of Jizhong Energy Group Co., Ltd., which itself is

wholly-owned by the SASAC.

3. NCPG has never transacted any business in relation to the current antitrust

litigations in any state or territory of the United States of America.

4. NCPG currently has no assets in any state or territory of the United States of

America and has never had assets in the U.S.

5. I declare under penalty of perjury that the foregoing is true and correct to the best

of my knowledge.

Case 1:06-md-01738-BMC-JO Document 883-1 Filed 05/09/14 Page 1 of 4 PageID #: 28893

A-169Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page176 of 191

Page 177: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

2

In witness whereof, I have executed this declaration on this 30th day of April, 2014, by

signing or affixing my personal Chop.

[Zhang Wencheng’s Signature]

Case 1:06-md-01738-BMC-JO Document 883-1 Filed 05/09/14 Page 2 of 4 PageID #: 28894

A-170Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page177 of 191

Page 178: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 883-1 Filed 05/09/14 Page 3 of 4 PageID #: 28895

A-171

,v1'-.D Wilson Sonsini Goodrich & Rosati W'tJ-1'- PRO J ESSIONAI CORPORATION

l init l9UI. .!'JI'. T 11WL' r C n .. ·iii n~ Yi111.1i Cl·1111·l' No.2 J1.1n~uo11h:11w.ii J\\'t'l\lll'

(:h:my:.111~ f )iMri<.·t . B(•iji ng 10002.! l'wplc\ lkpuhlic of Chiu"

'1 1ti;iJt,;0:11;MJ'H(}( m1<1n11-xm2 ~ 11u;rJ•.C:7i'i'HiCl'l\2?l.42901 ~ ~l.i:ftll'I: I 00022

Certificate of Accuracy

l'llO NI 8(1- I0-6i l'l-8JOll

rAX 86-I0-6 ' 2'1-8.19') www.~gr.com

1(! iii : ff(>- I 0-652'l-H300

{I( (( : 86- I 0 -M:!'l-S_l•J•J

l•H~: www.w.gr.com

I, Ke Li, am fluent in C hinese and English and certify that the attached trans lation, which I have made, is a true and correct trans lation of the original document.

1 certify under penalty of perjury under the laws of the United States of America that the foregoing is true and correct.

Executed on May 9, 2014

Ke i, Esq.

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page178 of 191

Page 179: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 883-1 Filed 05/09/14 Page 4 of 4 PageID #: 28896

A-172

T-~~J ~it~ E!ll ~.~HI!! IR)<! Wt m~*IR

~T- ) ~!'IE==-'E=--f{;:i....;c"'"""&"""'?!~lfi ......... YF-=l't}..__ _____ _,l ~ 7~~lUJf~f4

4 A. ~lot~, fi't! W J!o "F ;;:~rn)j :

) ) ;l#-~ : 1:06-md-01738-BMC-JO ) )

1. *A~$-ltlti1J~1 ~:W-l!R:lftff0E'l <··~£<iml2fl") r:~1m1J.~~it-~ifi . tF'1~J,~

i~ ~1-~rli, ,.fi:A fi .f.X 7 M~l~ ~1¥.J•M , iC."* i;A&ilii'F . -*;.traA~T--*A 7 Ml¥Jf~ .~. !;A&

2. .1¥i i~m 1~1J:i1::--*·ftH'l 9 , $A~ Jt:;f:O oo ~wm it! 1¥J iE 1:I 1E~ . M ¥t i:p ~~m!M! Iii

fHftJIH E i; fiJ O•riiiJ Jt ~-A R. ~ Rl ~ ~Hffl 1=I ) l¥J ~ f1Ff 0 E'J • ~~.It~ A~ J&Rl (BJ~ ffll

f~J .

4. ~!ti~~ IJ Htr i£ ~ ~1J ~ ~ .~d~ rt-1flfiiJ1'1i !!lit!! 18: :l1J ;t Wi F .

5. M f~.tW 1i 'fl ~~ijUJll¥J ~}i'. I *APUJJ' 8Jt~A.fl.fi~il' iitri!~ ~JeJt~im

rtlnvo (l<J .

4:At:'.-f 20 14 {f:'. 4 fJ 30 B IV-~*~.i!;ft.t!/i~~:lf-*Jl:l'DJL i;Ami.iEa~ .

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page179 of 191

Page 180: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

People’s Republic of China Enterprise Property Rights Registration Certificate

for State-owned Assets

According to the Administrative Measures for Property Rights Registration for the State-owned Assets (the Central People’s Government of the People’s Republic of China No. 192 Order)

through examination and review, it is hereby agreed that

North China Pharmaceutical Group Corporation

( )

is entitled to the possession and use of the state-owned assets of RMB649,497,000, and responsible for maintenance and increase in value of such assets.

State-owned Assets Supervision and State-owned Assets Supervision and Administration Commission of the State Administration Commission of the Council (Seal) People’s Government of Hebei Province (Seal)

Issuance Date: August 9, 2005

Note: The name of this enterprise and the amount of the state-owned assets possessed and used by such enterprise should conform to such information as specified in the latest property rights registration.

Case 1:06-md-01738-BMC-JO Document 886-1 Filed 05/09/14 Page 2 of 147 PageID #: 28944

A-173Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page180 of 191

Page 181: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

-2-

Enterprise Group or Enterprise Management Department

State-owned Assets Supervision andAdministration Commission of the People’s Government of Hebei Province

Legal Representative WANG Sheping Approved Establishment Date

December 29, 1995

Organizational Form Wholly State-Owned Registration Date January 1, 1996

Registration No. 1300001000197 Registration Assets RMB662,300,000

Enterprise Unified Code

10436196-x

RMB000’

Paid-in

Capital

State-owned Capital 649,497

Legal Person Capital

In the Legal Person Capital: the State-owned Legal Person Capital

Foreign Capital

Individual Capital

Total 649,497

Responsible Person: Verifier: Approver: KANG Jiuyong (Seal) ZHANG Zhigeng (Seal) GAO Yongshen (Seal)

August 9, 2005 August 9, 2005 August 9, 2005

Case 1:06-md-01738-BMC-JO Document 886-1 Filed 05/09/14 Page 3 of 147 PageID #: 28945

A-174Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page181 of 191

Page 182: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

-3-

Second Change of Investors

No. Name of Investor Address (Administrative Division Code)

Organizational Form (Code)

Industry Classification (Code)

Investment Amount (RMB000’)

Equity Ratio (%)

1 State-owned Assets Supervision andAdministration Commission of the People’s Government of Hebei Province(

)

130104 3200 9490 1,137,647 84.55

2 China Construction Bank Corporation (

)

110101 2121 6820 110,000 8.17

3 China Huarong Asset Management Co., Ltd.(

)

110101 2252 7190 98,000 7.28

4

5

6

7

8

9

10

11

12

Case 1:06-md-01738-BMC-JO Document 886-1 Filed 05/09/14 Page 4 of 147 PageID #: 28946

A-175Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page182 of 191

Page 183: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

-4-

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

Case 1:06-md-01738-BMC-JO Document 886-1 Filed 05/09/14 Page 5 of 147 PageID #: 28947

A-176Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page183 of 191

Page 184: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

-5-

37

38

39

40

41

42

43

44

45

46

47

48

49

50

Total ***** ***** ***** 1,345,647 100

Responsible Person: (Property Right Registration Special Seal by State-owned KANG Jiuyong (Seal) Assets Supervision and Administration Commission of the People’s Government of Hebei Province)

January 17, 2008

Case 1:06-md-01738-BMC-JO Document 886-1 Filed 05/09/14 Page 6 of 147 PageID #: 28948

A-177Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page184 of 191

Page 185: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

-6-

Third Change of Investors

No. Name of Investor Address (Administrative Division Code)

Organizational Form (Code)

Industry Classification (Code)

Investment Amount(RMB000’)

Equity Ratio (%)

1 Jizhong Energy Group Co., Ltd.(

)

130503 1213 0610 1,345,647 100

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

Case 1:06-md-01738-BMC-JO Document 886-1 Filed 05/09/14 Page 7 of 147 PageID #: 28949

A-178Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page185 of 191

Page 186: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

-7-

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

39

40

41

42

Case 1:06-md-01738-BMC-JO Document 886-1 Filed 05/09/14 Page 8 of 147 PageID #: 28950

A-179Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page186 of 191

Page 187: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

-8-

43

44

45

46

47

48

49

50

Total ***** ***** ***** 1,345,647 100

Responsible Person: (Property Right Registration Special Seal by State-owned KANG Jiuyong (Seal) Assets Supervision and Administration Commission of the People’s Government of Hebei Province)

September 22, 2009

Case 1:06-md-01738-BMC-JO Document 886-1 Filed 05/09/14 Page 9 of 147 PageID #: 28951

A-180Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page187 of 191

Page 188: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 886-1 Filed 05/09/14 Page 10 of 147 PageID #: 28952

A-181

,v~D Wilson Sonsini Goodrich & Rosati W'(rl'- f>Rt) I l.~'dl)i" 1\I. ( ORPOR1\ -l 1l) .-,;

llnic 2901. 291'. Tt)wcr C: lll'ijing Yi11f.1i C1.:111rc i'\o.2 j iJnguom('nwai Av ... ·nue Cli:wy:111g, Ui.11trict. LJdjing 1000:!2 Pe11plc'~ Rcpuhlk uf(:J1i11J

l'llONE 86-10-(>529-8300 eAX 86-10-6529-ll.\99 WWW.\.VSgr.com

<1•tE1 -1tn:mwim1<-&:l'lf 191-xlli2~- tl!ir'i: sr..10-6;29.inoo

~4' 1 f'•C.•1:J'i'tliCl'l~29Q2901 ~ 11/A: Rl\-10-6529-11399 Jlt:ll:H1tH11: 100022 Mir\': www.wsgr.com

Certificate of Accuracy

I, Ke Li, am fluent in Chinese and English and certify that the attached translation, which I have made, is a true and correct translation of the original document.

I cenify under penalty of perjury under the laws of the United States of America that the foregoing is true and correct.

Executed on May 5. 20 14

Ke L', Esq.

Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page188 of 191

Page 189: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Cas

e 1:

06-m

d-01

738-

BM

C-J

O

Doc

umen

t 886

-1

File

d 05

/09/

14

Pag

e 11

of 1

47 P

ageI

D #

: 2

8953

A-182Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page189 of 191

Page 190: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Cas

e 1:

06-m

d-01

738-

BM

C-J

O

Doc

umen

t 886

-1

File

d 05

/09/

14

Pag

e 12

of 1

47 P

ageI

D #

: 2

8954

A-183Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page190 of 191

Page 191: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Cas

e 1:

06-m

d-01

738-

BM

C-J

O

Doc

umen

t 886

-1

File

d 05

/09/

14

Pag

e 13

of 1

47 P

ageI

D #

: 2

8955

A-184Case 14-4375, Document 60-1, 01/16/2015, 1418253, Page191 of 191

Page 192: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 886-1 Filed 05/09/14 Page 15 of 147 PageID #: 28957

A-185Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page1 of 44

Page 193: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

» Print

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to colleagues, clients orcustomers, use the Reprints tool at the top of any article or visit: www.reutersreprints.com.

North China Pharmaceutical completes privateplacementThu, Apr 10 2014

North China Pharmaceutical Co Ltd:Completed issuance of 252,227,171 shares at 4.49 yuan per share, to Jizhong Energy GroupCo., Ltd. through private placement.Raised 1,132,499,997.79 yuan in total through the private placement.Says Jizhong EnergyGroup is holding 36.93 pct stake (602,227,171 shares) in the company up from 25.39 pct stake (350,000,000 shares), and NorthChina Pharmaceutical Group Corp. is holding 17.58 pct (286,770,678 shares) down from 20.80 pct (286,770,678 shares).

© Thomson Reuters 2010. All rights reserved. Users may download and print extracts of content from this website for their ownpersonal and non-commercial use only. Republication or redistribution of Thomson Reuters content, including by framing or similarmeans, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters and its logo are registeredtrademarks or trademarks of the Thomson Reuters group of companies around the world.Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevantinterests.This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to colleagues, clients orcustomers, use the Reprints tool at the top of any article or visit: www.reutersreprints.com.

Business & Financial News, Breaking US & International News | Reuters.com http://www.reuters.com/assets/sdPrint?aid=2965326&ticker=600812.SS...

1 of 1 5/5/2014 2:36 PM

Case 1:06-md-01738-BMC-JO Document 886-1 Filed 05/09/14 Page 133 of 147 PageID #: 29075

A-186Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page2 of 44

Page 194: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

» Print

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to colleagues, clients orcustomers, use the Reprints tool at the top of any article or visit: www.reutersreprints.com.

North China Pharmaceutical announces no dividendpayment for FY 2013Fri, Apr 25 2014

North China Pharmaceutical Co Ltd:To pay no dividend to shareholders for the fiscal year 2013.

© Thomson Reuters 2010. All rights reserved. Users may download and print extracts of content from this website for their ownpersonal and non-commercial use only. Republication or redistribution of Thomson Reuters content, including by framing or similarmeans, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters and its logo are registeredtrademarks or trademarks of the Thomson Reuters group of companies around the world.Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevantinterests.This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to colleagues, clients orcustomers, use the Reprints tool at the top of any article or visit: www.reutersreprints.com.

Business & Financial News, Breaking US & International News | Reuters.com http://www.reuters.com/assets/sdPrint?aid=2974962&ticker=600812.SS...

1 of 1 5/5/2014 2:37 PM

Case 1:06-md-01738-BMC-JO Document 886-1 Filed 05/09/14 Page 135 of 147 PageID #: 29077

A-187Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page3 of 44

Page 195: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Catalogue for the Guidance of Foreign Investment Industries (Amended in 2011)

February 21, 2012 - 14:51 BJT (19:51 GMT) MOFCOM

Catalogue of Encouraged Foreign Investment Industries

I. Farming, Forestry, Animal Husbandry and Fishery Industries

(1) Planting, development and production of woody edible oil, ingredient and industrial raw material

(2) Cultivation technologies development and production of green and organic vegetables (including edible fungus, watermelon and melon),

dried and fresh fruits and tea

(3) New technology development and production of sugar-yielding crops, fruit trees, forage grass

(4) Production of flowers and plants, and construction and operation of nursery base

(5) Planting of rubber, oil palm, sisals and coffees

(6) Cultivation of traditional Chinese medicines (limited to equity joint venture and contractual joint venture)

(7) Reusing in fields and comprehensive utilization of straws and stalks of crop, development and production of resources of organic fertilizers

(8) Planting of forest trees (including bamboo) and cultivation of fine strains of forest trees and cultivation of new breed varieties of polyploid

trees

(9) Breeding of aquatic offspring (excluding precious quality varieties peculiar to China)

(10) Construction and operation of ecological environment protection projects preventing and treating desertification and soil erosion such as

planting trees and grasses, etc.

(11) Breeding of aquatic products, cage culture in deep water, large-scale breeding of aquatic products and breeding of eco-ocean products

II. Mining and Quarrying Industries

(1) Prospecting, exploitation and utilization of coal-bed gas (limited to equity joint venture and contractual joint venture)

(2) Venture prospecting and exploitation of petroleum, natural gas (limited to equity joint venture and contractual joint venture)

(3) Exploitation of oil and gas deposits (fields) with low osmosis (limited to equity joint venture and contractual joint venture)

(4) Development and application of new technologies that can increase the recovery factor of crude oil (limited to equity joint venture and

contractual joint venture)

(5) Development and application of new technologies for prospecting and exploitation of petroleum, such as geophysical prospecting, well

drilling, well-logging and downhole operation, etc. (limited to equity joint venture and contractual joint venture)

(6) Prospecting and exploitation of such conventional oil resources as oil shale, oil sand, heavy oil and super heavy oil(limited to equity joint

venture and contractual joint venture)

(7) Prospecting, exploitation, and beneficiation of iron ores and manganese ores

(8) Development and application of new technologies for improving the utilization of tailings and the comprehensive utilization of recovery

technology of the mine ecology

(9) Prospecting and exploitation of unconventional natural gas resources such as shale gas and submarine natural gas hydrate (limited to

equity joint venture and contractual joint venture)

III. Manufacturing Industries 1. Farm Products Processing Industry

(1) Development and production of biology feeds, straws and stalks feeds and aquatic feeds

(2) Aquatic products processing, seashell products cleansing and processing, and development of function food made from seaweed

(3) Processing of vegetables, dried and fresh fruits, fowl and livestock products

News

Significant News

Spokesperson's Remarks

Press Conference

From Counselor's Office

Policies

Annoucement

Policy Interpretation

Gazette

Statistics

Brief Statistics

Foreign Investment

Foreign Trade Cooperation

Regional Trade Statistics

Import and Export Indicators

Services

Tax Law

Int'l Labor CooperationCompanies

List of China's QualifiedOverseas Contractors

China-New Zealand IdentifiedRecruitment Agents

Supply & Demand

Inquiry & Answer

Home > Policies > Foreign InvestmentAdministration

MINISTRY OF COMMERCEPEOPLE’S REPUBLIC OF CHINA

HomeNewsPoliciesTopicsStatisticsServicesPhoto Gallery

Search

Mon.5/5/2014

Other languages

Page 1 of 17Catalogue for the Guidance of Foreign Investment Industries (Amended in 2011) -

5/5/2014http://english.mofcom.gov.cn/article/policyrelease/aaa/201203/20120308027837.shtml

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 2 of 86 PageID #: 29091

A-188Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page4 of 44

Page 196: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

2. Food Manufacturing Industry

(1) Development and production of fond for babies and agedness, as well as health-care food

(2) Development and production of forest food

(3) Production of natural addictive for foodstuff and food ingredients

3. Drinks Manufacturing Industry

(1) Development and production of drinks of fruits, vegetables, albumen, tea, coffee and vegetables

4. Tobacco Processing Industry

(1) Production of secondary cellulose acetate and processing of tows (limited to equity joint venture and contractual joint venture)

5. Textile Industry

(1) Production of multifunctional textiles of lightweight, high-intensity, thermostability, cold-endurance, chemical-resistance and light fastness for

industrial use made with non-woven, machine knitting, knitting, and combined technologies

(2) Weaving and dyeing as well as post dressing of high-grade loomage face fabric made with advanced technologies and equipment of

energy-saving and emission reduction

(3) Processing of special natural fiber products satisfying the requirement of comprehensive utilization of ecology and resources and

environment protection (including animal fiber, fibrilia, silk and colored cotton such as cashmere)

(4) Production of clothes with computer integrated manufacturing system

(5) Production of functional, environment-friendly and special clothes

(6) Production of top-grade carpet, embroider and drawnwork product

6. Leather, Coat and Feather (Down and Feather) Products Industry

(1) Cleaning processing of leather and fur

(2) Post ornament and processing of leather with new technology

(3) Top-grade leather processing

(4) Comprehensive use of leather waste

7. Lumber Processing Industry and Wood Bamboo, Bine, Palm, Grass Products Industry

(1) Development and production of new technology and products for the comprehensive utilization of "sub-quality, small wood and fuel wood"

and bamboo in the forest area

8. Paper Making and Paper Products Industry

(1) Production of chemical wood pulp with an annual production capacity of over 300 thousand tons by a single production line, chemical

mechanical wood pulp with an annual production capacity of over 100 thousand tons by a single production line and concurrent high-end paper

and paperboard production mainly with overseas lumber resources

9. Petroleum Refining and Coking, Nuclear Fuel Processing Industry

(1) Deep processing of needle coke and coal tar

10. Chemical Raw Material and Products Manufacturing Industry

(1) Development and production of new-type downstream products of sodium-process bleaching powder, polyvinyl chloride and organosilicon

(2) Production of supporting raw materials for synthesized materials: production of propylene oxide by epoxidation of propylene with hydrogen

peroxide, epoxy chloropropane from glycerol, NDC and CHDM

(3) Production of synthetic fibre raw materials: precision terephthalic acid, vinyl cyanide, caprolactam, nylon 66 salt and polyurethane elastic

fiber and 1, 3-propanediol

(4) Production of synthetic rubber: liquid butadiene styrene rubber by butadiene method(excluding styrene-butadiene rubber), high cis-1, 4-

polybutadiene rubber, butyl rubber, isoamyl rubber, polyurethane rubber, acrylic rubber, chlorophydrin rubber, ethylene-propylene-rubber,

fluororubber, silicon rubber and other special rubber production)

(5) Production of engineering plastics and plastic alloys: PC with an annual production capacity of over 60 thousand tons, POM, polyamide

(nylon 6, nylon 66, nylon 11 and nylon 12), EVA, polyphenylene sulfide, PEEK, polyimide, polysulfone, polyether sulphone, PAR, liquid crystal

polymer and other products

(6) Fine chemistry industry: new products and technology for catalytic agent; processing technology for the commercialization of dye (pigment);

production of high-tech chemicals for electronics and paper-making, food additives, feed additives, leather chemical products (excluding N,N-

dimethylformamide), oil-well auxiliaries, surface active agent, water treatment agent, adhesivcs, inorganic fibre, inorganic nanomaterial

production and deep processing of pigment encapsulation.

(7) Production of environment-friendly printing ink and environment-friendly arene-oil

(8) Production of nature spices, synthetic spices and single ion spices

(9) Production of high capability coatings, water automotive coatings and assorted water resin

(10) Production of chlorofluorocarbon substitution

(11) Production of fluororesin, fluorine film materials, fluorine-containing intermediate products for medical use, environment-friendly cryogen

Page 2 of 17Catalogue for the Guidance of Foreign Investment Industries (Amended in 2011) -

5/5/2014http://english.mofcom.gov.cn/article/policyrelease/aaa/201203/20120308027837.shtml

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 3 of 86 PageID #: 29092

A-189Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page5 of 44

Page 197: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

and detergent

(12) Production of fluorine recycling from phosphorus chemicals and aluminum smelting

(13) Development and production of new technology and products for the forestry chemicals

(14) Development and production of inorganic, organic and biologic films for environment protection

(15) Development and production of new-type fertilizer: biologic fertilizer, high-density fertilizer, compound fertilizer, controlled release fertilizer,

compound microbial inoculant, Compound microbial manure, degradation agent for stalks and garbage and microbial preparation of special

functions

(16) Development and production of effective, safe and environment-friendly new varieties, new formulations, special-purpose intermediates

and accessory ingredients of pesticides; and development and application of relevant clean production processing (methylene technology for

producing acetochlor, method for paraquat by ammoniacal cyanide process, aqueous phase synthesis of chlorpyrifos, recycling chloromethane

during production of glyphosate, production of oriented synthesis chiral pesticides and cubic pesticides, and synthesis technology for diethyl

thiophosphoryl chloride)

(17) Development and production of biopesticide and bio-control products: microbial insecticide, microbial fungicide, agricultural antibiotic,

insect pheromone, enemy insect and microbial herbicide

(18) Comprehensive utilization and disposal of exhaust gas, discharge liquid, waste residue

(19) Production of organic polymer material: covering film for plane, rare earth cerium sulphide red dye, lead-free in electronic packages, serials

of special sizing agent by photoetching for color Plasma Display Panel, small diameter and large specific surface area superfine fibre, high

precision fuel filter paper, and Li-ion battery membrane

11. Medical and Pharmaceutical Products Industry

(1) Production of new type compound medication of active composition medication (including bulk drug and preparation)

(2) Production of amino acids: tryptophan prepared by zymotechnics, hstidine, methionine for feed

(3) Production of new anti cancer medication, new cardio-cerebrovascular medication and new nervous system using medication

(4) Production of new type medication using bioengineering technology

(5) Production of AIDS vaccine, hepatitis C vaccine, contraceptive vaccine, and new vaccines such as cervical cancer vaccine, malaria vaccine,

and hand-foot-mouth disease vaccine

(6) Production of biology vaccine

(7) Exploitation and production of marine drug

(8) Drug preparation: production of new formulation using new technologies of sustained-release, release, targeting and percutaneous

absorption

(9) Exploitation and production of new type of pharmaceutic adjuavant

(10) Production of antibacterial active pharmaceutical ingredients for animals (including antibiotics and chemosynthesis drugs)

(11) Exploitation and production of animal using antibacterial drug, insect repellent, pesticide, anticoccidial drug and new formulation

(12) Production of new diagnosis reagent

12. Manufacturing Industry of Chemical Fiber

(1) Production of hi-tech chemical fiber (excluding viscose fiber) of differential chemical fiber, aramid, carbon fiber, polyethylene of high-strength

and high-mode, polyphenylene sulfide(PPS) and so on

(2) Production of new style of fiber and non-fiber polyester: PTT, PEN, PCT, and PETG

(3) Production of biopolymer fiber by using new renewable resources and environment-friendly processing: lyocell, cellulose made from

bamboo and hemp, PLA, chitin fiber, PHA and plant and animal protein fiber

(4) Production of polyamide, single line production capacity of 150 ton a day

(5) Production of meridian tyre aramid fiber and tyre cord

13. Industry of Plastic Products

(1) Development and production of new-type multi-functional photo-biological broad agricultural films

(2) Digestion and recycle of waste plastics

(3) Exploitation and production of new technology and new production of plastic soft package (high barrier, multi-function film and material)

14. Non-metal Mineral Products Processing Industry

(1) Development and production of energy-saving, environment-protecting, lightweight and high-intensity, high-performance and multi-functional

architecture materials

(2) Use plastic to replace steel and wood, energy-saving and high-efficient chemical architecture material production

(3) Production of elastomer, plastic changeable asphaltum waterproof coiled materials, broad (more than 2 meters) waterproof EPDM coiled

materials and matched materials, broad (more than 2 meters) waterproof PVC coiled material, and TPO waterproof coiled materials with a

production capacity of more than 10,000,000 sq.m.

(4) Development and production of functional glass with new technologies: electromagnetic wave shielding glass, micro-electronics glass

Page 3 of 17Catalogue for the Guidance of Foreign Investment Industries (Amended in 2011) -

5/5/2014http://english.mofcom.gov.cn/article/policyrelease/aaa/201203/20120308027837.shtml

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 4 of 86 PageID #: 29093

A-190Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page6 of 44

Page 198: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

substrate, infrared transmitting lead-free glass, electronic-grade large-scale quartz glass products (pipes, boards, crucibles and apparatuses),

multi-functional windshield glass of excellent optical performance, extreme IT materials and products (including quartz glass bushing and

ceramic wafer for waveguide-grade, high-precise optical fiber preform rod), and purification processing of raw materials for high pure

( 99.998 ) or ultrapure ( 99.999 ) crystal

(5) Production of conductive glass for film batteries and glass for solar illuminator

(6) Production of glass fiber products and special glass fiber: low dielectric glass fiber, quartz glass fiber, high silica glass fiber, high strength

and high elasticity glass and ceramic fiber and their products

(7) Production of optical fiber and its products: coherent fiber bundle and laser medical optic fiber, exceeding two generation and three

generation microchannel plate, optic fiber panel and inverse image implement and light cone glass

(8) Standardization refine of ceramic material and production of high-level decorative materials used for ceramics.

(9) Production of environment-friendly (non-chromizing) refractory material used in furnaces such as cement, electronic glasses, ceramics and

microporous carbon brick.

(10) Production of AIN ceramic base piece and multiple-hole ceramics.

(11) Production of inorganic, non-metal materials and products: compound materials, special kind of ceramics, special kind of airproof materials

(including quick oil sealed materials), special friction materials (including high-speed friction brake materials), special kinds of cementation

materials, special type latex materials, water rubber materials, and nanomaterials.

(12) Production of thermal insulation materials of organic-inorganic compound foam

(13) Production of high-tech compound materials: sequential fiber increasing thermoplasticity compound materials and prepreg, endure heat >

300 colophony compound material moulding craftwork assistant materials, colophony compound material (including top grade sports articles

and vehicle parts of lightweight and high-intensity), special function compound materials and products (including deep water and diving

compound material products and medical and healing use compound material products), carbon/carbon compound materials, high capability

ceramic compound materials and products, metal compound materials and products, metal layer compound materials and products,

pressure 320MPa super-high-pressure compound rubber pipes, air bus aviation tyres.

(14) Production of precision high capability ceramic materials: carborundum super-minute powder(purity > 99%, average granule diameter <

1 m), Si3N4 super-minute powder(purity > 99%, average granule diameter < 1 m), high pure and super-minute alumina powder(purity > 99%,

average granule diameter < 0.5 m), low temperature sintered zirconia powder(sintered temperature < 1350 ) , high pure AlN powder (purity >

99%, average granule diameter < 1 m), rutile TiO2 powder(purity > 98.5%), white char black(average granule diameter < 100nm , barium

titanate (purity > 99%, average granule diameter < 1 m .

(15) Development and production of high-quality artificial crystal and crystal film products: high-quality artificially synthesized crystal

(piezoelectric crystal and crystals for ultraviolet ray transmitting crystal), super hard crystal (cubic boron nitride crystal), high-temperature

resistant and highly-insulated artificially synthesized crystal (artificially synthesized mica), new electro-optic crystal, high-power laser crystal and

large-size glittering crystal, diamond film tools, super-thin artificial diamond saw blades with thickness of not more than 0.3mm

(16) Deep processing of non-metal mineral products (super-thin comminution, high level pure, fine production, modification)

(17) Production of super high power black lead electrode.

(18) Production of pearlite mica (granule diameter: 3-150 m).

(19) Production of multi-dimension and multi-direction integer weaving fabric and profile modeling fabric.

(20) Use new dry cement kiln to innocuously dispose solid waste.

(21) Recycling of construction waste

(22) Comprehensive utilization of industrial by-products gypsum

(23) Development and application of new technologies for the comprehensive utilization of non-metal mine tailings, and the ecological

restoration of mines

15. Non-Ferrous Metallurgical Smelting and Rolling Processing Industry

(1) Production of diameter > 200mm silicon single crystal and polishing piece.

(2) Production of high tech non-ferrous metallurgical materials: compound semiconductor materials (gallium arsenide, gallium phoshpide,

gallium reexplanation, gallium nitride), high temperature superconduct materials, memory alloy materials (titanium nickel copper and iron

memory alloy materials) , super minute (nanometer) calcium carbide and super minute (nanometer) crystal hard ally, superhard compound

materials, noble metal compound materials, aluminum foil used for radiator, middle and high pressure cathode capacitance aluminum foil,

special kind of large aluminum alloy materials, aluminum alloy precise model forge product, electrization railway built on stilts leads, super-thin

copper strip, erosion proof heat exchanger copper alloy material, high capability copper nickel, copper and iron alloy strip, beryllium copper

strip, thread, tube and stick process material, high temperature bearable tungsten filament, magnesium alloy cast, non-lead solder, magnesium

alloy and its applicable products, bubble aluminum, titanium alloy strip materials and titanium jointing pipes, atomic energy grade sponge

zirconium, tungsten and molybdenum deep machining products.

16. Metal products industry

Page 4 of 17Catalogue for the Guidance of Foreign Investment Industries (Amended in 2011) -

5/5/2014http://english.mofcom.gov.cn/article/policyrelease/aaa/201203/20120308027837.shtml

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 5 of 86 PageID #: 29094

A-191Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page7 of 44

Page 199: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

(1) Research, development and manufacturing of new lightweight and environment-friendly materials for aviation, aerospace, automobiles and

motorcycles (special-purpose aluminum sheets, aluminum-magnesium alloy materials, and aluminum alloy motorcycle frames and so on)

(2) Development and production of high-grade hardware for construction, hot-water heating equipment and hardware parts.

(3) Production and processing (including painting and processing inner and outer surface of the products) of metal packing products (thickness

< 0.3mm) used to pack all kinds of grain, oil and food, fruits, vegetables, beverages, daily using materials and such contents.

(4) Manufacturing of nickel-saving stainless steel products

17. General Machine-building Industry

(1) Manufacturing of numerically controlled machine tools of high level and key spare parts: numerically controlled machine tools which exceed

quintuple linkage, digital control coordinate spindle processing centre digital control system which exceeds quintuple linkage and

servomechanism installations, high-speed and super-strong knifes for exact digital control manufacturing.

(2) Manufacturing of multi-station forging forming machine of 1000 tons or more

(3) Manufacturing of equipments for braking up and smashing retired cars

(4) Manufacturing of soft FTL product line

(5) Manufacturing of vertical articulated industrial robots, welding robots and welding equipments thereof

(6) Manufacturing of special processing machines: complete sets of laser cutting and welding equipments, exact processing laser equipments,

digital-control and low-speed wire-cuts, submicron cracker

(7) Manufacturing of wheel or crawler crane of 300 tons or more (limited to equity joint ventures or contractual joint ventures)

(8) Design and manufacturing of high pressure plunger pumps of pressure(35-42MPa) and engine, design and manufacturing of low-speed big

torquey engine of pressure(35-42MPa)

(9) Manufacturing of integrated hydraulic-pressure multiple unit valve with working pressure 25MPa and electro-hydraulic proportional servo

elements.

(10) Design and manufacturing of valve terminal, pneumatic solenoid valve of less than 0.35W and high-frequency electrically-controlled gas

valve of 200Hz or more

(11) Design and manufacturing of hydrostatic drive device

(12) Development and manufacturing of non-contacting gas film seal of pressure more than 10MPa, dry gas seal of pressure more than 10MPa

(including experience device)

(13) Development and manufacturing of macromolecule material device for automobiles(rub piece, changed phenol aldehyde plunger, non-

metal liquid pressure mother pump and so on)

(14) Manufacturing of car boss axletree of 3 and 4 generation(function elements of boss axletree of flange and transducer inside or outside of

the axletree digital control machine tool or processing centre axletree of high or mid class(the processing center should have more than three

axis interlocking function and 3-4 m repeated precision) high-speed wire or board rolling mill axletree(assistant axletree and roller axletree of

single-wire rolling mill of more than 120m/s and of thin-board rolling mill of more than 2mm) high-speed railway axletree(with speed of more

than 200km/h) low-noise axletree of vibration of less than Z4(Z4, Z4P, V4, V4P) level P4, P2 axletree of various axletree

(15) Manufacturing of high-density, high-precision and complex-shaped powder metallurgical parts and chains used for automobile, engineering

machinery, etc

(16) Manufacturing of gear transmission for wind power, high-speed train, gear transmission agent with adjustable blades for vessels, and

large-sized and heavy-loaded gear boxes

(17) Manufacturing of high binding spares of 12.9 level or more

(18) Development and manufacturing of accumulator bladders and rubber and plastic seals for hydropneumatic use

(19) Remanufacturing of machine tools, spare parts of cars(except five matured varieties)and project machines.

(20) Manufacturing of miniature precision transmission joint pieces (clutches)

(21) Manufacturing of coupling shaft for heavy rolling mills

(22) Remanufacturing of machinery such as machine tools, engineering machinery and railway locomotives and remanufacturing of automotive

parts and components

18. Special Equipment Manufacturing

(1) Manufacturing of mine trolley mining, loading and transporting device mechanical drive tipper for mine of 100 tons or more, mobile

crusher, wheeled digger of 3000m3/h or more, loading machine for mine of 5 m3 or more, electric driving mining machine of 2000 kw or more

and so on

(2) Manufacturing of geophysical, logging equipment: MEME geophone, digital telemetry seismograph, digital imaging, computerized logging

system, horizontal wells, directional wells, drilling rig equipment and apparatus, MWD logging while drilling

(3) Manufacturing of equipment for oil exploration, drilling, collection and transportation: floating drilling systems and floating production

systems with an operating water depth of more than 1500 meters and the supporting subsea oil extraction, collection and transportation

equipment

Page 5 of 17Catalogue for the Guidance of Foreign Investment Industries (Amended in 2011) -

5/5/2014http://english.mofcom.gov.cn/article/policyrelease/aaa/201203/20120308027837.shtml

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 6 of 86 PageID #: 29095

A-192Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page8 of 44

Page 200: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

(4) Manufacturing of large-caliber rotary drilling rigs with a caliber of 2 meters or more and depth of 30 meters or more, push benchers with a

diameter of 1.2 meters or more, complete sets of large equipment with a pull-back force of 300 tons or more for laying underground pipes and

lines without digging, and underground diaphragm wall construction drilling rigs

(5) Design and manufacturing of large bulldozers of 520 horesepower or more.

(6) Design and manufacturing of pedrail soil shifter of ground pressure of 0.03MPa or less, power of 220 hp or more large soil shifter of 520

hp or more

(7) Design and manufacturing of purge machine of 100 m3/h or more, digging device in digging vessel of 5000 tons or more

(8) Design and manufacturing of tuffcrete diosmosing-proof wall for flood control bar

(9) Manufacturing of machine for underwater mass soil shifter, loader and digger 9 miles under water

(10) Manufacturing of devices of road bridge maintaining and automatic testing

(11) Manufacturing of devices of road tunnel supervision, winding, disaster control and rescuing system

(12) Design and manufacturing of the large-scale railway construction, and operation of large-scale road maintenance machinery and safety

equipment

(13) Manufacturing of (asphalt) shingles equipment, galvanized steel and other metal roof production equipment

(14) Manufacturing of spot spraying polyurethane waterproof thermal insulation system equipment which could protect environment and

conserve energy, technology and equipment of polyurethane sealant paste preparation, technology and production equipment of modified

silicone sealing paste preparation

(15) Design and manufacturing of thin-slab continuous casting machine, high-precision strip mill (with thickness of precise 10 microns)

(16)Manufacturing of the key equipment of complete sets of ethylene equipment with an annual capacity of 1 million tons or more: mixing

granulators with an annual processing capacity of 400,000 tons or more, helical-conveyer centrifuges with a diameter of 1000 mm or more, and

low-flow high-head centrifugal pump

(17) Manufacturing of high power DC electric arc furnace of 50 tons or more

(18) Manufacturing of colorful panting or plating board devices

(19) Manufacturing of selecting device for multi-element, fine-powder and hard-selecting mine

(20) Design and manufacturing of production equipment for automotive power batteries

(21) Manufacturing of large complete devices of chemical processing of coal(limited to equity joint ventures or contractual joint ventures)

(22) Design, manufacturing and maintaining of metal product moulds(such as extrusion moulds of pipe, stick and shape of copper, aluminum,

titanium and zirconium)

(23) Design and maintaining of punching mould of cover elements of automobile outside, clamp and test tools of automobile and motorcycle

(24) Design and maintaining of punching mould with precision of more than 0.02 millimeter (including 0.02 millimeter), precise mould with

precision of more than 0.05 millimeter (including 0.05 millimeter) and mould standard elements.

(25) Design and manufacturing of nonmetal product moulds

(26) Manufacturing of beer filling device of 60000 bottles /h or more, drink mid or high hot filling device of 5 bottles /h, asepticism filling device of

36000 bottles /h or more

(27) Manufacturing of producing technologies and key equipments for aminophenol, zymi, food addiitive and so on

(28) Manufacturing of complete feed processing equipment of 10tons/h or more and key parts thereof

(29) Manufacturing of light board and box device of 0.75-millimeter high or less

(30) Manufacturing of single in folio colorful lithographic printing machine with speed of more than 16000 pages in folio /h(720×1020

millimeters) , diprosopia in folio colorful lithographic printing machine with speed of 13000 pages in folio /h(720×1020 millimeters) , colorful

lithographic in folio printing machine with speed of 13000 pages in folio /h(1000×1400 millimeters)

(31)Manufacturing of automatic coating machines for electron guns (32) Manufacturing of colorful soft printing machine with speed of

300meters/m or more and coverage of 1000 millimeters or more

(33) Manufacturing of computer mass color pre-coordination systems, mass color remote handling systems, mass speed following systems,

prints quality automatic testing and following systems, no-axis turning technologies, high-speed automatic splicer, paper giving machine and

high-speed and automatic remote handling paper folding machine, automatic overprinting system, cooling device, silanion putting system, bias-

adjusting device and so on.

(34) Deep processing technique and equipment manufacturing of plate glass

(35) Special high-tech Industrial sewing machines manufacturing

(36) Manufacturing of complete set of new type of paper (including pulp) making machines

(37) Manufacturing of equipment with new technique for post ornament and processing of leather (38) Development and Manufacturing of new

agriculture processing and storage equipment: new equipment for the processing, storage, preservation, classifying, packing, and drying of

food, oil, vegetables, diried fruits and fresh fruits, flowers, meat and aqua-products; agricultural product quality testing equipment ; the quality

detection equipment of agricultural products' damage; Rheometer; Farinograph; ultrafine pulverization equipment; Highly efficient dewatering

Page 6 of 17Catalogue for the Guidance of Foreign Investment Industries (Amended in 2011) -

5/5/2014http://english.mofcom.gov.cn/article/policyrelease/aaa/201203/20120308027837.shtml

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 7 of 86 PageID #: 29096

A-193Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page9 of 44

Page 201: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

equipment ; 5-grade plus high efficient fruit juice condensation equipment equipment for Disinfection of powder food in Media; Aseptic

packaging equipment for Semi-solid and solid food; Packaging Materials for Aseptic packaging, DVS Bacteria Starter for Dairy Production,

Disc-type Separation centrifuges

(39) Manufacturing of Agricultural machinery: facility agriculture equipment(greenhouse Automatic irrigation equipment, Autocontrol

configuration and fertilization Equipment of Nutritious Liquid, Efficient vegetable nursery equipment, Soil nutrient analysis instruments ), Tractor

and associated farm tools with 120 kilowatts and above Matching engine power, Low fuel consumption, low noise and low-emission diesel

engine, Spray Machines with Residual fog tablets Recovery Unit matching of large tractor, High-performance rice transplanter, Cotton

harvesting machine, Adapted to a variety of row-spacing Self-moving Maize Reaping Machine(Hydraulic drive or mechanical drive)

(40) Manufacturing of new technical forestry equipment

(41) Manufacturing of equipment for reusing in fields and comprehensive utilization of straws and stalks of crop, Manufacturing of equipment for

comprehensive utilization of Rice Husk

(42) Manufacturing of equipment for comprehensive utilization of waste agriculture products and waste fowl and livestock products which are

bred in scale

(43) Manufacturing of festival fertilizer, pesticide section, water-saving technical Agriculture equipment

(44) Manufacturing of cleaning equipment for electromechanical wells and equipments for Laundering drug production

(45) Manufacturing of electronic endoscopes

(46) Manufacturing of Fundus Cameras

(47) Manufacturing of Medical imaging equipments' Key components(high magnetic field intensity and superconduct MRI, CT, X-ray computed

tomography, type-B ultrasonic )

(48) Manufacturing of Medical Ultrasonic Transducer(3D)

(49) Manufacturing of boron neutron capture therapy equipments

(50) Manufacturing of X-ray Stereotactic Radiotherapy System

(51) Manufacturing of Hemodialysis, Blood Filter

(52) Manufacturing of multi-layer co-extruded water-cooled blown film equipment for non-PVC medical infusion bags

(53) New techniques of quality control of medicine products and new equipment manufacturing (54) New analytical techniques and extraction

technologies, and equipment development and manufacturing for the effective parts of traditional Chinese medicines

(55) Producing and manufacturing of new packing materials, new containers for medicine, and advanced medicine producing equipment

(56) Development and Manufacturing of equipment of new type of knitting machines, Key parts and Textile testing, laboratory equipment

(57) Manufacturing of water pollution prevention and control equipment: horizontal spiral centrifugal dehydrators, membrane and membrane

materials, ozone generators with a capacity of more than 50kg/h, chlorine dioxide generators with a capacity of more than 10 kg/h, ultraviolet

disinfection devices, small domestic sewage treatment equipment used in rural areas, and heavy metal wastewater treatment equipment

(58) Manufacturing of solid waste treatment and disposal equipment: sewage plant sludge disposal and resource utilization equipment,

complete sets of refuse incineration equipment with a daily treatment capacity of 500 tons or more, landfill leachate treatment technology and

equipment, anti-seepage geomembranes in landfills, building waste treatment and resource recovery utilization equipment, devices for disposal

of hazardous waste, devices for biogas power generation in landfills, scrap steel treatment equipment, and remediation equipment for

contaminated soil

(59)Development and manufacturing of equipment for the comprehensive utilization of red mud from aluminum industry

(60)Manufacturing of equipment for the comprehensive utilization of mine tailings

(61) Manufacturing of Waste plastics, electronics, rubber, battery Recycling Equipments

(62) Manufacturing of reclamation equipment for used and waste textiles

(63) Manufacturing of equipment for the remanufacturing of waste mechanical and electrical products

(64) Manufacturing of special Meteorological observation and analysis equipments

(65) Development of Seismic station, Seismic Network, and Mobile seismological observation technology System, and Manufacturing of

equipments

(66) Manufacturing of portable assembling water purification equipment

(67) Unconventional water treatment, recycling equipment and water quality monitoring instruments

(68) Leak test equipment and instruments for industrial water pipeline networks and equipment (appliances)

(69) Manufacturing of preparation, storage and transportation equipment and inspection systems of hydrogen energy

(70) Manufacturing of new Heavy residue gasification Atomization Nozzle, Steam leakage rate of 0.5 percent and below efficient Steam Traps,

1000 ° C and above high-temperature ceramic heat exchanger manufacturer

(71) Development of Seismic station, Seismic Network, and Mobile seismological observation technology System, and Manufacturing of

equipments

(72) Manufacturing of three-drum radial tire building machines

Page 7 of 17Catalogue for the Guidance of Foreign Investment Industries (Amended in 2011) -

5/5/2014http://english.mofcom.gov.cn/article/policyrelease/aaa/201203/20120308027837.shtml

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 8 of 86 PageID #: 29097

A-194Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page10 of 44

Page 202: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

(73) Manufacturing of Rolling resistance testing machine and Tire noise lab

(74) Manufacturing of new Heating measurement and Temperature Control Device Technical equipments

(75) Manufacturing of preparation, storage and transportation equipment and inspection systems of hydrogen energy

(76) Manufacturing of new Heavy residue gasification Atomization Nozzle, Steam leakage rate of 0.5 percent and below efficient Steam Traps,

1000 ° C and above high-temperature ceramic heat exchanger manufacturer.

(77) Manufacturing of devices for recovery of marine oil spill

(78) Manufacturing of equipment for utilization of low concentration coal-mine gas and ventilation air methane

19. Communication and Transportation Equipment Industries

(1) Manufacturing of complete automobiles (foreign investments shall not exceed 50%)and construction of automobiles research and

development organization

(2) Manufacturing of automobile engine, reused manufacture of engines and construction of engine research and development organization

gasoline motor with output per litre not lower than 50 kw, diesel motor with output per litre not lower than 40 kw and discharge capacity below 3

liters, diesel motor with output per litre not lower than 30 kw and discharge capacity above 3 liters, motor driven by such new resources as fuel

cells and compound fuel

(3) Manufacturing of key spare parts for automobiles as well as research and development of key technologies: complete disc brakes, complete

driving rods, automatic gearboxes, fuel pumps of diesel engine, inhalant supercharger of engines, adhesive axial organ(used for four-wheel

drive), hydraulic tappet, electronic cluster gauge, crankshaft and connecting bar(diesel motor above 8 liters), Anti Lock Brake System(ABS,

ECU, valve body, sensor) , ESP, BBW, electronic braking distribution system(EBD) , driving control system, gas generator for automobile

airbags, electronic fuel injection system, sprays technology on fuel common rail technology(utmost spray pressure above 1600 pa) , VGT, VNT,

discharge control equipment of motor meeting the pollutant discharge standard of the fourth phase of China, ITM and coupler assembly, Steer-

by-Wire System, Diesel Particulate Filter(DPF), intelligent cylinder, special rubber automobile components

(4) Manufacturing of key parts and components of new energy vehicles: high energy power batteries (energy density 110Wh/kg cycle life

2000 times, and the proportion of foreign investment not exceeding 50%), anode materials of batteries (specific capacity 150mAh / g, and

cycle life of 2000 times with not less than 80% of initial discharge capacity), battery separators (thickness of 15-40 m, porosity of 40% -60%);

Battery management systems, motor management systems, and electronic control integration of electric vehicles; driving motors of electric

vehicles (peak power density 2.5kW/kg, high efficiency area: 65%, working area efficiency 80%), automotive DC / DC (input voltage of

100V-400V), high-power electronic devices (IGBTs, voltage class 600V, current 300A); and plug-in hybrid electromechanical coupling drive

systems

(5) Manufacturing of key parts for high discharge motorcycle(discharge of over 250ml):technology of electrical control fuel injection for

motorcycle (limited to equity joint ventures or contractual joint ventures), engine discharging control device which satisfy motorcycle discharging

criteria stage of China

(6) Equipment for railway transportation(limited to equity joint ventures or contractual joint ventures): research and development, design as well

as manufacturing of complete train and key spare parts(drive system, control system, brake system)of rapid transit railway, railway of

passenger special line, intercity railway, trunk railway and equipment for urban railway transportation research and development, design as

well as manufacturing of passenger service facilities and equipment for rapid transit railway, railway of passenger special line, intercity railway

and urban railway transportation; design as well as research and development of related information system in the process of construction of

information age; research and development, design as well as manufacturing of railway and bridge facilities and equipments for rapid transit

railway, railway of passenger special line, intercity railway manufacturing of equipment and fixtures for electrical railway, research and

development of technologies for controlling railway noise and vibrating, manufacturing of discharging equipment for trains, manufacturing of

safety monitoring equipment for railway transportation

(7) Design, manufacturing and maintaining of civil plane: those of trunk and branch lines(Chinese part shall hold the majority of shares)

general ones(limited to equity joint ventures or contractual joint ventures)

(8) Production and maintaining of spares parts for civil planes

(9) Design and manufacturing of civil helicopters those of three tons or more(Chinese part shall hold the majority of shares), those of less than

three tons (limited to equity joint ventures or contractual joint ventures)

(10) Production of spares parts for civil helicopters

(11) Manufacturing of ground and water effect plane (Chinese part shall hold the majority of shares)

(12) Design and manufacturing of no-people plane and aerostat (Chinese part shall hold the majority of shares)

(13) Design, manufacturing and maintaining of plane engines and spare parts as well as air assistant power system (limited to equity joint

ventures or contractual joint ventures)

(14) Design and manufacturing of civil air-borne equipment (limited to equity joint ventures or contractual joint ventures)

(15) Manufacturing of flight ground equipments: civil airfield facilities, support equipment for civil airfield work, ground equipment for flight test,

equipment for flight simulation and practice, equipment for aeronautic testing and measuring, equipment for aeronautic ground testing,

Page 8 of 17Catalogue for the Guidance of Foreign Investment Industries (Amended in 2011) -

5/5/2014http://english.mofcom.gov.cn/article/policyrelease/aaa/201203/20120308027837.shtml

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 9 of 86 PageID #: 29098

A-195Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page11 of 44

Page 203: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

comprehensive testing equipment for machines, special equipment for aeronautic manufacturing, equipment for pilot manufacturing aeronautic

materials, ground receiving and applying equipment for civil aircraft, ground testing equipment for rocket launcher, equipment for dynamic and

environmental experience for rocket launcher

(16) Manufacturing of mechanical and electrical products for aircrafts, temperature control products for aircrafts, test equipment for planet

products and structure and organization products for aircrafts

(17) Manufacturing of light gas-turbine engine

(18) Design of luxury cruise and equipment for deep-water(over 3000 meters) ocean project(limited to equity joint ventures or contractual joint

ventures)

(19) Manufacturing and maintaining of equipment for ocean project(including stages)(Chinese part shall hold the majority of shares)

(20) Design of diesel engine in low or medium speed for vessel (limited to equity joint ventures or contractual joint ventures)

(21) Manufacturing of diesel engine in low and medium speed for vessel as well as crankshafts (Chinese part shall hold the majority of shares)

(22) Design and manufacturing of machinery for vessel compartment(Chinese part shall hold the relative majority of shares)

(23) Design and manufacturing of communication and directing systems for vessels communication systems, electronic directing equipment,

vessel radar, electric compass automatic pilot, public broadcasting systems inside vessels and so on

(24) Design and manufacturing of cruiser (limited to equity joint ventures or contractual joint ventures)

20. Electric Machinery and Equipment Manufacturing Industries

(1) Manufacturing of key auxiliary equipment used for 1 million KW ultra supercritical fire-electricity generating set(limited to equity joint

ventures and cooperative joint ventures): safety valve and control valve

(2) Manufacturing of the equipment of coal-fired power plant and denitrification technology for sintering machine in steel industry

(3) Design and manufacturing of seal parts for fire-electricity equipment

(4) Manufacturing of large scale castings and forgings used for coal-fired power plant and hydropower station

(5) Manufacturing of key auxiliary equipment used for hydroelectric generating set

(6) Manufacturing of power transmitting and transforming equipment (limited to equity joint ventures and cooperative joint ventures): amorphous

alloy transformer, operator used for high-voltage switch of 500KV or more, arc extinguishing device, large-scale disk type insulator(over

1000KV and 50KA), outlet device used for transformer of 500KV or more, casing pipe(AC:500KV,750KV,1000KV and all DC specifications),

voltage regulating switch(loaded and unloaded voltage regulating switch for AC 500KV,750KV and 1000KV), dry-type smoothing reactor used

for DC transmission, more or less 800KV converter valve used for DC transmission(water cooling equipment and DC field equipment), electrical

apparatus contact material as well as non-Pb and non-Cd solders accorded with EU command of RoHS

(7) Manufacturing of complete sets of or key new energy equipments for electricity power generation: photovoltaic power generation,

geothermal power generation, tidal power generation, wave power generation, rubbish power generation, methane power generation and wind

power generation of 2.5MW or above

(8) Manufacturing of large pumped-storage power units of 350MW power ratings or more(limited to equity joint ventures and cooperative joint

ventures): pump turbines and speed controller, large-scale reversible pump-turbine units with varied speed, power generator and excitation,

launching apparatus and other accessory equipments

(9) Manufacturing of Stirling generating set

(10) Development and manufacturing of straight line and plane motor and drive system

(11) Manufacturing of high-tech green battery: dynamic Ni-Mh battery, zinc and nickel storage cell, zinc and silver storage cell, lithium-ion

battery, solar battery, fuel battery and so on(excluding high power battery for new energy vehicles)

(12) Electric motor is manufactured by refrigerating and air-conditioning compressors adopting DC speed adjustment technology or CO2 natural

refrigerants, and by refrigerating and air-conditioning equipments applying renewable energy(air source, water source and geothermal source)

(13) Manufacturing of solar air conditioning, heating system and solar dryer apparatus

(14) Manufacturing of biomass drying pyrolysis system and biomass gasification unit

(15) Manufacturing of AC-FM voltage regulation drawbar

21. Communication Equipment, Computer and Other Electronic Equipment Manufacturing

(1) Manufacturing of HD digital video camera and digital sound-playing equipment

(2) Manufacturing of flat panel display such as TFT-LCD, PDP and OLED, and materials of flat panel display (excluding TFT-LCD glass

substrate of the 6th generation or below)

(3) Manufacturing of such key parts as optical engine, light source, projection screen, high-resolution projection tube and LCOS module used in

large screen color projection display

(4) Manufacturing of digital audio and visual coding or decoding equipment, digital broadcasting TV studio equipment, digital cable TV system

equipment, digital audio broadcasting transmission equipment, digital television converter, digital television broadcasting Single Frequency

Network(SFN), satellite digital TV up-linking station and front-end equipment of SMATV

(5) Design of integrate circuit, and manufacturing of large digital integrate circuit with its wire width of 0.18 micron or below, manufacturing of

Page 9 of 17Catalogue for the Guidance of Foreign Investment Industries (Amended in 2011) -

5/5/2014http://english.mofcom.gov.cn/article/policyrelease/aaa/201203/20120308027837.shtml

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 10 of 86 PageID #: 29099

A-196Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page12 of 44

Page 204: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

simulated and digital analogy integrate circuit of 0.8 micron or below, and the encapsulation and test of such advanced equipment as BGA,

PGA, CSP, MCM and so on

(6) Manufacturing of large and medium-sized computer, high-performance computer with its operation more than 100 trillion times, portable

micro computer, high-rank server with its operation more than 1 trillion times per second, large scale simulated system and large industrial

control mechanism and controller

(7) Manufacturing of computer digital signal processing system and board card

(8) Manufacturing of figure and image recognition and processing system

(9) Development and manufacturing of large-capability optical and disk driver as well as relevant components

(10) Manufacturing of high-speed storage system and intelligent storage equipment with its capability more than 100 TB

(11) Manufacturing of Computer Assistance Design(three-dimensional CAD), Computer Assisted Testing (CAT,Computer Aided Manufacture

(CAM), Computer Aided Engineering(CAE) and other computer application systems

(12) Development and manufacturing of software product

(13) Development and manufacturing of specialized electronic material (excluding the development and manufacturing of optical fibre perform

rod)

(14) Manufacturing of specialized electronic equipment, testing equipment and tools and moulds

(15) Manufacturing of new type electronic components and parts: slice components, sensitive components and sensors, frequency monitoring

and selecting components, mix integrated circuit, electrical and electronic components, photoelectric components, new type components for

machinery and electronics, high polymer solid capacitor, super capacitor, integrated passive components, high-density interlinked build-up

board, multilayer flexible board, flexible printing circuit board and packaging substrate

(16) Manufacturing of touch control system (touch control screen and components)

(17) High-brightness LBD with its luminous efficiency more than 1001m/W, epitaxial slice LBD(blue) with its luminous efficiency more than

1001m/W, white luminous tube with luminous efficiency more than 1001m/W and its power more than 200mW

(18) Development and manufacturing of key components and parts used in high-precision digital CD drive

(19) Reproduction of read-only compact disk and manufacturing of recordable compact disk

(20) Design and manufacturing of civil satellites (Chinese partner shall hold the majority of shares)

(21) Manufacturing of civil satellites effective payload (Chinese partner shall hold the majority of shares)

(22) Manufacturing of spare parts for civil satellites

(23) Manufacturing of telecommunication system equipment for satellites

(24) Manufacturing of receiving equipment of satellite navigation and key components

(25) Manufacturing of optical communication measuring instrument and light transceiver with its speed more than 10Gb/s

(26) Manufacturing of Ultra Broad Band (UWB) communication equipment

(27) Manufacturing of wireless Local Area Network(including support of WAPI) and Wide Area Network equipment

(28) Rate time division multiplex equipment(TDM) with speed more than 40Gbps, dense wavelength division multiplex equipment(DWDM),

broadband passive network devices(including EPON, GPON, WDM-PON, etc.), next-generation DSL chip and its equipement, optical cross

connect(OXC), automatic switch optical network(ASON), and optical fiber communication and transmission equipment more than 40G/sSDH

(29) Development and manufacturing of next-generation Internet system equipment, terminal equipment, testing equipment, software and chips

based on IPv6

(30) Development and manufacturing of third-generation and the following mobile communication system mobile phone, base station, core

network equipment and network testing equipment

(31) Development and manufacturing of high-end router, network switcher of more than 1 gigabit

(32) Manufacturing of the equipment for air traffic control system (limited to joint venture and cooperation)

22. Machinery Manufacturing Industries for Instrument and Meter as well as Culture and Office

(1) Manufacturing of automation control system and apparatus in industrial processing: field-bus control system, large programmable logic

controller(PLC), two-phase flowmeter and solid flowmeter, new type sensor and field measurement instrument

(2) Development and manufacturing of large-scale sophisticated instruments: electron microscope, laser scanning microscope, scanning

tunneling microscope, electron microprobe, large-scale metallurgical microscope, photoelectric direct-reading spectrometer, Raman

spectrometer, mass spectrometer, chromatography-mass spectrometer, nuclear magnetic resonance spectrometer, nergy dispersive system,

X-ray fluorescence spectrometer, diffraction analysis system, industrial CT, 450KV industrial X-ray inspection machine, large-scale dynamic

balancing machine, automatic testing system of on-line mechanical quality, three coordinate measuring machine, laser comparator, electrical

prospecting apparatus, over 500m airborne electrical prospecting and gamma-ray spectrometry measuring insrument, borehloe gravimetry and

three dimensional magnetograph, high-precision microgal and aviation gravity gradiometer, high precision micro-gamma gravity and airborne

gravity gradiometry instrument, grating scale and encoder

(3) Manufacturing of high-precision digital voltmeter, current meter(with measuring range of seven bit and a half and above)

Page 10 of 17Catalogue for the Guidance of Foreign Investment Industries (Amended in 2011) -

5/5/2014http://english.mofcom.gov.cn/article/policyrelease/aaa/201203/20120308027837.shtml

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 11 of 86 PageID #: 29100

A-197Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page13 of 44

Page 205: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

(4) Manufacturing of wattless power automatic compensation equipment

(5) Manufacturing of new instrument and equipment for safety production

(6) Manufacturing of VXI bus automatic test system (in accordance with IEEE1155 international standards)

(7) Development and manufacturing of comprehensive management system for under-mine monitoring and disaster-forecasting apparatus and

coal safety measurement

(8) Manufacturing of the equipment for engineering measurement and global geographical observation: digital triangle surveying system, digital

programmed system for three-dimensional topography model (acreage>1000×1000mm, horizontal error<1mm, altitude error <0.5mm), ultral

wideband seismograph( <5cm, frequency band0.01-50 , equivalent qua ing speed noise<10- m s), integrated earthqua e data processing

system, extensive under-well earthquake and auspice observation apparatus, sophisticated controllable epicenter system, engineering velocity

measuring system, high-precision GPS receiver(precision 1mm+1ppmm), INSAR graphics receiving and processing system, absolute

gravimeter with the precision less than 1 microgal, satellite gravimeter, Doppler weather radar adopting coherent technology or double

polarization technology, visibility measuring apparatus, meteorological sensor, (including temperature, pressure, humidity, wind, precipitation,

cloud, visibility, radiation, frozen earth and depth of snow), anti lightning stroke system, multilevel soot and dust sampler, three-dimensional

supersonic anemoscope, high-precision intelligent total station machine, three-dimensinal laser scanner, high performance diamond bit used for

drilling, laser rangerfinder without cooperative target, wind profiler(affixed with RASS) GPS electronic probe system, CO2/H2O general

observation system, boundary layer laser doppler radar, granule chromatography( nm-20 m), high-performance data collector and under-water

glider

(9) Manufacturing of environment motoring apparatus: SO2 automatic sampler and calcimeter, NOX or NO2 automatic sampler and calcimeter,

O3 automatic monitor, CO automatic monitor, sampler and sample cutter for soot and Pm2.5 dust, portable calcimeter for harmful and toxic

gas, automatic analyzer for organic pollutants in the air, COD automatic online monitor, BOD automatic online monitor, automatic online

monitor for turbidity, DO automatic online monitor, TOC automatic online monitor, automatic online monitor for ammonia nitrogen, radiation

dose monitor, ray analyzer, heavy metal online monitoring equipment, online warning and monitoring equipment for biological toxicity of water

quality

(10) Manufacturing of instrument and equipment for hydrological data collecting, processing, transmitting and flood warning

(11) Manufacturing of ocean exploring apparatus and equipment: underwater video camera and underwater camera in mesopelagic zone,

multi-beam explorer, shallow and deeper subbottom profiler, navigation warm-salt profiler, fluxgate compass, hydraulic wire line winch,

underwater airproof electronic connector, energy recycle device used in filtration-proof seawater desaltation with its efficiency more than 90%,

marine ecosystem inspection buoy, section probing buoy, disposable measuring instrument of electrical conductivity, temperature and depth

(XCTD), on-the-spot water quality measuring apparatus, intelligent chemical transducer for measuring the water quality of the ocean(continues

work for 3-6 months), electromagnetic current meter sensor, navigating acoustic Doppler current profiler(self-contained, direct-read, used-in-

ship), electricity conductivity rate deep-section profiler, acoustic responding emancipator, far deep sea tide measuring system(set deep into the

ocean)

(12) Manufacturing of digital camera of over 10 million pixels

(13) Office machinery manufacturing: multifunctional integration office equipment(copying, printing, facsimile and scanning), color printing

equipment, color printer head with high resolution of 2400dpi or above

(14) Manufacturing of film machinery: 2K or 4K digital cinema projector, digital movie camera as well as digital image production and editing

device

23. Handicraft and Other Manufacturing Industries

(1) Development and utilization of clean-coal technical product as well as equipment manufacturing (coal gasification, coal liquefaction, water-

coal and industrial lump-coal)

(2) Coal ore dressing by washing as well as comprehensive utilization of powered coal(including desulphurized plaster) and coal gangue

(3) Production of the all biodegradable material

(4) Recovery and treatment of waste electrical appliances and electronic product, automobiles, electrical and mechanical equipment, rubber,

metal and battery

IV. Production and Supply of Power, Gas and Water

1. Construction and operation of electricity power by employing the clean fuel technology of integral gasification combined circulation(IGCC),

circulating fluidized bed over of 0.3 million KW or above, pressurized fluidized bed combustion combined cycle(PFBC)of 0.1 million KW or

above

2. Construction and operation of back pressure heat power plant

3. Construction and management of hydropower station with the main purpose of power generating

4. Construction and management of nuclear power plant (Chinese partner shall hold the majority of shares)

Page 11 of 17Catalogue for the Guidance of Foreign Investment Industries (Amended in 2011) -

5/5/2014http://english.mofcom.gov.cn/article/policyrelease/aaa/201203/20120308027837.shtml

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 12 of 86 PageID #: 29101

A-198Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page14 of 44

Page 206: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

5. Construction and management of new energy power plant (solar energy, wind energy, geothermal energy, tide energy, wave energy and

biological mass energy, etc.)

6. Utilization of sea water(direct use of sea water, seawater desaltation)

7. Construction and operation of water-supply plant

8. Construction and management of regenerated water plant

9. Construction and management of charging and battery replacement station for vehicle

VIII. Scientific research, technology service and geological exploration

1. Biological engineering technique and bio-medical engineering technique

2. Isotope, irradiation and laser technique

3. Sea development and sea energy development technology, comprehensive technology of sea chemical resources, development of the

relevant products and deep-processing technology, sea medicine and biochemical product development technology

4. Sea surveying technology( sea tidal wave, meteorology, environmental monitoring) sea bed probing, exploration and evaluation technology

of ocean resource

5. Comprehensively use the high chemical additional value technology to distill chemical potassium, bromine, magnesium from dense sea

water after desaltation and its deep procession

6. Development of offshore oil pollution cleanup and ecological restoration technology and related product, technology of water eutrophication

control, technology of disaster prevention for explosive growth of marine organisms, and technology of coastal eco-environmental remediation.

7. Development and services of energy-saving technology

8. Technology for recycling and comprehensive utilization of resource, development and application of the recycling technology of the waste

dispelled by enterprises

9. Technology for environment pollution treatment and monitoring

10. Energy-saving and consumption-reduction in chemical fiber production and the new technology to deal with polluted air,water and solid

waste

11. Technology for preventing from desertification and desert improvement

12. Comprehensive management technology for balancing grass and domestic animal

13. Application technique of civil satellite

14. Research and development centers

15. Incubator for hi-tech, new products developing, and incubation of enterprises

IX. Water, environment and public facility management industry

1. Construction and management of key water control projects for comprehensive utilization (the Chinese party shall hold the relative majority of

shares)

2. Construction and management of urban access-controlled roads

3. Construction and management of metro and city light rail (Chinese partner shall hold the majority of shares)

4. Construction and management of treatment plants for sewage, garbage, the dangerous wastes (incineration and landfill), and the facilities of

environment pollution treatment

X. Education

1. Advanced educational institution (only limited to joint venture or cooperative)

2. Vocational skills training

XI. Public health, social security and social welfare 1. Service agencies for the elderly, the handicapped and children

XII. Culture, sports and entertainment

1. Operation of the performance site ((the Chinese party shall hold the relative majority of shares) 2. Operation of the gymnasium, body-fitting,

competition performance, sports training and agency service

Catalogue of Restricted Foreign Investment Industries

Page 12 of 17Catalogue for the Guidance of Foreign Investment Industries (Amended in 2011) -

5/5/2014http://english.mofcom.gov.cn/article/policyrelease/aaa/201203/20120308027837.shtml

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 13 of 86 PageID #: 29102

A-199Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page15 of 44

Page 207: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

I. Farming, Forestry, Animal Husbandry and Fishery Industries

1. Breeding and seeds developing production of new train crop breed (Chinese party shall hold the majority of shares)

2. Processing of the logs of precious varieties of trees (limited to equity joint ventures or contractual joint ventures)

3. Cotton (raw cotton) processing

II. Mining Industries

1. Exploring and mining of special and scarce coals exploration (Chinese partner shall hold the majority of shares)

2. Exploring and mining of barite (limited to equity joint ventures or contractual joint ventures)

3. Exploring and mining of precious metals (gold, silver, platinum families)

4. Exploring and mining of precious non-metals such as diamond

5. Exploring and cradling of phosphorite

6. Production of butadiene rubber (high cis butadiene rubber), the emulsion polymerization of styrene butadiene rubber, thermoplastic styrene-

butadiene rubber.

7. Production of acetylene process PVC, and the following scale ethylene and post-processing products.

8. Production of Backward process, contain harmful substances, and pigments and paint production

9.Mining of szaibelyite and szaibelyite iron ores

10. Inorganic salts production with great resource consumption and serious environmental pollution using outdated technologies

III. Manufacturing Industries

1. Farming Subsidiary Foodstuff Industry

(1) Processing of soybean, rapeseed edible oil (Chinese partner shall hold the majority of shares), deep-processing of corn

(2) Manufacturing of biology liquid fuel

2. Beverage Manufacturing Industries

(1) Processing of green lea and special tea with China's traditional crafts

(2) Carbonic acid beverage manufacturing

3. Tobacco Industries

(1) Manufacturing of threshing and curl tobacco leaf

4. Printing and Copy of Recording Vehicle

(1) Print of publication (Chinese partner shall hold the majority of shares, except packing and presentation)

5. Petroleum Processing and Coking Industries

(1) Construction and management of refineries which annual produce less than 800 ten thousand tons

6. Chemical Raw Material Products Manufacturing Industry

(1) Sodium hydroxide and potash production

(2) Production of sensitive materials

(3) Production of benzidine

(4) Production of chemical products from which narcotics are easily made (ephedrine, 3, 4-idene dihydro phenyl-2-acctonc, phenylacetic acid,

1-phenyl-2-acetone, heliotropin, safrole, isosafrole, acetic oxide)

(5) Production of fluorine-chlorocardon, hydrogen- fluorine-chlorocardon, tetrafluoroethylene, fluorination-aluminum and hydrofluoric acid

(6). Production of butadiene rubber (except for high cis-butadiene rubber), emulsion polymerization of styrene butadiene rubber and

thermoplastic styrene-butadiene rubber

(7). Production of PVC with acetylene process and small-scale production of ethylene and post-processed products

(8). Small-scale production of paint with obsolete process and hazardous substances

(9). Processing of baron, magnesium, iron ores

(10). Production of inorganic salts using outdated process with big resource consumption and serious environmental pollution.

7. Medical and Pharmaceutical Products Inidustry

(1) Production of chloramphenicol, penicillin G, lincomycin, gentamicin, dihydrostreptomycin, amikacin, tetracycline hydrochloride,

oxytetracycline, medemycin, kitasamycin, ilotyin, ciprofloxacin and offoxacin

(2) Production of analgin, paracetamol, Vitamin B1, Vitamin B2, Vitamin C, Vitamin E

(3) Production of immunity vaccines included in the state plan

Page 13 of 17Catalogue for the Guidance of Foreign Investment Industries (Amended in 2011) -

5/5/2014http://english.mofcom.gov.cn/article/policyrelease/aaa/201203/20120308027837.shtml

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 14 of 86 PageID #: 29103

A-200Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page16 of 44

Page 208: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

(4) Production of material medicines for addiction narcotic and A class psychoactive drug (Chinese partner shall hold the majority of shares)

(5) Production of blood products

8. Chemical Fibre Production Industry

(1) Production of chemical fibre drawnwork of conventional chipper

(2) Production of rayon staple viscose fibre

9. Non-Ferrous Metal Smelting and Rolling Processing Industry

(1) Non-ferrous metal refining of tungsten, molybdenum, stannum (except tin compounds), antimony (including antimony oxide and antimony

sulphide)

(2) Non-ferrous metal refining of electrolytic aluminium, copper, lead, zinc and another non-ferrous metal

(3) Smelting and separation of rare earth metal (limited to equity joint ventures or contractual joint ventures)

10. Common Purpose Equipment Manufacturing Industry

(1) Manufacture of all kinds of general (p0) axletree and accessory (steel ball, cage), rough (2) Manufacture of wheeled model, crawler crane

less than 300 tons

11. Special Purpose Equipment Manufacturing Industry

(1) Manufacture of equipment for producing long dacron thread and short fibre

(2) Manufacture of crawler dozers of less than 320 horsepower, hydraulic excavator less than 30 tons, wheel loader less than 6tons, grader of

less than 220 horsepower, road roller, fork-lift truck, non-calzada dumper truck, road surface milling rework machinery, garden machine and

tools, production of commodity concrete machinery (pump, agitating lorry, pump vehical)

12. Manufacturing of transport and communication facilities

(1) Repairing, design and manufacture of common ship (including subsection) (Chinese partner shall hold the majority of shares)

13. Manufacturing of Communication Apparatus, Computers and another Electric Installation

(1) Production of satellite television receivers and key parts

IV. Production and Supply of Power, Gas and Water

1. Construction and management of conventional coal-fired power of condensing steam plants whose unit installed capacity is less than

300,000kW, within the small power grid, and the coal-fired power of condensing-extraction steam plants with dual use unit cogeneration

2. Construction and operation of power grids (Chinese partner shall hold the majority of shares)

3. Construction and operation of fuel gas, heating, water supply and sewage networks in cities with population of over 500,000 (Chinese partner

shall hold the majority of shares)

V. Communication and Transportation, Storage, Post and Telecommunication Services

1. Railway freight transportation companies

2. Railway passenger transportation companies (Chinese partner shall hold the majority of shares)

3. Corporate of highway passenger transport

4. Corporate of enter-leave country fleet operation

5. Corporate of water transportation (Chinese partner shall hold the majority of shares)

6. General aviation companies engaging in photographing, prospecting and industry (Chinese partner shall hold the majority of shares)

7. Tele communication companies: telecommunication increment service (the foreign capital less than 50 percent), motion tone and data

service in basic telecom, interior business and international business (the foreign capital less than 35 percent,49 percent no later than 11th in

December in 2007 is permitted )

VI. Wholesale and Retail Trade Industries

1. Commercial companies of commodity direct selling, mail order selling, Internet selling, franchising, commissioned operation, commercial

management

2. Wholesale, retail and logistic distribution of grain, cotton, vegetable oil, sugar, medicines, tobaccos, automobiles, crude oil, capital goods for

agricultural production(Chinese should hold the majority of shares of the multiple shops which have more than 30 branch stores and sale

different kinds and brands of commodities from multi-suppliers)

3. Construction and operation of large-scale wholesale markets of agriculture products.

4. Distributing and selling of audiovisual products (excluding movies)(joint venture or Chinese should hold the majority of shares)

5. Ship agent (Chinese should hold the majority of shares), tally for foreign vessels (limited to equity joint ventures or contractual joint ventures)

Page 14 of 17Catalogue for the Guidance of Foreign Investment Industries (Amended in 2011) -

5/5/2014http://english.mofcom.gov.cn/article/policyrelease/aaa/201203/20120308027837.shtml

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 15 of 86 PageID #: 29104

A-201Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page17 of 44

Page 209: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

6. Wholesaling product oil and construction and operation of gasoline stations (Chinese should hold the majority of shares of the multiple shops

which have more than 30 branch stores and sale different kinds and brands of commodities from multi-suppliers)

VII. Banking and Insurance Industries

1. Banks, finance companies, trust investment companies, currency brokerage companies

2. Insurance companies (the share of life-insurance companies is less than 50%)

3. Security companies (confined to A share consignment-in, B share, H share and government and company bonds consignment-in and

transaction, the foreign-capital is less than one-third), security investment fund management companies (the foreign-capital is less than 49%)

4. Insurance brokerage companies

5. Futures companies (Chinese should hold the majority of shares)

VIII. Real Estate Industry

1. Development of pieces of land (limited to equity joint ventures or contractual joint ventures)

2. Construction and operation of high-ranking hotels, villas, high-class office buildings and international exhibition centers

3. Real estate transaction in second-grade market and medium and brokerage companies

IX. Leasing and Commercial Service Industry

1. Legal consulting

2. Market Research (limited to equity joint ventures or contractual joint ventures)

3. Status enquiry and grade service companies

X. Scientific Research and technical Services Industries, Geological Prospecting

1. Mapping companies (Chinese partner shall hold the majority of shares)

2. Inspection, verification and attestation companies for imported and exported goods

3. Photography service (including trick photography like airphotograph, except maping aerial photography, limited to equity joint ventures)

XI. Education 1. Common high school education mechanism

XII. Art, Sports and Entertainment Industries

1. Production and publication of broadcasting and TV programs and film-making (limited to contractual joint ventures)

2. Construction and operation of cinemas (Chinese partner shall hold the majority of shares)

3. Construction and operation of large theme park

4. Brokering agency of stage performances

5. Operation of entertainment places (limited to joint venture and contractual joint venture)

XIII. Other industries restricted by the State or international treaties that China has concluded or taken part in

Catalogue of Prohibited Foreign Investment Industries

I. Farming, Forestry, Animal Husbandry and Fishery Industries

1. Cultivation of China's rare precious breeds (including tine genes in plants industry, husbandry and aquatic products industry)

2. Production and development of genetically modified plants' seeds

3. Fishing in the sea area within the Government jurisdiction and in in-land water

II. Mining and Quarrying Industries

1. Exploring and mining of tungsten, molybdenum, tin, antimony, fluorite

Page 15 of 17Catalogue for the Guidance of Foreign Investment Industries (Amended in 2011) -

5/5/2014http://english.mofcom.gov.cn/article/policyrelease/aaa/201203/20120308027837.shtml

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 16 of 86 PageID #: 29105

A-202Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page18 of 44

Page 210: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

2. Exploring, mining and dressing of radioactive mineral products

3. Exploring, mining and dressing of rare earth metal

III. Manufacturing Industry

1. Beverage Industry

(1) Processing of green lea and special tea with China's traditional crafts (famous tea, dark tea, etc.) 2. Medical and Pharmaceutical Products

Industry

(1) Processing of traditional Chinese medicines that have been listed as the Regulations on Conservation and Management of Wild Chinese

Medicinal Material Resources and Rare and Endangered Plants in China

(2) Application of preparing technique of traditional Chinese medicines in small pieces ready for decoction, like steam, frying, moxibustion,

calcining, and production of the products of secret recipe of traditional Chinese patent medicines

3. Non-Ferrous Metal Smelting and Rolling Processing Industry

(1) Smelting and processing of radioactive mineral products

4. Special Equipment Manufacture Industry

(1) Manufacture of Weapons and Ammunition

5. Electric Machinery and Equipment Manufacture Industry

(1) Manufacture of open-lead-acid cells, mercury Button Type Silver Oxide Cells, paste dioxide-zinc battery and nickel cadmium cells

6. Industry Products and Other Manufacturing Industries

(1) Ivory carving

(2) Tiger-hone processing

(3) Production of bodiless lacquerware

(4) Production of enamel products

(5) Production of Xuan-paper (rice paper) and ingot-shaped tablets of Chinese ink

(6) Production of carcinogenic, teratogenic, mutagenesis and persistent organic pollutant products

IV. Production and Supply of Power, Gas and Water

1. Construction and management of conventional coal-fired power of condensing steam plants whose unit installed capacity is less than

300,000kW, within the small power grid, and the coal-fired power of condensing-extraction steam plants with dual use unit cogeneration

V. Communication and Transportation, Storage. Post and Telecommunication Services

1. Companies of air traffic control

2. Companies of postal services

VI. Leasing and Commercial Service Industry

1. Social investigation

VII. Scientific Research and technical Services Industries, Geological Prospecting

1. Development and application of human stem cells and gene diagnosis therapy technology

2. Geodetic survey, marine charting, mapping aerial photography, administrative region mapping, relief map of map compilation and navigation

electronic map compilation of common map compilation

VIII. Irrigation, environment and public utilities management

1. Construction and management of nature reserve and international signify marshy

2. Development of resources about wild animals and plants be native to domestic protected by nation

IX. Education

Page 16 of 17Catalogue for the Guidance of Foreign Investment Industries (Amended in 2011) -

5/5/2014http://english.mofcom.gov.cn/article/policyrelease/aaa/201203/20120308027837.shtml

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 17 of 86 PageID #: 29106

A-203Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page19 of 44

Page 211: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

All articles marked with "Article type: Original" posted on the website of the Ministry of Commerce and its sub-sites are copyrighted by this

Website and its sub-sites. Any reproduction or use by any other websites, media or individuals must be attached with a clear indication of

"Source: Ministry of Commerce Website".

All articles posted on this website or its sub-sites marked with "Article type: reproduced" or "Article type: translated" and "Article type:

redistributed" come from other media, and are provided solely for the user's information, which does not mean this Website or its sub-sites

endorse the ideas thereof or assume any legal liability or responsibility for their authenticity. Any other media, websites or individuals must

maintain the source of information indication on this Website or its sub-sites when using the information, and shall assume legal liability for the

use.

1. Institution of compulsory education and special education, like military, policeman, politics and party school

X. Art, Sports and Entertainment Industries

1. News agencies

2. Business of publishing, producing, master issuing, and importing of books, newspaper and periodical

3. Business of publishing, producing, master issuing and importing of audio and visual products and electronic publications

4. Radio stations, TV stations, radio and TV transmission networks at various levels (transmission stations, relaying stations, radio and TV

satellites, satellite up-linking stations, satellite receiving stations, microwave stations, monitoring stations, cable broadcasting and TV

transmission networks)

5. Companies of publishing and playing of broadcast and TV programs

6. Companies of films making, issuing, business

7. News website, network audiovisual service, on line service location, internet art management

8. Construction and management of golf course

9. Gambling industry (including gambling turf)

10. Eroticism

XI. Other Industries

1. Projects that endanger the safety and performance of military facilities

XII. Other industries restricted by the State or international treaties that China has concluded or taken part in

Note:

1. In case Mainland and Hong Kong Closer Economic Partnership Arrangement and its supplementary agreements, the Mainland and Macao

Closer Economic Partnership Arrangement and its supplementary agreements, the Cross-Straits Economic Cooperation Framework Agreement

and its supplementary agreements, and free trade agreements signed between China and other countries have made provisions otherwise, the

provisions shall prevail.

2. In case special provisions and industrial policy of the State Council have made provisions otherwise, the provisions shall prevail.

All information published in this website is authentic in Chinese. English is provided for reference only.

Big Medium-sized Small Print

Ministry of Commerce Website Copyright and Disclaimer Statement

Approved by: MINISTRY OF COMMERCE,PRC

Jing ICP Bei No.05004093

Add: No.2 Dong Chang'an Avenue,Beijing China(100731)

Supported by: Cofortune Information Technology Co., Ltd

Tel: +86-10-51651200-612/613/623 Fax: +86-10-65677512

E-mail: MOFCOMMailbox

Page 17 of 17Catalogue for the Guidance of Foreign Investment Industries (Amended in 2011) -

5/5/2014http://english.mofcom.gov.cn/article/policyrelease/aaa/201203/20120308027837.shtml

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 18 of 86 PageID #: 29107

A-204Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page20 of 44

Page 212: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Provisions on Guiding Foreign Investment Direction

July 26, 2007 - 16:03 BJT (20:03 GMT) chengdu.gov.cn

(Approved and promulgated by the State Council on Feb.21, 2002.)

Article 1 These provisions are formulated according to the related legal provisions of the State in order to guide the direction of foreign

investment, to make foreign investment in accordance with the plan of the national economy and social development legitimate rights and

interests of investors.

Article 2 These provisions shall apply to the projects of Sino-foreign equity joint ventures, Sino-foreign contractual joint ventures, wholly foreign

owned enterprise (hereafter referred to as ¡°foreign investment enterprises¡±),as well as to other forms of foreign investment (hereafter referred

to as ¡°foreign investment projects¡±) within the territory of the People¡¯s Republic of China.

Article 3 The State Development Planning Commission (SDPC), the State Economy and Trade Commission (SETC) and the Ministry of Foreign

Trade and Economic Cooperation (MOFTEC),in conjunction with the concerned ministries of the State Council, shall formulate Catalogue for

Guidance of Foreign Investment Industries and Catalogue of Advantaged Industries for Foreign Investment in Mid-west China, and promulgate

these Catalogues after approval of the State Council. According to practical circumstance that partial adjustment need to be made to these

catalogues, SETC, SDPC and MOFTEC, in conjunction with the concerned ministries of the State Council shall make revision and promulgation

in time.

Catalogue for the Guidance of Foreign Investment Industries and Catalogue of Advantaged Industries for Foreign Investment in Mid-west China

shall be the basis for the guidance of examination and approval of foreign investment projects and for the policy application of foreign

investment enterprises.

Article 4 Foreign investment projects shall be classified into four categories: encouraged, permitted, restricted and prohibited projects.

Foreign investment projects belonging to encouraged, restricted and prohibited categories are listed in Catalogue for the Guidance of Foreign

investment Industries. Those permitted foreign investment projects with do not belong to the above three categories are not to be listed in

Catalogue for the Guidance of Foreign Investment Industries.

Article 5 Those foreign investment projects under one of the following circumstances shall be listed as encouraged foreign investment projects:

1¡¢Projects for new agricultural technology, comprehensive agricultural development and for energy, transportation and key raw materials

industries:

2¡¢Projects for new and high technology, advanced applicable technology which can improve performance of products and increase techno-

economic efficiency of enterprises or produce new equipment and material that domestic capacity is deficient.

3¡¢Projects that meet market demands, and can promote the quality of products, enter into new markets or strengthen the competing capability

of products in international markets;

4¡¢Projects adopting new technology and new equipment for saving energy and raw materials, for comprehensive utilization of resources and

renewable resources, and for prevention environment pollution;

5¡¢Projects that can make full use of man power and resource advantage in mid-west region and are in accordance with the State¡¯s industrial

policies;

6¡¢Other cases that are regulated by laws and administrative regulations of the State.

Article 6 Those foreign investment projects under one of the following circumstances shall be listed as restricted foreign investment projects:

1¡¢Projects adopting out-of-date technologies;

2¡¢Projects unfavorable to use resource-saving and ecological environment improvement;

News

Significant News

Spokesperson's Remarks

Press Conference

From Counselor's Office

Policies

Annoucement

Policy Interpretation

Gazette

Statistics

Brief Statistics

Foreign Investment

Foreign Trade Cooperation

Regional Trade Statistics

Import and Export Indicators

Services

Tax Law

Int'l Labor CooperationCompanies

List of China's QualifiedOverseas Contractors

China-New Zealand IdentifiedRecruitment Agents

Supply & Demand

Inquiry & Answer

Home > Topic > China Invest > Invest inChina

MINISTRY OF COMMERCEPEOPLE’S REPUBLIC OF CHINA

HomeNewsPoliciesTopicsStatisticsServicesPhoto Gallery

Search

Mon.5/5/2014

Other languages

Page 1 of 3Provisions on Guiding Foreign Investment Direction -

5/5/2014http://english.mofcom.gov.cn/aarticle/topic/chinainvest/foreigntradelaw/200707/200707049...

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 20 of 86 PageID #: 29109

A-205Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page21 of 44

Page 213: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

3¡¢Projects for prospecting and/or mining specified mineral resources protected by laws and regulations of the State;

4¡¢Projects in those industries that shall be opened gradually;

5¡¢Other cases that are regulated by laws and administrative regulations of the State.

Article 7 Those foreign investment projects under one of the following circumstances shall be listed as prohibited foreign investment projects:

1¡¢Projects that endanger the safety of the State or damage social and public interests;

2¡¢Projects that pollute environment, destroy natural resources or impair the health of human beings;

3¡¢Projects that occupy large amounts of arable land, unfavorable to protection and development of land resources;

4¡¢Projects that endanger the safety of military facility and its performance;

5¡¢Projects that adopt the unique craftsmanship or technology of our country to make products;

6¡¢Other cases that are regulated by laws and administrative regulations of the State.

Article 8 ¡°Equity joint venture and contractual joint venture only¡± or ¡°Chinese partners shall hold the majority of shares¡± or ¡°Chinese

partners shall hold relative majority of shares¡± may be regulated for certain foreign investment projects in Catalogue for the Guidance of

Foreign Investment Industries.

¡°Equity joint venture and contractual joint venture only¡± means that such projects shall be conducted in forms of Chinese-foreign equity joint

venture and Chinese ¨Cforeign contractual joint venture only; ¡°Chinese partner shall hold the majority of shares¡± means that the sum of

shares held by Chinese investor(s) of such a project shall be 51% of the total or up; ¡°Chinese partner shall hold the relative majority of

shares¡± means that the sum of shares held by Chinese investor(s) of such a project shall greater than the shares held by any single foreign

investor in the project.

Article 9 Encouraged foreign investment projects apart form the preferential terms stipulated in the relevant laws or administrative regulation of

the State, may enlarge their scope of business with approval, if they are engaged in the construction and operation and infrastructure facilities

related to energy, transportation and urban utility sectors (coal, oil, natural gas, power, railway, highway, port, airport, urban road, sewerage

treatment and garbage disposal, etc.), which need a large amount of investment and a long payoff period.

Article 10 Those permitted projects that export all their products directly shall be deemed as encouraged projects. Restricted foreign investment

may be deemed as permitted foreign provinces, autonomous regions, municipalities directly under the Central Government or cities of direct

planning by the State, if the export sales of products amount to over 70% of the total sales of the product.

Article 11 Restrictions can be properly eased for those permitted and restricted foreign investment projects that can really make full use of the

advantages of mid-west regions. Those projects which listed in Catalogue of Advantaged Industries for Foreign Investment in Mid-west China

can enjoy preferential treatments for encourage foreign investment projects.

Article 12 With existing project approval authorization, foreign investment projects shall be examined and approved or be filed for record by

development planning departments and economy and trade departments respectively according to the construction nature of the projects.

Contracts and articles of associations of foreign investment enterprises shall be examined and approved or be filed for record by the

department in charge of foreign trade and economic cooperation. Those restricted foreign investment projects whose investment is lower than

the competence limit shall be examined and approved by regions, municipalities directly under the Central Government or higher-up

responsible ministries and corresponding line ministries investment projects shall not be allowed to be delegated to the lower levels. Foreign

investment projects in service and approved according to relevant regulations of the State.

Foreign investment projects that involve issues of quota or license shall apply to the competent departments of foreign economy and trade for

quota or license.

If laws or administrative regulations have otherwise stipulations concerning the procedures and measures of examination and approval of

foreign investment projects, stipulations of those laws or administrative regulations shall be followed.

Article 13 Examination and approval organs of higher levels shall cancel the foreign investment projects that are examined and approved in

violation of these Provisions within 30 working days after receiving the recorded files of the concerned projects. The contracts and articles of

association shall be invalid. The enterprise registration organs shall not register these projects. And the Customs shall not handle import or

export formalities for these projects.

Article 14 The relevant parties of foreign investment projects who have obtained approval of the project through swindle or other illicit means

shall be investigated for legal responsibility in the light of the seriousness of cases according to law. The examination and approval organs shall

cancel the approval of the project, and relevant competent units should deal with these projects correspondingly according to the law.

Page 2 of 3Provisions on Guiding Foreign Investment Direction -

5/5/2014http://english.mofcom.gov.cn/aarticle/topic/chinainvest/foreigntradelaw/200707/200707049...

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 21 of 86 PageID #: 29110

A-206Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page22 of 44

Page 214: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

All articles marked with "Article type: Original" posted on the website of the Ministry of Commerce and its sub-sites are copyrighted by this

Website and its sub-sites. Any reproduction or use by any other websites, media or individuals must be attached with a clear indication of

"Source: Ministry of Commerce Website".

All articles posted on this website or its sub-sites marked with "Article type: reproduced" or "Article type: translated" and "Article type:

redistributed" come from other media, and are provided solely for the user's information, which does not mean this Website or its sub-sites

endorse the ideas thereof or assume any legal liability or responsibility for their authenticity. Any other media, websites or individuals must

maintain the source of information indication on this Website or its sub-sites when using the information, and shall assume legal liability for the

use.

Article 15 Staff of examination and approval organs who abuse their authority, neglect their duties, shall be investigated for criminal

responsibility as the crime of authority abusing or the crime of duty neglecting according to the criminal law. In case that offenses are not

serious enough to trigger criminal punishments, disciplinary sanctions harsher than special demerit for record shall be applied according to

laws.

Article 16 Investment projects sponsored by overseas Chinese and investors from Hong Kong Special Administrative Region, Macao Special

Administrative Region and Taiwan region shall be handled by reference of these provisions.

Article 17 These provisions shall enter into force on Apr.1, 2002. And Interim Provisions on Guiding Foreign Investment Direction promulgated

by the State Planning Commission, SETC and MOFTEC on Jun. 20, 1995 shall e abrogated simultaneously.

(Note: In case of differences of interpretation, the text in the English language should be considered as the text of reference.)

Big Medium-sized Small Print

Ministry of Commerce Website Copyright and Disclaimer Statement

Approved by: MINISTRY OF COMMERCE,PRC

Jing ICP Bei No.05004093

Add: No.2 Dong Chang'an Avenue,Beijing China(100731)

Supported by: Cofortune Information Technology Co., Ltd

Tel: +86-10-51651200-612/613/623 Fax: +86-10-65677512

E-mail: MOFCOMMailbox

Page 3 of 3Provisions on Guiding Foreign Investment Direction -

5/5/2014http://english.mofcom.gov.cn/aarticle/topic/chinainvest/foreigntradelaw/200707/200707049...

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 22 of 86 PageID #: 29111

A-207Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page23 of 44

Page 215: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 58 of 86 PageID #: 29147

A-208Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page24 of 44

Page 216: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 59 of 86 PageID #: 29148

A-209Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page25 of 44

Page 217: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

AuthoritiesChina - Central Authority & practical information

Address

Central Authority(ies):

Ministry of Justice, Department of Judicial Assistance and Cooperation, Division of JudicialAssistance

Contact details:

Address:

Ministry of JusticeInternational Legal Cooperation Center (ILCC)6, Chaoyangmen NandajieChaoyang DistrictBEIJINGP.C. 100020People's Republic of China

Telephone: +86 (10) 6515 3113

Fax: +86 (10) 6515 3144

E-mail: -

General website: www.moj.gov.cn/sfxzjlzx/node_24388.htm

Contact person: Ms LI ZhiyingE-mail: [email protected]

Languages spokenby staff: Chinese, English

Practical Information:(The following information was provided by the relevant State

authorities or was obtained from the replies to the 2003 ServiceConvention Questionnaire)

Guide to filling outthe Model Form,and FAQs (drawnup by the ChineseMinistry ofJustice):

The Guide is available here.

The FAQs are available here.

HCCH | Authorities http://www.hcch.net/index_en.php?act=authorities.details&aid=243

1 of 3 5/5/2014 3:26 PM

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 81 of 86 PageID #: 29170

A-210Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page26 of 44

Page 218: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Forwardingauthorities(Art. 3(1)):

The Ministry of Justice, Higher People’s Courtand five province authorities: Beijing, Shanghai,Jiangsu, Zhejiang and Guangdong.

Methods of service(Art. 5(1)(2)):

Formal Service (Art. 5(1)(a))The Central Authority of China refers thedocument to the competent court. The courtwill serve the document directly to theaddressee or the person who is entitled toreceive the document. Where direct service isimpracticable in some cases, other methodsmay be employed in accordance with the CivilProcedure Law.

Informal delivery (Art. 5(2))There is no such method in the Chinesedomestic law, and the addressee may refuse toaccept it in any case.

Service by a particular method (Art. 5(1)(b))In such cases, the Central Authority of Chinaforwards the documents to the competent court.The competent court may execute the serviceto the extent not contrary to Chinese domesticlaw.

Translationrequirements(Art. 5(3)):

According to the Civil Procedure Law of thePeople’s Republic of China, service requestedwithin the meaning of Art. 5(1) of theConvention requires that all documents andevidence to be served must be written inChinese or that a translation in Chinese beattached thereto, unless there are contraryprescriptions in the mutual treaties betweenChina and other Contracting States of theHague Convention.

Costs relating toexecution of therequest for service(Art. 12):

Charges are incurred on a reciprocal basis andat the equivalent amount.

Time for executionof request: Within three to four months.

Oppositions anddeclarations(Art. 21(2)):

Click here to read all the declarations andreservations made by China under thisConvention.

Art. 8(2): Opposition

Art. 10(a): Opposition

HCCH | Authorities http://www.hcch.net/index_en.php?act=authorities.details&aid=243

2 of 3 5/5/2014 3:26 PM

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 82 of 86 PageID #: 29171

A-211Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page27 of 44

Page 219: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Art. 10(b): Opposition

Art. 10(c): Opposition

Art. 15(2): Declaration of applicability

Art. 16(3): Declaration of applicability

Derogatorychannels (bilateralor multilateralagreements orinternal lawpermitting othertransmissionchannels)(Arts. 11, 19, 24and 25)

Disclaimer:Information maynot be complete orfully updated –please contact therelevantauthorities toverify thisinformation.

http://www.legalinfo.gov.cn/english/Judicial-Assistance/node_7628.htm, under the headings:

Table 1-Table of Treaties about Civil(Commercial) Judicial AssistanceandTable 2-Table of Treaties about Civil(Commercial) and Criminal JudicialAssistance

Useful links:

Ministry of Justice:

General Situation of China's Cooperationwith Foreign Countries in JudicialAssistanceCivil and Commercial Judicial Assistance

(This page was last updated on 30 March 2014)

Conventions Convention of 15 November 1965 on the Service Abroad of Judicial and ExtrajudicialDocuments in Civil or Commercial Matters [14]

HCCH | Authorities http://www.hcch.net/index_en.php?act=authorities.details&aid=243

3 of 3 5/5/2014 3:26 PM

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 83 of 86 PageID #: 29172

A-212Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page28 of 44

Page 220: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 85 of 86 PageID #: 29174

A-213Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page29 of 44

Page 221: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 886-2 Filed 05/09/14 Page 86 of 86 PageID #: 29175

A-214Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page30 of 44

Page 222: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 886-3 Filed 05/09/14 Page 2 of 31 PageID #: 29177

A-215

KOBRE & KIM LLP

TEL +852 2127 3288

FAX +852 2127 3280

WWW.KOBREKIM.COM.HK

ICBC TOWER, 6TH FLOOR

3 GARDEN ROAD

CENTRAL, HONG KONG

~M~~ ~'iii ~H~ JiJT 'ifi'i~cf:rfil7£ li'Jlill.=:~~

cf> liJl I ilMlH'i::k 1fl Ml!

BY DHL AND REGISTERED MAIL

Hebei Welcome Pharmaceutical Co. 11 North Zhaiying Street, Shijiazhuang Hebei Province, China 050031

April 15, 2014

NEW YORK

LONDON

HONG KONG

WASHINGTON DC

MIAMI

CAYMAN ISLANDS

BVI

Re: In re Vitamin C Antitrust Litigation, 1:06-MD-01738; Animal Science Products, Inc. et al. v. Hebei Welcome Pharmaceutical Co. Ltd., et al., Case No. CV-05-453 (BMC) (JO)

Dear Sir I Madam,

We are counsel to the Plaintiff, The Ranis Company, as representative of the Direct Purchaser Damages Class in the above-titled action in the United States District Court for the Eastern District of New York. Enclosed is a restraining notice issued pursuant to the United States Federal Rules of Civil Procedure and New York Civil Practice Law and Rules § 5222 (the "Restraining Notice") in connection with the final judgment entered in the action against North China Pharmaceutical Group Corporation and Hebei Welcome Pharmaceutical Co., Ltd. ("Hebei Welcome) jointly and severally in the amount of US $147,831,471.03 plus post­judgment interest. The Restraining Notice forbids Hebei Welcome to make or suffer any sale, assignment or transfer of, or any interference with, any property or pay over or otherwise dispose of any debt to any person other than the sheriff or marshal, except under direction of the sheriff or marshal or pursuant to order of a court.

For your convenience, we have enclosed an unofficial Chinese translation of the restraining notice. The Chinese translation of the restraining notice is not an official translation and you are bound by the original English language version of the restraining notice.

Kobre & Kim LLP

<?01±

Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page31 of 44

Page 223: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 886-3 Filed 05/09/14 Page 3 of 31 PageID #: 29178

A-216

Hebei Welcome Pharmaceutical Co. April 15, 2014 Page2

En els.

cc: Daniel Mason, Esq. Zelle, Hofmann, Voelbel & Mason LLP

Daniel Paul Weick, Esq. Jonathan Mitchel Jacobson, Esq. Wilson Sonsini Goodrich & Rosati

John Han [email protected] ICBC Tower 3 Garden Road Central, Hong Kong Tel: +852 2127 3288 Fax: +852 2127 3280

Michael S. Kim [email protected] Carrie A. Tendler [email protected] 800 Third A venue New York, New York 10022 Tel: +l 212 488 1200 Fax: +l 212 488 1220

Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page32 of 44

Page 224: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 886-3 Filed 05/09/14 Page 4 of 31 PageID #: 29179

A-217.~

TEL +852 2127 3288

FAX +852 2127 3280

WWW.KOBREKIM.COM.HK

¥PJ ~ t ~i$ J.ll ilitl §';] ~ ~lH~ ~ i:p OO¥PJ~t~'1=1•am­iFg~tA:m 11 % 050031

KOBRE & KIM LLP

ICBC TOWER, 6TH FLOOR

3 GARDEN ROAD

CENTRAL, HONG KONG

f.16 iiJJ: ~ ~ ~'ifi ~H~ fiJT 'ifritf<PllHt:m1m=:\'I,~

<p li:il I ft'!jjRff:;k:J}'.!1'~.!S

20141¥ 4 J=J 15 B

NEW YORK

LONDON

HONG KONG

WASHINGTON DC

MIAMI

CAYMAN ISLANDS

BVI

~-T: ~1:.~ c .&~WTWilk, 1:06-MD-01738; ~@J~~tz:ifn*1i.l~W fllJ~t~$Mtfli!J~:flllt{*iij~, ~{lffNU-1% CV-05-453 (BMC) (JO)

~1f]£!*1'r Ranis 0~1¥J{~:FJ[1*Yfli, Rains 0~£~00~1l~f.J*IKJtO~ti!!7JY!~

$:FJ[1¥J~~•#*••~•~~•~1¥J~~.n~Mffl£*•<~oo•n~•w~~ .mu» lk cm~f.J~.$Wv~Y!~.m» ~ 5222 ~~tl:ll¥J~ffftl:®Jn c "~fffiJJN~n" ) , .!.=ffx11¥dt ilitl§';J·~~~lt~ff0EJ&¥PJ~t~iHFJ.llfff1Jp,j~~~0~ C "¥PJ~t~l$J.l" ) 1'!= tl:l 1¥J~~*U {}cff:~>.K~xt~~m}g$141, s31, 471. 03 ~.7GR.*HR:J§5fu,1~,~:tEtitw~1~~1f~?iC. * ~ifi1Jj,fil;;n~Jt¥PJ~t~t$1*.±Z9r~l(;*&'.iJ.JnH:r1±1iif ti:\~, ff1.l:::~lUt~~, ~ !V-1f1iif-¥¥5Ffrin 1fOOM~l¥Jff7g, ~~~7¥*&~Y!~ff~~*l¥1ffMA•tt~~~~7J~~-1f 1iif1~%. ~~i=:~:tEV*~~Y!~1T~1¥11~~r, :sx£1:&•¥t~1fis~.

7g 71~ 1¥11J fl, ~{J'] fl.®: f§ l!ft ~ 7 -fu\~f!J1J j,fil~Q 1¥1 ~FlE~ i:p Jti'~ ~ . ~f!J1J jIDj;n 1¥1 i:f:!Jtll~~!=:~7J1E~IJ~, 1~§'t*~iliiJ:®.;;nl¥Jl*~f:l~Jtlt/i;zjs: 1¥J~f.JJR:.

Kobre & Kim LLP

John Han John. han@kobrekim. com. hk

Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page33 of 44

Page 225: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 886-3 Filed 05/09/14 Page 5 of 31 PageID #: 29180

A-218

¥1iJ~t~i$Jmilltl~lH~0EJ 2014~4.F.l158

m1:in:

Encls.

cc: Daniel Mason, Esq. Zelle, Hofmann, Voelbel & Mason LLP

Daniel Paul Weick, Esq. Jonathan Mitchel Jacobson, Esq. Wilson Sonsini Goodrich & Rosati

ICBC Tower 3 Garden Road Central, Hong Kong Tel: +852 2127 3288 Fax: +852 2127 3280

Michael S. Kim Michael. kim@kobrekim. com Carrie A. Tendler Carrie. [email protected] 800 Third Avenue New York, New York 10022 Tel: +l 212 488 1200 Fax: +1 212 488 1220

Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page34 of 44

Page 226: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 886-3 Filed 05/09/14 Page 7 of 31 PageID #: 29182

A-219

KOBRE & KIM LLP

ICBC TOWER, 6TH FLOOR

3 GARDEN ROAD

CENTRAL, HONG KONG

~Mit~ffili$~Ji.Jf

NEW YORK

LONDON

HONG KONG TEL +852 2127 3288

FAX +852 2127 3280

WWW.KOBREKIM.COM.HK

~rlli<Pln?trrum=:\'i,~

'41 U2I I RU!Hr ;k Iii t\ fl}!

WASHINGTON OC

MIAMI

CAYMAN ISLANDS

BY DHL AND REGISTERED MAIL

North China Pharmaceutical Group Corporation 388 Heping Road, Shijiazhuang Hebei Province, China 050015

April 15, 2014

Re: In re Vitamin C Antitrust Litigation, 1:06-MD-01738; Animal Science Products, Inc. et al. v. Hebei Welcome Pharmaceutical Co. Ltd., et al., Case No. CV-05-453 (BMC) (JO)

Dear Sir I Madam,

We are counsel to the Plaintiff, The Ranis Company, as representative of the Direct Purchaser Damages Class, in the above-titled action in the United States District Court for the Eastern District of New York. Enclosed is a restraining notice issued pursuant to the United States Federal Rules of Civil Procedure and New York Civil Practice Law and Rules § 5222 (the "Restraining Notice") in connection with the final judgment entered in the action against North China Pharmaceutical Group Corporation ("NCP Group") and Hebei Welcome Pharmaceutical Co., Ltd. jointly and severally in the amount of US $147,831,471.03 plus post-judgment interest. The Restraining Notice forbids NCP Group to make or suffer any sale, assignment or transfer of, or any interference with, any property or pay over or otherwise dispose of any debt to any person other than the sheriff or marshal, except under direction of the sheriff or marshal or pursuant to order of a court.

For your convenience, we have enclosed an unofficial Chinese translation of the restraining notice. The Chinese translation of the restraining notice is not an official translation and you are bound by the original English language version of the restraining notice.

Kobre & Kim LLP

<?&1±

BVI

Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page35 of 44

Page 227: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 886-3 Filed 05/09/14 Page 8 of 31 PageID #: 29183

A-220

Hebei Welcome Pharmaceutical Co. April 15, 2014 Page 2

Encls.

cc: Daniel Mason, Esq. Zelle, Hofmann, Voelbel & Mason LLP

Daniel Paul Weick, Esq. Jonathan Mitchel Jacobson, Esq. Wilson Sonsini Goodrich & Rosati

John Han [email protected] ICBC Tower 3 Garden Road Central, Hong Kong Tel: +852 2127 3288 Fax: +852 2127 3280

Michael S. Kim [email protected] Carrie A. Tendler [email protected] 800 Third A venue New York, New York 10022 Tel: +1212488 1200 Fax: +l 212 488 1220

Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page36 of 44

Page 228: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 886-3 Filed 05/09/14 Page 9 of 31 PageID #: 29184

A-221

KOBRE & KIM LLP

TEL +852 2127 3288

FAX +852 2127 3280

WWW.KOBREKIM.COM.HK

ICBC TOWER, 6TH FLOOR

3 GARDEN ROAD

CENTRAL, HONG KONG

f.6 iW ~~ ~'ili $ fjl PJT ~ill: <F J,R1~ [\'if ill.=:. i~

NEW YORK

LONDON

HONG KONG

WASHINGTON DC

MIAMI

'F Ji:!! I jffj 11H'f ;le JSl /\ til! CAYMAN ISLANDS

BVI

$it*u~•m1f~L~3Nf0i§J i:p 001ilJ it~, -15 *EE m *114'-1.Kfti 388-% 050015

2014i:F4~ 15 B

~-T: ~1::l( C .&~lmiJfi'k, 1:06-MD-01738; i;IJ!fm~~f'=&10WJ~i)f rnJ~~£t.$Jjt$fJ~:¥f~0WJ~, ~flf:~~ CV-05-453 (BMC) (JO)

:flt{f]£~~ Ranis 0i§Jfi<J1-~:f.lt=l!YiP, Rains 0~£*00~3l~"J1.KJXl{kn:til!.1J¥*~%

•J.ta<JL~a#i:p•~~*~~•~B<1~*·~m~~£*•<*oo•n~•w~• .!im> JJ<. 03ltf.J~¥Wi!~¥*1.ffi» 1fJ 5222 :9.kbttl:la<J•flitlm!9;i:i c "•tjjtlm!9;i:i" ) , .!:jxt$it i111J~•m1f~~~1±0i§J c "$~•m" ) JJ<.¥"iiJit~fHF1*$1J~1f~~0~1twa<J:;:~*tl?:1c :ft~*~xt~t)Jll5J$147, 831, 471. 03 *7GJJ<.*tl?R:J§':fU.~.7}(1f!.3iw9lfH~~1f1f~. ~­~-~-~$~-m~~--~*ffffWlliW, ~ild~8. d~ffW~m+ffiffW M~B<Jff75J, -~-7~¥*~ff-JJ<.¥*V~*B<1ffWAMttd~~~1J~~-ffWm *' -~1=£ifi§J¥*~ff•d¥*1fa<J1m-~""f' •£*•¥*~%$~.

75171&;. a<J)j-f!, ftfr'J~f~ llf1L7 -1'3'-•tjjtlm!~i:iB<J~l=iEJ:.\: i:p )(Jli'3W~. •illtlim.9;i:i B<J i:j=t)(IJ~~l=-:1J"iE~~~. 1&J.~~-fjjtlm!9;1:JB{J~~&~>cit&;;ijs:B<J~"J*·

Kobre & Kim LLP

John Han John.han@kobreki~co~hk

Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page37 of 44

Page 229: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 886-3 Filed 05/09/14 Page 10 of 31 PageID #: 29185

A-222Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page38 of 44

Page 230: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF NEW YORK

IN RE VITAMIN C ) ANTITRUST LITIGATION ) ECF Case ) ) Case No.: 1:06-md-01738-BMC-JO ) ) )

SUPPLEMENTAL DECLARATION OF LIU RONGLIANG

I, Liu Rongliang, declare as follows:

1. I am the same person who previously submitted declarations in these proceedings

dated April 11, 2014 and April 17, 2014, respectively. I make this declaration on the basis of my

personal knowledge and my review of Hebei Welcome Pharmaceutical Co. Ltd.’s (“Hebei

Welcome”) records.

2. The Hebei Welcome bank accounts at Bank of China (last 4 digits 1014 & 3001),

Bank of Communications (last 4 digits 0513), and China Minsheng Banking Corp. (last 4 digits

3913 & 0104), as identified by Direct Purchaser Plaintiffs in their Renewed Motion for Turnover

Orders dated April 25, 2014, no longer exist.

3. I declare under penalty of perjury that the foregoing is true and correct to the best

of my knowledge.

In witness whereof, I have executed this declaration on this 6th day of May, 2014, by

signing or affixing my personal Chop.

[Liu Rongliang’s Signature]

Case 1:06-md-01738-BMC-JO Document 886-3 Filed 05/09/14 Page 29 of 31 PageID #: 29204

A-223Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page39 of 44

Page 231: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 886-3 Filed 05/09/14 Page 30 of 31 PageID #: 29205

A-224

,v1'-.D Wilson Sonsini Goodrich & Rosati W'tJ-1'- PRO J ESSIONAI CORPORATION

l init l9UI. .!'JI'. T 11WL' r C n .. ·iii n~ Yi111.1i Cl·1111·l' No.2 J1.1n~uo11h:11w.ii J\\'t'l\lll'

(:h:my:.111~ f )iMri<.·t . B(•iji ng 10002.! l'wplc\ lkpuhlic of Chiu"

'1 1ti;iJt,;0:11;MJ'H(}( m1<1n11-xm2 ~ 11u;rJ•.C:7i'i'HiCl'l\2?l.42901 ~ ~l.i:ftll'I: I 00022

Certificate of Accuracy

l'llO NI 8(1- I0-6i l'l-8JOll

rAX 86-I0-6 ' 2'1-8.19') www.~gr.com

1(! iii : ff(>- I 0-652'l-H300

{I( (( : 86- I 0 -M:!'l-S_l•J•J

l•H~: www.w.gr.com

I, Ke Li, am fluent in C hinese and English and certify that the attached trans lation, which I have made, is a true and correct trans lation of the original document.

1 certify under penalty of perjury under the laws of the United States of America that the foregoing is true and correct.

Executed on May 9, 2014

Ke i, Esq.

Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page40 of 44

Page 232: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 886-3 Filed 05/09/14 Page 31 of 31 PageID #: 29206

A-225

-T~;ftJ ~.g.~ ~~~ilk!&~~

m~*i&

~-T ) ~·=~=:*~C~ffe.~~~ltJT~i)f~it"'~:-.. ------~> it! r.rli~~r$f~#

) ) ~flt:~: 1:06-md-01738-BMC-JO ) )

Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page41 of 44

Page 233: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF NEW YORK

IN RE VITAMIN C ) ANTITRUST LITIGATION ) ECF Case ) ) Case No.: 1:06-md-01738-BMC-JO ) ) )

SUPPLEMENTAL DECLARATION OF ZHANG WENCHENG

I, Zhang Wencheng, declare as follows:

1. I am the same person who previously submitted a declaration in these proceedings

dated April 30, 2014. I make this declaration on the basis of my personal knowledge and my

review of North China Pharmaceutical Group Corporation’s (NCPG) records.

2. Upon inquiry, the NCPG bank account at China Everbright Bank (last 4 digits

3291), as identified by Direct Purchaser Plaintiffs in their Renewed Motion for Turnover Orders

dated April 25, 2014, does not currently exist.

3. NCPG’s shares in public companies are registered at China’s securities exchanges

according to Chinese laws, and are not reflected in share certificates.

4. I declare under penalty of perjury that the foregoing is true and correct to the best

of my knowledge.

In witness whereof, I have executed this declaration on this 4th day of May, 2014, by

signing or affixing my personal Chop.

[Zhang Wencheng’s Signature]

Case 1:06-md-01738-BMC-JO Document 886-4 Filed 05/09/14 Page 2 of 177 PageID #: 29208

A-226Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page42 of 44

Page 234: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 886-4 Filed 05/09/14 Page 3 of 177 PageID #: 29209

A-227

,v1'-.D Wilson Sonsini Goodrich & Rosati W'tJ-1'- PRO J ESSIONAI CORPORATION

l init l9UI. .!'JI'. T 11WL' r C n .. ·iii n~ Yi111.1i Cl·1111·l' No.2 J1.1n~uo11h:11w.ii J\\'t'l\lll'

(:h:my:.111~ f )iMri<.·t . B(•iji ng 10002.! l'wplc\ lkpuhlic of Chiu"

'1 1ti;iJt,;0:11;MJ'H(}( m1<1n11-xm2 ~ 11u;rJ•.C:7i'i'HiCl'l\2?l.42901 ~ ~l.i:ftll'I: I 00022

Certificate of Accuracy

l'llO NI 8(1- I0-6i l'l-8JOll

rAX 86-I0-6 ' 2'1-8.19') www.~gr.com

1(! iii : ff(>- I 0-652'l-H300

{I( (( : 86- I 0 -M:!'l-S_l•J•J

l•H~: www.w.gr.com

I, Ke Li, am fluent in C hinese and English and certify that the attached trans lation, which I have made, is a true and correct trans lation of the original document.

1 certify under penalty of perjury under the laws of the United States of America that the foregoing is true and correct.

Executed on May 9, 2014

Ke i, Esq.

Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page43 of 44

Page 235: 14-4375-cv L - Vitamin C Antitrustvitamincantitrust.com/indirect/Portals/0/Documents/8... · 2015-08-24 · 14-4375-cv (L) 14-4378-cv(XAP) IN THE United States Court of Appeals FOR

Case 1:06-md-01738-BMC-JO Document 886-4 Filed 05/09/14 Page 4 of 177 PageID #: 29210

A-228

-T~~J~-€i~~J£HfHtIB:~~ m~*IB:

*T ) =*=~=• ....... c=& ..... ?E=!fi"'-'iJf'-'-""=·~-------'> ~ -T~~~tJt~1tf

) ) ~1tf.Ji} : J :06-md-01738-BMC..JO ) )

*JtlVt~~ ft, f! im

~A ' ~~ )( 1£' fat l±Hlll -F JS PA :

4. ¥-f- i'tW r:p ~ :rcf13 YEmHl''.J:Mi1.~ ' *A JB f!,Ej' K.t* A ,Ei}f ~J, mr ~pg~)! 10t ffii

(ft fefH ff.J •

Case 14-4375, Document 60-2, 01/16/2015, 1418253, Page44 of 44